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Summary - Resumen
 1 
Summary 
The regulation of microbiota through the use of prebiotics has been 
widely studied in the last decades, due to its high correlation with human 
health and several diseases. In this sense, there are a huge number of reports 
regarding the beneficial effects of these compounds on gut microorganisms, 
however, scarce efforts have been made towards their previous passage 
through gastrointestinal digestion. In a first part of this PhD Thesis, the 
digestibility of several recognised prebiotics has been studied and results are 
presented in the first three chapters. A more efficient and reliable in vitro 
method based on the use of rat small intestinal extract has been proposed for 
carbohydrate digestion overcoming the limitations of general standardised 
models for gastrointestinal digestion which overlook the critical role of the 
small intestine mucosal carbohydrases. Likewise, considering the high 
physiological and anatomical similarity of the pig and human digestive tracts, 
the isolation of brush border membrane vesicles of the pig small intestine has 
been carried out in order to, subsequently, assess the intestinal digestibility of 
a series of commercial galactooligosaccharides differing in the predominant 
glycosidic linkage, as well as that of novel lactulose-derived 
galactooligosaccharides. In this sense, to a greater or lesser extent, all 
carbohydrates tested presented degradation rates by small intestinal enzymes. 
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Crucial structure-function relationship was found by determining the key role 
of structural features (glycosidic linkage or monosaccharides composition) on 
their resistance to degradation, increasing therefore essential knowledge 
towards the eventual development of new customized prebiotics. On the other 
hand, interest towards the production and obtainment of prebiotics using 
more sustainable methods has also raised a great interest. Therefore, in a 
second part of this dissertation, the prebiotic potential of pectic compounds 
obtained from agricultural by-products of artichoke, sunflower and citrus 
products was evaluated. A high prebiotic effect similar to well-recognized 
prebiotics was revealed after the in vitro fermentation study. Moreover, 
structure-function relationships were also found by elucidating the effect of 
the structural features (molecular weight, methylation degree, 
monosaccharide composition) on their ability to grow beneficial bacteria. 
Findings in this part of the thesis provided evidence on the prebiotic potential 
of theses substrates and may enhance the use of waste agricultural by-
products as a renewable source of bioactive compounds. 
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Resumen 
La modulación de la microbiota intestinal a través del uso de prebióticos ha 
sido ampliamente estudiada en las últimas décadas debido a su relación con la salud 
humana. Existen numerosos estudios acerca de los efectos beneficiosos de estos 
prebióticos sobre la microbiota intestinal, sin embargo, el conocimiento actual sobre 
su paso previo por el tracto gastrointestinal superior y, más concretamente, sobre los 
posibles cambios estructurales durante el proceso de digestión gastrointestinal es 
muy limitado, dando por hecho su total resistencia . En ese sentido, una primera 
parte de esta tesis doctoral está enfocada en el estudio de la digestibilidad de 
distintos carbohidratos prebióticos reconocidos (Capítulos 1-3). Se ha propuesto un 
método in vitro fiable y eficaz, basado en la utilización de extractos intestinales de 
rata, para evaluar la digestión de estos carbohidratos que solventaría importantes 
limitaciones que presentan los métodos actualmente en uso y que ignoran el papel 
clave de las carbohidrasas expresadas en la mucosa intestinal. Asimismo, y dado que 
el cerdo es un mamífero fisiológicamente más similar a la especie humana que la 
rata, se ha procedido al aislamiento de vesículas del epitelio intestinal de cerdos 
para, posteriormente, evaluar la digestibilidad intestinal de galactooligosacáridos 
comerciales caracterizados por diferentes enlaces glicosídicos, así como de nuevos 
galactooligosacáridos derivados de lactulosa. Los resultados de esta primera parte 
resaltan la idoneidad del empleo de estos extractos para la simulación de la 
digestibilidad intestinal de carbohidratos. Se ha observado una degradación, en 
mayor o menor medida, de los prebióticos analizados tras el tratamiento con las 
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enzimas intestinales y, además, se han establecido correlaciones importantes entre la 
estructura química de estos compuestos (composición monomérica, tamaño 
molecular o enlace glicosídico) y su resistencia a la degradación durante la digestión 
intestinal. Por otro lado, y debido al interés creciente hacia el desarrollo de nuevas 
estrategias sostenibles para la obtención de prebióticos emergentes, la segunda parte 
de esta tesis se ha centrado en la evaluación del potencial prebiótico de sustratos 
alternativos, como son los compuestos pécticos, obtenidos a partir de subproductos 
de la industria agrícola de alcachofa, girasol y cítricos. Para ello, se han utilizado 
modelos de fermentación in vitro estáticos y dinámicos que suponen un avance 
debido a la posibilidad de simular las diferentes etapas gastrointestinales en un 
entorno fisiológicamente más relevante. En general, se observó una alta actividad 
prebiótica en los sustratos analizados, siendo similar a la de prebióticos reconocidos. 
Además, ha sido posible correlacionar determinadas características estructurales 
(tamaño molecular, grado de metilación y composición de monosacáridos) con su 
capacidad para promover el crecimiento de bacterias beneficiosas. De este modo, los 
resultados obtenidos en esta parte aportan evidencias sobre el potencial prebiótico de 
estos sustratos y apuntan hacia la potencial utilización de determinados 
subproductos agrícolas como fuentes sostenibles para la obtención de compuestos 
bioactivos. 
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1. General Introduction 
1.1  The Gastrointestinal Microbiota 
Human body hosts over trillions of bacteria, viruses, fungi and other 
microorganisms, conforming together the microbiome that constitutes 90% of 
the total number of cells associated with our body and only the remaining 
10% are human cells (Ley et al, 2006). These microorganisms represent a 
source of genetic diversity causing that two human microbiomes are not 
considered to be the same.  
Among the different sites of the human body inhabited by these 
microorganisms such as, the mouth, throat and airways, skin or the urogenital 
system, the digestive gastrointestinal tract represents the most important 
colonized source of microbial stimulation of the human body (Grice, Segre 
2012; Hooper et al, 2001). Over 1014 microorganisms colonize the 
gastrointestinal tract and continuously engage in a dynamic dialog with the 
host cells (Marchesi, Shanahan, 2007). In this sense, the total mucosal surface 
of an adult human gastrointestinal tract is up to 300 m2, making it the largest 
body area interacting with these microorganisms, named “gut microbiota”. 
The metabolic activity performed by these microorganisms could be 
considered equal to a virtual organ, causing gut microbiota to be often 
referred as a “forgotten” organ (O’Hara, Shanahan, 2006). A fraction 
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estimated as < 30% of the gut microbiota was cultured in the last decades 
(Fraher et al. 2012). However, contemporary culture-independent techniques 
such as the introduction of microbial culturomics has increased our 
knowledge of the gut microbiota allowing to culture previous uncultured gut 
bacteria, providing an estimation of the microbial composition and 
biodiversity (Lagier et al. 2016; Lagier et al. 2015), although there is still a 
long way to investigate.  
Figure 1 shows the highly dynamic behaviour and distribution of the 
gut microbiota. Different physicochemical characteristics of each anatomical 
region, such as pH, redox potential, availability of diet-derived compounds, 
transit rates or host secretions establishing the contrasting concentrations and 
prevalence of the bacteria in the gastrointestinal tract.  
  
 
 
 
 
 
 
 
 
 
Figure 1. Key microbiological features (main genera and relative bacterial concentrations) 
and pH values of the human gastrointestinal tract. [cfu: colony-forming units]. Adapted from 
Iannitti and Palmieri (2010) and Kovatcheva (2013). 
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The upper gastrointestinal tract, consisting of the oral cavity, stomach, 
duodenum and jejunum, holds a scarce microbiota whose concentration is 
below 104 microorganisms (cfu) per mL of digesta. The relative low 
microbial population in this part is firstly affected by the fast flow of food in 
the mouth that causes a rapid wash out of the microbes. Moreover, the highly 
acidic conditions in the stomach and the subsequent release of bile acids and 
pancreatic enzymes in the duodenum limit the prevalence of these 
microorganisms. Microbial concentration increases toward the end of the 
small intestine and the colon reaching values of 107-108 and 1012 bacterial 
cells per mL, respectively. Slow transit time, higher exposure to nutrients at 
nearly neutral pH, and low redox potential provide a more favourable 
environment to bacterial colonization and growth in these gut regions 
(Donaldson et al 2016; Kovatcheva, 2013). However, microbial populations 
have been associated not only with the different anatomical regions and 
conditions of the gut but also with host genetics, age, diet, geographical 
location, medication intake, lifestyle and other environmental factors, as it is 
summarized in Figure 2.  
The colonization of the human gut begins at birth. In this sense, initial 
colonization of the gut in infants appears to be dependent on delivery mode. 
Vaginally delivered babies acquire a microbiota similar to those of their 
mother’s vagina (i.e., dominated by Lactobaccillus and Prevotella), and 
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babies delivered via caesarean section (C-section) acquire microbiota similar 
to those typically associated with the skin (i.e. Propionibacterium, 
Staphylococcus, and Corynebacterium) (Dominguez-Bello, et al 2010). 
Moreover, gestational age has been reported to impact on the infant gut, 
whereby a dominance of Proteobacteria, with high values of Clostridium and 
Staphylococcus, and much lower levels of Actinobacteria have characterized 
pre-term infants. In contrast, the full-term infant gut has been correlated with 
higher levels of Bifidobacterium and Bacteroides, which tend to be dominant 
in the early weeks of life (Arboleya et al, 2015; Barrett et al 2013).  
Effects of breast feeding versus formula feeding have been also 
reported and babies that are solely breastfed until weaning tend to have a 
more stable, less diverse bacterial community with higher proportions of 
bifidobacteria than formula-fed babies (Klaassens et al, 2009). After the 
introduction of solid food, gut microbiota composition develops towards the 
adult pattern and resembles that of an adult by age 3 years with increased 
diversity and increased abundance of anaerobic Firmicutes (Fallani et al 
2011). In this sense, early colonization of the gut has been shown to influence 
maturation of the immune system. Lastly, Bacteroidetes become more 
abundant and Firmicutes decrease in elderly adults (aged > 65 years) 
compared with younger adults (Claesson et al, 2011). In addition, a decline in 
microbiota diversity has been reported in old age, with reducing numbers of 
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bifidobacteria and increases in Enterobactericeae (Woodmansey, 2007) 
(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Variability of microbiota and factors involved in microbiota establishment. 
Adapted from Villanueva-Millán et al, 2015; Municio 2015.  
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1.1.1 Gut microbiota and health 
As with any other ecological system, microorganisms in the 
gastrointestinal tract live in a natural balance called “symbiosis”. Bacteria 
such as “symbionts”, which have a mutualistic relationship with the host (that 
is, both are beneficial to each other); “commensal”, which do not provide 
benefit but neither harm the host, and some potentially pathogenic 
microorganism, coexist in perfect equilibrium. In this sense, microbiota of 
healthy individuals is known to confer a number of health benefits relating to, 
for example, pathogen protection, nutrition, host metabolism or immune 
modulation (Figure 3) (Blum, 2017). The perspective that the gut microbiota 
may have an important role in both human health and disease was by no 
means a new concept, as the Russian scientist Elie Metchnikoff already a 
century ago indicated the clinical importance of the host colonic microbiota, 
suggesting that certain microorganisms might promote health. 
However, when the balance is altered causing changes in the bacterial 
composition, diversity or function (either a reduction in the numbers of 
symbiont and/or an increase in the numbers of pathogenic microorganisms), 
“dysbiosis” occurs. In this case, the gastrointestinal microbiota loses its 
protective capabilities and can lead to several diseases such as Crohn’s 
disease, colorectal cancer, irritable bowel syndrome, celiac disease, obesity, 
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diabetes or simply digestive discomfort such as bloating, flatulence, and 
abdominal pain (Wang et al, 2017). 
In view of the numerous and diverse physiological functions of the 
intestinal microbiota in human health, it is not surprising that, in recent years, 
microbiota has also been related with other very important diseases such as 
bone diseases (Ibañez et al 2019), where the gut microbiota has been pointed 
out as a major regulator of the bone mineral density, and also several 
neurological/psychiatric diseases (Blum, 2017). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of the role of the gut microbiota in health and disease by 
given some examples of the positive and negative effects. (IPA = indolepropionic acid; 
SCFA = short chain fatty acid). 
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1.1.1.1 The gut-brain axis 
 The complex microbiota-host interactions are very dynamic, 
involving a variety of mechanisms that include immune, hormonal, and even 
neural pathways. In this sense, the connection between the microbiota and the 
brain has been of great interest in recent years. 
Through a bi-directional communication network with the brain, 
called the “microbiota gut-brain axis”, the commensal bacteria contribute to 
maintain homeostasis of the central nervous system (CNS) and influence our 
behaviour and mood. Interactions mechanisms are slowly being elucidated 
but these include production of microbial metabolites and immune mediators, 
such as cytokines and signalling directly to the brain via the vagus nerve 
(Dinan et al, 2015; El Aidy et al, 2014; Sherwin et al, 2016) (Figure 4). 
 The vagus nerve plays a crucial role in facilitating this bidirectional 
communication and it represents the main afferent pathway from the 
abdominal cavity to the brain. The vagus nerve transmits the information 
from the luminal environment to the CNS. In this sense, neurochemical and 
behavioural effects are not present in vagotomised mice, recognising the 
vagus nerve as a major modulatory constitutive communication pathway 
between microbiota and brain (Bravo et al, 2011). Moreover, bacterial 
commensal microbiota can also communicate with the brain via regulating 
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neurotransmission. Microbiota produces molecules that act as local 
neurotransmitters such as GABA (γ-Aminobutyric acid), which represents the 
main inhibitory neurotransmitter in the CNS, and dysfunctions in this 
transmitter system are linked to mood disorders, such as depression, anxiety 
and autism (Möhler, 2012). Microbiota can also synthesize histamine, which 
is linked to central processes such as circadian rhythms, food intake, learning 
and pain perception (Brown et al 2001). Microbiota could also contribute to 
the production of catecholamines, such as dopamine and noradrenaline 
(Asano et al 2012; Matsumoto et al 2013), whose dysfunction has been 
linked to various neurological and psyquiatric disorders, such as Parkinson’s 
disease and depression. Lastly, bacterial metabolites (SCFAs) such as 
butyric, propionic and acetic acids have shown to be able to stimulate 
sympathetic nervous system (Kimura et al 2011). In fact, the brain-affecting 
disorders, where the intestinal microbiome and enteric nervous networks are 
actively involved are quite numerous (Table 1). 
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Figure 4. Key communication pathways of the microbiota gut-brain axis. Putative 
mechanisms by which bacteria access the brain and influence behaviour include bacterial 
products that gain access to the brain via the bloodstream and the area postrema, via cytokine 
release from mucosal immune cells, via the release of gut hormones such as 5-
hydroxytryptamine (5-HT) from enteroendocrine cells, or via afferent neural pathways, 
including the vagus nerve. On the other hand, stress and emotions can influence the 
microbial composition of the gut through the release of stress hormones or sympathetic 
neurotransmitters that influence gut physiology and alter the normal habitat of the 
microbiota. GABA (γ-Aminobutyric acid), TNF tumour necrosis factor, IL interleukin, GLP 
glucagon-like peptide, PYY peptide YY, CCK cholecystokinin. Figure adapted from Sherwin 
et al (2016) and reproduced with kind permission from Springer. 
 
The main mechanisms for the brain to influence the gut are mediated 
by the alteration of the normal luminal/mucosal habitat. In this sense, the 
brain has a prominent role in the modulation of gut functions, such as 
motility, secretion of acids, bicarbonates and mucus and mucosal immune 
response (Macfarlane, Dillion, 2007); thus, a dysregulation on the gut-brain 
axis can affect gut microbiota through the perturbation of the normal mucosal 
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habitat. In addition, brain might also affect microbiota composition and 
function by alteration of the intestinal permeability, by allowing bacterial 
antigens to pass through the epitelium and stimulate an immune response in 
the mucosa (Demaude et al 2006). 
 
Table 1. Summary of brain-affecting disorders, where gastrointestinal manifestation exists 
and the intestinal microbiome and enteric nervous are actively involved. Table modified 
from Lerner et al. (2017) 
 
 
Parkinson’s disease 
 
[Sun et al. (2018); Perez-Pardo et al (2017); Cersosimo et al, 
(2013); Mulak et al, (2015); Poirier et al, (2016); Rietdijk et al, 
(2017); Houser et al, (2017)] 
Autism spectrum disorder [Li et al, (2017); Luna et al, (2016); Li et al, (2016); Kraneveld 
et al, (2016)] 
Amyotrophic lateral 
sclerosis 
[Wright et al. (2018); Fang et al. (2016); Wu et al. (2015); 
Luesma et al. (2014)] 
Alzheimer diseases [Mancuso et al. (2018); Vogt et al. (2017); Jiang et al. (2017); 
Shoemark et al. (2015); Friedland (2015)]  
Prion diseases [Bradford et al. (2017); Davies et al. (2006); Albanese et al. 
(2008); Donaldson et al. (2016); Natale et al. (2011)] 
Creutzfeldt-Jakob disease [Donaldson et al. (2016); Beekes et al. (2007)] 
Transmissible spongiform 
encephalopathies 
[Friedland (2015); Donaldson et al. (2016); Beekes et al. 
(2007); Natale et al. (2011)] 
Additional conditions that 
affect the microbiota 
 
Depression [Clapp et al. (2017); Jiang et al. (2015); Zheng et al. (2016); 
Foster et al. (2013); Luna et al. (2015); Dinan et al. (2013)] 
Anxiety [Clapp et al. (2017); Foster et al. (2013); Luna et al. (2015); 
Bercik et al. (2011)] 
Behaviour [Dinan et al. (2015); Zeng et al. (2016); Cryan et al. (2011)] 
Cognition [Proctor et al. (2017); Esposito et al. (2016); MacFabe et al. 
(2011)] 
Mood [Dinan et al. (2017); Dinan et al. (2016); MacQueen et al. 
(2017)] 
Stress [Luna et al. (2015); Bauer et al. (2016); Moloney et al. (2014); 
Fujikawa et al. (2015)] 
Fatigue [Nagy-Szakal et al. (2017); Giloteaux et al. (2016); Van Erp et 
al. (2017); Lakhan et al. (2010)] 
Aging 
 
[Buford (2017); Shoemark et al. (2015)] 
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 Thereby, regulation or restoring the gut microbiota is considered as a 
therapeutic tool for several of the diseases noted above. Nowadays, the two 
main methods of modifying the gastrointestinal microbiota include dietary 
compounds supplementation (prebiotics) and supplementation of live 
microorganisms, which have shown to positively influence health 
(probiotics). Moreover, the combination of these two methods to obtain 
synergistic benefits has been named “synbiotics”. 
1.1.2 Probiotics 
Élie Metchnikoff (a Russian scientist) and Henry Tisser (a French 
paediatrician) were the first to make suggestions concerning a positive role 
played by some bacteria during the early years of the 1900s. However, it was 
not until 1965 when Lilly & Stillwell first introduced the term “probiotic” 
that in contrast to antibiotics, defined probiotics as “microbially derived 
factors that stimulate the growth of other organisms”. The word “probiotic”, 
which is translated from the Greek, meaning “for life”, was redefined by 
Parker (1974) as “organisms and substances which contribute to intestinal 
microbial balance”, later on by Fuller (1989) as “a live microbial feed 
supplement which beneficially affects the host animal by improving its 
intestinal microbial balance”. This last definition removed the reference to 
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particles and a probiotic would therefore incorporate living microorganisms, 
seen as beneficial for gut health, into the diet. 
Nowadays, the most widely adopted definition of probiotics was 
proposed in 2001 at an Expert Consultation meeting arranged by the Food 
and Agriculture Organization of the United Nations (FAO) and the World 
Health Organization (WHO) (FAO/WHO). This definition was ratified by the 
International Scientific Association for Probiotics and Prebiotics consensus 
(ISAPP) in a report in 2014 (Hill et al. 2014) with a minor grammatical 
correction as “live microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host”. 
The most common types of microorganisms used as components of 
probiotics preparations are lactic acid bacteria, such as Lactobacillus and 
Bifidobacterium, although other bacteria and certain yeasts are also used 
(Didari et al. 2014). Most of these health-promoting bacterial strains are 
normal residents or common transients of the human digestive system and as 
such do not display infectivity or toxicity. The most common probiotic 
microorganisms with claimed health benefits for humans are noted in Table 
2.  
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Table 2. Relevant strains of probiotic microorganisms. Table adapted from Fijan 
(2014). 
 
 
Genus 
 
Species 
 
Lactobacillus 
 
L. rhamnosus, L. acidophilus, L. plantarum, L. casei, L. 
delbrueckii subsp. bulgaricus, L. brevis, L. johnsonii, L. 
fermentum, L. reuteri 
 
Bifidobacterium  B. infantis, B. animalis subsp. lactis, B. bifidum, B. 
longum, B. breve 
 
Others Saccharomyces boulardi, Lactococcus lactis subsp. 
lactis, Enterococcus durans, E. faecium, Streptococcus 
thermophilus, Pediococcus acidilactici, Leuconostoc 
mesenteroides, Bacillus coagulans, B. subtilis, B. 
cereus, Escherichia coli Nissle 1917. 
 
Emerging genera Faecalibacterium prausnitzii, Eubacterium rectale, 
Roseburia spp., etc. 
 
 
However, as probiotics involve live colonic microorganisms, to be a 
good candidate these should fulfil certain requirements. Microorganisms 
must retain their properties during large-scale industrial preparation, it should 
also remain viable and stable during storage and use, be recognized as 
“generally regarded as safe” (GRAS) and naturally the organisms should be 
able to survive in the gastrointestinal conditions such as the low gastric pH 
and the digestive enzymes and bile salts activity.  
 There are several reports regarding the positive effects associated with 
the intake of probiotics; however, probiotics may frequently present different 
performances between strains, where some of them have shown a limited 
colonization of the intestine or even a limited resistance to gastrointestinal 
conditions. According to this, species such as Lactobacillus, for example, are 
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broadly resistant, whereas some strains of Bifidobacteria are extremely 
sensitive to low pH, exhibiting low or no survival rates at pH 2 and pH 3 
(Fontana et al. 2013; Sanz 2007; Takahashi et al. 2004). For these reasons, a 
very good alternative approach for microbiota management through diet is 
the use of “prebiotics” which are directed toward specifically changes in the 
gut microbiota composition. 
1.2  Prebiotics 
The prebiotic concept was initiated to uphold the probiotic concept. 
The prebiotic concept may also overcome the major drawback of probiotics, 
which is to ensure a high viability in the product and, therefore, to have a 
robust survival rates in the gut. In this way, the target bacteria are already in 
the host and prebiotics stimulate its growth. 
Back to 1921, almost 100 years ago, Rettger & Cheplin described 
assays with humans whose microbiota was enriched with lactobacilli 
following consumption of carbohydrates. However, it was not until 1995 
when the prebiotic concept was defined for the first time and, later on, it has 
been refined and validated several times. Gibson & Roberfroid (1995) 
defined a prebiotic as a “non-digestible food ingredient that beneficially 
affects the host by selectively stimulating the growth and/or activity of one or 
a limited number of bacteria already resident in the colon”. In this sense, 
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whereas probiotics use live microorganisms, prebiotics were defined as non-
viable substrates that serve as nutrients for beneficial microorganisms 
harboured by the host. Table 3 shows the evolution and the most relevant 
changes to keep the concept updated and to expand the original idea of the 
prebiotic definition over time. 
 
Table 3. Evolution and changes of the definition of prebiotic over time. 
 
 
1995 - “Non-digestible food ingredient that beneficially affects the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria 
already resident in the colon”. 
Gibson G.R. & Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing 
the concept of prebiotics. 1995, J. Nutr. 125: 1401-1412. 
 
2004 - “Selectively fermented ingredients that allow specific changes, both in the 
composition and/or activity in the gastrointestinal microflora that confers benefits 
upon host well-being and health” 
Gibson G.R., Probert H.M., Van Loo J.A.E., Rastall R.A. & Roberfroid M.B. Dietary modulation of 
the human colonic microbiota: updating the concept of prebiotics. 2004, Nutr. Res. Rev. 17: 259-
275. 
 
2008 - “A non-viable food component that confers a health benefit on the host 
associated with modulation of the microbiota” 
Pineiro, M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O. & Tuohy K. Food and 
Agriculture Organization of the United Nations (FAO) technical meeting on prebiotics. 2008, J. 
Clin. Gastroenterol. 42, S156–S159. 
 
2010 - “A selectively fermented ingredient that results in specific changes in the 
composition and/or activity of the gastrointestinal microbiota, thus conferring 
benefit(s) upon host health” 
Gibson G.R., Scott K.P., Rastall R.A., Tuohy K.M., Hotchkiss A., Dubert-Ferrandon A., Gareau M., 
Murphy E.F., Saulnier D., Loh G., Macfarlane S., Delzenne N., Ringel Y., Kozianowski G., 
Dickmann R., Lenoir-Wijnkoop I., Walker C., Buddington R. Dietary prebiotics: current status and 
new definition. 2010, Food Sci. Technol. Bull.- Funct. Foods, 7: 1-19 
 
2015 - “A non-digestible compound that, through its metabolization by 
microorganisms in the gut, modulates the composition and/or activity of the gut 
microbiota, thus, conferring a beneficial physiological effect on the host” 
Bindels, L.B., Delzenne, N M., Cani, P.D. & Walter, J. Towards a more comprehensive concept for 
prebiotics. 2015. Nat. Rev. Gastroenterol. Hepatol. 12, 303–310 
 
2017 - “A substrate that is selectively utilized by host microorganisms conferring a 
health benefit” 
Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton 
C., Swanson K.S., Cani P.D., Verbeke K. & Reid G. The International Scientific Association for 
Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. 
(2017). Nat. Rev. Gastroenterol. Hepatol. 14, 491-502. 
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Therefore, the most recently proposed definition by the panel of 
experts of the ISAPP in 2017 remarks prebiotics as “a substrate that is 
selectively utilized by host microorganisms conferring a health benefit”. In 
this sense, this new definition includes prebiotics to interact with 
extraintestinal microbiota, such as the located in the vagina or skin. Even 
more, this new definition opens the field for candidates structurally different 
from carbohydrates. In consequence, in addition to carbohydrate-based 
compounds that have been traditionally considered as top prebiotics, other 
substances such as polyphenols and polyunsaturated fatty acids might fit the 
updated definition assuming convincing weight of evidence in the target host.  
1.2.1 Prebiotic substrates 
 By definition, the prebiotic concept emphasises the specific 
stimulation of host microorganisms leading to a health benefit. In this sense, 
the criterion of selective utilization differentiates prebiotics from many other 
substrates that can also affect the microbiota (Roberfroid et al. 2010). 
Selectivity does not necessarily mean effects on just one microbial group; a 
selective effect could extend to several microbial groups. As based on the 
evidence so far, prebiotic targets extend beyond stimulation of bifidobacteria 
and lactobacilli, and recognizes that health benefits can derive from 
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stimulating other beneficial bacteria such as Roseburia, Eubacterium or 
Faecalibacterium spp. for example (Gibson et al. 2017). 
Thus, to be considered a prebiotic, the involved compound must fulfil 
the following criteria, which should be adequately evidenced by in vitro and 
in vivo studies: a) A prebiotic must be selectively utilized by host 
microorganisms, b) A prebiotic must have an adequate evidence of its health 
benefits on the target host and, c) Dietary prebiotics should be non-digested 
by the host but utilized by the microbiota.  
 To date, the main substrates for bacterial modification are dietary 
non-digestible carbohydrates that evade upper gastrointestinal hydrolysis and 
absorption. It is noteworthy to mention that resistance to degradation of these 
substrates contributes positively to the regulation of the caloric intake and 
diminishes the absorption of free monosaccharide that are usually released 
and absorbed in the small intestine. These non-digestible carbohydrates 
include dietary fibres such as resistant starch/dextrin, non-starch 
polysaccharides (i.e. pectins, arabinogalactans, hemicellulose), non-digestible 
oligosaccharides of plant origin (inulin and oligofructoses), as well as 
undigested disaccharides (i.e. lactulose) and sugar alcohols (i.e. lactitol and 
isomalt). However, the most extensively prebiotics documented to have 
health benefits in humans and, consequently, the most widely accepted are 
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lactulose, inulin, and non-digestible oligosaccharides (NDOs): 
fructooligosaccharides (FOS), galactooligosaccharides (GOS), and the human 
milk oligosaccharides (HMOs) 
1.2.1.1 Dietary fibre 
 According to the Codex Alimentarius Commission, a dietary fibre is 
defined in the European Union as: “carbohydrate polymers with three of 
more monomeric units, which are neither digested not absorbed in the human 
small intestine and belong to the following categories: a) edible carbohydrate 
polymers naturally occurring in foods as consumed, b) edible carbohydrate 
polymers which have been obtained from food raw materials by physical, 
enzymatic, or chemical means and which have a beneficial physiological 
effect demonstrated by generally accepted scientific evidence, and c) edible 
synthetic carbohydrate polymers which have a beneficial physiological effect 
demonstrated by generally accepted scientific evidence” (Codex 
Alimentarius, 2010). In this sense, dietary fibre refers to a highly chemical 
heterogeneous group of substances that are resilient to upper gastrointestinal 
digestion and absorption. However, categorizing fibres as prebiotics would be 
inappropriate due to their higher variability and heterogeneous behaviour. 
Nevertheless, certain soluble fibres have shown to have a prebiotic 
effect being considered as prebiotics (inulin-type fructans and GOS) and 
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some others are being considered as prebiotic candidates (polydextrose, 
pectins, pectic-oligosaccharides, polysaccharides from algae) (Míguez et al 
2016). 
1.2.1.1.1 Inulin 
 Inulin is naturally present in several foods such as chicory, Jerusalem 
artichoke, garlic, artichoke, onion, wheat, banana, and oats as well as 
soybean. Inulin-type fructans are oligo-/polymers of D-fructose joined by 
β(2→1) bonds with an α(1→2) linked D-glucose at the terminal end of the 
molecule. Molecules with DP between 3 and 10 are referred to as 
oligofructoses, and those with a DP between 10 and 65 are known as inulin. 
The prebiotic activity of inulin-type fructans has been widely 
confirmed (Kolida & Gibson 2007). This is mainly because these compounds 
are preferably metabolized by bifidobacteria, which are able to break down 
and utilize these substrates due to their β-fructosidase enzymes. In this 
context, chicory inulin has received an EU health claim: “Inulin improves 
bowel function” endorsed by the EFSA (EFSA, 2015).  
1.2.1.1.2 Fructooligosaccharides (FOS) 
 Concerning non-digestible oligosaccharides (NDOs), FOS represent 
the oligomers formed of D-fructose joined by β(2→1) bonds with an α(1→2) 
linked D-glucose at the terminal end of the molecule. These oligosaccharides 
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are obtained by degradation of chicory inulin or using sucrose as substrate in 
a transfructosylation process. In the first approach, chicory inulin is cleaved 
randomly by microbial endoinulinases (EC 3.2.1.7) yielding oligofructosides 
(Fn series) with a DP between 2 and 10. In the second approach, cane sugar or 
beet sugar is fructosylated to GF2, GF3, and GF4 by β-fructofuranosidase (EC 
3.2.1.26) or β-fructosyltransferase (EC 2.4.1.100) from microbial origin 
(Ganaie et al. 2014; Bali et al. 2015; Flores-Maltos et al. 2016). Similar to 
inulin, it is generally accepted that FOS reach the colon where it can 
selectively stimulate the beneficial host microorganisms, especially 
bifidobacteria (Kolida & Gibson 2007). 
1.2.1.2 Galactooligosaccharides (GOS) 
 GOS are prebiotic compounds that are currently produced by the 
enzymatic transgalactosylation of lactose with β-galactosidase (E.C. 3.2.1.23) 
from different microbial strains. Transgalactosylation process in GOS is 
similar to the obtainment of FOS using sucrose as substrate. In this process, 
the enzyme β-galactosidase hydrolyses lactose and, instead of transferring the 
galactose unit to the hydroxyl group of water (hydrolysis), the enzyme 
transfers galactose to another carbohydrate, in this case lactose, to result in 
oligosaccharides with a higher degree of polymerization (DP) (Kim et al. 
1997) (Figure 4).  
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Figure 4. Schematic representation of the reaction mechanism of GOS synthesis by transgalactosylation with β-galactosidases (E). Adapted 
from Vera et al. (2016). 
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 Regarding the synthesis reaction, lactose hydrolysis and 
transgalactosylation are concomitant reactions catalysed by β-glycosidase, 
therefore resulting products of the reaction will be monomeric products, as 
well as many newly formed β-glycosides, mainly di-, tri-, and 
tetrasaccharides (Prenosil et al. 1987). In this regard, it is important to notice 
the high caloric value and glycaemic index of these monosaccharides that 
sometimes are removed. GOS obtained after reaction are constituted by a 
complex mixture of galactoses linked by different linkages β(1↔1), β(1→2), 
β(1→3), β(1→4) and β(1→6) and can vary from 1 to 8 units and a terminal 
glucose (Moreno et al. 2014). In this sense, composition of GOS mixture 
have shown to be deeply affected by several factors, such as the enzyme 
source, lactose concentration, substrate composition and reaction conditions 
(temperature, time and pH) (Moreno et al. 2014; Gänzle 2012; Torres et al. 
2010). These compounds present a widely recognised prebiotic effect since 
they selectively stimulate the growth of lactic acid bacteria and bifidobacteria 
in the gut (Roberfroid et al. 2010). Moreover, GOS has been recognised as 
dietary ingredients and not as additives due to the presence of galactose-
based oligosaccharides, which are also present in human milk 
oligosaccharides (HMOs). 
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1.2.1.3 Human Milk Oligosaccharides (HMOs) 
 HMOs are key constituent of human milk. They represent a 
structurally and biologically diverse group of complex indigestible sugars 
(Bode et al. 2006). HMOs are composed of both neutral and anionic species 
with building blocks of 5 monosaccharides: D-glucose, D-galactose, N-
acetylglucosamine, L-fucose and N-acetylneuraminic acid. The basic 
structure as well as in GOS, includes lactose core at the reducing end and are 
elongated by N-acetyllactosamine units, with greater structural diversity 
provided by extensive fucosylation (Newburg et al. 2005). More than 200 
different oligosaccharides have been identified to date, varying in size from 3 
to 22 monosaccharide units (Bode 2012; Bode 2015). These compounds 
reach the colon where they are preferred substrates for several species of gut 
bacteria producing SCFA and promoting the growth of beneficial bacteria. 
HMOs has also shown to directly modulate host-epithelial responses, 
favouring reduced binding of pathogenic microbiota to the gut epithelium 
(Smilowitz et al 2014). Moreover, HMOs has been attributed as the main 
responsible of the higher presence of Actinobacteria, mainly represented by 
Bifidobacterium genus in breastfed infants, compared to formula-fed infants 
(Filippo et al 2010). 
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1.2.1.4 Lactulose and oligosaccharides derived from lactulose 
 Lactulose, 4-β-D-galactopyranosyl-D-fructose, represents the simplest 
recognised prebiotic. Lactulose does not occur naturally and it is obtained by 
isomerization of lactose where the glucose moiety is transformed to fructose 
in alkaline conditions (Zokaee et al. 2002) or by enzymatic methods, using β-
glycosidases in a bioconversion process or β-galactosidases in a 
transgalactosylation mechanism in presence of fructose (Wang et al. 2013). 
Moreover, regarding the latter method using β-galactosidases from certain 
microorganism, such as Aspergillus oryzae, new potential prebiotic 
oligosaccharides can be synthesized by a direct reaction of 
transgalactosylation of lactulose (OsLu) in a similar way to GOS from lactose 
(Martinez-Villaluenga et al. 2008; Hernandez-Hernandez et al. 2011). As in 
the case of transgalactosylation of lactose, the released galactose moiety from 
lactulose is linked by β(1→6) and β(1→3), β(1→1) or β(1→4) glycosidic 
bonds to the galactosyl or fructosyl moiety of another lactulose molecule 
(Figure 5). 
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Figure 5. Schematic representation of the reaction mechanism of oligosaccharides from lactulose synthesis by transgalactosylation with β-
galactosidases (E). Adapted from Diez-Municio et al. (2014). 
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Therefore, oligosaccharides derived from lactulose (OsLu) comprises 
a mixture of oligosaccharides with different linkages (mainly β(1→6)) 
containing one fructose residue (Martínez-Villaluenga et al. 2008; Hernádez-
Hernández et al. 2011; Padilla et al. 2012; Cardelle-Cobas et al. 2016; Yin et 
al. 2018). 
 As the rest of prebiotics, lactulose presents a high resistance to the 
upper gastrointestinal degradation reaching the colon where it selectively 
stimulates the growth of beneficial bacteria and decreases in the counts of 
clostridia, streptococcus and enterobacteria (Gibson et al. 2000). It is well 
known that the resistance of oligosaccharides towards microbial degradation 
depends on their glycosidic linkages, monosaccharide composition, and 
degree of polymerization. Rapidly fermented carbohydrates mainly show a 
prebiotic effect in the caecum and proximal colon whereas the more slowly 
fermented oligosaccharides, such as OsLu, reach the distal colon and 
influence the microbial composition present there (Cardelle-Cobas et al. 
2009a). In this sense, β(1→6) OsLu have shown to exert a better bifidogenic 
and anti-inflammatory effect than lactulose and GOS (Hernández-Hernández 
et al. 2012; Algieri et al. 2014; Li et al. 2015). 
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1.2.2 Biological properties and application of recognised prebiotics: 
As previously stated in section 1.1, it is well established that the 
composition and activity of the microbiota significantly contribute to the 
health and well-being of the host. In this sense, prebiotics alter positively the 
composition of the intestinal microbiota, generally increasing the growth of 
beneficial bacteria such as bifidobacteria and lactobacilli. To date, there are a 
large number of publications reporting the possitive effect of recognised 
prebiotics on health and it continues increasing. Prebiotics’ benefits to host 
health is managed by two principal mechanisms; the first one is related to the 
stimulation of the growth of beneficial bacteria in the gut and the other one is 
related to the production of short chain fatty acids (SCFA) (acetate, 
propionate, butyrate) during fermentation of carbohydrates (see section 
1.2.4). The positive effects of prebiotic oligosaccharides have been largely 
reviewed in the literature and have been identified to play a key role in 
minimizing health-related risks, such as diabetes, cardiovascular disorders, 
cancer, acute infection, inflammation, gastrointestinal diseases and obesity 
(Cho et al. 2010; Slavin et al. 2013). Prebiotic consumption also enhances 
bioavailability of nutritionally important minerals such as calcium, 
magnesium, and iron (Slavin et al. 2013).  
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Regarding the application of recognised prebiotics, all prebiotic uses 
are situated as food ingredients. In this sense, the commercial market at 
present is dominated by inulin, FOS and GOS. FOS was approved as food 
ingredient in Japan since 1980 and has an approved FOSHU (Foods for 
Specified Health Uses) status. In the European Union has been recognised as 
food ingredient since 1991. FOS was first made commercially available in 
1988 in the United States, it is considered GRAS (Generally Recognised as 
Safe) and it currently can be found in several food products worldwide under 
several trade names like Neosugar, NutraFlora®, Meioligo®, and Actilight, 
for example (Bali et al. 2015). Similarly, the use of GOS is increasing 
gradually in various applications worldwide. The first product for a specific 
target group was introduced in the early 1990s, when an infant formula 
containing GOS was launched (Cho et al. 2010). Since then, GOS are 
increasingly applied as ingredients for infant formula to mimic the biological 
functions of human milk oligosaccharides. Furthermore, because of their high 
solubility and stability (e.g., under pasteurization and sterilization conditions 
and in acid environments), GOS are particularly suitable for use in acid 
products, such as fruit juices, yogurts and heat-treated products such as 
bakery products. In general, prebiotics have been included in a wide variety 
of foods and supplements globally including beverages, dairy products 
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(yogurts, ice cream), desserts, bakery products, breakfast cereal, 
infant/toddler foods, food supplements (Cho et al. 2010). 
1.2.3 Emerging and potential prebiotic compounds 
 At this stage, any dietary component that reaches the colon intact 
could be a potential candidate for prebiotic attribute; however, the criterion of 
selective utilization by the microbiota is the most difficult to fulfil. In this 
sense, there is a growing list of potential prebiotic compounds, and some of 
them are already commercialized such as, α-glucooligosaccharides, 
isomaltooligosaccharides (IMOS), lactosucrose, soy oligosaccharides and 
xylooligosaccharides (XOS) (Gibson et al. 2010). There is increasing 
evidence on the properties of these compounds even though more studies (i.e. 
human volunteer trials) are still needed to recognise these as prebiotics. 
The growing interest towards prebiotic compounds and their effects to 
the host led to the pursuit of new compounds, which can be produced, 
through more efficient, sustainable, simple and less expensive processes for 
their application on a large scale. In this regard, other compounds with 
potential prebiotic effect, such as pectin and pectic-oligosaccharides, along 
with others like polydextrose (PDX), bacterial exopolysaccharides (EPS), 
polysaccharides from algae and sugar alcohols, are still in early stages of 
investigation. 
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1.2.3.1 Pectin  
 Pectins are a family of plant cell wall structural complex 
polysaccharides. Exact chemical composition of these compounds is still 
under debate, due to the high complexity of this molecule; however, their 
structure present common features, such as homogalacturonan (HG), 
rhamnogalacturonan-I (RG-I) and rhamnogalacturonan-II (RG-II). Pectins 
mainly consist of a galacturonic acid (GalA) rich backbone, known as 
homogalacturonan (HG ≈ 65%), which is partially methyl esterified in the 
carboxyl group at the C-6 position and O-acetyl-esterified in positions C-2 
and C-3 (Mohnen, 2008). According to the amount of carboxyl groups that 
can be esterified with methyl groups, pectins are classified on the basis of 
their degree of esterification (DE) (Oakenfull 1991), also known as degree of 
methoxyl esterification (DM). Pectins with more than 50% of the carboxyl 
groups esterified are named as high methoxyl (HM) and pectins with less 
than 50% of carboxyl groups esterified are classified as low methoxyl (LM) 
(Thakur et al. 1997). Rhamnose (Rha) residues interrupt the HG structure to 
form rhamnogalacturonan-I (RG-I ≈ 20–35%) which is based on a backbone 
consisting of a repeating disaccharide of [→2)-α-L-Rhap-(1→4)-α-D-GalAp-
(1→] residues. In addition, some rhamnose residues may contain sidechains 
that can vary from single glycosyl to polymeric of different types (1→5)-α-L-
arabinans, (1→4)-β-D-galactans and arabinogalactans (Buffetto et al., 2015). 
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The highly branched nature of RG-I has led to the name of “hairy region”. 
RG-II consists of a linear backbone chain of galacturonic acid units, 
substituted with L-rhamnose, D-galactose and many unusual sugars, such as 
apiose, aceric acid, 3-O-methyl-L-fucose, 2-O-methyl-D-xylose, 3-C-
carboxy-5-deoxy-L-xylose, 3-deoxy-D-manno-octulosonic acid and 3-deoxy-
D-lyxo-heptulosaric acid (Palin et al. 2012; Yapo 2011). RG-II structure is 
the most structurally complex pectin domain and it is largely conserved 
across many plant species. 
Most pectins are commercially obtained from citrus fruits like orange, 
lemons, grapefruit, and apples. These substrates contain high amounts of 
pectic substances. However, in recent years, the search of new sources of 
pectin appears very promising. In this sense, the use of waste by-products 
from the agricultural industry has become an interesting alternative for 
extraction of pectin, some examples include sunflower head residues, 
artichoke residues, and sugar beet pulp, among others (Muñoz-Almagro et al. 
2018; Sabater et al. 2018; Ishii 1994).  
Currently, pectins with no less than 65% GalA (FAO) are mainly used 
in the food industry as food additive (E440). However, the suitability of 
pectins for specific applications is governed by the structural features, 
including molecular weight (Mw), neutral sugar content, proportion of 
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HG:RG-I regions or the DM as these factors can affect their applicability as 
thickeners or as gelling and stabilizing agents (Gullón et al. 2013). Biological 
properties of pectins, and other dietary fibres, are mainly due to their non-
digestibility in the gastrointestinal tract, reaching the hindgut where they are 
fermented by the colonic microbiota. In this sense, a positive effect of these 
compounds on gut beneficial microbiota has been observed after citrus and 
apple pectin fermentation, consisting of a growth of bifidobacteria and 
lactobacillus and an increase in SCFA (Jakobsdottir et al. 2013; Nazzaro et 
al. 2012; Olano-Martín et al. 2002; Dongowski et al. 2000). 
1.2.3.1 Modified pectins and pectic-oligosaccharides (POS)  
 Pectin that has been treated with pH (low or high), heat or enzymes is 
generally referred to as ‘modified pectin’ (MP), although this term remains 
ambiguous, as pectin is a highly heterogeneous material and these modified 
pectin structures can vary widely depending on the pectin source, extraction 
and method modification. In this sense, it is generally understood that 
modifying pectin with heat, pH, enzymes or ultrasound (Díaz et al. 2007; 
Muñoz-Almagro et al. 2017; Muñoz-Almagro et al. 2018; Sabater et al. 2018) 
can decrease the molecular weight and proportionally increase the content in 
total neutral sugars.  
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Regarding biological properties, most of the studies addressing the 
bioactive effects of pectins have been carried out using a modified form of 
pectin. There are several investigations that have demonstrated a better 
bifidogenic effect and production of SCFA of lower molecular weight pectic 
compounds (Ho et al. 2017; Daguet et al. 2016; Khodaei et al. 2016), 
although neutral sugar content (arabinans and galactans) seems to play also a 
key role in their prebiotic potential (Di et al. 2017; Onumpai et al. 2001). 
Furthermore, there is growing evidence linking modified forms of pectic 
polysaccharides with anti-cancer activity, where pectins with a high neutral 
sugar content are more bioactive due to the hypothesis that galactan side-
chains on pectin can bind to and inhibit the pro-metastatic protein galectin-3, 
resulting in the suppression of cancer cell proliferation, aggregation, adhesion 
and metastasis (Maxwell et al. 2012; Maxwell et al. 2016; Park et al. 2017; 
Nangia-Makker et al. 2002). Other beneficial health properties might include 
the reduction of atherosclerotic lesions (Lu et al., 2017), anti-inflammatory 
and antioxidant properties (Popov & Ovodov, 2013; Ramachandran, et. al. 
2017) or immunostimulatory properties (Vogt et al., 2016). Taken that into 
account, to date there are two forms of modified citrus pectin commercialized 
obtained by chemical and enzymatic methods, GCS-100 (̴ 10 kDa) patented 
as a mammalian anticancer agent (Raz & Pienta, 1998) and Pectasol-C (5-10 
kDa), respectively (Morris et al 2013). 
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 POS represent the oligosaccharide obtained by pectin 
depolymerization. This term includes oligogalacturonides (OGalA), alpha-
galactooligosaccharides (GalOS), arabinooligosaccharides (AraOS), 
rhamnogalacturonoligosaccharides (RhaGalAOS), xylooligogalacturonides 
(XylOGalA) and arabinogalactooligosaccharides (AraGalOS). These 
compounds are obtained after the breakdown of the various pectin fractions 
(HG, RG-I, RG-II) from both agro-industrial by-products and purified 
pectins, by enzymatic hydrolysis, acid hydrolysis, hydrothermal processing, 
dynamic high-pressure microfluidization or photochemical reaction in media 
containing TiO2 (Gullón et al. 2013).  
Regarding their bioactivity, there is a vastly amount of studies that 
support POS as a new class of prebiotics. Their effect on health-promoting 
includes, apart from being fermented by intestinal bacteria producing SCFA, 
stimulation of apoptosis in human colonic adenocarcinoma cells, potential for 
cardiovascular protection in vivo, reduction of damage by heavy metals, 
antiobesity effects, antitoxic, antiinfection, antibacterial, and antioxidant 
properties (Gómez et al. 2016; Babbar et al. 2016; Samuelsson et al. 2016; 
Maxwell et al. 2015; Gullón et al. 2013; Olano-Martín et al. 2002). 
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1.2.4  Metabolism and colonic fermentation of prebiotics 
According with previous sections, prebiotics benefits to host health 
are driven mainly by two mechanisms;  
The first one is associated with the positive modification of microbial 
population, increasing health-promoting organisms such as bifidobacteria and 
lactobacilli and, in certain situations, reducing the numbers of bacterias 
which may have a harmful role in host health (clostridia, bacteroides, 
enterococci, and enterobacteria) (Roberfroid et al. 2010) (Figure 6). In this 
sense, despite the large amount of publications on prebiotic properties, there 
is still a poor understanding of the mechanisms by which they could 
selectively stimulate the growth of only some members of microbial 
population. One example of prebiotics action is that certain members of 
colonic microbiota possess cell-associated glycosidases, which allow the 
hydrolysis of prebiotics, and the subsequent uptake of the monosaccharides 
released. A second paradigm is that certain microbes possess oligosaccharide 
transport systems that can scavenge oligosaccharides from the gut 
environment for the subsequent intracellular hydrolysis (Rastall 2010).  
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Figure 6. Postulated mechanisms of health benefits induced by prebiotics via the selective 
proliferation of beneficial populations of intestinal bacteria. DC, dendritic cell; Th1, T helper 
cell type 1; Th2, T helper cell type 2; Tr, regulatory T cell. Figure reported from Crittenden 
(2006) Reproduced with kind permission from Wiley. 
 
 
The second mechanism of prebiotics’ effect on health is related to the 
modifications of the metabolic activity of the microbiota based on the ability 
of some bacterial species to ferment prebiotic carbohydrates (saccharolytic 
fermentation). In this regard, the metabolization of these prebiotics by 
colonic bacteria is the perfect example of the synbiotic relationship between 
the host and the microbiota. Mammalian genomes do not encode most of the 
enzymes needed to degrade the structural linkages of polysaccharides present 
in plant material. In fact, human enzymes are capable of degrading only a few 
glycosidic linkages via the action of pancreatic amylase and the 
disaccharidases present in the brush border. Therefore, degradation of these 
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carbohydrates relies on the colonic bacteria that possess many different 
enzymes that allow them to metabolize different complex carbohydrates 
(Martens et al. 2011; Flint et al. 2012).  
The products of saccharolytic fermentation are, principally, short 
chain fatty acids (SCFA) (acetate, propionate, and butyrate) as well as other 
products (lactate, pyruvate, ethanol, succinate) and gases (carbon dioxide, 
methane, hydrogen). SCFA play a crucial role for intestinal and host health 
and have been identified as modulators of certains aspects of metabolic 
activity including colonocyte function, gut homeostasis, energy gain, the 
immune system, blood lipids, appetite, renal physiology (Kieffer et al. 2016; 
Pluznick et al. 2016) and have also shown to exert a protective role against 
colon cancer (Bailón et al. 2010; Zeng 2014) (Figure 7). In this sense, a 
healthy microbiota is considered when saccharolytic fermentation is 
predominant compared to proteolytic fermentation (metabolism of peptides 
and proteins) that can generate toxic substances (i.e. biogenic amines and 
sulphides, ammonia, thiols, indols) and increase the risk of colon cancer. 
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Figure 7. Postulated mechanisms of health benefits induced by prebiotics via the stimulation 
of beneficial microbial activities within selected populations of intestinal bacteria. IBD, 
inflammatory bowel diseases; SCFA, short-chain fatty acids. Figure reported from 
Crittenden (2006) Reproduced with kind permission from Wiley. 
 
 
Furthermore, interaction between bacteria must be taken into account 
when studying the mechanisms of action of prebiotics. Thus, while certain 
bacteria such as bifidobacteria do not produce butyrate, they can however 
stimulate other butyrate-producing bacterial species that can use acetate and 
lactate (intermediate products) produced by bifidobacteria to produce 
butyrate (cross-feeding interaction). 
However, SCFA production of itself can not be accepted as validated 
biomarkers of prebiotic activity, that is selected bacterial growth or activity. 
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Hence, well-designed methods with specific bacterial enumeration are highly 
preferred (Roberfroid 2005).  
1.2.4.1 Colonic fermentation models 
In vivo animal studies and human trials provide the most 
physiologically relevant information about the dynamic microbial processes 
during the fermentation occurring in the gastrointestinal tract. However, 
drawbacks such as the high costs, high complexity, inter-individual variations 
and the lack of easy access to the gut to sampling, restrict these in vivo 
studies to in vitro approaches that cannot fully provide information on 
dynamic microbial process in the gut (Venema et al, 2013; Verhoeckx et al. 
2015). However, in vitro models offer unique advantages such as their 
reproducibility, simplicity, cost-effectiveness and the better control of the 
experimental variables than animal or human studies. Thus, regarding the 
ability of prebiotics to exert their effect on the host microbiota, a variety of in 
vitro fermentation models have been developed (Payne et al. 2012; Rumney 
et al. 1992). One of the simplest ways to support the fermentation on gut 
microbiota is the demonstration that these compounds are metabolized when 
incubated with pure probiotic strains in a basal medium. However, this does 
not confirm the selectivity of the substrate since possible interactions 
between bacteria are not considered. Therefore, modifications of this method 
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involve the use of defined mixed- or co-cultures, which introduces 
competition between microbes, although it still does not represent the 
complex interactions in the human large intestine. A more significant method 
to assure this complex diversity involves the use of faecal inocula, which 
provides a better representation of the events occurring in the distal colon. In 
this sense, few authors revealed that in vitro models can maintain a human-
like gut microbiota (Rajilic-Stojanovic et al. 2010; Van den Abbeele et al. 
2010), reporting that the microbial spectra unique to specific human subjects 
can be maintained in vitro. In addition, when comparing microbial 
fermentation spectra of different prebiotic compounds in different in vitro 
models for the human GIT, similar behaviour was observed for each prebiotic 
supporting the reproducibility between different in vitro models (Van den 
Abbeele et al., 2013). Besides that, results from human clinical trials have 
shown that bifidogenic as well as butyrogenic effect of prebiotics can be 
reproduced in vitro (Venema et al. 2003). Thus, to date, there are different in 
vitro models developed for the evaluation of the effect of prebiotics in 
microbiota and are briefly summarized below with their advantages and 
limitations (Table 4).  
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In this regard, development of multistage continuous fermentation 
models, so-called “gut models” which enable the simulation throughout the 
entire colon processes by setting up different vessels in series and the 
artificial digestive systems represent the most advanced attempt, so far, at 
 
Table 4. Current available in vitro fermentation models with their advantages and 
limitations. Adapted and modified from Payne et al. (2012). 
 
Models 
 
Advantages 
 
Limitations 
 
References 
 
Batch 
cultures - 
Single stage 
reactors 
 
Easy to set up, useful 
for fermentation studies 
and especially substrate 
digestion assessment. 
 
 
Short-term 
fermentation studies 
and weakness in 
microbiological 
control 
 
 
Pompei et al. (2008); 
Gumienna et al. (2011)  
Continuous 
cultures – 3-
stage 
continuos 
systems 
Continuous flow 
mimicking conditions 
found in vivo. 
Environmental 
parameters are well 
controlled. 
 
No host functionality 
and experiments are 
time limited (days or 
weeks) 
Maccaferri et al. 
(2010); Duncan et al. 
(2009); Gibson et al. 
(1988); Macfarlane et 
al. (1989) 
Multistage 
continuous 
cultures – 4-
5 stage 
system 
Continuous flow into 
several vessels 
mimicking conditions 
found in portions of the 
digestive tract. 
 
No host functionality 
and experiments are 
time limited (days or 
weeks) 
Minekus et al. (1999); 
Mäkivuokko et al. 
(2005); Van den 
Abbeele et al (2010); 
Barroso et al. (2015) 
Immobilized 
continuous 
cultures 
High-cell density and 
long-term stability of 
continuous fermentation 
system with 
immobilized faecal 
microbiota. 
 
No host functionality Le Blay et al. (2009); 
Zihler et al. (2010) 
Artificial 
digestive 
systems 
Continuous flow with 
metabolites and water 
exchange mimicking 
conditions found in vivo 
No immune and 
neuroendocrine 
response and 
experiments are 
limited to few days’ 
time 
 
Blanquet-Diot et al. 
(2009); Kovatcheva-
Datchary et al. (2009) 
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simulating interdependent physiological functions within the human gut, 
stomach and small intestine (Verhoeckx et al, 2015). Therefore, these in vitro 
models allow a dynamic sampling over time in the consecutive regions of the 
gut providing a unique tool to study the possible mechanism of action of 
dietary ingredients or drugs. To date, few multistage continuos models have 
been developed and provide probably the closest simulation to in vivo 
conditions (Molly et al. 1993; Minekus et al. 1995; Minekus et al. 1999; 
Barroso et al. 2015; Mäkivuokko et al. 2005; Cinquin et al. 2004). However, 
although dynamic mulstistage models also facilitate long-term studies, they 
can present disadvantages such as, they are expensive to set up, take more 
labor intense and time consuming and require higher operation costs in terms 
of working volumes and addition of substances mimicking gastrointestinal 
fluids. Additionally, in vitro continuos systems may oversimplify in vivo 
situation due to the absence of metabolits/substrates absorption in some of 
these models. It is therefore difficult to properly reproduce in vitro all entirely 
colon fermentation dynamics although high valuable information can be 
obtained due to their use (Macfarlane & Macfarlane 2007). Thus, given the 
high interest on this topic, important new approaches have being developed 
in the last decade, such as, the combination of dynamic gut models with 
human cell culture systems (Bahrami et al. 2011; Marzorati et al. 2014) or the 
cultivation of single intestinal stem cells into spherical crypt-like structures, 
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called “organoids”, with several distinct cell types found in the gut  
(Roeselers et al. 2013; Sato et al. 2009), among other approaches (Barrila et 
al. 2010; Radtke et al. 2010) 
1.3  Resistance to the gastrointestinal digestion of prebiotic 
carbohydrates 
 As indicated above, one of the requirements for these compounds to 
be considered as prebiotics is their resistance to the upper gastrointestinal 
tract digestion. In this sense, ever since prebiotics were first defined in 1995, 
the investigations have focused on their effect on the microbiota activity 
and/or composition. However, despite the generally accepted concept that 
prebiotics pass through the upper gastrointestinal tract without modifications, 
few efforts have been made toward the study of the resistance of these 
compounds to digestion and conditions in the upper gastrointestinal stage. 
Whether or not chemical or structural changes occur when they are exposed 
to this environment is important, because even minor chemical or structural 
differences could substantially affect their properties and therefore their 
impact on colonic microbiota (Li et al. 2015). 
Human gastrointestinal degradation of carbohydrates constitutes a 
multistage process starting in the oral cavity with a very scarce hydrolysis by 
the α-amylase present in the saliva and continues its degradation and 
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absorption in the small intestine, being the main site for carbohydrate 
digestion involving the secreted pancreatic α-amylase. In addition, brush 
border membranes of the intestinal mucosa contain several key enzymes for 
carbohydrate digestion present as multienzyme complexes, i.e. sucrase-
isomaltase, lactase-phlorizin hydrolase, maltase-glucoamylase and trehalase. 
In fact, dietary carbohydrate digestion involves up to six different 
carbohydrases produced by three different organs (Table 5). Moreover, the 
mammalian upper gastrointestinal tract (small intestine) contains a variety of 
distinct microbial population. More acidic conditions and higher levels of 
oxygen than those present in colon allow a dominance by fast-growing 
facultative anaerobes, such as Lactobacillaceae or Enterobacteraceae, that 
tolerate the combined effect of antimicrobials and bile salts (Donaldson et al. 
2016). In this regard, conditions such as, presence of oxygen, antimicrobial 
compounds (bile salts) or pH, limit the bacterial density below 104 colony-
forming units (cfu/g) (Figure 1) and only at the distal end of the small 
intestine, in the terminal ileum, bacterial densities reach levels similar to 
those found in the large intestine. With all these characteristics, it is not 
misplaced to consider that prebiotic compounds can suffer changes that could 
affect their properties when they reach the colon to be fermented. 
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Table 5. Human carbohydrases involved in dietary carbohydrate digestion. Reproduced from Hernandez-Hernandez et al. (2019).  
 
Digestive carbohydrases 
Type of 
enzyme 
 
Glycoside 
Hydrolase 
Family1 
Production organ / Main 
site of digestion 
Glycosidic linkage 
specificity 
Main substrates2 Main products2 
Salivary α-amylase3 
Secreted (α-
glucosidase) 
13  Salivary gland / Mouth Glcα(1→4)Glc 
Starch; linear 
maltooligosaccharides 
(n˃6) 
Maltose; maltotriose; 
α-dextrins 
Pancreatic  α-amylase3 
Secreted (α-
glucosidase) 
13 Pancreas / Small intestine Glcα(1→4)Glc 
Starch; linear 
maltooligosaccharides 
(n˃6) 
Maltose; maltotriose; 
α-dextrins 
Sucrase-isomaltase 
Mucosal (α-
glucosidase) 
31 
Small intestine (brush border 
membrane) / Small intestine  
Glcα(1↔2)βFru 
Glcα(1→4)Glc 
Glcα(1→6)Glc 
Sucrose; isomaltose; 
maltose; maltotriose; α-
dextrins 
Glucose; fructose 
Maltase-glucoamylase 
Mucosal (α-
glucosidase) 
31 
Small intestine (brush border 
membrane) / Small intestine 
Glcα(1→4)Glc 
Glcα(1→6)Glc 
Linear and branched 
maltooligosaccharides 
(n=2-9) 
Glucose 
Lactase-phorizin hydrolase 
Mucosal (α-
glycosidase) 
1 
Small intestine (brush border 
membrane) / Small intestine 
Glcα(1→4)Gal 
Glcα(1→4)Glc 
Lactose, cellobiose, 
cellotriose, cellulose 
Glucose; galactose 
Trehalase 
Mucosal (α-
glucosidase 
37 
Small intestine (brush border 
membrane) / Small intestine 
 
Glcα(1↔1)αGlc Trehalose Glucose 
 
 
1 According to CAZy database (http://www.cazy.org/) [Lombard et al. (2013)]. 
2 Based on and updated from Alpers (2003). 
3 Human salivary and pancreatic amylases have 94% amino acid identity although they are encoded by different genes. [Meisenberg & Simmons (2016)] 
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1.3.1  Models for the assessment of digestibility 
To date, only scarce and fragmented information on their pass 
throughout the small intestine is available. As it is well-known, in vivo 
feeding methods, using animals or humans, usually provide the most accurate 
results but they are time consuming and very costly, that is why much effort 
has been devoted to the development of in vitro procedures. Few in vivo 
studies have evidenced the partial degradation of prebiotic compounds after 
their pass through the small intestine. Holloway et al. (1983) pointed out a 
recovery of 68% of pectin at the human terminal ileum in an ileostomy study 
whereas Saito et al. (2005) observed a 90% of recovery in the terminal ileum 
after colonic intubation of volunteers. Moreover, Hernandez-Hernandez et al. 
(2012) found out 13-53% of small intestinal digestibility of purified GOS 
(with a degree of polymerization from 3 onwards) in an in vivo study with 
rats. 
 Apart from that, in vitro digestion models provide a very useful 
alternative to animal and human models by rapidly screening food 
ingredients. In this sense, the most frequently approach to measure the 
digestion process is by simulating as much as possible the human 
physiological conditions, taking into account the presence of digestive 
enzymes and their concentrations, pH, temperature, digestion time, and salt 
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concentrations, among other factors (Kopf-Bolanz et al. 2012; Minekus et al. 
2014). 
 Static methods represent the simplest techniques in this context and 
could include two or three separated digestion steps (oral, gastric and 
intestinal). Oral phase is sometimes not taken into account given that the 
process in the mouth lasts from a few seconds to minutes, and since the 
salivary pH value is close to neutral, significant compound degradation from 
food samples is not expected in this stage. However, although the majority of 
models reported in literature are static simulators, some computer-controlled 
multi-compartmental continuous system models (Table 4) overcome some 
limitations present on static models allowing the simulation of dynamic 
aspects of digestion, such as transport of digested components, variable 
enzyme concentrations, pH changes, peristaltic movements, continuous 
changes, and secretion flow rates (Ouwehand & Vaughan, 2006). To date, 
these multi-compartmental models that mimic the different gastrointestinal 
stages in a continuous flow represent the most advanced attempt at simulating 
interdependent physiological functions within the stomach lumen, small 
intestine and human gut (Barroso et al. 2015; Minekus et al. 1995; Molly et 
al. 1993). 
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 1.3.1.1 Standarised protocols of digestion  
The most widely accepted standardised static in vitro method for 
digestion was developed in 2014 (Minekus et al. 2014). The static protocol 
published by InfoGest network represents an international consensus of 
scientist from 32 countries working in the field of digestion and it has been 
widely used in several works since its release (Egger et al. 2016). Given the 
large variety of methods available, this in vitro digestion consensual method 
for food aimed to unify and produce data that are more comparable and 
reproducible between studies (Figure 8). 
This developed method presents two approaches regarding the 
enzymes used at the small intestine stage. Firstly, the use of a pancreatic 
extract (pancreatin) containing all the relevant enzymes is suggested for 
reasons of simplicity. As alternative, individual enzymes such as trypsin, 
chymotrypsin, pancreatin lipase, colipase, pancreatin amylase and bile salts 
can also be used. However, given the complexity of the gastrointestinal 
process at the small intestine, enzymes and substrates proposed in this 
method for intestinal digestion cannot reflect the real enzymes activities of 
the human gut towards carbohydrate digestion since the model ignores the 
inclusion of small intestinal mucosal carbohydrases (section 1.3 and Table 
5).  
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Figure 8. Flow diagram of the digestion presented at the InfoGest Consensus method 
involving simulated salivary fluid (SSF), simulated gastric fluid (SGF) and simulated 
intestinal fluid (SIF). Figure reproduced from Verhoeckx et al. (2015) Chapter 2 (Mackie & 
Rigby) with kind permission of Springer. 
 
Based on the literature, only few studies have been carried out on the 
resistance to digestion of non-digestible carbohydrates. Most of them 
describe this process as a previous step for the latter fermentation of these 
compounds and no focus is put on their digestibility, assuming they reach the 
colon without alterations. As it has been said above, the most common 
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approach to simulate the small intestinal digestion is by the use of digestive 
enzymes from pancreas, which could not really reflect the enzyme activity of 
the upper gastrointestinal digestion. However, studies on the digestion of 
different types of fibre such as resistant starch, FOS, pectic polysaccharides 
from kiwifruit, and sugar beet pectin using simulated gastric and intestinal 
fluids, similar to InfoGest method, have shown a partial degradation or 
changes in their structural features (Foucault et al. 2016; Sancho et al. 2017; 
Logan et al. 2015; Carnachan et al. 2012). Molecular weight diminution and 
decreases in their initial concentration were observed on these substrates, 
although enzymes (pancreatin, α-amyloglucosidase or invertase) and 
concentration used were different in each study, not showing any consensus 
between methods. 
The Association of Official Analytical Chemist (AOAC) developed 
an integrated determination method for dietary fibre, including non-digestible 
oligosaccharides and resistant starch (AOAC 2009.01) (McCleary et al 2010). 
This method, as well as the others, is based on the use of isolated digestive 
enzymes. Porcine pancreatic α-amylase and a fungal amyloglucosidase from 
Aspergillus niger are used to produce the complete hydrolysis of digestible 
saccharides and, therefore, to distinguish between digestible and non-
digestible carbohydrates. However, similar to the InfoGest protocol, these 
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enzymes cannot completely hydrolyse digestible saccharides such sucrose, 
lactose, panose, etc. since they not represent the fully complex enzymatic 
environment of the small intestine. As a result, digestible saccharides that are 
not fully degraded are detected as non-digestible oligosaccharides leading to 
an inaccurate determination of these resistant carbohydrates (Tanabe et al. 
2014). 
Consequently, alternative methods based on the use of mammalian 
intestinal extracts, which could provide a more accurate approach of the 
intestinal process, represent a good option to overcome the disadvantages of 
the use of isolated enzymes. In this sense, similarity between humans and rats 
with regard to hydrolysing activity of small intestinal disaccharidases was 
proved (Oku et al. 2011). Small intestinal mucosa obtained from healthy 
human donors and rats were used to test the digestibility of different 
oligosaccharides showing a similar enzymatic activity providing a good 
alternative to the evaluation of functional food digestion in the small 
intestine. To date, there are limited reports regarding the use of a rat small 
intestinal extract for the evaluation of digestibility of non-digestible 
carbohydrates. The most common use of these extracts is referred to previous 
steps of digestion focusing on their fermentability, (Kaulpiboon et al. 2015; 
Ito et al. 2008). However, other studies have also successfully applied these 
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intestinal enzymes from rat for the assessment of digestibility of resistant 
carbohydrates, such as FOS (Oku et al. 1984), GOS (Ohtsuka et al. 1990), as 
well as to a range of maltose and sucrose isomers (Lee et al. 2016). 
Furthermore, given the limitations of the AOAC 2009.01 method, an 
improvement method by the addition of mammalian small intestinal enzymes 
from pigs was suggested Tanabe et al. (2014). In this sense, incomplete 
degradation of digestible saccharides that lead to overestimate non-digestible 
oligosaccharides was improved by the addition of the enzymes present at the 
small intestinal brush border from pig, providing therefore a more realistic 
environment and an accurate quantification method of non-digestible 
oligosaccharides in processed food (Tanabe et al. 2015).  
 Nonetheless, use of these extracts still remains sparsely used despite 
of they have proved their successful utility on carbohydrate digestion and 
their similarity to human intestinal activity (Oku et al. 2011; Humphray et al. 
2007; Lander et al. 2001). Therefore, the lack of interest on the intestinal 
degradation of non-digestible carbohydrates, has led to the use of 
standardized official methods to determine their digestibility despites their 
limitation (Drechsler et al. 2018; Egger et al. 2016; McCleary et al 2010). 
Moreover, the scarce information about the use of mammalian intestinal 
enzymes highlights the need for developing a standardised method that may 
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provide a better understanding of the processes occurring in the small 
intestine and, so, that it can be used in the evaluation of functional ingredients 
in food. 
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2. Justification and aim of the research 
 In last decades, the interest towards the modulation of the human 
microbiota has undergone a huge growth due to its strong relationship with 
the regulation of the health and well-being. To date, several illnesses such as, 
celiac disease, obesity, colorectal cancer, irritable bowel syndrome, liver and 
cardiovascular pathologies, bone ailment and, in recent years, several 
neurological/psychiatric disorders have been also related with the incorrect 
function or alterations in the composition of the human microbiota. One of 
the most common used approaches to regulate the homeostasis, maintaining a 
proper functioning/behaviour of microbiota is the use of “prebiotics” which 
are selectively fermented in the gut, giving rise to positive changes not only 
in the singular ecosystem that inhabits the colon but also at systemic level. 
Thereby, since prebiotics were first defined in 1995, relevant advances have 
been made on the development of potential new prebiotic compounds. In this 
regard, one of the focuses has pointed toward the obtainment of molecules 
with new structures of higher molecular weight as is the case of the 
oligosaccharides derived from lactulose, which could reach the distal portions 
of the gut where the main chronic diseases can take place. Another approach 
that has been carried out in recent years is the search for new sources of 
potential prebiotics that can involve more efficient, sustainable, simple and 
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less expensive obtainment processes. That is the case of pectin and pectic 
derivatives whose obtainment from waste by-products from the agricultural 
industry represents a very interesting alternative for this emerging prebiotic. 
 However, despite the great progress that has been made related to 
prebiotics and their benefits on human health, few studies have been made 
concerning their changes during their passage in the upper gastrointestinal 
tract, even when structural differences/alterations could substantially affect 
their properties. Nevertheless, the scarce information on this regard and the 
lack of specific methods to accurately determine their digestion, compel the 
use of general standardized methods/protocols such as the AOAC or InfoGest 
methods, which cannot reflect the real enzymes activities during the human 
small intestinal digestion of carbohydrates.  
 Therefore, taking the above indicated as starting point, this Thesis 
aims to contribute to provide more insight into the gastrointestinal digestion 
and degradation that recognized and emerging prebiotics could undergo in 
the upper gastrointestinal tract, and to support the potential prebiotic 
properties of the latter  obtained from waste by-products from the agro-food 
industry. Therefore, this Thesis comprises a multidisciplinary study that 
includes: i) a more suitable method to evaluate digestibility of carbohydrates 
using mammalian small intestinal extracts; ii) a wide range of analytic 
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techniques and iii) the use of robust fermentation in vitro models for the 
evaluation of the bioactivity of substrates. In this sense, the main objectives 
of this PhD Thesis are the evaluation of the in vitro digestibility of 
prebiotics such as lactulose, galactooligosaccharides (GOS) and 
fructooligosaccharides (FOS) using mammalian small intestinal mucosal 
carbohydrases and the in vitro fermentability of emerging proposed 
prebiotics such as pectin and derivatives. Hence, in order to accomplish 
these two main objectives, the following partial objectives have been 
established: 
1. In vitro digestibility of dietary prebiotics using mammalian 
digestive enzymes.  
a) To characterize (enzymatic activity, protein content, monosaccharide 
composition) a commercial small intestinal extract from rats and to 
establish the adequate conditions to carry out a simulated in vitro 
digestion of carbohydrates. To meet that aim, temperature and the 
ratio carbohydrate:enzyme has been optimized. 
b) To validate the in vitro digestion method developed evaluating the 
digestibility of dietary carbohydrates (lactose, sucrose, and maltose) 
and prebiotics with different structure such as lactulose, GOS with 
different linkages and monomers and lactosucrose. Degradation was 
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followed using adequate analytic techniques by the measurement of 
the release of their monomers and the diminution of initial 
concentrations after digestion. 
c) To perform a standardized in vitro gastrointestinal digestion model 
(InfoGest) on the digestion of prebiotics added to a food matrix such 
as milk and to compare the different effect of the gastrointestinal 
digestion with the in vitro digestion model obtained with the small 
intestinal rat extract. 
d) To apply an in vitro method using the brush border membrane 
vesicles from the small intestine of pig, evaluating the impact of 
different structural features of GOS in their capability to resist 
enzymatic degradation. All of this has been performed to establish the 
structure-function relationships of these oligosaccharides by using 
small intestinal mucosal carbohydrases. 
2. In vitro digestibility and fermentability of pectin and pectic 
compounds obtained from agricultural by-products. 
e) To structurally characterize (degree of polymerization, 
monosaccharide composition, degree of methoxyl esterification) a 
range of modified pectins obtained by enzymatic hydrolysis of initial 
pectin. Once the structure was elucidated, an in vitro evaluation of the 
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fermentation properties was carried out in pH-controlled batch 
fermentation systems inoculated with human faecal slurries. 
f) To study the behaviour of pectin during its gastrointestinal digestion 
and fermentation properties in a dynamic multi-compartmental 
continuous in vitro model, which simulated the process occurring in 
the stomach, small intestine, and ascending, transverse and 
descending colon.  
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3. Work Plan and structure/outline of the Thesis 
In order to achieve the goals outlined above, the work plan for this 
PhD Thesis is schematically represented below. Thus, the schematic diagram 
provides an overview of the studies carried out which have been organized in 
two main parts.  
On a first stage, the enzyme activity characterization of a commercial 
small intestinal extract from rat was carried out for its subsequent application 
to the digestibility of different recognized prebiotic and dietary carbohydrates 
(Chapter 1). Successful optimization of the method allowed its application in 
the assessment of the matrix effect during the degradation of prebiotic within 
a real food such as milk, considering a first step of gastrointestinal digestion 
by InfoGest method (Chapter 2). In addition, non-commercial intestinal 
brush border membrane vesicles isolated in the laboratory from pig whose 
carbohydrase activities were firstly tested, was also used to, eventually, 
determine the effect of structural features of prebiotics on their intestinal 
digestion (Chapter 3).  
On a second part, a subset of different pectins and modified pectins 
obtained from agro-food wastes were subjected to a static in vitro 
fermentation to evaluate their potential prebiotic properties (Chapter 4). 
Lastly, given the potential prebiotic properties observed in the static 
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fermentation, a commercial pectin isolated from citrus by-products was 
subjected to an in vitro dynamic gastrointestinal system (Chapter 5). A multi-
compartmental simulator (simgi®) was used at this stage, evaluating the 
changes on pectin structure during digestion and the positive effect on 
microbiota. 
Each of these chapters corresponds to scientific papers (all of them 
published in peer-reviewed journals) that this PhD Thesis has triggered. They 
are presented in the conventional format of publication (abstract, 
introduction, material and methods, results and discussion, and conclusion). 
The abstract briefly states the purpose of each research, the most-remarkable 
results and major conclusions. Introduction states the objectives of the work 
and provides an adequate background to the article. Material and methods 
section shows the details about the starting material and the methods to allow 
the work to be reproduced. A results and discussion section (combined or 
not) explores the significance of the results of the research. Finally, the main 
conclusions of the study are presented in a short conclusions section, which 
may stand alone or form a subsection of a results and discussion section. 
References of all chapters are placed at the end of the manuscript. In addition, 
reader can find supplementary material to chapters when it is specified at the 
end of the dissertation (Annexes A-C), an additional published scientific paper 
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carried out in collaboration with a private enterprise of digestive supplements 
(Annex D) and the scientific publications obtained from the work developed 
in this Thesis (Annex E).  
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Chapter 1 
Assessment of in vitro digestibility of dietary 
carbohydrates using rat small intestinal extract 
Alvaro Ferreira-Lazarte, Agustín Olano, Mar Villamiel, and F. Javier Moreno 
Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM). C/Nicolás 
Cabrera, 9, Campus de la Universidad Autónoma de Madrid, 28049 Madrid, Spain 
 
Reproduced from ACS Publications 
Journal of Food and Agricultural Chemistry 
2017, 65, 8046-8053 
DOI: 10.1021/acs.jafc.7b01809 
 
 
 
Abstract:  
There are few studies on the assessment of digestibility of non-digestible 
carbohydrates, despite their increasingly important role in human health. In vitro 
digestibility of a range of dietary carbohydrates classified as digestible (maltose, 
sucrose, and lactose), well recognized (lactulose, fructooligosaccharides (FOS), and 
two types of galactooligosaccharides (GOS) differing in the predominant glycosidic 
linkage), and potential (lactosucrose and GOS from lactulose, OsLu) prebiotics 
using a rat small intestinal extract (RSIE) under physiological conditions of 
temperature and pH is described. Recognized and potential prebiotics were highly 
resistant to RSIE digestion although partial hydrolysis at different extents was 
observed. FOS and lactulose were the most resistant to digestion, followed closely 
by OsLu and more distantly by both types of GOS and lactosucrose. In GOS, β(1→ 
6) linkages were more resistant to digestion than β(1 →4) bonds. The reported in 
vitro digestion model is a useful, simple, and cost-effective tool to evaluate the 
digestibility of dietary oligosaccharides. 
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Introduction:  
There is growing evidence indicating that dietary nondigestible 
oligosaccharides (NDO) play an increasingly important role in health. Low 
glycemic index foods, characterized by slowly absorbed carbohydrates, are 
linked with reduced risk of common chronic Western diseases associated 
with central obesity and insulin resistance (Jenkins et al. 2002; Augustin et al. 
2002). These pieces of evidence have boosted the interest in the use of 
nondigestible (or with slow digestion rate) carbohydrates as food ingredients 
due to their ability to reduce postprandial glycemic response (Lee et al. 
2016). The attention to NDO is also reinforced by the fact that regulatory 
agencies such as the EFSA have acknowledged that the consumption of 
foods/drinks, in which NDO replace simple sugars, reduces postprandial 
glycaemic and insulinaemic responses. This behavior is attributed to the 
resistance of NDO to hydrolysis and absorption in the small intestine (EFSA 
2011; EFSA 2014a, 2014b, 2014c).  
A specific subset of nondigestible carbohydrates, so-called prebiotics, 
have attracted especial interest due to their capability to reach the colon and 
be selectively fermented by the intestinal microbiota that results in specific 
changes in its composition and/or activity, thus contributing to human health 
promotion (Gibson et al. 2004; Roberfroid et al. 2010). Intestinal microbiota 
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plays an important role in a great variety of physiological process, such as the 
development of the host immune system, anti-inflammatory activity, uptake 
of energy from the host diet, production of short-chain fatty acids by 
fermentation, alteration of human glucose and fatty acid metabolism, 
regulation of intestinal permeability, or stimulation of mineral absorption by 
the large intestine (Chung et al. 2010; Ding et al. 2010; Havenaar 2011; 
Giacco et al. 2016).   
However, despite the generally accepted concept that NDO pass 
through the upper gastrointestinal tract without substantial modifications 
(Roberfroid et al. 2010), few efforts have been made toward the study of the 
resistance of this type of oligosaccharides to the digestion in the small 
intestine, and only scarce and fragmented information on their pass 
throughout the small intestine is available. In this context, the limitations of 
AOAC method 2009.01 (McCleary et al 2010), for the measurement of NDO 
have already been highlighted, such as the use of a very limited number of 
enzymes (i.e., α-amylase and amyloglucosidase) which fail to hydrolyze 
digestible saccharides (including sucrose or starch-decomposed products), as 
well as the use of enzymes from fungal origin despite it being well-known 
that the hydrolyzing activity of enzymes from fungal or microbial sources 
does not reflect the carbohydrase activities of enzymes of the human 
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gastrointestinal tract.(Tanabe et al. 2014). Consequently, alternative methods, 
which are based on the use of mammalian intestinal enzymes, such as those 
derived from pigs (Tanabe et al. 2015) and weaning piglets, (Strube et al. 
2015) have recently been proposed. However, up to date, the regular supply 
of porcine small intestinal enzymes is not commercially available, which may 
hinder an easy and broad implementation of these useful methods to evaluate 
the in vitro intestinal digestion of oligosaccharides. In this sense, the use of 
rat small intestinal extract (RSIE) can be advantageous because of its 
commercial availability, as well as the reported similarity of hydrolyzing 
activities between human and rat small intestinal disaccharidases (Oku et al. 
2011). In fact, the use of RSIE has been successfully applied for the 
assessment of digestibility of prebiotics, such as fructooligosaccharides 
(FOS) (Oku et al. 1984) and galactooligosaccharides (GOS), (Ohtsuka et al. 
1990; Ferreira-Lazarte et al. 2017a) as well as to a range of maltose and 
sucrose isomers3 and isomaltooligosaccharides (Kaulpiboon et al. 2015). 
However, to the best of our knowledge, a comparative study of well-
recognized prebiotics, that is FOS, GOS, and lactulose, and potential and 
novel candidates, such as lactosucrose and GOS derived from lactulose 
(OsLu), has not been carried out. Particularly, GOS comprise a complex 
mixture of, mainly, disaccharides and trisaccharides having a variety of 
glycosidic linkages with β-anomeric configuration. While β(1→4) and 
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β(1→6) are the most common glycosidic linkages found in GOS structures, 
β(1→2) and β(1→3) can also be found in the mixture (Torres et al. 2010; 
Otieno et al. 2010). Bearing in mind that there is evidence in the literature 
indicating that the linkage type could be a factor more important than 
monomer composition in determining the susceptibility of carbohydrates to 
digestive glycosidases (Lee et al. 2016), the enzymatic susceptibility of GOS 
could be largely affected by differences in the predominant glycosidic 
linkage.  
Therefore, the aim of the present study was to evaluate the small 
intestinal digestibility of well-recognized prebiotics, that is lactulose, FOS 
(kestose and nystose), and two types of conventional GOS with predominant 
β(1→4) or β(1→6) linkages, respectively, as well as emerging prebiotic 
candidates such as lactosucrose and OsLu, and their comparison with 
digestible disaccharides (lactose, sucrose, and maltose) used as appropriate 
controls in an in vitro digestion model using RSIE. 
Materials and methods:  
 
Chemicals and reagents. Fructose (Fru) standard was purchased from Fluka 
analytical. D-Galactose (Gal), D-glucose (Glc), lactose (β-D-Gal(1→4)-D-
Glc), sucrose (β-D-Fru(2→1)-α-D-Glc), maltose (α-D-Glc(1→4)-D-Glc), 
trehalose (α-D-Glc(1→1)-α-D-Glc), palatinose (also termed isomaltulose) (α-
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D-Glc(1→6)-D-Fru), lactulose (β-D- Gal(1→4)-D-Fru), kestose (β-D-
Fru(2→1)-β-D-Fru(2→1)-α-D-Glc), nystose (β-D-Fru(2→1)-β-D-Fru(2→1)-
β-D-Fru(2→1)-α-D- Glc), phenyl-β-glucoside, o-nitrophenyl (o-NP), p-
nitrophenyl (p-NP), o-nitrophenyl-β-D-glucopyranoside (o-NPG) and p-
nitrophenyl-α-glucopyranoside (p-NPG) standards, and intestinal acetone 
powders from rat (Rat Small Intestinal Extract, RSIE) were obtained from 
Sigma-Aldrich (St Louis, MO). Lactosucrose (β-D-Gal(1→4)-α-D-
Glc(1→2)-β-D-Fru) standard was obtained from Wako Chemical Industries 
(Neuss, Germany). All standard carbohydrates were of analytical grade 
(purity ≥ 95 %). 
Obtainment of prebiotic ingredients. OsLu were obtained at pilot scale by 
the company Innaves S.A. (Vigo, Spain) following the method described by 
López-Sanz et al. (2015). In brief, OsLu were synthesized using a 
commercial lactulose preparation (670 g/L; Duphalac, Abbott Biologicals 
B.V., Olst, The Netherlands), diluted with water at 350 g/L and pH adjusted 
to 6.7 with KOH, and a β-galactosidase from Aspergillus oryzae (16 U/mL; 
Sigma). The mixture of oligosaccharides (20% [w/v]) was treated with fresh 
Saccharomyces cerevisiae (1.5% [w/v]; Levital, Paniberica de Levadura S.A., 
Valladolid, Spain) at 30 °C and aeration at 20 L/min to remove 
monosaccharides. Finally, the samples were vacuum concentrated at 40 °C in 
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a rotary evaporator (Büchi Labortechnik AG, Flawil, Switzerland). The two 
commercial GOS syrups with predominant β(1→4) (named GOS-1) and 
β(1→6) (named GOS-2) linkages were kindly provided by the corresponding 
manufacturers whereas a mixture of FOS consisting of kestose and nystose 
was obtained from Wako Chemical Industries (Neuss, Germany).  
The composition of OsLu syrup, whose main involved glycosidic linkage 
was β(1→6), expressed in g per 100 g of ingredient was as follows: 0.5% 
fructose, 12.5% galactose, 26% lactulose, 19.6% OsLu disaccharides, 16.0% 
OsLu trisaccharides (making 61.6% of potential NDO) and 25.7% moisture. 
GOS-1 syrup had 21% moisture and the composition of carbohydrates was 
1% galactose, 21.4% glucose, 13% lactose, 19.2% GOS-disaccharides, 20.8% 
GOS-trisaccharides and 3.6% GOS-tetrasaccharides (equivalent to 43.6% of 
potential NDO). GOS-2 syrup composition was: 6.7% galactose, 22.6% 
glucose, 19.0% lactose, 9.9% GOS-disaccharides, 14.2% GOS-trisaccharides, 
0.7% GOS-tetrasaccharides (equivalent to 24.8% of potential NDO) and 27% 
moisture. 
Determination of protein content and main enzyme activities of the Rat 
Small Intestinal Extract (RSIE). RSIE was used to prepare an 
enzyme/enzymatic solution according to the method of Olaokun et al. (2013), 
with minor modifications. RSIE (10 mg/ mL) was homogenized in ice-cold 
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0.05 M sodium phosphate buffer solution. Then, the solution was centrifuged 
at 2,415 x g for 15 min and the supernatant obtained was used as the enzyme 
solution for determining protein content and enzymatic activity. 
Protein content. The total protein content of the enzymatic solution was 
quantified according to the Bradford method using the Bio-Rad Protein 
Assay kit and bovine serum albumin as a standard. The absorbance was 
monitored at 595 nm (Bradford 1976).  
Hydrolytic activities. β-galactosidase and maltase activities. The 
determination of the rat intestinal β-galactosidase activity was adapted from 
Warmerdam et al. (2014). A solution of o-NPG in phosphate buffer 0.05 M, 
pH 7.0 with a concentration of 0.5 mg/mL (0.05% w/w) was prepared. The 
enzymatic activity was determined by incubating 1,900 μL of the o-NPG 
solution and 100 μL of enzyme solution from RSIE for 2 h at 37 °C. The 
method is based on the measuring of the continuous release of o-NP from o-
NPG. Absorbance of released o-NP was measured at 420 nm every 20 s using 
a spectrophotometer (Specord Plus, Analytik Jena) together with a 
temperature controller (Jumo dTRON 308, Jumo Instrument Co.). The 
specific enzymatic activity (U) was expressed in μmol min−1 g−1, where one 
unit was defined as the amount of enzyme that produced 1 μmol of o-NP in 
one min of reaction (n=6). Similar procedure was used to determine the 
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maltase activity but using a solution of p-NPG in phosphate buffer 0.05M, 
pH 6.8 with (0.05% w/w) and monitoring the release of p-NP at 420 nm 
every 20 s (n=3). 
Sucrase, trehalase and palatinase activities. Sucrase, trehalase and 
palatinase activities were determined following the method described by 
Ghazi et al. (2005) with slight modifications. An individual solution of 
sucrose, trehalose or palatinose (0.5% w/w) in sodium phosphate buffer 0.05 
M, pH 6.5 was used. An eppendorf tube with 250 μL of sucrose, trehalose or 
palatinose solution was preheated at the reaction temperature, 37 °C. 
Subsequently, 100 μL of enzyme solution was added and the mixture was 
incubated for 2 h and different aliquots were taken at different times (5, 10, 
15, 30, 60, 90, and 120 min). Hydrolysis was stopped by adding 350 μL of a 
3,5-dinitrosalicylic acid (DNS) solution prepared according to Asare-Brown 
& Bullock (1988). Sucrase, trehalase and palatinase activities were 
determined measuring the reducing sugars released from the corresponding 
disaccharide hydrolysis, at 540 nm, according to the DNS method (Miller 
1959). The specific enzymatic activity (U) was expressed in μmol min−1 g−1, 
where one unit was defined as the amount of enzyme that produced 1 μmol of 
reducing sugars in one min of reaction (n=3). 
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In vitro small intestinal digestion using RSIE. The digestibility of two 
types of conventional GOS, (GOS-1 and GOS-2), OsLu, a mixture of FOS 
(comprised of kestose and nystose), lactosucrose, lactulose and digestible 
oligosaccharides such as lactose, sucrose and maltose were evaluated using 
RSIE. In a first step, preliminary assays aimed to determine an optimal RSIE-
carbohydrate weight ratio within 2 h of reaction were carried out using 
lactulose and lactose as appropriate controls. Finally, a solution of 20 mg of 
RSIE and 1 mL distilled water was prepared as a digestive enzyme solution, 
resulting in a pH value of 6.8. Subsequently, 0.5 mg of carbohydrate was 
added and the mixture was incubated at 37 °C under continuous agitation 
(450 rpm) for 2 h. Aliquots were taken at 15, 30, 60, 90, and 120 min of 
digestion and heated in boiling water for 5 min to stop the reaction. The 
digestion was monitored by GC-FID as described below. In addition, a series 
of control samples, based on the incubation of RSIE without carbohydrates 
during the same reaction times, were analysed. Results showed a slight 
increase of galactose and a notable release of glucose as the digestion 
proceeded. These values were conveniently subtracted in order to avoid any 
overestimation of the monosaccharide fraction.  
Carbohydrate analysis by GC-FID. Trimethylsilylated oximes (TMSO) of 
carbohydrates (mono-, di- and trisaccharides) present in samples were 
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determined following the method of Cardelle-Cobas et al. (2009b). 
Chromatographic analysis was carried out on an Agilent Technologies gas 
chromatograph (Mod7890A) equipped with a flame ionization detector 
(FID). The TMSO were separated using a 15 m x 0.32 mm × 0.10 μm film, 
fused silica capillary column (DB-5HT, J&W Scientific, Folson, California, 
USA). Nitrogen was used as carrier gas at a flow rate of 1 mL/min. Injector 
and detector temperatures were 280 and 385 °C, respectively. The oven 
temperature was programmed from 150 to 380 °C at a heating ratio of 3 
°C/min. Injections were made in the split mode (1:5). The TMSO derivatives 
were formed following the method of Ruiz-Matute et al. (2012). First, a 
volume of 450 μL of the resulting intestinal digesta, corresponding to 225.0 
μg of saccharides was added to 200 μL of internal standard solution, 
containing 0.5 mg/mL of phenyl-β-glucoside. Afterward, the mixture was 
dried at 40 °C in a rotary evaporator (Büchi Labortechnik AG, Flawil, 
Switzerland). Sugar oximes were formed by adding 250 μL hydroxylamine 
chloride (2.5%) in pyridine and heating the mixture at 70 °C for 30 min. 
Subsequently, the oximes obtained in this step were silylated with 
hexamethyldisylazane (250 μL) and trifluoroacetic acid (25 μL) at 50 °C for 
30 min (Brobst & Lott 1966). Derivatization mixtures were centrifuged at 
6,700 x g for 2 min and supernatants were injected in the GC. Data 
acquisition and integration were done using Agilent ChemStations software 
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(Wilmington, DE, USA). Response factors were calculated after the duplicate 
analysis of standard solutions (fructose, galactose, glucose, lactose, lactulose, 
sucrose, raffinose and stachyose), at different concentrations ranging from 
0.005 to 4 mg/ mL. 
Statistics. All digestions were carried out in duplicate and two GC-FID 
analysis were performed for each digestion treatment (n=4). The comparisons 
of means using analysis of variance (ANOVA) were made using the 
statistical package (SPSS Inc., Chicago, Il). The differences were considered 
significant when p<0.05. 
Results and discussion:  
 
Determination of the main enzymatic activities of the RSIE. Table 1 
shows the protein content and β-galactosidase, maltase, sucrose, trehalase and 
palatinase activities of RSIE measured under the assayed digestion 
conditions. Maltase activity was the highest with 17-, 19-, 65 and 134-fold 
increases as compared to -galactosidase, sucrose, trehalase and palatinase 
activities, respectively. These data are in agreement with the huge difference 
previously reported between the activity of maltase and the rest of 
disaccharidases of the whole region of the small intestine of rats (Oku et al. 
2011). In consequence, RSIE exhibited much more moderate β-galactosidase 
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and sucrase activities with similar values of 26.7 U and 23.5 U, respectively. 
In contrast to these values, Oku et al. (2011) observed a 4-fold increase of 
sucrase activity as compared to -galactosidase activity in the small intestine. 
This dissimilarity could be attributed to several methodological factors, such 
as different assay and detection methods, and/or different substrates (lactose 
vs o-NPG) used in both studies. In addition, -galactosidase activity 
gradually decreases during aging of the rat (Alexandre et al. 2013), which 
could impair the comparison between different studies. Finally, RSIE showed 
low trehalase and palatinose activities whose specific values were in 
agreement with previous work (Oku et al. 2011). 
 
 
 
Table 1. Protein Content and Enzymatic Activities of Rat Small Intestine Extract (RSIE) 
Measured at the Studied Conditions. 
 
Activity  Substrate  Condition (pH; 
T) 
 U (µmol/min g) 
β-galactosidase  o-NPGa  7.0; 37 ˚C  26.7 ± 2.0b 
Maltase  p-NPGa  6.8; 37 ˚C  443.2 ± 2.0c 
Sucrase  Sucrosed  6.8; 37 ˚C  23.5 ± 0.7c 
Palatinase  Palatinosed  6.8; 37 ˚C  3.3 ± 0.4c 
Trehalase  Trehalosed  6.8; 37 ˚C  6.8 ± 1.0c 
Protein content of RSIE: 8.9 ± 0.4% (w/w). 
a Enzyme activity determined by measuring the absorbance of released NP at 420 nm. 
b Values are expressed as means ± SD (n=6). 
c Values are expressed as means ± SD (n=3). 
d Enzyme activity determined by measuring the absorbance of released reducing sugars at 540 nm. 
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Small intestinal digestion of digestible carbohydrates  
Figure 1 shows the evolution of maltose, sucrose and lactose throughout the 
intestinal digestion process with the extract. Although substantial hydrolysis 
rates were observed in all cases, dissimilar trends were observed for each 
carbohydrate. Thus, maltose was rapidly and fully digested as it disappeared 
after 15 min of digestion, which was the first sampling time (Figure 1A). 
Sucrose showed a slower but also high digestion rate, achieving a relative 
hydrolysis rate of 88.1% at the end of the digestion (Figure 1B), whereas 
lactose was the less hydrolysed substrate with a maximum degradation of 
55.8% (Figure 1C). Among the human and rat dissacharidases, -
galactosidase has been reported to have the lowest activity which could 
explain the lower hydrolysis rate of lactose as compared to maltose and 
sucrose (Oku et al. 2011).  
Small intestinal digestion of prebiotic carbohydrates 
The digestibility of a total of six carbohydrates classified as well-known 
(lactulose, GOS-1, GOS-2 and FOS) or potentially prebiotics (lactosucrose 
and OsLu) was assessed using RSIE and, conveniently, monitored and 
quantified by GC-FID in order to draw insights from the partial breakdown, if 
any, of the tested prebiotics.  
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Figure 1. Hydrolysis rates of maltose (A), sucrose (B) and lactose (C) and their released monosaccharides upon small intestinal 
digestion at 37 ˚C, pH 6.8 for 2 hours using RSIE. 
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Single carbohydrates as lactosucrose and, specially, lactulose, showed a 
high resistance to the intestinal digestion, resulting in low hydrolysis degrees 
of 26.0% and 11.1% (Table 2), respectively, after 2 h of digestion.  
Remarkably, GOS-2, with (1→6) predominant linkage, showed a 
significantly higher overall resistance to intestinal digestion (23.3% of 
hydrolysis degree at the end of digestion) than GOS-1 (34.2% of hydrolysis 
degree), whose main linkage is (1→4), highlighting the key role played by 
the glycosidic linkage involved in the oligosaccharide chain.  
Novel galacto-oligosaccharides derived from lactulose (OsLu) presented 
an overall hydrolysis degree (i.e., 18%) which was significantly higher than 
that of lactulose only at longer digestion times (90 and 120 min), whereas no 
significant differences between both carbohydrates were observed during the 
first hour of digestion. Nevertheless, OsLu had a hydrolysis degree 
significantly lower than those of GOS-2 and, specially, GOS-1 throughout 
the digestion process (Table 2). OsLu and GOS-2 are mainly comprised of 
oligosaccharides containing (1→6) as the main glycosidic linkage but they 
differ in the presence of fructose at the reducing end of OsLu instead of 
glucose. Therefore, this result reveals that the monomer composition is also a 
critical factor for carbohydrate digestibility. These data are in good 
agreement with previous findings described by Hernández-Hernández et al. 
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(2012), who reported a lower ileal digestibility of OsLu as compared to GOS 
following an in vivo approach using rats. In addition, also in line with our 
findings, these authors observed that (1→6) and (1→2) linkages between 
galactose and glucose monomers were significantly more resistant to in vivo 
gastrointestinal digestion than the (1→4) linkage between galactose units 
within the GOS mixture. According to these comparative findings, it could be 
inferred that the in vitro digestion model developed in the present work is 
suitable for replacing in vivo rat models, stressing the usefulness of the RSIE 
as a reliable, simple and cost-effective tool to assess carbohydrate 
digestibility. Recently, OsLu have also shown to be more resistant to in vitro 
digestion than conventional GOS following their inclusion in milk (Ferreira-
Lazarte et al. 2017a).  
 Finally, FOS, a mixture comprised of kestose and nystose, were also less 
prone to intestinal degradation than GOS-1 and GOS-2, showing a low 
hydrolysis degree of 12.0% after 2 h of digestion (Table 2). These data 
confirm the high resistance to mammalian digestive enzymes of (2→1) 
linkages previously observed in FOS (Roberfroid et al. 2010; Oku et al. 
1984). In addition, the overall hydrolysis degree obtained with the current in 
vitro digestion model is fairly similar to a previous in vivo study carried out 
with healthy humans and based on aspiration of the gut content at the 
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terminal ileum (Molis et al. 1966). Concretely, up to 89% of ingested FOS in 
a single meal was recovered in intact form. Consequently, these authors 
indicated that around 11% of FOS was hydrolysed by either acidic conditions 
or digestive enzymes in the small intestine. 
 
Table 3 shows the individual content in the monosaccharide fraction of 
all prebiotic oligosaccharides assayed, as well as the joint content of di-, tri- 
and tetrasaccharide fractions in GOS and OsLu mixtures. In agreement with 
the overall hydrolysis degree displayed in Table 2, in GOS-1 the minor 
tetrasaccharide fraction was substantially reduced and also, although at a 
lesser extent, the tri- and disaccharide fractions, whereas GOS-2 and OsLu 
presented substantial hydrolysis only in the disaccharide fraction (Table 3). 
Furthermore, Figures 2 and 3 illustrate the different resistance of the 
 
Table 2. Hydrolysis Degree A (%) of Non-Digestible Carbohydrates during the Small 
Intestinal Digestion Treatment using RSIE at 37 ˚C, pH 6.8. 
 
Digestion 
time (min) 
 
 Lactulose GOS-1B 
 
GOS-2B 
 
OsLuC 
 
FOSD 
 
Lactosucrose 
 
15  
 
3.2 ± 0.5 a 13.2 ± 1.7 c 9.7 ± 1.5 b 2.5 ± 1.3 a 
 
2.9 ± 0.1 a 7.4 ± 0.8 b 
30  4.5 ± 0.3 a 21.1 ± 1.2 d 15.7 ± 1.5 c 6.2 ± 1.0 a 4.3 ± 0.2 a 10.4 ± 0.4 b 
60  7.9 ± 0.1 a 30.1 ± 1.0 c 18.0 ± 1.1 b 8.1 ± 0.8 a 7.2 ± 0.3 a 18.0 ± 1.4 b   
90  8.9 ± 0.2 a 34.2 ± 1.3 d 22.4 ± 1.7 c 16.0 ± 1.1 b 10.3 ± 0.4 a 21.4 ± 2.3 c   
120 
  
11.1 ± 0.1 a 34.2 ± 0.5 d 
 
23.3 ± 0.7 c 
 
18.0 ± 3.2 b 
 
12.0 ± 0.6 a   26.0 ± 1.7 c 
 
 
A Data are expressed as the mean ± SD (n=4). 
B Hydrolysis degree (%) based on the joint digestibility of di-, tri- and tetrasaccharide fractions. 
C Hydrolysis degree (%) based on the joint digestibility of di- and trisaccharide fractions. 
D Hydrolysis degree (%) based on the joint digestibility of kestose and nystose. 
a, b, c Different letters indicate statistical differences between all tested carbohydrate samples at the same reaction 
time using a one-way analysis of variance (ANOVA) (p < 0.05) (n=4).  
 
 103 
individual carbohydrates of GOS-1 and OsLu, respectively, to intestinal 
digestion based on their corresponding GC-FID profiles. Peaks 5 and 7, 
identified as 4’-galactosyl-lactose (β-D-Gal(1→4)-β-D-Gal-(1→4)-D-Glc) 
and 4’-digalactosyl-lactose (β-D-Gal(1→4)-β-D-Gal(1→4)-β-D-Gal-(1→4)-
D-Glc), respectively (Cardelle-Cobas et al. 2009b), were the main tri- and 
tetrasaccharide present in GOS-1 and clearly diminished after two hours of 
RSIE digestion (Figure 2). However, peak 4, identified as allolactose (β-D-
Gal-(1→6)-D-Glc), an isomer of lactose having a (1→6) linkage, and the 
minor peak 8, identified as 6’-digalactosyl-lactose (β-D-Gal(1→6)-β-D-
Gal(1→6)-β-D-Gal-(1→4)-D-Glc), appeared to be fully resistant to RSIE 
digestion. In contrast, no measurable differences were observed in any of the 
individual chromatographic peaks corresponding to the trisaccharide fractions 
of OsLu, and only very small decreases could be detected in the disaccharide 
fraction (Figure 3). Therefore, the contribution to the overall hydrolysis 
degree of OsLu displayed in Table 2 seems to be due basically to the 
disaccharide fraction (Table 3).  
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Table 3. Carbohydrate Content Determined by GC-FID Analysis in Non-Digestible Oligosaccharides during the Small Intestinal Digestion Treatment using RSIE at 37 ˚C, pH 6.8. 
 
Sample Reaction time  Carbohydrate content (mg/100 mg of total carbohydrates)a 
  Fructose Galactose Glucose Lactose Lactulose Disaccharides Trisaccharides Tetrasaccharides Total OSb 
Lactulose blank 0.0 ± 0.0 0.0 ± 0.0  N.D. N.D. 100.0 ± 0.0 N.D. N.D. N.D. N.D. 
 15 min 1.1 ± 0.1 2.1 ± 0.4 N.D. N.D. 96.8 ± 0.5 N.D. N.D. N.D. N.D. 
 30 min 2.1 ± 0.2 2.4 ± 0.2 N.D. N.D. 95.5 ± 0.3 N.D. N.D. N.D. N.D. 
 60 min 3.6 ± 0.1 4.3 ± 0.1 N.D. N.D. 92.1 ± 0.1 N.D. N.D. N.D. N.D. 
 90 min 4.3 ± 0.1 4.4 ± 0.4 N.D. N.D. 91.3 ± 0.5 N.D. N.D. N.D. N.D. 
 120 min 5.1 ± 0.1 6.1 ± 0.1 N.D. N.D. 88.8 ± 0.1 N.D. N.D. N.D. N.D. 
GOS-1 blank N.D. 1.2 ± 0.0 27.1 ± 0.5 16.5 ± 0.3 N.D. 24.3 ± 0.4 26.3 ± 0.4 4.6 ± 0.6 55.2 ± 0.7 
 15 min N.D. 7.9 ± 0.2 29.3 ± 1.0 14.8 ± 0.4  N.D. 20.7 ± 0.4 24.1 ± 0.3 3.1 ± 0.3 48.0 ± 1.0 
 30 min N.D. 12.5 ± 0.8 29.8 ± 0.7 14.1 ± 0.4 N.D. 20.0 ± 0.3 21.5 ± 0.5 2.1 ± 0.2 43.6 ± 0.9 
 60 min N.D. 16.6 ± 0.6 32.4 ± 1.0 12.4 ± 0.3 N.D. 17.2 ± 0.3 19.7 ± 0.3 1.7 ± 0.4 38.6 ± 0.9 
 90 min N.D. 22.2 ± 1.0 30.1 ± 1.4 11.3 ± 0.2 N.D. 17.1 ± 0.6 17.7 ± 0.2 1.4 ± 0.1 36.3 ± 0.8 
 120 min N.D. 23.7 ± 0.9 30.1 ± 0.8 10.6 ± 0.2 N.D. 16.7 ± 0.3 17.7 ± 0.4 1.7 ± 0.1 36.3 ± 0.3 
GOS-2 blank N.D. 9.2 ± 0.1 31.0 ± 0.1 26.0 ± 0.1 N.D. 13.5 ± 0.1 19.4 ± 0.1 0.9 ± 0.1 33.8 ± 0.1 
 15 min N.D. 14.0 ± 0.5 33.3 ± 0.6 22.1 ± 0.7 N.D. 11.5 ± 0.1 18.4 ± 0.6 0.6 ± 0.1 30.5 ± 0.6 
 30 min N.D. 16.3 ± 1.0 36.5 ± 1.5 18.7 ± 0.2 N.D. 10.6 ± 0.5 17.5 ± 1.6 0.4 ± 0.1 28.5 ± 1.2 
 60 min N.D. 18.4 ± 0.4 36.5 ± 1.3 17.3 ± 0.5 N.D. 9.4 ± 0.4 17.8 ± 0.3 0.6 ± 0.1 27.7 ± 0.5 
 90 min N.D. 18.1 ± 0.5 41.7 ± 0.1 13.9 ± 0.3 N.D. 7.9 ± 0.3 17.3 ± 0.4 1.0 ± 0.1 26.3 ± 0.6 
 120 min N.D. 20.2 ± 0.1 40.8 ± 1.8 12.9 ± 0.2 N.D. 7.9 ± 0.4 17.1 ± 1.2 0.8 ± 0.1 25.9 ± 1.5 
OsLu blank 0.6 ± 0.0 16.7 ± 0.3 N.D. N.D. 34.7 ± 0.1 26.2 ± 0.1 21.3 ± 0.2 N.D. 47.5 ± 0.2 
 15 min 0.9 ± 0.3 20.8 ± 0.9 N.D. N.D. 31.9 ± 0.9 23.5 ± 0.8 22.8 ± 0.8 N.D. 46.5 ± 0.8 
 30 min 0.9 ± 0.2 23.0 ± 0.8 N.D. N.D. 31.4 ± 0.7 22.6 ± 0.6 22.0 ± 1.0 N.D. 44.6 ± 0.5 
 60 min 1.2 ± 0.1 24.0 ± 0.7 N.D. N.D. 31.1 ± 0.4 20.0 ± 0.3 23.7 ± 0.4 N.D. 43.7 ± 0.4 
 90 min 2.2 ± 0.1 27.6 ± 0.8 N.D. N.D. 30.2 ± 0.1 18.9 ± 0.5 21.1 ± 1.0 N.D. 39.9 ± 0.5 
 120 min 2.0 ± 0.2 28.1 ± 1.4 N.D. N.D. 30.6 ± 0.4 17.8 ± 0.1 21.0 ± 1.9 N.D. 38.9 ± 1.8 
  Fructose Galactose Glucose - Sucrose - Kestose Nystose FOS 
FOS blank 0.3 ± 0.0 N.D. N.D.  2.7 ± 0.1  65.2 ± 1.1 31.8 ± 1.2 97.0 ± 0.1 
 15 min 2.5 ± 0.1 N.D. N.D.  3.3 ± 0.2  65.1 ± 0.8 29.1 ± 0.8 94.2 ± 0.1 
 30 min 3.8 ± 0.1 N.D. N.D.  3.3 ± 0.2  65.4 ± 1.0 27.5 ± 1.2 92.8 ± 0.2 
 60 min 6.6 ± 0.2 N.D. N.D.  3.4 ± 0.1  66.6 ± 0.6 23.4 ± 0.5 90.0 ± 0.1 
 90 min 9.8 ± 0.4 N.D. N.D.  3.2 ± 0.2  67.0 ± 0.8 20.0 ± 0.9 87.0 ± 0.3 
 120 min 11.6 ± 0.4 N.D. N.D.  3.1 ± 0.2  67.4 ± 0.5 18.0 ± 0.1 85.4 ± 0.5 
Lactosucrose  Fructose Galactose Glucose Lactose Sucrose - Lactosucrose -  
 blank 0.1 ± 0.1 0.0 ± 0.0 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.0  98.8 ± 0.3   
 15 min 0.8 ± 0.1 0.6 ± 0.1 2.5 ± 0.4 1.6 ± 0.1 3.0 ± 0.1  91.5 ± 0.6   
 30 min 1.4 ± 0.1 1.5 ± 0.1 2.7 ± 0.4 2.1 ± 0.1 3.8 ± 0.1  88.5 ± 0.4   
 60 min 2.5 ± 0.2 2.9 ± 0.2 5.9 ± 0.9 3.3 ± 0.2 4.6 ± 0.1  81.0 ± 1.4   
 90 min 3.9 ± 0.1 4.2 ± 0.2 4.5 ± 2.3 4.6 ± 0.1 5.2 ± 0.1  77.7 ± 2.3   
 120 min 5.4 ± 0.3 5.5 ± 0.4 4.9 ± 0.9 5.9 ± 0.5 5.3 ± 0.2  73.1 ± 0.7   
a Data are expressed as the mean ± SD (n=4).  
b Total oligosaccharide contents based on the sum of di-, tri- and tetrasaccharide fractions. 
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Figure 2. GC-FID profiles of TMSO derivatives of carbohydrates present in GOS-1 undigested (red) and after 2 h of small intestinal 
digestion with RSIE (blue). Peaks: 1: Galactose, 2: Glucose, I.S.: Internal standard (phenyl-β-D-glucoside), 3: Lactose, 4: Allolactose, 5: 4’-
galactosyl-lactose, 6: 6’-galactosyl-lactose + unknown peak, 7: 4’-digalactosyl-lactose, 8: 6’-digalactosyl-lactose. 
+ Other disaccharides, ++ other trisaccharides, +++ other tetrasaccharides. * Disaccharides were considered the sum of peaks 3 to 4. ** 
Trisaccharides were the sum of peaks 5, 6 and other trisaccharides. *** Tetrasaccharides were quantified as the sum of peaks 7, 8 and other 
tetrasaccharides. 
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Figure 3. GC-FID profiles of TMSO derivatives of carbohydrates present in OsLu undigested (red) and after 2 h of small intestinal digestion 
with RSIE (blue). Peaks: 1: Fructose, 2: Galactose, 3: Glucose, I.S.: Internal standard (phenyl-β-D-glucoside), 4: Lactulose, 5: 1,1-
galactobiose, 6: 1,3-galactobiose, 7: 1,1-galactosyl-fructose 1, 8: 1,6-galactobiose E, 9: 1,6-galactobiose Z, 10: 6’-galactosyl-lactulose.  
+ Other disaccharides, ++ Other trisaccharides. * Disaccharides were considered the sum of peaks 5 to 9. ** Trisaccharides were the sum of 
peaks 10 and other trisaccharides. 
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Regarding FOS, nystose was partially hydrolysed and, probably, 
converted to kestose as indicated by the slight increase found in fructose 
content and the non-detection of released glucose and/or the trisaccharide 
inulotriose (β-D-Fru(2→1)-β-D-Fru(2→1)-β-D-Fru)  (Table 3). This could 
be indicative of a higher lability of the linkage (2→1) when is bonding 
fructose monomers instead of fructose and glucose in inulin-type FOS. 
Finally, the partial hydrolysis of lactosucrose gave rise to the release of 
similar levels of sucrose and lactose indicating, thus, no particular preference 
of the digestive enzymes between the (1→4) linkage of the lactose moiety 
and the (2→1) linkage of the sucrose moiety. 
To sum up, nine dietary carbohydrates, three digestible and six 
considered as non-digestible, were subjected to digestion using RSIE 
combined with physiological conditions (i.e., temperature and pH) and their 
hydrolysis products were comprehensively analysed and quantified by GC-
FID. The results confirmed the high and readily digestibility of maltose and 
sucrose, followed distantly by lactose. In any case, either the well-known or 
the potential prebiotics showed a higher resistance to RSIE digestion 
although partial hydrolysis at different extent was observed in all tested 
carbohydrates. Thus, FOS (a mixture of kestose and nystose) and lactulose 
were the most resistant carbohydrates to intestinal digestion, followed closely 
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by OsLu and, then, by GOS-2, lactosucrose and, finally, GOS-1 (Tables 2 
and 3). To the best of our knowledge, the present data are the first comparing 
the digestibility rates of two types of GOS differing in the predominant 
glycosidic linkage, revealing the higher resistance of (1→6) than (1→4) 
linkages to rat digestive enzymes. Moreover, the observed differences 
between OsLu and GOS-2 also pointed out the role of the monomer 
composition and, more concretely, the higher resistance of galactosyl-
fructoses than galactosyl-glucoses.  
There are currently very few studies and reliable data on the digestibility of 
potentially non-digestible carbohydrates, despite their increasingly important 
role in human health. The in vitro digestion model, based on the use of RSIE 
under physiological conditions of temperature and pH, described in this work 
has shown to be a useful, simple and cost-effective tool to evaluate the 
digestibility of dietary oligosaccharides. In general terms, the described 
method allows the distinction between digestible and non-digestible 
carbohydrates of degree of polymerization up to four, as the tested digestible 
carbohydrates were readily hydrolysed whereas the oligosaccharides 
classified as non-digestible were barely or significantly less hydrolysed than 
the digestible carbohydrates. The combination of RSIE digestion with 
sensitive and powerful separation methods, such as GC-FID, instead of 
 109 
colorimetric methods as it has been traditionally performed, allows much 
more informative read-outs of the digestion process (e.g., lability of different 
glycosidic linkages, determination of the released carbohydrates resisting 
digestion). In addition, the developed in vitro digestion model has the 
advantage of requiring a minimum quantity of carbohydrates (0.5 mg), which 
is typically a limiting factor when the digestibility of novel carbohydrates 
produced at laboratory scale is assessed. 
 
 
 111 
Chapter 2 
Study on the digestion of milk with prebiotic 
carbohydrates in a simulated gastrointestinal model 
Alvaro Ferreira-Lazartea, Antonia Montillaa, Ana-Isabel Mulet-Caberob, Neil 
Rigbyb,c, Agustín Olanoa, Alan Mackieb,c and Mar Villamiela 
 
 
a Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), C/ Nicolás 
Cabrera, 9, Campus de la Universidad Autónoma de Madrid, 28049 Madrid, Spain  
b Institute of Food Research, Norwich Research Park, Norwich NR4 7UA, United Kingdom  
c School of Food Science and Nutrition, University of Leeds, Leeds LS2 9JT, UK 
 
 
Reproduced from Elsevier 
Journal of Functional Foods 
2017, 33, 149-154  
DOI: 10.1016/j.jff.2017.03.031 
 
 
Abstract:  
The behaviour of oligosaccharides from lactulose (OsLu) included with milk was 
examined during in vitro gastrointestinal digestion using the Infogest protocol as 
well as some small intestine rat extract. The digestion was compared with 
commercial prebiotics GOS and Duphalac®. Electrophoretic analysis demonstrated 
that the prebiotic carbohydrates did not modify the gastric digestion of dairy 
proteins. Similarly, no significant effect of gastrointestinal digestion was shown on 
the prebiotic studied. In contrast, under the intestinal conditions using a rat extract, 
the oligosaccharides present in OsLu samples were less digested (<15%) than in 
GOS (35%). Moreover, lactulose was more prone to digestion than their 
corresponding trisaccharides. These results demonstrate the limited digestion of 
OsLu and their availability to reach the large intestine as prebiotic. 
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Introduction:  
Prebiotics can reach the distal portions of the colon to selectively 
stimulate the growth of bifidobacteria and lactobacilli, providing important 
benefits to health (Gibson et al. 2004). The most relevant compounds are 
oligosaccharides. These prebiotics may exert other bioactive properties such 
as improving mineral absorption and metabolic disorders and slow gastric 
emptying, among other effects (Moreno et al. 2014). 
Several commercial preparations of galactooligosaccharides (GOS) and 
fructooligosaccharides (FOS) are used as prebiotic ingredients in some foods 
such as infant formula and dairy products (Sabater et al. 2016). Lactulose (i.e. 
lactose isomer) is also a recognized prebiotic for the treatment of constipation 
and systemic portal encephalopathy (Schumann et al. 2002; Olano & Corzo 
2009). Given the huge interest in recent years towards the gastrointestinal 
function and new structures with improved properties, new routes to obtain a 
second-generation of prebiotic oligosaccharides are being explored (Moreno 
et al. 2017). This is the case of the oligosaccharides derived from lactulose 
(OsLu). These prebiotic mixtures, obtained by enzymatic synthesis using β-
galactosidases from microbial origin, might impart better prebiotic properties 
than commercial GOS (Moreno et al. 2014).  
One of the requirements for oligosaccharides to be considered as 
prebiotics is their resistance to digestion in the upper gastrointestinal tract. 
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The susceptibility of prebiotic oligosaccharides to hydrolysis during their 
passage through the gastrointestinal tract is largely affected by the chemical 
structure and can impact their final state when they reach the colon to be 
fermented by the microbiota. Ohtsuka et al. (1990) found that the 
trisaccharide 4’-galactosyl-lactose was hardly digested in vitro with a 
homogenate of intestinal mucosa of rats. According to Torres et al. (2010), 
more than 90% of GOS are stable to digestive enzymes and can reach the 
colon to exert their positive effect. Carbohydrate analysis before and after 
exposure to certain protocols of in vitro digestion have shown that xylo-
oligosaccharides, palatinose condensates, commercial GOS and lactulose 
were very resistant to hydrolysis, In contrast, lactosucrose, gentio-
oligosaccharides, soybean oligosaccharides, fructo-oligosaccharide and inulin 
were slightly hydrolysed under such conditions (Playne and Crittenden 
2009). 
To our knowledge, limited studies have been carried out on the 
digestibility of OsLu. Hernandez-Hernandez et al. (2012) pointed out in in 
vivo assays a higher resistance of OsLu compared to GOS during 
gastrointestinal digestion. This was ascribed to the presence of fructose in 
β(1→4) linkage with galactose at the reducing end of the OsLu molecules. 
However, there is a lack of studies on the susceptibility of OsLu to the 
gastrointestinal digestion when they are added in a food matrix and the 
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impact of these compounds on the digestion of other food components. These 
considerations are important since standards would be more prone to changes 
as they are not protected in a food medium. Establishing the digestibility of 
prebiotic carbohydrates is of great practical application, since this influences 
on the final dose of substrate that reaches the distal portions of gut to exert its 
prebiotic effect. Thus, the aim of this work has been to study the effect of the 
OsLu inclusion in milk on the digestion of proteins and the changes in the 
carbohydrate fraction using standardised in vitro digestive conditions with a 
more physiological relevant gastric digestion approach. A subsequent 
treatment with a rat small intestine extract has been included to study the 
effect of intestinal enzymes from mammals. The commercial prebiotics GOS 
and Duphalac® were also employed for comparison purposes. 
 
Materials and methods:  
 
Chemicals and reagents. Galactose, D-glucose, fructose, lactose, lactulose, 
raffinose, stachyose, phenyl-β-glucoside and intestinal acetone powders from 
rat (rat intestine extract, RSIE) from Sigma-Aldrich chemical Company (St 
Louis, MO).  
Obtainment of prebiotic ingredients. OsLu were obtained at pilot scale by 
Innaves S.A. (Vigo, Spain) following the method described by Anadón et al. 
(2013). In brief, OsLu were synthesised using a commercial lactulose 
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preparation (670 g/L; Duphalac®, Abbott Biologicals B.V., Olst, The 
Netherlands), diluted with water to 350 g/L and pH adjusted to 6.7 with 
KOH, and β-galactosidase from Aspergillus oryzae (16 U/mL; Sigma), 
selected by its high yield for synthesis of OsLu (Cardelle-Cobas et al. 2016). 
Enzymatic reactions were carried out at 50 ˚C in an orbital shaker at 300 rpm 
for 24 h. Afterwards, samples were immediately immersed in boiling water 
for 10 min to inactivate the enzyme. The mixture of oligosaccharides (20% 
[w/v]) was treated with fresh Saccharomyces cerevisiae (1.5% [w/v]; Levital, 
Paniberica de Levadura S.A., Valladolid, Spain) at 30ºC and aeration at 20 
L/min, to decrease the monosaccharides content (Sanz et al. 2005). Finally, 
the samples were vacuum concentrated at 40 ºC in a rotary evaporator (Büchi 
Labortechnik AG, Flawil, Switzerland). GOS syrup was kindly provided by 
Friesland Campina Domo (Hanzeplein, The Netherlands). 
Milk samples. Skim Milk Powder (low-heat organic, protein 42.34%, fat 
0.89%, lactose 49.8% (w/w) (SMP) was kindly provided by Fonterra NZ. 
The SMP was reconstituted at 10% with distilled water and, subsequently, 
lactulose (Duphalac®), GOS or OsLu were added at 5% (w/w), taking into 
account previous recommendations for prebiotic doses (3.3 g of prebiotic 
carbohydrates/100 mL) (Walton et al. 2012; Whisner et al. 2013; López-Sanz 
et al. 2015). The samples were labeled as SMP+Duphalac®, SMP+GOS and 
SMP+OsLu and were kept refrigerated until subsequent assays. 
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In vitro gastrointestinal digestion. The solutions (see Figure 1) used for the 
simulation of the oral and gastric phases were based on the standardized 
static digestion protocol Infogest (Minekus et al. 2014). 5 mL of sample was 
placed into a 70 mL glass v-form vessel thermostated at 37 oC. To simulate 
the oral phase, 4 mL of Simulated Salivary Fluid (SSF, (Table 1S, Annex A) 
Verhoeckx et al. (2015), 25 µL 0.3 M CaCl2(H2O) and 0.975 mL Milli-Q 
water were added and mixed for approximately 2 min using a 3D action 
shaker (Mini-gyro rocker-SSM3-Stuart, Barloworld Scientific limited, UK) at 
35 rpm.  The simulation of the gastric phase was conducted using a semi-
dynamic model described by Mulet-Cabero et al. (2017). The gastric fluids 
and enzyme solution were added gradually. Two solutions were added at a 
constant rate for 2 h: (1) 9 mL of  a mixture consisted of 88.9% Simulated 
Gastric Fluid (SGF), 0.06% 0.3 M CaCl2(H2O), 4.4% Milli-Q water and 
6.7% 2 M HCl was added using the dosing device of an autotitrator (836 
Titrando-Metrohm, Switzerland) and (2) 1 mL of pepsin (3,214 U/mg solid, 
using haemoglobin as substrate) solution (in water) was added to reach the 
protease activity of 2,000 U/mL in the final digestion mixture. This enzyme 
solution was added using a syringe pump (Harvard apparatus, PHD ultra, 
USA). The system was agitated using the 3D action shaker at 35 rpm during 
the digestion time. 
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The pH was recorded throughout the procedure. Samples (0.5 mL) were 
taken after 0, 1 and 2 h of digestion and the pepsin activity was stopped with 
100 L of 1 M NaHCO3 for a subsequent analysis of the protein fraction and 
the rest of the sample with 150 L of 5 M NaOH for the following intestinal 
digestion. This last sample was labelled as GPhase sample. After gastric 
digestion two different procedures for small intestinal digestion were carried 
out:  
 
 
Figure 1. Scheme of the experimental procedure. 
 
 119 
i) 2 mL of GPhase was freeze-dried and kept at -20°C until used for 
intestinal digestion assays with a crude enzyme of rat small intestine 
extract (RSIE). 5 mg of GPhase was mixed with 100 mg of RSIE and 
1 mL distilled water. The mixture was incubated at 37° for 2 h, taking 
samples after 0, 0.5, 1 and 2 h. These samples were centrifuged at 
10,000 rpm for 2 min and 100 µL of the supernatant was taken for 
carbohydrate analysis.  
ii) The rest of the liquid GPhase (~ 16.5 mL) was subjected to the small 
intestine conditions following the Infogest Protocol (Minekus et al., 
2014). The digestion was carried out at 37°C for 2 h. Samples (5 mL) 
were taken at 0, 1 and 2 h of small intestinal digestion, which were 
respectively labelled as 0-IPhase, 1-IPhase and 2-IPhase. They were 
freeze-dried until further analysis. 
Protein determination. The changes in the protein fraction during gastric 
digestion of milk containing prebiotic ingredients (GPhase 0, 1 and 2 h) were 
followed by SDS-PAGE. 65 µL of sample was mixed with 25 μL of 4X 
NuPAGE LSD sample buffer (Invitrogen, Carlsbad, California, USA) and 10 
μL of 8% dithiothreitol. The mixture was heated at 70 ºC for 10 min. 20 μL 
of mixture was loaded on a 12% polyacrylamide  NuPAGE Novex Bis-Tris 
precast gel (Invitrogen,Carlsbad, California, USA) and  RunBlue Precast 
SDS-PAGE gel cassette (Expedeon Ltd., Cambridgeshire, United Kingdom). 
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SDS-PAGE was performed according to the manufacture’s instructions. 
Mark 12 Unstained Standard (Invitrogen) was used as a molecular weight 
marker (ranging from 2.5 to 200 kDa).  
Carbohydrate analysis by GC-FID. Trimethyl silylated oximes (TMSO) of 
carbohydrates (mono-, di- and trisaccharides) present in samples were 
determined by Gas Chromatography following the method described by 
Montilla et al. (2009). Samples corresponding to 0.5 mg of saccharides were 
added to 0.2 mL of Internal Standard (I.S.) solution which contained 0.5 
mg/mL of phenyl-β-glucoside. Response factors respect to I.S. were 
calculated after the duplicate analysis of standard solutions (fructose, 
galactose, glucose, lactose, lactulose, sucrose, raffinose and stachyose), at 
different concentrations ranging from 0.005 to 4 mg/mL.  
Statistical analysis. All digestions were carried out in duplicate and analyses 
were also performed in duplicate (n=4). The comparison of means was 
carried out using one-way analysis of variance (Tukey HSD Multiple Range 
Test). Statistical analyses were performed using the SPSS statistical package 
(Inc., Chicago, Il). The differences were considered significant when p < 
0.05. 
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Results and discussion:  
 
Effect on protein digestion. Figure 1S (Annex A) shows the pH profile of the 
different samples of SMP with the addition of prebiotic ingredients (Table 
2S, Annex A, carbohydrate composition analysed by GC-FID) during their 
digestion in the semi-dynamic gastric model. The initial pH values were close 
to 7 in all cases and gradually decreased to 1.8 at the end of the gastric 
digestion. In general, the profiles of the milk samples with prebiotic 
ingredients were similar to that of the SMP (no prebiotic ingredient added).  
The gradual lowering of pH enables the restructuring of the proteins due to 
acid induced coagulation to be simulated and is based on typical pH profiles 
measured in vivo (Malagelada et al. 1979).  
The electrophoretic profile of proteins corresponding to samples 0, 1 and 2 h 
of gastric digestion are illustrated in Figures 2 and 3. These figures show 
bands of pepsin, caseins, BSA, β-lactoglobulin (β-Lg) and α-lactalbumin (-
La). In the case of mixtures with OsLu and GOS at 0 h (Figure 2) more 
intense bands appeared in the area corresponding to -La, probably due to 
the formation of complexes between the protein and carbohydrates, which 
disappeared during the digestion. In general, after 2 h of gastric digestion, the 
bands corresponding to undigested proteins from both SMP and SMP with 
added prebiotics were not detected with the exception of β-Lg which has 
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been shown to be more resistant to pepsin hydrolysis (Mandalari et al. 2009). 
Figure 3 shows some diffuse, low molecular weight bands in samples 
corresponding to 1 and 2 h of digestion which could be related to small 
molecular weight peptides formed after milk protein digestion (lanes 5-12). 
The intensity of these bands was estimated by the Quantity One software. 
This showed an increase of intensity with digestion time obtaining values of 
0.54 at 0.62 after 1 h and 0.64 at 0.75 after 2 h, with the lowest values 
corresponding to skim milk control.  
These results show that the SDS-PAGE profile of milk with prebiotic 
carbohydrates was similar to that of milk without addition of these 
ingredients, indicating that the presence of these prebiotics in milk at the 
concentration required to achieve a prebiotic effect, did not modify the 
gastric digestion of dairy proteins. 
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Figure 2. Electrophoretic profiles of milk protein fractions (caseins, β-Lg, α-La, BSA) 
before and after 2 h of digestion (Bis-Tris-Gel, Novex, NuPage). M: Marker, 1: SMP 0 h, 2: 
SMP 2 h, 3: SMP+OsLu 0 h, 4: SMP+OsLu 2 h, 5: SMP+ Duphalac 0 h, 6: 
SMP+Duphalac® 2 h, 7: SMP+GOS 0 h, 8: SMP + GOS 2 h, 9: blank  
 
 
 
Figure 3. Electrophoretic profiles of milk protein fractions (caseins, β-Lg, α-La, BSA) 
during 0, 1 and 2 h of digestion (RunBlue Precast gels).  M: Marker; 1, 5 and 9 SMP; 2, 6 
and 10 SMP+OsLu; 3, 7 and 11 SMP+GOS; 4, 8 and 12 SMP+Duphalac.  *Optical density 
was measured in the maximum of the peak with the Software Quantity One.  
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Effect on carbohydrate fraction. The effect of gastrointestinal digestion on 
the three different prebiotics, Duphalac®, GOS and OsLu included in milk 
was investigated. For this purpose, the samples from the semi-dynamic 
gastric model were subjected to two different intestinal digestion protocols, 
as indicated above (Infogest protocol or RSIE). In the case of the Infogest 
method, Figure 2S (Annex A) illustrates, as an example, the chromatogram 
obtained by GC-FID of TMSO derivatives of carbohydrates present in the 
milk samples with OsLu after gastric digestion and the beginning of the 
intestinal phase (G+I 0 h). The peaks corresponding to carbohydrates with 
degree of polymerization (DP) from 1 to 4 were found; among them 
galactose, lactulose and di-, tri- and tetrasaccharides derived from OsLu 
ingredient, and galactose, glucose and lactose from milk. Galactose was 
present in SMP with OsLu in higher proportion than in SMP with GOS 
(Table 1) in which the most abundant monosaccharide was glucose, due to 
their presence in the original prebiotic mixtures. In this respect, the addition 
of OsLu to milk or other products could be more interesting since OsLu 
presents lower proportion of caloric carbohydrates with lower glycaemic 
index than GOS (López-Sanz et al. 2015). As observed in Table 1, 
SMP+Duphalac® had higher concentration of lactulose than SMP+OsLu 
because lactulose is used as substrate during its enzymatic hydrolysis and 
transgalactosylation. 
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Table 1 – Carbohydrate evolution of milk samples during Intestinal digestion (G+I Phase), according to Infogest Protocol. 
 
  Carbohydrate content (%)  
  
Galactose 
 
Glucose 
 
Lactulose 
 
Lactose 
 
Other 
Disaccharides 
 
Trisaccharides 
 
Tetrasaccharides 
 
Oligosaccharides* 
 
SMP 0h 0.3 ± 0.1  0.4 ± 0.2 N.D. 99.4 ± 0.2 N.D. N.D. N.D. N.D. 
 
1h 0.3 ± 0.1 0.5 ± 0.1 N.D. 99.2 ± 0.1 N.D. N.D. N.D. N.D. 
 
2h 0.3 ± 0.0 0.4 ± 0.2 N.D. 99.4 ± 0.2 N.D. N.D. N.D. N.D. 
          SMP + GOS 0h 0.5 ± 0.1 7.6 ± 1.0 N.D. 65.6 ± 3.7 11.0 ± 0.8 12.9 ± 1.8 2.4 ± 0.6 26.4 ± 3.1 
 
1h 0.5 ± 0.0 7.7 ± 1.5 N.D. 66.3 ± 3.3 12.0 ± 2.2 12.3 ± 1.4 3.3 ± 0.7 27.6 ± 4.2 
 
2h 0.5 ± 0.0 6.9 ± 0.2 N.D. 68.4 ± 1.4 10.8 ± 1.3 10.9 ± 0.7 2.4 ± 1.7 24.1 ± 1.5 
          SMP + 
Duphalac® 0h 3.6 ± 0.4 0.4 ± 0.4 22.0 ± 5,1 73.6 ± 4.9 N.D. N.D. N.D. N.D. 
 
1h 3.4 ± 0.8 0.2 ± 0.2 20.6 ± 1,1 76.5 ± 1.1 N.D. N.D. N.D. N.D. 
 
2h 3.1 ± 0.2 0.4 ± 0.2 21.6 ± 1,9 75.6 ± 1.7 N.D. N.D. N.D. N.D. 
          SMP + OsLu 0h 5.0 ± 0.3 0.3 ± 0.1 6.3 ± 2.1 68.4 ± 1.7 9.8 ± 0.3 9.3 ± 0.2 0.9 ± 0.2 20.1 ± 0.6 
 
1h 5.0 ± 0.1 0.4 ± 0.2 7.1 ± 1.4 67.4 ± 1.3 9.8 ± 0.4 9.5 ± 0.4 0.8 ± 0.3 20.1 ± 0.3 
 
2h 5.3 ± 0.3 0.3 ± 0.0 6.0 ± 0.4 69.0 ± 1.1 10.2 ± 0.5 8.6 ± 1.0 0.8 ± 0.6 19.6 ± 1.6 
 
The data are expressed as the mean ± SD (p>0.05). No statistical difference was determinates between 0, 1 and 2 h samples in all compounds using a 
one-way analysis of variance (ANOVA) (n=4). N.D. No detected. 
*Oligosaccharides: Values represent the sum of di-, tri- and tetrasaccharides. 
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Limited modifications were observed in the carbohydrate fraction following 
digestion using the Infogest protocol. In spite of the fact that there was a 
slight decrease of OS and trisaccharides in SMP+GOS after 2 h of digestion, 
these differences were not statistically significant. None of the carbohydrates 
derived from the prebiotic ingredients provided any significant change, 
indicating their stability during this enzymatic digestion by pancreatic fluids 
and bile salts. Moreover, it seems to be clear that the presence of other milk 
components did not impact the passage of GOS, Duphalac® and OsLu 
throughout the gastrointestinal digestion evaluated by the Infogest protocol.  
In order to gain more insight in this subject and given that the Infogest 
protocol is mainly focus on the digestion of proteins, this study was 
completed with the evaluation of carbohydrate fraction of SMP with the three 
prebiotic ingredients after a subsequent digestion by means of an intestinal 
extract of from rats, labelled as RSIE, as indicated in Materials and Methods 
section. Figure 4 A, B, C, D illustrates the evolution of each carbohydrate 
fraction in the SMP added with Duphalac®, GOS and OsLu after their gastric 
and intestinal (Infogest) and with RSIE (0.5, 1 and 2 h) of digestion. Data are 
expressed as percentage of hydrolysis, for lactose, lactulose and 
oligosaccharides, and increase of monosaccharides, taking into account the 
control samples immediately taken after the addition of RSIE. The hydrolysis 
of compounds with DP ≥ 2 and mainly lactose increased with time of 
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reaction, probably due to the presence of lactase (β-galactosidase) in the 
RSIE, in good agreement with the increase of the monosaccharide proportion.  
In general, lactose was more hydrolysed than lactulose due to the 
presence of fructose instead of glucose in the β linkage of the latter (Olano & 
Corzo, 2009), being SMP+Duphalac® the sample with the highest degree of 
hydrolysis of lactose. In general, no significant differences (p > 0.05) were 
found for SMP samples with OsLu and GOS. Lactulose was significantly less 
susceptible to hydrolysis in SMP+Duphalac® than in SMP+OsLu. 
Furthermore, lactulose present in OsLu and Duphalac® was more prone to 
degradation than OS, probably ascribed to its lower Mw, although the 
difference was only significant after 1 h of digestion. Finally, OS were 
significantly more hydrolysed in SMP+GOS than in SMP+OsLu reaching 
values of 35% and 15%, respectively after 2 h; this was probably due to the 
more stable β(1→6) linkages in the OsLu mixture as compared to β(1→4) in 
GOS and the presence of fructose at the terminal end of molecule 
(Hernandez-Hernandez et al. 2012). These results indicate that OS (DP≥3) 
present in OsLu were scarcely affected by the gastrointestinal digestion under 
the conditions used in the present work, being digested in a very low 
proportion in the small intestine which would favour the presence of a OS in 
the distal portions of colon to be fermented by beneficial bacteria. 
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Figure 4. Evolution of carbohydrates over time during the gastric and intestinal digestion 
with RSIE. Figure shows the results for each fraction analyzed A) Monosaccharides, B) 
Lactose, C) Lactulose and D) Oligosaccharides after 0.5, 1.0 and 2.0 h of digestion. Grey bar 
represents SMP samples; Striped bar, SMP+Duphalac; Black bar, SMP+GOS and White bar, 
SMP+OsLu. The results are shown as percentage of increase (A) or hydrolysis (B, C, D) 
relatively to their respective controls. Results are presented as mean ± SD (n=4). Bar with 
different lower-case letters (a–d) represent statistical significant differences between each 
carbohydrate fraction at the same digestion time for their mean values at the 95.0 % 
confidence. 
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To the best of our knowledge this is the first in vitro study on the digestion of 
prebiotics derived from lactose and lactulose as ingredients in a real food. 
The results obtained underline those of Hernandez-Hernandez et al. (2012) 
who pointed out, in in vivo assays with rats, that mixtures of OsLu were less 
digested than GOS. Particularly, the trisaccharide fraction of the former was 
13% digested in the ileum, whereas in the latter case digestion was close to 
53%. In both cases, the studied samples were the corresponding enzymatic 
mixtures obtained by transglycosylation and the presence of other food 
components was not considered. The small differences found in the total 
hydrolysis values with respect of our results could be ascribed to the 
differences in the experimental conditions.  
 
Conclusions:  
 
According to the results obtained is possible to conclude that the presence of 
prebiotic carbohydrates in milk, at prebiotic doses, did not affect the gastric 
digestion of milk proteins, following the Infogest protocol. Similarly, under 
the same gastrointestinal digestion method, hardly any change was detected 
in the carbohydrate fraction of milk with GOS, Duphalac® and OsLu after 2 h 
of digestion. This might indicate the resistance of the three prebiotic 
mixtures, including OsLu, to gastric and pancreatic fluids and bile salts. 
 130 
However, when the digested samples of milk with prebiotics were subjected 
to intestinal digestion by a small gut intestinal extract of rat a dissimilar 
behaviour in the three cases was observed, OsLu samples being the most 
resistant to the action of enzymes present in the rat intestine extract, mainly 
in the case of OS fraction. These results highlight the possibility of OsLu to 
reach the large intestine, target organ, to exert their potential prebiotic effects.  
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Abstract:  
Small intestinal brush border membrane vesicles (BBMV) from pig were used to 
digest galactooligosaccharides from lactose (GOS) and from lactulose (OsLu). 
Dissimilar hydrolysis rates were detected after digestion. Predominant glycosidic 
linkages and monomeric composition affected the resistance to intestinal digestive 
enzymes. β(1→3) GOS mixture was the most susceptible to hydrolysis (50.2%), 
followed by β(1→4) (34.9%), whereas β(1→6) linkages were highly resistant to 
digestion (27.1%). Monomeric composition provided a better resistance in β(1→6) 
OsLu (22.8%) as compared to β(1→6)-GOS (27.1%). This was also observed for β-
galactosyl-fructoses and β-galactosyl-glucoses where the presence of fructose 
provided higher resistance to digestion. Thus, the resistance to small intestinal 
digestive enzymes highly depends on structure and composition of prebiotics. 
Increasing knowledge on this regard could contribute to the future synthesis of new 
mixtures of carbohydrates, highly resistant to digestion and with potential to be 
tailored prebiotic with specific properties, targeting, for instance, specific probiotic 
species. 
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Introduction:  
Knowledge about the diversity of human microbiota and its relation to health 
has been largely gathered during last years. Moreover, there is a clear 
evidence suggesting that our microbiota is deeply implicated in a wide range 
of metabolic functions extending beyond the gut (Heinz-Buschart et al. 
2018), such as, the regulation of the central nervous system homeostasis 
through immune, vagal and metabolic pathways (Carabotti et al. 2015; 
Forsythe et al. 2014; Sherwin et al. 2016) or the prevention of bone and 
respiratory diseases (Ibañez et al. 2019; Sozanska et al. 2019). One of the 
most used strategies to modulate the composition and metabolic activity of 
microbiota is the use of prebiotics (Moreno et al. 2017).   
Prebiotics definition refers to a “substrate that is selectively utilized by host 
microorganisms conferring a health benefit” (Gibson et al. 2017). These 
compounds are characterized by the resistance to the digestion and acid 
conditions in the upper gastrointestinal tract and the ability to reach the colon 
without  alteration in their structure (Roberfroid et al. 2010). To date, 
although a considerable number of compounds have been proposed as 
potential prebiotics, all well-recognized prebiotics are carbohydrates, mainly 
inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS) and 
lactulose. Among these, GOS have attracted growing interest due to the 
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presence of galactose-based oligosaccharides, similar to those in human milk 
oligosaccharides (HMOs) (Sangwan et al. 2011).  
GOS are commonly obtained by enzymatic synthesis from lactose by β-
galactosidases and they are constituted by a complex mixture of galactoses 
linked by different linkages β(1→1), β(1→2), β(1→3), β(1→4) and β(1→6)  
and can vary from 1 to 8 units and a terminal glucose (Moreno et al. 2014). 
Composition of the obtained GOS mixture is deeply affected by several 
factors such as, the enzyme source, lactose concentration, substrate 
composition and reaction conditions (temperature, time and pH) (Moreno et 
al. 2014; Gänzle et al. 2012; Torres et al. 2010). Galactooligosaccharides 
derived from lactulose (OsLu) have been also proposed as emerging prebiotic 
compounds since they might provide enhanced prebiotic properties compared 
to conventional GOS by increasing short-chain fatty acids content and the 
population of Bifidobacterium and Lactobacillus species (Moreno et al. 2014; 
Hernández-Hernández et al. 2012). OsLu are obtained similarly to GOS using 
lactulose as substrate and are constituted by galactose units, linked by a 
variety of glycosidic linkages (β(1→6), β(1→1) and/or β(1→4)) determined 
by the enzyme source, and a terminal fructose (Díez-Municio et al. 2014).   
The susceptibility of oligosaccharides to small intestinal digestion highly 
depends on their structure, compromising their absorption and digestion fate 
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(Gosling et al. 2010). However, ever since prebiotics were first defined, most 
of the investigations have been carried out focusing on their effect on the gut 
microbiota composition and/or activity, and few efforts have been made 
towards the study of the resistance of these compounds to digestion in the 
small intestine (Tanabe et al. 2014; Tanabe et al. 2015; Oku et al. 1984; 
Ohtsuka et al. 1990; Ferreira-Lazarte et al. 2017a; Ferreira-Lazarte et al. 
2017b). Moreover, the standardized official methods to determine the 
digestibility of carbohydrates present several limitations, such as those 
related to the matrix composition of the sample should be limited in 
complexity, the lack of simulation of realistic enzyme substrate ratios and 
removal of digested products; but most importantly, they do not take into 
consideration the disaccharidases that are present in the small intestinal brush 
border membrane vesicles in mammals (Drechsler et al. 2018; Egger et al. 
2016; McCleary et al. 2010). Recently, the use of mammalian intestinal 
enzymes has been reported as an excellent alternative method to determine 
carbohydrate digestion (Tanabe et al. 2015; Ferreira-Lazarte et al. 2017b; 
Strube et al. 2015). 
In vivo and in vitro studies have described considerable digestion rates in the 
small intestine of different types of GOS in rats (15-53% hydrolysis degree 
after 2 h of digestion), (Hernández-Hernández et al. 2012; Ferreira-Lazarte et 
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al. 2017a; Ferreira-Lazarte et al. 2017b; Jantschen-Krenn et al. 2013; Marín-
Manzano et al. 2013), questioning the general acceptance that these 
compounds reach intact the colon. These authors also have reported a 
different resistance to the upper gastrointestinal tract conditions as well as a 
different effect on microbiota depending on the main β-linkage in the 
mixture. Thus, β(1→6) linkages have been reported to be less prone to 
degradation by intestinal enzymes and to exert better prebiotic effect as 
compared to other β-linkages. 
Bearing that in mind, the aim of the present study was to evaluate the 
digestibility of recognized prebiotics such as GOS, with predominant 
β(1→3), β(1→4) or β(1→6) linkages, as well as emerging prebiotic 
candidates derived from lactulose (OsLu, β(1→6)) using small intestinal 
brush border membrane vesicles from pig.  
 
Materials and methods:  
 
Chemicals and reagents. D-Galactose (Gal), D-glucose (Glc), sucrose (β-D-
Fru(2→1)-α-D-Glc), trehalose (α-D-Glc(1→1)-α-D-Glc), lactulose (β-D-
Gal(1→4)-D-Fru), phenyl-β-glucoside, o-nitrophenyl (o-NP), p-nitrophenyl 
(p-NP), o-nitrophenyl-β-D-galactopyranoside (o-NPG) and p-nitrophenyl-α-
glucopyranoside (p-NPG) standards were obtained from Sigma-Aldrich (St 
 138 
Louis, MO). Lactose (β-D-Gal(1→4)-D-Glc) was obtained from ACROS 
organics (Geel, Belgium) and fructose was obtained from Fluka analytical 
(St. Gallen, Switzerland). All standard carbohydrates were of analytical grade 
(purity ≥ 95%). Kluyveromyces marxianus cells were kindly provided by 
Professor Robert Rastall from The University of Reading (United Kingdom). 
Nutritive medium (peptone, lactose and yeast extract) were supplied by 
Sigma-Aldrich. 
Small intestinal brush border membrane vesicles (BBMV) preparation. 
Small intestinal brush border vesicles from six post-weaned pigs (7-10 
months old) were obtained following methodology previously reported 
(Kessler et al. 1978; Tanabe et al. 2015). Briefly, three pig small intestines, 
from the duodenum to the ileum, were obtained from a local slaughterhouse 
(Coca, Segovia, Spain). Immediately after sacrifice, the samples were kept at 
4 ºC and transferred to the laboratory in less than 2 h. The small intestines 
were rinsed with cold phosphate buffered saline solution (PBS) (pH 7.3 – 
Oxoid; Basingstoke, UK), then slit open and scrapped with a glass slide. The 
mucose scrapped was suspended (1:1, w/v) in 50 mM mannitol dissolved in 
PBS at 4 ºC, homogenized during 10 min using a Ultra-Turrax® (IKA T18 
Basic), adjusted with CaCl2 to a final concentration of 10 mM and 
centrifuged at 3,000 g during 30 min. The supernatant was centrifuged at 
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27,000 g during 40 min and the resulting pellet, containing the BBMV, was 
re-suspended in buffer maleate (50 mM) pH 6.0 containing CaCl2 (2 mM) 
and sodium azide (0.02%). Samples were lyophilized and kept at -80ºC. 
Prebiotic oligosaccharides. OsLu were obtained at pilot plant scale by 
Innaves S.A. (Vigo, Spain) following the method described by López-Sanz et 
al. (2015). Briefly, OsLu were synthesized using a commercial lactulose 
preparation (670 g/L; Duphalac, Abbott Biologicals B.V., Olst, The 
Netherlands), and a commercial preparation including β-galactosidase from 
Aspergillus oryzae (16 U/mL; Sigma) at pH 6.5, 50 ºC and 350 rpm during 
24 h. In addition, three different commercially available GOS mixtures with 
predominant β(1→3) linkages GOS (named GOS-1), predominant β(1→4) 
linkages GOS (named GOS-2) and predominant β(1→6) GOS (named GOS-
3), were tested. 
Prebiotic oligosaccharides purification. Purification of prebiotic 
compounds was carried out by yeast treatment with K. marxianus.  
K. marxianus cells were grown in YPD (1 % (w/v) yeast extract, 2 % peptone 
and 2 % lactose) (500 mL) at 37 ºC during 48 h. Samples were then 
centrifuged at 4,000 g for 10 min and washed three times on PBS (500 mL), 
supernatant was discarded, and washed samples were taken to incubation. 
Twenty-five mL of prebiotic ingredients (10% in PBS) and K. marxianus 
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yeast (equivalent to 25 mL YPD) were incubated at 37 ºC for 48 h. Samples 
were then centrifuged at 4,000 xg for 20 min, filtered by 0.2 µm and then 
lyophilized and kept at -20ºC until analysis. Purification process was carried 
out three times for each sample (n=3) and monitored by GC-FID as explained 
below. GOS-1 mixture which was previously constituted by 30% 
monosaccharides, 22% lactose, 25% disaccharides and 23% trisaccharides 
(w:w) showed a loss of 67% monosaccharides after K. marxianus treatment. 
GOS-2 was composed by 22% monosaccharides, 19% lactose, 8% 
disaccharides, 44% trisaccharides and 7% tetrasaccharides (w:w) showing a 
97.4 % decrease in monosaccharides composition. GOS-3 composition which 
was 38% monosaccharides, 14% lactose and 52% oligosaccharides (w:w) 
showed a decrease of 95% of monosaccharides. OsLu was constituted by 
7.8% monosaccharides, 49.3% lactulose 28.8% disaccharides and 14.1% 
trisaccharides (w:w). 
Small Intestinal BBMV characterization. Pig small intestinal BBMV (10 
mg/mL) was homogenized in ice-cold 0.05 M sodium phosphate buffer 
solution and then centrifuged at 6,000 xg for 15 min. Supernatant was used as 
enzyme solution for determining protein content and enzymatic activity.  
Protein content determination. Total protein content of the pig small 
intestinal BBMV was quantified according to the Bradford method, using the 
 141 
Bio-Rad Protein Assay kit and bovine serum albumin as a standard. The 
absorbance was monitored at 595 nm (Bradford 1976).  
Hydrolytic activities. β-galactosidase and maltase activities. The 
determination of the pig intestinal β-galactosidase activity was adapted from 
Warmerdam et al. (2014). Briefly, a solution of o-NPG (0.5 mg/mL) in 
phosphate buffer 0.05 M, pH 7.0 was prepared. The enzymatic activity was 
determined by incubating 1,900 μL of the o-NPG solution and 100 μL of 
enzyme solution from BBMV for 2 h at 37 °C. The method is based on the 
measurement of the continuous release of o-NP from o-NPG. The absorbance 
of released o-NP was measured at 420 nm every 30 s using a 
spectrophotometer (Specord Plus, Analytik Jena) together with a temperature 
controller (Jumo dTRON 308, Jumo Instrument Co.). The specific enzymatic 
activity (U) was expressed in μmol min−1 g−1, where one unit was defined as 
the amount of enzyme that produced 1 μmol of o-NP in one min of reaction 
(biological replicates - n = 3). Similar procedure was used to determine the 
maltase activity by using a solution of p-NPG in phosphate buffer 0.05 M, 
pH 6.8 (0.05% w/w) and monitoring the release of p-NP at 420 nm every 20 s 
(n=3).  
Sucrase and trehalase activities. Sucrase and trehalase activities were 
determined following a method described in a previous work (Ferreira-
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Lazarte et al. 2017b). A solution of sucrose or trehalose (0.5% w/v) in 
sodium phosphate buffer 0.05 M, pH 6.5 was used. An eppendorf tube with 
500 μL of sucrose or trehalose solution was preheated at the reaction 
temperature, 37 °C. Subsequently, 200 μL of enzyme solution was added and 
the mixture was incubated for 2 h and different aliquots were taken at 
different times (5, 10, 15, 30, 60, 90 and 120 min). Hydrolysis was stopped 
by adding 700 μL of a 3,5-dinitrosalicylic acid (DNS) solution. Sucrase and 
trehalase activity were determined measuring the reducing sugars released 
from the corresponding disaccharide hydrolysis at 540 nm, according to the 
DNS method (Miller et al. 1959). The specific enzymatic activity (U) was 
expressed in μmol min−1 g−1, where one unit was defined as the amount of 
enzyme that produced 1 μmol of reducing sugars in one min of reaction 
(n=3). 
In vitro digestion of prebiotic compounds with BBMV. The digestibility of 
three different types of GOS, OsLu and lactose and lactulose was evaluated 
using BBMV. First, a solution of BBMV (10 mg/mL) in PBS solution, 6.8 
pH, was prepared. Fifteen milliliters of this solution containing BBMVs (10 
mg/mL) were placed in centrifuge tubes (two per sample) and prebiotic or 
disaccharides samples were added at a concentration of 0.2 mg/mL. 
Digestions were then initiated at 37 ºC during 5 h using 750 rpm in an orbital 
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Thermomixer comfort (Eppendorf®). Aliquots of 1 mL (x2) were taken at 0, 
1, 2, 3, 4 and 5 h of digestion and immediately heated in boiling water for 5 
min to stop the reaction. 
Furthermore, incubation of BBMV without any carbohydrate source was also 
analyzed. Results showed quantifiable amounts of glucose as the digestion 
proceeded. These values were conveniently substracted to avoid any 
overestimation of the monosaccharide fraction. 
Carbohydrates quantification by GC-FID. Carbohydrates present in the 
samples and digested mixtures were analysed as trimethylsilylated oximes 
(TMSO) by gas chromatography coupled to ionization flame detector (GC-
FID) following the method of Brobst & Lott Jr, (1966). First, 500 µL of 
samples (0.1 mg carbohydrates) was added to 500 µL of phenyl-β-glucoside 
(Internal Standard, IS) and the mixture was dried in a rotary evaporator 
(Büchi Labortechnik AG, Flawil, Switzerland). TMSO derivatives were 
formed by adding 250 µL of hydroxylamine chloride in pyridine (2.5% w/v) 
and heating the mixture at 70 ºC for 30 min, followed by the addition of 
hexamethyldisilazane (250 µL) and trifluoroacetic acid (25 µL) and incubated 
at 50 ºC for 30 min. Mixtures were centrifuged at 6,700 g for 2 min and 
supernatants were injected in the GC-FID. TMSO derivatives were separated 
using a fused silica capillary column DB-5HT (5%-phenyl-
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methylpolysiloxane; 30m x 0.25mm x 0.10µm, Agilent). Nitrogen at 1 
mL/min was used as carrier gas. Injector and detector temperatures were set 
at 280 and 385 ºC, respectively. The oven temperature was set from 150 ºC to 
380 ºC at a ratio of 3 ºC/min. Data acquisition and integration were done 
using Agilent ChemStation software (Wilmington, DE, USA). Response 
factors were calculated after duplicate analysis of standard solutions 
(fructose, glucose, galactose, lactose, lactulose and raffinose) over the 
expected concentration range in samples, (0.005–1 mg) and IS (0.25 mg). 
Statistical Analysis. Statistical analysis was carried out using SPSS for 
Windows, version 23.0. One-way analysis of variance (ANOVA) and 
Tukey’s post hoc test was used to determine significant differences (p < 0.05) 
between concentrations of carbohydrates in each prebiotic sample (n=3). 
 
Results and discussion:  
 
High decreases in monosaccharide composition was observed after K. 
Marxianus (Material and methods section 2.3.1). In this sense, 
monosaccharides are the major impurities in GOS obtainment, therefore, 
removal of these compounds is recommended mainly due to their undesirable 
caloric value and glycaemic index (Gosling et al. 2010). Furthermore, 
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inhibition of β-galactosidase by glucose and galactose in transgalactosylation 
and hydrolysis reaction of carbohydrates was reported (Vera et al. 2011). 
BBMV enzymatic characterization. The brush border of the mammalian 
intestinal mucosa contains several key enzymes present as multienzyme 
complexes, i.e. sucrase-isomaltase, lactase-phlorizin hydrolase, maltase-
glucoamylase and trehalase (Feher 2012). Accordingly, it is well reported the 
presence of those carbohydrases in the brush border of the intestinal mucosa 
of pig (Tanabe et al. 2015; Kidder et al. 1978; Rubio et al. 2014). Table 1 
shows the protein content and main enzymatic activities (β-galactosidase, 
maltase, sucrase and trehalase) of BBMV measured under the assayed 
digestion conditions. Maltase activity (753.1 U/g) was the highest with ten-
fold higher values than the other measured activities. This higher value can 
be ascribed to the multiple maltase activities carried out by different 
enzymatic complexes such as maltase-glucoamylase which has two catalytic 
sites able to hydrolyse maltose. This maltase activity is also present in both 
catalytic sites found in the complex sucrase-isomaltase. Both enzymatic 
complexes are the most abundant glycosidases in the small intestine (Hooton 
et al. 2015). To date, some studies have characterized the carbohydrase 
activities of small intestinal enzymes in pigs (Tanabe et al. 2015; Rubio et al. 
2014; Gnoth et al. 2000; Sørensen et al 1982), showing a clear predominance 
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of maltase activity as compared to other activities, which agrees with the data 
obtained in this work. 
 
 
 
 
 
 
Digestion of prebiotic carbohydrates by BBMV. Figure 1 shows GC-FID 
profiles of oligosaccharides before and after 5h of digestion with BBMV. 
Differences were observed between the profiles of the three GOS mixtures, 
1,4-galactobiose (β-Gal-(1→4)-Gal) and 1,6-galactobiose (β-Gal-(1→6)-Gal) 
were identified as peaks 2 and 5, respectively in all samples. β-Gal-(1→3)-
Glc and allolactose (β-Gal-(1→6)-Glc), both isomers of lactose were also 
detected in all samples as peaks 3 and 4, respectively. Further structural 
differences were found in the trisaccharides fraction. β-1,4-Galactosyl-lactose 
(β-Gal-(1→4)-β-Gal-(1→4)-Glc, peak 6)  was detected in all samples, β-1,6-
galactosyl-lactose (β-Gal-(1→6)-β-Gal-(1→4)-Glc, peak 8) was found in 
GOS-2 and GOS-3 samples and β-1,3-galactosyl-lactose (β-Gal-(1→3)-β-
Gal-(1→4)-Glc, peak 7) was only detected in GOS-1 mixture.  
 
Table 1. Specific enzymatic activities and protein content of 
Small Intestinal BBMV. 
 
Activity Substrate 
 
Conditions 
 
U (µmol/min g) 
 
β-galactosidase o-NPG 7.0; 37 °C 70.1 ± 1.4 
Maltase p-NPG 6.8; 37 °C 753.1 ± 16.5 
Sucrase Sucrose 6.8; 37 °C 19.9 ± 2.2 
Trehalase Trahalose 6.8; 37 °C 21.4 ± 7.6 
Protein content of BBMV was 7.3 ± 0.5 % 
Data are expressed as means ± SD (n = 3) 
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Figure 1. Chromatographic profiles of TMSO derivatives of prebiotics oligosaccharides before 
(continuous line) and after 5 h of digestion with BBMV (striped line). GOS Disaccharides: 1, lactose; 
2, 1,4-galactobiose; 3, β-Gal-(1→3)-Glc; 4, allolactose; 5, 1,6-galactobiose and * other disaccharides. 
GOS Trisaccharides: 6, β-Gal-(1→4)-β-Gal-(1→4)-Glc; 7, β-Gal-(1→3)-β-Gal-(1→4)-Glc; 8, β-Gal-
(1→6)-β-Gal-(1→4)-Glc and ** other trisaccharides. OsLu Disaccharides: a, lactulose; b, 1,4-
galactobiose; c, 1,2-galactobiose+1,3-galactobiose; d, β-Glc-(1→6)-Fru; e, β-Glc-(1→1)-Fru; f, , 1,6-
galactobiose and * other disaccharides. OsLu trisaccharides: g, β-Gal-(1→6)-β-Gal-(1→4)-Fru and ** 
other trisaccharides. 
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Tetrasaccharides were also noticed in GOS-2 mixture (Table 2) and this 
fraction was mainly constituted by β-Gal-(1→4)-β-Gal-(1→4)-β-Gal-(1→4)-
Glc and other tetrasaccharides not identified in this work (Hernández-
Hernández et al. 2012; Ruiz-Matute et al. 2012; Moreno et al. 2014). 
OsLu mixture was constituted by β(1→6) as the main glycosidic linkage and 
mostly by galactosyl galactoses (Gal-Gal) and galactosyl fructoses (Gal-Fru). 
β-(1→6)-galactosyl-lactulose (β-Gal-(1→6)-β-Gal-(1→4)-Fru) was identified 
as the main trisaccharide in the sample. In general, all assessed GOS and 
OsLu showed a diminution after the BBMV digestion, although considerable 
differences among all studied samples were observed. 
Tables 2 and 3 show the quantitative determination of individual 
carbohydrates in GOS and OsLu during digestion, respectively. A 
progressive increase in the level of monosaccharides was found in all samples 
as digestion proceeded, which was concomitant with the decrease in di- and 
trisaccharide fractions. Digestion of standard solutions of lactose or lactulose 
with BBMV is also shown for comparative purposes. As expected, lactose 
was much more prone to degradation than lactulose due to the presence of 
fructose instead of glucose in the β-linkage of the latter (Olano & Corzo 
2009).
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Table 2. Carbohydrate content (mg/100 mg of total carbohydrates) determined by GC-FID analysis in  GOS samples during the digestion with pig small intestinal brush border 
membrane vesicles at 37 °C, pH 6.8 
Digestion 
time (h) Galactose Glucose Lactose 
β(1→4)  
Gb 
 
β(1→3) 
Gal-Glc 
β(1→6) 
Gb  Allolactose 
Other 
Disaccharides 
β(1→4) 
Gal-la 
β(1→3) 
Gal-la 
β(1→6) 
Gal-la 
Other 
Trisaccharides Σ DI  Σ TRI 
 
Σ 
TETRA OSa 
Lactose     
 
         
 
 
0 0.7 ± 0.0 1.1 ± 0.0 98.2 ± 0.0 - - - - - - - - - - - - - 
1 26.7 ± 4.5 17.3 ±  7.0 56.1 ± 7.2 - - - - - - - - - - - - - 
2 37.1 ± 6.3 28.9 ± 0.7 34.0 ± 2.7 - - - - - - - - - - - - - 
3 31.5 ± 7.8 38.4 ± 11.5 30.0 ± 11.0 - - - - - - - - - - - - - 
4 39.8 ± 7.7 41.9 ± 2.4 18.3 ± 6.6 - - - - - - - - - - - - - 
5 47.4 ± 4.5 49.8 ± 5.1 2.8 ± 0.4 - - - - - - - - - - - - - 
 
                
GOS-1                 
0 5.5 ± 0.0 5.5 ± 0.0 34.2 ± 0.0 1.3 ± 0.0 5.4 ± 0.0 2.5 ± 0.0 4.8 ± 0.0 8.3 ± 0.0 9.6 ± 0.0 15.5 ± 0.0* - 7.4 ± 0.0 22.4 ± 0.0 32.4 ± 0.0 - 54.8 ± 0.0 
1 13.1 ± 3.5 15.7 ± 3.7 24.9 ± 2.4 1.3 ± 0.5 4.5 ± 1.1 2.7 ± 0.8 4.8 ± 0.7 6.0 ± 3.1 7.8 ± 1.1 12.0 ± 3.1* - 7.1 ± 0.6 19.3 ± 4.1 26.9 ± 2.0 - 46.2 ± 6.1 
2 18.2 ± 3.0 16.6 ± 3.0 23.9 ± 1.9 1.3 ± 0.3 4.2 ± 0.3 2.1 ± 0.6 4.7 ± 0.6 6.1 ± 0.7 8.1 ± 3.0 8.7 ± 1.1* - 6.2 ± 0.7 18.3 ± 0.8 23.0 ± 2.6 - 41.3 ± 1.8 
3 23.6 ± 3.2 29.9 ± 7.1 20.8 ± 2.2 1.1 ± 0.4 3.5 ± 0.3 2.3 ± 0.5 4.1 ± 2.3 6.1 ± 2.4 4.4 ± 1.0 9.1 ± 4.6* - 4.9 ± 1.6 17.3 ± 4.5 18.4 ± 7.2 - 35.7 ± 11.5 
4 29.0 ± 1.2 21.5 ± 2.2 17.2 ± 1.2 1.2 ± 0.1 3.2 ± 0.3 2.1 ±  0.6 3.6 ± 0.6 4.9 ± 0.1 3.3 ± 0.1 8.2 ± 0.3* - 5.9 ± 0.7 15.0 ± 0.6 17.4 ± 1.0 - 32.3 ± 1.2 
5 33.1 ± 4.0 28.9 ± 0.6 10.7 ± 2.1 1.2 ± 0.2 2.8 ± 0.3 2.1 ± 0.3 3.3 ± 0.2 3.2 ± 0.5 3.1 ± 0.1 6.0 ± 0.5* - 4.7 ± 0.1 12.6 ± 0.2 14.7 ± 0.4 - 27.3 ± 0.7 
 
                
GOS-2                 
0 0.6 ± 0.0 0.0 ± 0.0 1.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.9 ± 0.0 20.4 ± 0.0 - 18.2 ± 0.0
 38.5 ± 0.0 4.1 ± 0.0 77.1 ± 0.0 16.4 ± 0.0 97.6 ± 0.0 
1 8.6 ± 1.2 6.9 ± 0.2 1.7 ± 0.1 2.4 ± 0.6 0.9 ± 0.5 0.4 ± 0.1 3.2 ± 0.5 2.9 ± 0.6 15.0 ± 0.9 - 16.2 ± 1.0 26.9 ± 1.1 9.9 ± 0.7 58.1 ± 3.2 14.9 ± 0.5 82.9 ± 1.2 
2 13.5 ± 1.0 9.5 ± 1.1 1.6 ± 0.5 2.2 ± 0.2 1.1 ± 0.1 0.4 ± 0.2 5.0 ± 0.9 3.1 ± 1.1 13.3 ± 1.3 - 15.6 ± 0.9 25.3 ± 0.9 11.7 ± 1.1 54.1 ± 2.0 12.8 ± 1.1 78.6 ± 0.9 
3 16.0 ± 0.7 10.9 ± 0.2 1.3 ± 0.4 2.1 ± 0.5 1.2 ± 0.2 0.3 ± 0.3 5.8 ± 1.0 3.0 ± 0.5 10.5 ± 0.7 - 14.3 ± 0.7 23.7 ± 1.3 12.5 ± 0.4 48.5 ± 1.5 10.8 ± 1.3 71.8 ± 1.3 
4 18.3 ± 0.3 12.3 ± 0.5 1.2 ± 0.3 2.4 ± 1.1 1.2 ± 0.3 0.3 ± 0.1 6.8 ± 0.7 3.9 ± 0.4 9.7 ± 0.4 - 14.1 ± 0.5 18.4 ± 0.8 14.5 ± 1.2 42.1 ± 0.9 10.5 ± 0.9 67.2 ± 0.7 
5 21.2 ± 1.5 13.4 ± 1.0 0.9 ± 0.1 2.5 ± 0.8 1.0 ± 0.4 0.4 ± 0.2 8.0 ± 0.8 3.3 ± 0.2 8.8 ± 1.1 - 13.5 ± 0.3 16.1 ± 0.7 15.1 ± 0.9 38.4 ± 1.4 10.1 ± 1.1 63.5 ± 1.6 
 
                
GOS-3                 
0 0.7 ± 0.0 1.1 ± 0.0 25.1 ± 0.0 1.6 ± 0.0 4.1 ± 0.0 2.6 ± 0.0 9.0 ± 0.0 9.0 ± 0.0 9.4 ± 0.0 - 32.1 ± 0.0 5.3 ± 0.0 26.4 ± 0.0 46.8 ± 0.0 - 73.1 ± 0.0 
1 5.9 ± 1.6 4.5 ± 1.0 20.1 ± 1.5 1.1 ± 0.1 3.1 ± 0.1 2.9 ± 0.2 9.2 ± 1.0 6.6 ± 0.2 8.2 ± 1.3 - 31.0 ± 2.2 6.2 ± 1.0 22.9 ± 1.4 45.4 ± 2.6 - 68.3 ± 1.2 
2 10.3 ± 0.9 8.5 ± 1.7 16.1 ± 1.5 1.0 ± 0.0 2.5 ± 0.1 3.1 ± 0.3 9.2 ± 0.3 6.4 ± 0.2 7.7 ± 1.5 - 28.9 ± 1.7 6.2 ± 0.7 22.2 ± 0.2 42.8 ± 2.3 - 65.1 ± 2.2 
3 13.7 ± 0.4 11.0 ± 0.1 11.6 ± 0.6 0.9 ± 0.1 2.4 ± 0.4 3.0 ± 0.2 8.7 ± 1.1 6.2 ± 0.6 7.1 ± 1.5 - 29.2 ± 1.1 6.2 ± 0.7 21.2 ± 0.8 42.5 ± 0.6 - 63.7 ± 0.4 
4 18.3 ± 1.2 15.6 ± 0.5 9.8 ± 0.4 0.9 ± 0.2 2.2 ± 0.3 2.9 ± 0.1 8.3 ± 2.0 5.5 ± 0.2 6.7 ± 0.2 - 25.1 ± 1.0 4.7 ± 0.6 19.8 ± 1.7 36.5 ± 1.3 - 56.3 ± 0.9 
5 21.9 ± 0.3 17.0 ± 1.2 7.9 ± 0.1 0.9 ± 0.1 2.0 ± 0.5 3.4 ± 0.0 6.8 ± 0.2 4.6 ± 0.7 5.1 ± 0.5 - 26.7 ± 1.1 3.7 ± 0.0 17.8 ± 0.4 35.5 ± 1.2 - 53.3 ± 1.6 
Data are expressed as the mean ± SD (n = 4). 
Gb = galactobiose (β-Gal-(1→4/6)-Gal) 
Gal-la = galactosyl-lactose (β-Gal-(1→4/6)-β-Gal-(1→4)-Glc) 
a Oligosaccharides content based on the sum of di-, tri- and tetrasaccharides. 
*Represents the peak constituted mainly by β-1,3 galactosyl-lactose and traces of β-1,6 galactosyl-lactose 
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Table 3. Carbohydrate content (mg/100 mg of total carbohydrates) determined by GC-FID analysis in OsLu samples during the digestion with pig small intestinal 
brush border membrane vesicles at 37 °C, pH 6.8  
Digestion time 
(h) Fructose Galactose Lactulose 
β(1→4) 
Gb 
β(1→3)  
β(1→2) 
Gb 
β(1→6) 
Glc-Fru 
β(1→1) 
Gal-Fru 
β(1→6) 
Gb 
Other 
Disaccharides 
β(1→6) 
Gal-lu 
Other 
Trisaccharides Σ DI  Σ TRI OSa 
Lactulose             
  
0 5.1 ± 0.0 5.5 ± 0.0 89.5 ± 0.0 - - - - - - - - - - - 
1 8.1 ± 3.2 8.0 ± 2.5 83.9 ± 4.2 - - - - - - - - - - - 
2 10.4 ± 2.7 11.2 ± 2.2 78.4 ± 4.1 - - - - - - - - - - - 
3 11.9 ± 1.0 14.2 ± 1.0 74.0 ± 2.4 - - - - - - - - - - - 
4 15.2 ± 2.0 16.7 ± 1.3 68.1 ± 3.1 - - - - - - - - - - - 
5 18.1 ± 0.4 18.9 ± 0.3 63.0 ± 0.5 - - - - - - - - - - - 
               
OsLu               
0 1.2 ± 0.0 6.6 ± 0.0 49.3 ± 0.0 6.9 ± 0.0 5.7 ± 0.0 2.9 ± 0.0 5.5 ± 0.0 5.3 ± 0.0 2.5 ± 0.0 8.2 ± 0.0 5.9 ± 0.0 28.8 ± 0.0 14.1 ± 0.0 42.9 ± 0.0 
1 2.3 ± 0.2 12.5 ± 2.1 44.0 ± 0.6 6.4 ± 0.3 5.4 ± 0.9 3.1 ± 0.0 5.6 ± 0.2 5.4 ± 0.2 2.2 ± 0.3 7.9 ± 0.8 5.4 ± 0.1 28.1 ± 1.1 13.2 ± 0.5 41.2 ± 1.5 
2 3.4 ± 0.2 17.5 ± 0.3 40.4 ± 1.5 5.9 ± 0.3 5.1 ± 1.0 2.9 ± 0.8 5.2 ± 0.2 4.9 ± 0.1 2.0 ± 0.7 7.4 ± 1.1 5.1 ± 0.3 25.9 ± 1.0 12.5 ± 0.1 38.4 ± 1.0 
3 4.7 ± 0.4 20.5 ± 1.1 37.5 ± 1.0 5.6 ± 0.6 4.6 ± 0.3 2.8 ± 0.1 5.1 ± 0.1 4.9 ± 0.1 2.0 ± 0.1 7.3 ± 0.2 5.0 ± 0.1 25.0 ± 0.6 12.3 ± 0.3 37.3 ± 0.8 
4 5.0 ± 0.5 24.5 ± 0.5 35.7 ± 0.5 5.4 ± 0.2 4.5 ± 0.7 2.5 ± 0.5 4.7 ± 0.1 4.5 ± 0.2 1.7 ± 0.5 7.1 ± 0.5 4.4 ± 0.6 23.3 ± 0.5 11.4 ± 0.9 34.7 ± 0.9 
5 7.1 ± 0.2 26.7 ± 2.4 33.1 ± 1.5 5.6 ± 0.6 4.3 ± 0.3 2.6 ± 0.1 4.6 ± 0.1 4.5 ± 0.1 1.1 ± 0.0 6.6 ± 0.8 4.0 ± 0.9 22.6 ± 0.5 10.5 ± 1.3 33.1 ± 1.4 
Data are expressed as the mean ± SD (n = 4). 
Gb = galactobiose (β-Gal-(1→1/2/3/4/6)-Gal) 
Gal-lu = galactosyl-lactulose (β-Gal-(1→6)-β-Gal-(1→4)-Fru) 
a Oligosaccharides content based on the sum of di- and trisaccharides. 
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Lactose degradation in GOS samples was remarkably lower (50-68 %) when 
compared to the standard solution (97 %) (Table 1S, Annex B), probably due 
to the fact that the degradation of particular GOS trisaccharides or 
tetrasaccharides could revert released lactose, as well as to the presence of 
other carbohydrates in the GOS mixtures which might mitigate the 
straightforward digestion of lactose when is present alone. Regarding 
lactulose digestion, the standard solution showed a slight lower hydrolysis 
than that observed for lactulose present in OsLu (29.5 and 32.8 %, 
respectively, after 5 h of digestion). Similar behaviour was obtained in a 
previous work comparing the digestibility of prebiotics added to milk in an in 
vitro study with a small intestine rat extract (Ferreira-Lazarte et al. 2017a).  
Concerning disaccharides degradation, β-Gal-(1→3)-Glc and β-Gal-(1→6)-
Glc (allolactose) exhibited a slight decrease in their content after the BBMV 
digestion. Allolactose (β(1→6)) was the most resistant to hydrolysis when 
compared to lactose (β(1→4)) and β(1→3) structures. In this regard, it has 
been previously reported the high resistance of allolactose to intestinal 
mucosa with less than 5% of hydrolysis compared with lactose in an in vitro 
human assay (Burvall et al. 1980) and in an in vivo study with rats 
(Hernández-Hernández et al. 2012). Concerning galactosyl galactoses, none 
of these carbohydrates provided any noticeable change, indicating their 
stability during the digestion with BBMV. Indeed, an increase of these 
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compounds was found in some samples. Specifically, GOS-2 mixture showed 
an increase of 4’ and 6’-galactosyl galactose, respectively, suggesting the 
possible breakdown of the β(1→4) linkage of the terminal glucose in their 
trisaccharide fraction. Regarding OsLu disaccharides, high resistance of 
galactosyl galactoses was also observed. Limited hydrolysis of galactosyl-
fructoses was found, with β(1→6)-galactosyl-fructose linkages as the lowest 
decrease among all determined disaccharides (Table 3). According to 
Hernandez-Hernandez et al. (2012), it is plausible that, in a similar way to 
lactulose, other galactosyl-fructoses can be highly resistant to digestion 
within the mammalian small intestinal system. In line with our results, Julio-
Gonzalez et al. (2019) have recently reported the potential higher resistance 
to mammalian digestion of galactosyl-galactoses than galactosyl-glucoses. 
Regarding trisaccharides fraction, data in Table 2 shows that β(1→3)-
galactosyl-lactose in GOS-1 exhibited a higher hydrolysis than β(1→4)-
galactosyl-lactose in GOS-2 and β(1→6)-galactosyl-lactose in GOS-3. 
However, to provide more insight into the effect on linkage on trisaccharides 
fraction, Table 4 shows the hydrolysis degree of each different linkage 
trisaccharide present in all samples. In addition, the slope of the 
representation of hydrolysis degree (%) vs time (h), which could be 
considered as the hydrolysis rate, is also shown.  
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Taking into account a standard intestinal digestion time of 2 h, the hydrolysis 
degree of trisaccharides showed β(1→3)-galactosyl-lactose (hydrolysis rate 
of 21.9% as determined in GOS-1) to be more prone to degradation by 
intestinal enzymes followed by β(1→4)-galactosyl-lactose (7.8-17.4%), 
whereas β(1→6)-galactosyl-lactose (5.0-7.1%) and β(1→6)-galactosyl-
lactulose (4.9%) exhibited the highest resistance to hydrolysis.  
Concerning oligosaccharides as a whole (that is, the sum of di, tri and 
tetrasaccharides), the linkages β(1→6), abundant in GOS-3 and OsLu, 
demonstrated to be the most resistant to intestinal degradation (Figure 2, 
Table 1S, Annex B), where the presence of fructose at the reducing end of 
 
Table 4. Hydrolysis degree (%) evolution of different linkage trisaccharides (Tri) in each 
sample during the in vitro digestion with BBMV. 
 
 
GOS-1  GOS-2  GOS-3  OsLu 
Digestion 
time (min) 
β(1→3) 
Gal-la 
β(1→4) 
Gal-la 
 β(1→4) 
Gal-la 
β(1→6) 
Gal-la 
 β(1→4) 
Gal-la 
β(1→6) 
Gal-la 
 β(1→6) 
Gal-lu 
 
0 0.0 0.0 
 
0.0 0.0 
 
0.0 0.0 
 
0.0 
1 22.6 18.8  26.5 11.0  12.8 3.4  3.7 
2 43.9 15.6  34.8 14.3  18.1 10.0  9.8 
3 41.3 54.2  48.5 21.4  24.5 9.0  11.0 
4 47.1 65.6  52.5 22.5  28.7 21.8  13.4 
5 61.3 67.7  56.9 25.8  45.7 16.8  19.5 
           
Hydrolysis 
degree slope 
(after 2h) 
21.9 7.8 
 
17.4 7.1 
 
9.0 5.0 
 
4.9 
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molecules provided OsLu a slight better resistance to digestion with 22.8 % 
against 27.1 % of hydrolysis for GOS-3 after 5 h (Figure 2C).  
 
Figure 2. Evolution of hydrolysis (%) of carbohydrates during digestion with small intestine 
BBMV from pig at 37 ºC, pH 6.8. Disaccharides (A), trisaccharides (B) and oligosaccharides 
(C) expressed as the sum of di-, trisaccharides and tetrasaccharides in GOS-2 
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Furthermore, hydrolysis rate for GOS-3 and OsLu (Table 5) showed a lower 
degradation for OsLu as compared to GOS-3 after 2 and 5 h of digestion. 
GOS-2 oligosaccharides mixture was slightly more prone to degradation 
(34.9 %) with a higher hydrolysis rate after the BBMV digestion whereas 
GOS-1 oligosaccharides mixture exhibited the highest degree of hydrolysis 
with 50.1 % (Table 1S) degradation and the highest hydrolysis rate after 2 h 
(12.3) and 5 h (9.6) of treatment with BBMV from pig small intestine as 
compared to the other samples (Table 5). 
 
 
Table 5. Hydrolysis rate of oligosaccharides* in all samples 
during the in vitro digestion with BBMV. 
 
 GOS-1 GOS-2 GOS-3 OsLu 
 OS OS* OS OS 
Hydrolysis rate 
(after 5h) 
9.6 6.6 5.3 4.6 
Hydrolysis rate 
(after 2h) 
12.3 9.7 5.5 5.2 
* Expressed as the sum of di-, tri- and tetrasaccharides in GOS-2. 
 
 
 
In this sense, a recent work highlighted the utility of a similar BBMV from 
pig small intestine to produce prebiotic GOS, and revealed that BBMV 
preferably synthesizes GOS linked by β(1→3) bonds, finding β-Gal-(1→3)-
β-Gal-(1→4)-Glc as the main trisaccharide after comprehensive NMR 
analysis (Julio-Gonzalez et al. 2019). This study also pointed out no presence 
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of β-Gal-(1→6)-β-Gal-(1→4)-Glc, whereas the β-Gal-(1→4)-β-Gal-(1→4)-
Glc trisaccharide was present but only at trace amounts. These findings 
support the data obtained in the current work since the most abundant 
glycosidic linkages, formed when mammalian intestinal -galactosidase act 
as transgalactosidase, are expected to be preferentially broken under 
hydrolytic conditions. 
In the other hand, regarding monosaccharides release, galactose amounts 
were slightly higher compared to glucose release, probably due to the 
composition of the main oligosaccharides in the samples. Table 2 showed 
that the highest hydrolysis of GOS-1 oligosaccharides produced a higher 
release of total monosaccharides (62 mg/100 mg of total carbohydrates) after 
5 h of digestion as compared to GOS-2, GOS-3 and OsLu (34.6, 38.9 and 
33.8 mg/100 mg total carbohydrates, respectively). In this sense, the highest 
resistance of galactobioses and galactosyl-fructoses could affect positively to 
regulate the caloric intake and diminish the possible absorption of free 
monosaccharides in the small intestine, highlighting the key role of the 
monomer composition and type of glycosidic linkage in prebiotic 
oligosaccharide samples. 
Results obtained in this work have demonstrated that the use of small 
intestinal BBMV from pig is a reliable and useful strategy to evaluate 
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prebiotic carbohydrate digestibility. Intestinal in vitro digestion with BBMV 
revealed the partial degradation of recognized prebiotics such as lactulose, 
different mixtures of GOS and an emerging prebiotic OsLu at considerably 
dissimilar levels. Our findings have revealed a stronger resistance of β(1→6) 
linkages oligosaccharides to in vitro digestion when compared to β(1→4) and 
β(1→3) linkages GOS. In general, β(1→3) followed by β(1→4) linkages 
were more prone to small intestinal degradation using BBMV. This less 
resistance to intestinal digestion was also found for galactosyl-glucose 
disaccharides as compared to galactosyl-galactoses (galactobioses). The key 
role of monomer composition was also underlined by the presence of fructose 
in OsLu mixture, providing, thus, a higher resistance to digestion of 
galactosyl-fructoses. Findings described in this work could be extrapolated to 
humans providing evidence on the structure-function relationship, as well as 
an increase on the knowledge of the different resistance of β-linkages for the 
sake of a future potential development of new tailored prebiotics. Moreover, 
the observed hydrolysis with mammalian small intestinal enzymes of 
recognized prebiotics could challenge the general belief that these 
compounds reach the colon without any alterations in their structure. More 
investigation should be done in order to gain more insight in the concept of 
prebiotics’ digestibility. 
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Abstract:  
 
The suitability of artichoke and sunflower by-products as renewable sources of pectic 
compounds with prebiotic potential was evaluated by studying their ability to modulate the 
human faecal microbiota in vitro. Bacterial populations and short-chain fatty acid (SCFA) 
production were measured. Reduction of the molecular weight of artichoke pectin resulted in 
greater stimulation of the growth of Bifidobacterium, Lactobacillus and 
Bacteroides/Prevotella, whilst this effect was observed only in Bacteroides/Prevotella for 
sunflower samples. In contrast, the degree of methoxyl esterification did not have any impact 
on fermentability properties or SCFA production, regardless of the origin of pectic 
compounds. Although further in vivo studies should be conducted, either pectin or 
enzymatically-modified pectin from sunflower and artichoke by-products might be 
considered as prebiotic candidates for human consumption showing similar ability to 
promote the in vitro growth of beneficial gut bacteria as compared to well-recognized 
prebiotics such as inulin or fructo-oligosaccharides. 
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Introduction:  
One of the most complex polysaccharides that exist in the cell wall of all 
higher plants is pectin (Kac̆uráková, et al. 2000). Pectin is not a single 
structure and comprises of a family of plant cell wall polysaccharides that 
contain galacturonic acid (GalA) linked at α-1,4 positions. It mainly consists 
of a GalA-rich backbone, known as homogalacturonan (HG ≈ 65%) which is 
partially methyl-esterified in C-6 and O-acethyl-esterified in positions 2 and 
3 (Mohnen 2008). Rhamnose residues interrupt the HG structure to form 
rhamnogalacturonan I (RG-I ≈ 20-35%) which is based on a backbone 
consisting of a repeating disaccharide of GalA and rhamnose residues. In 
addition, some rhamnose residues may contain sidechains consisting of α-L-
arabinose and/or β-D-galactose (arabinans, galactans and arabinogalactans). 
RG-II constitutes ≈ 2-10% of pectin and is the most complex, but is also 
believed to be the most conserved part of pectin molecules. RG-II has a HG 
backbone and is branched with rhamnose and other minor sugars such as 
fucose, glucuronic acid and methyl esterified glucuronic acid among other 
rare carbohydrates such as apiose, 2-O-methylxylose, and 2-O-methylfucose 
(Holck et al. 2014; Noreen et al. 2017). 
The biological effects of pectins have been mainly studied on in vitro assays 
and they are highly fermentable dietary fibres. Furthermore, pectic-
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oligosaccharides (POS) have been proposed as a new class of prebiotics 
capable of exerting a number of health-promoting effects (Olano‐Martin et al. 
2002). These benefits include a desirable fermentation profile in the gut 
(Gómez et al. 2016), potential in vitro anti-cancer properties (Maxwell et al. 
2015), potential for cardiovascular protection (Samuelsson et al. 2016), as 
well as antibacterial, anti-inflammatory and antioxidant properties, among 
others (Míguez et al. 2016). Nevertheless, the details of the underlying 
mechanisms are still largely unknown and additional studies are needed on 
the structure-function interrelationship, as well as on the claimed effects 
caused by POS in humans (Gullón et al. 2013). 
Apart from POS, whose degree of polymerization range from 3 to 10, during 
the past few years there has been a flourishing interest towards pectin 
derivatives, especially the so-called “modified pectins” (MP), a term standing 
for pectin-derived, water-soluble polysaccharide of lower molecular weight 
(Mw) than the original pectin and, normally, produced from citrus peel and 
pulp (Holck et al. 2014). These compounds can be obtained from pectins in 
their native form using chemical and enzymatic treatments, which produce 
lower Mw HG and fragments enriched in RG (Morris et al. 2013). The break-
down of pectins not only leads to modification of their physico-chemical and 
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gelling properties (Ngouémazong et al. 2015), but also modulation of their 
bioactivity (Morris et al. 2013). 
There are several in vitro and in vivo studies on the ability of MP to inhibit 
tumour growth and metastasis (Morris et al. 2013; Nangia-Makker et al. 
2002; Park et al. 2017). Citrus MP inhibits in vitro and in vivo angiogenesis 
in different types of cancer by blocking the association of galectin-3 to its 
receptors (Zhang et al. 2015). Other beneficial health properties might 
include the reduction of atherosclerotic lesions (Lu et al. 2017), anti-
inflammatory and antioxidant properties (Popov & Ovodov 2013; 
Ramachandran et al. 2017) or immunostimulatory properties (Vogt et al. 
2016). However, most of these studies were performed using cell cultures or 
in mice and extrapolation of the results to human or clinical investigations 
should be considered with caution. 
Nonetheless, only a few recent studies have addressed the prebiotic potential 
of MP in terms of the fermentation properties. A slight or no increase was 
observed in the faecal lactobacilli count during an in vivo study with rats fed 
with citrus MP (Odun-Ayo et al. 2017). Di et al. (2017) compared five 
structurally different citrus pectic samples (3 of them were POS and 2 were 
MP) and found that two POS and one MP exhibited bifidogenic effects with 
similar fermentabilities in human faecal cultures. These authors concluded 
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that Mw and degree of methoxylation did not affect their bifidogenic 
properties; however, structural diversity in pectic compounds is possible as 
long as significant arabino- and galacto-oligosaccharide content is present. 
Fanaro et al. (2005) investigated the effect of acidic oligosaccharides from 
pectin on intestinal flora and stool characteristics in infants, showing that 
they were well tolerated as ingredient in infant formulae but did not affect 
intestinal microecology. 
To the best of our knowledge, the fermentation and prebiotic properties of 
pectin derived from artichoke (Sabater et al. 2018) and sunflower (Muñoz-
Almagro et al. 2018a) by-products have not been explored. In the case of 
artichoke, only one previous study showed a selective growth of two specific 
strains, i.e. Lactobacillus plantarum 8114 and Bifidobacterium bifidum 
ATCC 11863 which was ascribed to the combination of its high inulin and 
low methylated pectin contents (Fissore et al. 2015). Also, Costabile et al. 
(2010) reported, in a double-blind, cross-over study carried out in healthy 
adults, a pronounced prebiotic effect (i.e., increasing of bidifobacteria and 
lactobacilli) of a very-long-chain inulin derived from artichoke on the human 
faecal microbiota composition. The lack of knowledge of potential alternative 
sources of active pectic compounds for human consumption is surprising as 
previous studies reported that structure and composition can make a 
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significant difference to the fermentation properties (Onumpai et al. 2011). 
Thus, bifidogenic properties seem to highly depend on the composition and 
structure of pectins, with neutral sugar content and GalA:Rha ratio being 
critical factors (Di et al. 2017). 
In this context, considering the structural diversity of pectins dependent on 
their origin, the aim of this study was to evaluate the effect of a variety of 
pectins and enzymatic-modified pectins from different sources (in particular, 
citrus, sunflower and artichoke) on the profile changes in human faecal 
microbiota population and fermentation metabolites, i.e. short-chain fatty 
acids.  
Materials and methods:  
Raw material. Sunflower by-products based on heads and leftover stalks and 
artichoke by-products derived from external bracts, leaves and stems, were 
supplied by Syngenta AG and Riberebro S.L. (Spain), respectively. Prior to 
experiments, raw material was ground with a knife mill to particle size < 500 
µm. Commercial citrus pectin (trade name Ceampectin®, ESS-4400) was 
kindly provided by CEAMSA (Porriño, Pontevedra, Spain). 
Pectin extraction and modification. Sunflower pectin was extracted from 1 
kg of dried substrate by suspending in 20 L of sodium citrate (0.7 %) at 52 
ºC, pH 3.2 for 184 min  under agitation and the residue was precipitated with 
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ethanol and then freeze-dried (Muñoz-Almagro et al. 2018a). Artichoke 
pectin was extracted using a cellulase from Trichoderma reesei (Celluclast® 
1.5 L, Novozymes, Bagsvaerd, Denmark) in an orbital shaker at 50 °C, pH 5 
with constant shaking (200 rpm) following the method described by Sabater 
et al. (2018). After hydrolysis, samples were centrifuged (1,300 x g for 10 
min at 4 °C) and supernatants were filtered through cellulose paper. Residues 
were washed and precipitated in 70 % ethanol, centrifuged (1,200 x g, 20 
min) and then freeze-dried. Extraction yield of pectin (expressed as 
percentage) represents the amount of pectin extracted from 100 g of initial 
dried raw material, being 10.0% and 22.1% the obtained values for sunflower 
and artichoke pectin, respectively. 
The extracted sunflower and artichoke pectins, as well as the commercial 
citrus pectin were then subjected to an enzymatic treatment using a 
commercial cellulase from Aspergillus niger (Sigma Aldrich, Steinheim, 
Germany) with pectinolytic activity to reduce their Mw. Then, the resulting 
material was transferred to a continuous membrane reactor to separate the 
modified pectin from oligosaccharides and free sugars formed (Olano-Martin 
et al. 2001). The reactor consisted of an ultrafiltration dead-end stirred cell 
(model 8000, Amicon, Watford, U.K.) where the substrate was added and 
then pushed from a pressurized feed tank filled with water at a rate matching 
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the permeate flow rate. All filtrations were carried out with an Ultracel® 
ultrafiltration disk membrane, with a Mw cut-off (MWCO) of 3 kDa and a 
diameter of 76 mm as determined by the manufacturers. Checking of absence 
of low molecular weight carbohydrates in the ultrafiltered samples was 
accomplished by the analysis of the resulting retentates and permeates by 
SEC-ELSD following the method described in subsection 2.3.2. All pectin 
and MP samples were free from monosaccharides, as well as 
oligosaccharides below 10 kDa (Figure 1). 
Characterisation of pectin and enzymatic-modified pectin samples.  
Monosaccharide analysis.  Monosaccharide analysis was performed after 
the acid hydrolysis of samples with 2 M trifluoroacetic acid (TFA) at 110 °C 
for 4 h. After that, released monosaccharides were analysed by gas 
chromatography (GC) carried out with an Agilent Technologies gas 
chromatograph (7890A) equipped with a flame ionisation detector (FID). 
Prior to GC analysis, trimethylsilyl oximes (TMSO) of monosaccharides 
were formed (Cardelle-Cobas et al. 2009b). 500 µL of hydrolysed samples 
were evaporated to remove the acid and then 400 µL of phenyl-β-glucoside 
(0.5 mg/mL) used as internal standard (I.S.) were added. Afterward, the 
mixture was dried at 40 °C in a rotary evaporator (Büchi Labortechnik AG, 
Flawil, Switzerland).  
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Figure. 1. SEC-ELSD profiles of pectins (blue), enzymatic-modified pectins (MP) (green), 
and corresponding ultrafiltrated permeates (black) derived from A) citrus, B) sunflower, and 
C) artichoke sources. Elution positions of standard polysaccharide polymers (pullulans) are 
indicated by arrows.    
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Sugar oximes were formed by adding 250 μL hydroxylamine chloride (2.5%) 
in pyridine and heating the mixture at 70 °C for 30 min. Subsequently, the 
oximes obtained in this step were silylated with hexamethyldisylazane (250 
μL) and TFA (25 μL) at 50 °C for 30 min. Derivatisation mixtures were 
centrifuged at 6,700 x g for 2 min and supernatants were injected in the GC-
FID. Analyses were carried out using a DB-5HT capillary column (15 m x 
0.32 mm x 0.10 µm, J&W Scientific, Folson, California, USA). Nitrogen was 
used as carrier gas at a flow rate of 1 mL/min. Injector and detector 
temperatures were 280 and 385 °C, respectively. The oven temperature was 
programmed from 150 to 380 °C at a heating ratio of 1 °C/min until 165 °C 
and then up to 300 °C at a heating rate of 10 °C/min. Injections were made in 
the split mode (1:5).  
Data acquisition and integration were done using Agilent ChemStations 
software (Wilmington, DE, USA). Response factors were calculated after 
duplicate analysis of standard solutions (glucose, mannose, rhamnose, 
arabinose, galactose, GalA and xylose) over the expected concentration range 
in samples, (0.01–2 mg) and IS (0.2 mg). 
Estimation of the molecular weight (Mw).  Estimation of Mw was carried 
out by Size Exclusion Chromatography (SEC) according to the method 
described by (Muñoz-Almagro et al. 2018b). The analysis was performed on 
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a LC Agilent Technologies 1220 Infinity LC System 1260 (Agilent 
Technologies, Germain), equipped with two consecutive TSK-GEL columns 
(G5000 PWXL, 7.8 x 300 mm, particle size 10 µm, G2500 PWXL, 7.8 x 300 
mm, particle size 6 µm) connected in series with a TSK-Gel guard column 
(6.0mm×400mm) (Tosoh Bioscience, Stuttgart, Germany). Samples (20 µL) 
were eluted with 0.1 M NaCl at a flow rate of 0.5 mL/min for 50 min at 30 
°C. The eluent was monitored with an Evaporative Light Scattering Detector 
(ELSD) (Boeblingen, Germain) at 30 °C. Pullulans of Mw 788, 473, 212, 
100, 1.3, 0.34 kDa were used as standards to calibration. All the Mw values 
specified were weight-average. 
Estimation of the degree of methoxylation. Degree of methoxylation of 
samples was determined by Fourier transform infrared spectroscopy (FTIR). 
KBr discs were prepared mixing the pectin and enzymatic-modified pectin 
samples with KBr (1:100) and pressing. FTIR spectra Bruker IFS66v 
(Bruker, US) were collected in absorbance mode in the frequency range of 
400-4000 cm-1, at a resolution of 4 cm-1 (mid infrared region) with 250 co-
added scans. The degree of methoxylation was determined as the average of 
the ratio of the peak area at 1747 cm-1 (COO-R) and 1632 cm-1 (COO-) as 
previously described (Singthong et al. 2004).  
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Determination of in vitro fermentation properties and prebiotic 
activities.  
Faecal Inocula.  Faecal samples from five healthy adults (2 male, 3 female, 
mean age of 30.6 ± 4.2 years old) who had not consumed prebiotic or 
probiotic products, nor had received antibiotic treatment within 3 months 
before study were obtained in situ. Samples were kept in an anaerobic cabinet 
and used within a maximum of 15 min after collection. Faecal samples were 
diluted (10% w/w) in anaerobic phosphate-buffered saline (PBS; 0.1 mol/L, 
pH 7.4, Oxoid, Basingstoke, UK) and homogenised in a stomacher 
(Stomacher 400, Seward, UK) at normal speed for 2 min.  
In vitro batch fermentations.  Sterile stirred batch culture fermentation 
systems were set up and aseptically filled with a volume of sterile, basal 
medium: (per litre) 2 g  peptone water, 2 g yeast extract, 0.1 g NaCl, 0.04 g 
K2HPO4, 0.04 g KH2PO4, 0.01 g MgSO4·7H2O, 0.01 g CaCl2·6H2O, 2 g 
NaHCO3, 2 mL Tween 80, 0.05 g haemin, 10 µL vitamin K1, 0.5 g L-
cysteine HCl, 0.5 g bile salts and 4 mL resazurin (0.25 g/L). Medium was 
sterilised at 120 °C for 30 min before aseptically dispensing into the sterile 
fermenters. Sterile stirred fermenters were filled with 9 mL of autoclaved 
basal medium and were gassed overnight by constant sparging oxygen-free 
nitrogen to maintain anaerobic conditions. 100 mg of substrates were added 
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(final concentration of 1% (w/v)) to the respective fermentation just prior to 
the addition of the faecal inoculum (1 mL). The temperature was maintained 
at 37 °C using a water jacket and the pH was maintained between 6.7 and 6.9 
using an automated pH controller (Fermac 260; Electrolab, Tewkesbury, 
UK). The batch cultures were run for a period of 48 h and samples were 
taken from each vessel at 0 and 24 h for bacterial enumeration by fluorescent 
in situ hybridisation (FISH) and at 0, 10, 24, 36 and 48 h for SCFA by GC-
FID. 3 extra vessels with inulin, fructooligosaccharides (FOS) and no added 
carbohydrate source were also included as positive and negative control, 
respectively. 
Short-chain fatty acid (SCFA) analysis.  Before chemical analysis, samples 
from each fermentation time were centrifuged at 13,000 x g for 10 min to 
obtain the supernatant. The clear solutions were kept at -20 °C until analysis. 
SCFA analysis was carried out using GC-FID based on the method described 
by (Richardson et al. 1989). Before analysis, samples were thawed on ice and 
then vortexed. After that, 400 µL of each sample were taken into a glass tube 
and 25 µL of 2-ethylbutyric acid (0.1 M) (IS) was added. Following that, 250 
µL of concentrated HCl and 1.5 mL of diethyl ether were added and the 
solution was mixed 1 min and centrifuged 10 min at 2,000 x g. 400 µL of the 
upper layer (ether layer) was transferred to a GC screw-cap vial and 50 µL of 
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N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) was 
added and leave 72 h to produce fully derivatisation. 
A 5890 Series II Gas Chromatograph (Hewlett Packard) fitted with a Rtx-1 
10 m x 0.18 mm column with a 0.20 µm coating (Crossbond 100 % dimethyl 
polysiloxane; Restek) was used for analysis. Helium was used as carrier gas 
at a flow rate of 0.7 mL/min. Injector and detector temperatures were 275 °C. 
Oven temperature was programmed from 63 °C for 3 min and then heated to 
190 °C at a heating ratio of 3 °C/min and held at 190 °C for 3 min. Injections 
were made in the split mode (100:1). SCFA standards analysis was also 
carried out to quantify concentrations of all compounds. 
Enumeration of bacterial populations.  Enumeration of the target faecal 
bacteria groups was achieved by FISH with fluorescently labelled 16S rRNA 
probes according to the method described by (Wagner et al. 2003). Briefly, 
375 µL aliquots were obtained from each fermenter and were mixed with 
1.125 mL 4% (w/v), ice-cold paraformaldehyde and fixed for 4-10 h at 4 °C. 
Fixed cells were then centrifuged at 13,000 x g for 5 min and washed twice 
on 1 mL cold filter-sterilised PBS (0.1 M). The washed cells were then 
resuspended in 150 μL PBS and 150 μL of absolute ethanol (99 %) and 
stored at −20 °C until analysis. 
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To obtain an appropriate number of fluorescent cells in each field of view of 
the microscope, samples to hybridise were then diluted in a suitable volume 
of PBS with 1% (v/v) of sodium dodecyl sulphate, and 20 µL of the dilution 
was added to each well of a six-well polytetrafluoroethylene/poly-L-lysine-
coated slide (Tekdon Inc., Myakka City, USA). Samples were dried at 48-50 
°C for 15 min in a desktop plate incubator and dehydrated in an alcohol series 
(50, 80 and 96% (v/v) ethanol, 2 min each) and placed again at 48-50 °C to 
evaporate the excess of ethanol before adding the hybridisation solution. 50 
µL of hybridisation solution (per 1 mL; 5 M NaCl 180 µL, 1 M Tris/HCl 20 
µL, ddH2O 799 µL, 1 µL SDS 10% (w/v) and 100 µL of probe) was added to 
each well and left to hybridise for 4 h in a microarray hybridisation incubator 
(Grant-Boekel, UK) at 46-50 °C depending on the probe. After hybridisation, 
slides were washed in 50 mL washing buffer (5 M NaCl 9 mL, ddH2O 40 mL 
and 1 M Tris/HCl 1 mL) for 15 min and dipped in cold distilled water for 2-3 
seconds. Slides were then dried with compressed N2 and a drop of PVA-
DABCO antifade (polyvinyl alcohol mounting medium with 1,4-diazabicyclo 
(2.2.2) octane) was added onto each well. A coverslip (20 mm, thickness no. 
1; VWR) was placed on each slide and cell numbers of microorganisms were 
determined by direct counting under an epifluorescence microscope (Eclipse 
400; Nikon, Surrey, UK) with Fluor 100 lens. A total of 15 random fields of 
view were counted for each well.  
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The oligonucleotide probes used and conditions for each one are detailed in 
Table 1. These probes were selected to account for major bacterial groups in 
the Actinobacteria (Bif164), Bacteroidetes (Bac303), and Firmicutes 
(Lab158, Erec482, Chis150) phyla. 
 
Statistical analysis.  Statistical analysis was performed using SPSS for 
Windows, version 23.0. One-way analysis of variance (ANOVA) and 
Tukey’s post hoc test was used to determine significant differences among 
the bacterial group populations and organic acid concentrations among the 
 
Table 1. Oligonucleotide probes used in this study for FISH enumeration of bacteria. 
 
Probe Specificity DNA Sequence  
(5’ to 3’) 
Temperature 
(°C) 
Reference 
   HB* WB*  
 
Bac303 
 
Most Bacteroidaceae and 
Prevotellaceae. some 
Porphyromonadaceae 
 
 
CCA ATG TGG GGG 
ACC TT 
 
46 
 
48 
 
Manz et al. 
(1996) 
Bif164 Bifidobacterium spp. CAT CCG GCATTA 
CCA CCC 
 
50 50 Langendijk 
et al. (1995)  
Chis150 Most of the Clostridium 
histolyticum group 
(Clostridium cluster I and II) 
 
TTA TGC GGT ATT 
AAT CT(C/T) CCT TT 
50 50 Franks et al. 
(1998) 
Erec482 Most of the Clostridium 
coccoides-Eubacterium 
rectale group (Clostridium 
cluster XIVa and XIVb) 
 
GCTTCT TAGTCA 
(A/G)GT ACC G 
50 50 Franks et al. 
(1998) 
Lab158 Lactobacillus; Enterococcus GGT ATT AGC 
A(C/T)C TGT TTC CA 
 
50 50 Harmsen et 
al. (1999) 
*HB: hybridisation buffer; WB: washing buffer 
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different substrates. Differences were considered significant at p < 0.05 
(n=5). 
Results and discussion:  
 
The yields of extraction of pectin from artichoke (22.1%) and sunflower by-
products (10.0%) were in line with those obtained for other well-established 
sources of pectin, such as citrus peel (Kurita et al. 2008), lime peel 
(Dominiak et al. 2014), apple pomace (Wikiera et al. 2015) or passion fruit 
peels (Liew et al. 2016), suggesting their potential use as renewable pectin 
sources. 
Characterisation of pectin and enzymatic-modified pectin samples. 
Pectins from different sources (that is, citrus, artichoke and sunflower) and 
their enzymatic modified polysaccharides (modified pectin (MP)) were 
evaluated in this study. Neutral sugars and GalA content, average degree of 
methoxylation and average estimated Mw are included in Table 2. The 
GalA:Rha ratio displayed in the table shows the number of GalA residues per 
Rha residue, giving an indication of the RG-I backbone respect to HG 
content. Thus, a lower value shows a compound richer in RG-I chains. 
Ara:Rha and Gal:Rha ratios indicate the number of neutral sugar residues 
attached to the RG-I backbone.    
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As expected, GalA was the major monosaccharide residue in all pectic 
samples, ranging from 46.5 % (w/w) to 88.1% (w/w). The lowest values of 
GalA content were observed in those samples which had the highest values of 
rhamnose content. In consequence, the GalA:Rha ratio indicated that citrus 
MP, artichoke pectin, artichoke MP and citrus pectin were the most enriched 
samples in RG-I as compared to sunflower samples, which were the most 
enriched in HG structure according to the monomeric composition (27.4 and 
24.1 for GalA:Rha ratio for sunflower pectin and sunflower MP, 
respectively). Instead, artichoke pectin and MP presented high amounts of 
arabinose, surpassing rhamnose content, which could be indicative of a 
highly enriched structure in arabinan and arabinogalactan branches to the 
RG-I chains. The amount of rhamnose and arabinose with respect to GalA 
may also indicate the substitution of the rhamnogalacturonan branching along 
the HG with arabinan and arabinogalactan structures (Manderson et al., 2005; 
Yuliarti et al. 2015). The high content of arabinose and GalA determined in 
artichoke samples support the data obtained in previous studies (Femenia et 
al. 1998; Sabater et al. 2018). Galactose content in all samples was higher 
than other neutral sugars, with the exception of arabinose in artichoke pectin, 
which may also indicate the presence of galactose-based oligosaccharides 
branched to the HG backbone. 
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Table 2. Chemical characterisation of pectins and enzymatic-modified pectins from different renewable bioresources. 
 
 
                                                                     Monosaccharide (%*) 
 Sample 
 
Xylose Arabinose Rhamnose Galactose Mannose Glucose 
Galacturonic 
acid 
 
Average 
Mw 
(kDa) 
GalA:Rha Ara:Rha Gal:Rha 
Average 
degree of 
methoxylation 
(%) 
Citrus Pectin  
0.9 ± 0.0 3.5 ± 0.0 5.8 ± 0.0 20.2 ± 0.1 1.4 ± 0.0 1.8 ± 0.0 66.5 ± 0.2 800-100  11.52 0.61 3.50 
70.7  
Citrus MP 
1.3 ± 0.2 3.7 ± 0.2 9.8 ± 0.1 14.0 ± 0.3 2.4 ± 0.3 13.3 ± 0.3 55.6 ± 0.6 12.0-10.0 5.70 0.38 1.44 
14.2  
Sunflower 
Pectin 
2.2 ± 0.1 1.1 ± 0.0 3.2 ± 0.4 4.3 ± 0.0 0.1 ± 0.0 0.9 ± 0.0 88.1 ± 0.9 800-100 27.39 0.35 1.35 
 45.7 
Sunflower MP 
0.9 ± 0.0 2.3 ± 0.0 3.2 ± 0.1 12.2 ± 0.0 1.3 ± 0.0 1.8 ± 0.0 78.2 ± 0.5 12.5 24.13 0.71 3.77 
 17.0 
Artichoke 
Pectin 
1.1 ± 0.1 18.9 ± 0.6 7.6 ± 0.1 8.2 ± 0.3 1.0 ± 0.3 16.7 ± 0.7 46.5 ± 0.6 >500 6.13 2.50 1.09 
 8.9 
Artichoke MP 2.3 ± 0.2 10.7 ± 0.1 5.4 ± 0.0 21.1 ± 0.0 1.2 ± 0.0 3.9 ± 0.0 55.5 ± 0.8 300-80 10.34 1.99 3.94  8.5 
 
Analysis were carried out at least in duplicate (n=2) 
*Monosaccharide content (%) is referred regarding the total carbohydrate measured on each sample. 
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 Xylose that can be present in more complex structural features of pectin, 
such as RG-II regions or arabinoxylans and xylogalacturonan (Maxwell et al. 
2012), ranged from 0.9% to 2.3%. Lastly, glucose (from 0.9% to 16.7%) and 
mannose (from 0.1% to 2.4%) were found in all samples and they could 
likely derive from non-pectic polysaccharides extracted in minor amounts 
together the target pectins, such as xyloglucan, hemicellulose, and/or 
cellulose (Yapo 2009; Wang et al. 2016; Sabater et al. 2018).  
In both artichoke samples the degree of methoxylation was the lowest (8.9 
and 8.5 % for pectin and MP, respectively), whereas MP samples from citrus 
and sunflower had moderately higher values (14.2 and 17.0 %, respectively) 
and citrus and sunflower pectin had the highest data of all samples with 70.7 
% and 45.7 % of degree of methoxylation, respectively. This behaviour could 
be ascribed to the pectin methyl esterase activity of the enzyme employed to 
produce the corresponding MP. 
On the other hand, all resulting MP showed a reduction of the Mw as 
compared to their respective pectin due to the polygalacturonase enzyme 
activity, which was concomitant with a decrease in GalA and an increase in 
RG-I to HG. However, modified artichoke pectin showed a decrease in 
arabinose which led to a higher relative content of GalA compared to its 
parent pectin. The initial high content of arabinose observed in artichoke 
 182 
pectin could be related to the resulting high Mw of artichoke MP following 
enzymatic treatment. It is well known that arabinose is present in pectin as 
arabinan side chains and, consequently, a high degree of branching may 
create steric hindrance impairing the efficient cutting of the main chain 
composed by GalA. The decrease in Mw was correlated to the diminution of 
degree of methoxylation observed in citrus and sunflower samples. It is 
interesting to note that citrus and sunflower MP exhibited a Mw of 10-12.5 
kDa which is in line with other modified pectins obtained from citrus (̴ 10 
kDa) that have shown to be effective supplements in the treatment of cancer 
and other diseases (Morris et al. 2013). Artichoke MP showed a small 
decrease in this parameter which is in accordance with its high Mw, as shown 
in Figure 1. 
In vitro fermentation.  
Bacterial population changes during in vitro fermentation. Changes in the 
human faecal bacterial populations during the in vitro fermentation with the 
different pectins and enzymatic-modified pectins after 24 h are shown in 
Table 3. A significant increase (p < 0.05) of Bifidobacterium (Bif164) 
population for all carbohydrate samples was observed after 24 h of 
fermentation. It is well known that oligosaccharides deriving from pectins 
have bifidogenic activities, however there are also studies that have 
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demonstrated a bifidogenic effect in intact pectins suggesting a potential role 
of this polysaccharide as a prebiotic (Gómez et al. 2016; Yang et al. 2013). In 
our study, numerical increases up to 0.79 – 1.19 log10 in population were 
determined. Some authors indicated that increments of 0.5 - 1.0 log10 in 
bifidobacteria could be considered as a major shift in the gut microbiota 
towards a potentially healthier composition of intestinal microbiota (Kolida 
& Gibson 2007). Thus, all pectic samples could be considered bifidogenic 
under the studied conditions. Remarkably, artichoke MP was the substrate, 
which promoted the significantly highest growth in bifidobacteria among all 
assayed samples, including positive controls as inulin and FOS which in turn 
showed a similar bifidobacterial growth as compared to sunflower and citrus 
samples. This fact could be attributed to the high combined content of 
arabinose and galactose found in artichoke MP (Table 2) according to 
previous studies reporting a correlation between arabinose and galactose 
content with bifidogenic properties (Di et al. 2017; Manderson et al. 2005; 
Onumpai et al. 2011). Moreover, a positive effect of the decrease of Mw in 
pectin on its ability to promote bifidobacteria growth was observed for citrus 
and artichoke sources since their MP derivatives exhibited a significant (p < 
0.05) increase as compared to unmodified pectin (9.63 vs 9.42 log10 for citrus 
and 9.82 vs. 9.50 for artichoke), whereas sunflower pectin and MP presented 
a statistically identical bifidogenic activity. 
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Table 3. Bacterial populations (log10 cells per ml) enumerated by FISH at 0 and 24 h of in vitro fermentation with Inulin, FOS, citrus pectin, citrus 
modified pectin (MP), sunflower pectin, sunflower MP, artichoke pectin and artichoke MP.  
 
Probe/Strain 
Time 
point (h) 
Bacterial concentration (log10 cells/mL) 
  
  Control Inulin FOS 
Citrus 
Pectin 800-
100 kDa 
Citrus MP 
10.0 – 12.0 
kDa 
Sunflower 
Pectin 800-
100 kDa 
Sunflower 
MP 
12.50 kDa 
Artichoke 
Pectin      > 
500 kDa 
Artichoke 
MP 300-80 
kDa 
Bif164 0 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 
  24 8.75 (0.03)
a 9.52 (0.15)bc,1 9.48 (0.05)bc,1 9.42 (0.06)b,1 9.63 (0.04)cd,1 9.72 (0.12)cd,1 9.74 (0.06)cd,1 9.50 (0.14)bc,1 9.82 (0.13)d,1 
Bac303 0 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 
  24 8.59 (0.08)
a 9.36 (0.05)ef,1 9.39 (0.04)f,1 9.05 (0.08)bc,1 9.06 (0.03)bc,1 9.02 (0.09)b,1 9.19 (0.07)cd,1 9.23 (0.11)de,1 9.45 (0.04)f,1 
Lab158 0 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 
  24 8.38 (0.07)
a 9.05 (0.04)de,1 8.98 (0.03)cd,1 8.65 (0.06)b,1 9.04 (0.03)d,1 9.05 (0.02)d,1 8.98 (0.09)cd,1 8.92 (0.05)c,1 9.17 (0.05)e,1 
Erec482 0 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 
  24 
8.51 (0.04)a 8.97 (0.11)bc,1 9.08 (0.11)c,1 9.02 (0.05)bc,1 9.06 (0.06)c,1 8.83 (0.11)b,1 8.97 (0.07)bc,1 8.95 (0.06)bc,1 9.01 (0.11)bc,1 
Chis150 0 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 
  24 8.35 (0.04)
a 8.77 (0.06)b,1 8.72 (0.03)b,1 8.70 (0.09)b,1 8.73 (0.03)b,1 8.77 (0.01)b,1 8.70 (0.02)b,1 8.72 (0.04)b,1 8.70 (0.06)b,1 
 
A control sample without carbohydrate source is also included. Experiments were carried out in batch cultures systems inoculated with faecal inocula from five healthy human donors. 
Results shown as mean (n = 5) with the corresponding standard deviation in parentheses.  
a. b. c Significant differences (p < 0.05) between substrates are indicated with different letters in the same row. 
1 Significant difference (p < 0.05) from the 0 h value for each bacterial group and for the same substrate.  
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Evidently, there was not any significant increase during fermentation of 
negative controls, confirming the suitability of these substrates as a carbon 
source for the metabolism of bifidobacteria. The degree of methoxylation did 
not have impact on the bifidogenic properties. More specifically, sunflower 
samples had different value of this parameter with the same bifidogenic 
activity and artichoke samples had almost the same one with different 
bifidogenic activity. 
The second highest increase (up to 0.56 – 0.93 log10) was observed in 
Bacteroides/Prevotella (Bac303) population. This general increase is 
explained by the fact that Bacteroides species are major carbohydrate-
degrading organisms in the gut and have the capacity to degrade diverse plant 
polysaccharides, including pectins (Dongowski et al. 2000; Flint et al. 2012; 
Onumpai et al. 2011). Indeed, many Bacteroides strains from human faeces 
can produce pectinolytic enzymes, including polygalacturonase and pectin 
methylesterase (Dekker & Palmer 1981; Jensen & Canale-parola 1986). 
Therefore, Bacteroides can be involved in cross-feeding with Bifidobacteria 
by releasing breakdown products of pectin or MP which might be utilised by 
the latter, thus, promoting their growth. Inulin, FOS and artichoke MP 
samples exhibited the highest increase in Bacteroides. With respect to the 
effect of Mw on Bacteroides/Prevotella growth, sunflower and artichoke MP 
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demonstrated a significantly higher increase than their respective pectins. 
This difference could be attributed to the galactan chains branched to the RG-
I since Gal:Rha ratio increased in both sunflower and artichoke MP after the 
enzymatic hydrolysis.  
A significant increase in Lactobacillus/Enterococcus (Lab158) was also 
observed for all tested carbohydrate samples, with the most significant 
increases found in inulin and artichoke MP. Similar to Bifidobacterium, 
Lactobacillus is considered one of the major microbial targets for prebiotic 
action due to their health effects. The high increment in 
Lactobacillus/Enterococcus population following artichoke MP fermentation 
further established the correlation of arabinose and galactose content with the 
prebiotic properties. Mw did not affect sunflower samples but it seemed to 
have an impact on citrus and artichoke sources, in a similar manner to the 
behaviour observed for Bifidobacterium selectivity.  
Clostridium coccoides/Eubacterium rectale (Erec482) showed a significant 
increase in all tested samples but no significant differences were found 
among any of the carbohydrate substrates including inulin and FOS. Increase 
in Eubacterium rectale is of particular interest due to its ability to produce 
butyrate (Manderson et al. 2005). Di et al. (2017) reported an increase of 
Erec482 numbers when testing a citrus MP of similar Mw (9.2 kDa), 
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although they did not find a positive correlation with the determined butyrate 
concentrations. In the same way, Chen et al. (2013) reported enhanced 
Eubacteria growth on apple pectin compared to the respective POS, 
suggesting that the Mw was not a relevant factor. In our work, similar 
behaviour was observed since all pectic samples resulted in a significant 
stimulation of the butyrate producing bacteria groups (Erec482) and no 
differences were found between samples with different Mw or origin.  
Clostridium histolyticum (Chis150) population displayed the lowest changes 
in all cases, leading to a rather moderate increase (lower than 0.5 log10) after 
24 h of fermentation. No significant differences among any substrates were 
observed after fermentation. In general, Clostridium species are considered as 
potentially harmful bacteria, so in this way, all pectic samples induced a 
favourable behaviour. 
Short-chain fatty acids (SCFA) production. Acetate, propionate, butyrate 
and total SCFA formation was analysed throughout the fermentation in batch 
cultures (Table 4). Total SCFA concentration increased strongly during the 
first 10 or 24 h of fermentation in all tested substrates. In general terms, 
neither the degree of methoxylation nor Mw of pectin samples had an 
influence on the SCFA production, as reflected by the values contained in 
Table 4.  
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Table 4.  SCFA concentrations (mM) determined by GC-FID at 0, 10, 24, 36 and 48 h on in vitro fermentations with Inulin, FOS, citrus pectin, citrus 
modified pectin (MP), sunflower pectin, sunflower MP, artichoke pectin and artichoke MP. 
 
SCFA 
Time 
point  
(h) 
Mean SCFA concentration (mM) in substrate 
  
  Control Inulin FOS 
Citrus Pectin 
800-100 kDa 
Citrus MP 
10.0 – 12.0 
kDa 
Sunflower 
Pectin 800-
100 kDa 
Sunflower 
MP 
12.50 kDa 
Artichoke 
Pectin      > 
500 kDa 
Artichoke 
MP 300-80 
kDa 
Acetate 0 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 3.80 (1.55) 
  10 12.28 (3.30)a,1 36.99 (6.60)b,1 54.64 (15.10)bcd,1 61.65 (11.81)cd,1 68.49 (6.19)d,1 50.64 (9.15)bcd,1 58.47 (4.13)cd,1 49.35 (5.54)bcd,1 42.19 (3.77)bc,1 
  24 21.11 (3.31)a,2 62.44 (11.68)bcd,2 57.89 (14.88)bc 78.42 (9.02)cd 78.83 (12.87)cd 82.65 (11.80)d,2 69.21 (10.29)bcd 55.33 (1.62)b 50.86 (7.81)b 
  36 26.18 (4.49)a 65.24 (11.98)bc 63.68 (10.80)bc 71.18 (11.38)bc 78.95 (11.71)c 78.95 (11.62)c 67.64 (9.27)bc 55.64 (4.57)b 55.60 (11.09)b 
  48 17.62 (3.38)a 64.42 (10.55)bc 63.55 (10.86)bc 77.99 (14.69)bc 85.40 (11.34)c 78.49 (13.31)bc 73.87 (10.49)bc 61.00 (12.27)bc 55.94 (8.95)b 
      
       
Propionate 0 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 0.54 (0.27) 
  10 2.28 (0.92)a 7.58 (1.91)ab 12.20 (6.90)b 8.13 (3.22)ab,1 11.6 (3.76)b,1 6.35 (2.33)ab,1 10.00 (1.10)ab,1 11.35 (4.10)b,1 11.27 (3.17)b,1 
  24 4.7 (1.26)a,2 18.17 (4.69)b,2 15.64 (6.76)b,1 12.12 (4.58)ab 16.04 (1.86)b 11.82 (1.26)ab,2 13.84 (0.90)b,2 13.49 (3.98)b 15.69 (1.37)b,2 
  36 4.1 (0.60)a 19.51 (5.68)cd 23.77 (2.89)d 11.92 (4.26)b 16.15 (2.26)bcd 11.80 (1.47)b 14.12 (1.61)bc 14.55 (3.51)bc 16.97 (1.62)bcd 
  48 2.12 (0.99)a 18.41 (4.95)bc 20.69 (6.22)c 12.71 (3.51)b 17.35 (2.12)bc,2 13.60 (3.01)bc 14.15 (1.82)bc 14.10 (3.61)bc 16.10 (2.03)bc 
             
Butyrate 0 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 0.96 (0.17) 
  10 1.29 (0.64)a 6.57 (0.75)b 3.43 (2.17)ab 1.82 (1.94)a 2.51 (1.36)a 2.22 (1.10)a 3.26 (1.52)ab 2.70 (1.88)a 2.74 (1.12)a 
  24 1.77 (1.03)a 9.13 (2.22)b,1 5.20 (3.28)ab 4.52 (1.94)a,1 4.94 (1.54)ab,1 4.54 (2.19)a,1 5.42 (1.59)ab,1 5.30 (1.68)ab,1 4.50 (0.78)a,1 
  36 2.31 (0.67)a,1 9.66 (3.14)c 7.60 (3.20)bc,1 5.86 (2.26)abc,2 5.35 (1.87)abc,2 5.13 (1.88)abc 6.23 (1.80)abc 5.25 (2.22)abc 4.98 (1.34)ab 
  48 1.06 (0.38)a 9.08 (2.87)b 8.40 (3.85)b 4.92 (2.08)ab 5.89 (1.59)ab 4.78 (1.31)ab 6.33 (2.61)b 6.04 (3.04)b 4.98 (1.87)ab 
             
Total 0 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 5.26 (1.90) 
  10 15.84 (4.61)a,1 49.14 (13.14)b,1 83.76 (17.01)c,1 71.42 (12.18)bc,1 82.95 (6.94)c,1 59.21 (11.65)bc,1 71.74 (6.46)bc,1 63.89 (10.69)bc,1 56.20 (7.58)b,1 
  24 27.83 (3.69)a,2 90.30 (11.28)bcd,2 84.14 (17.36)bcd 94.15 (11.21)bcd 102.36 (14.94)d 99.01 (11.79)cd,2 89.70 (9.42)bcd 74.99 (3.97)bc 72.42 (9.24)b 
  36 32.24 (4.55)a 95.90 (13.77)b 90.74 (15.10)b 88.97 (14.71)b 97.03 (18.08)b 95.88 (12.16)b 89.64 (10.97)b 77.27 (8.63)b 79.42 (13.64)b,2 
  48 21.21 (3.96)a 90.38 (18.27)bc 91.45 (11.89)bc 95.63 (16.72)bc 109.42 (12.10)c 96.87 (13.57)bc 98.84 (9.49)bc,2 83.19 (17.16)bc 77.02 (11.35)b 
             
A control sample without carbohydrate source was also included. Experiments were carried out in batch cultures systems inoculated with faecal inocula from five healthy human donors. Results 
shown as mean (n = 5) with the corresponding standard deviation in parentheses.  
a. b. c Significant differences (p < 0.05) between substrates are indicated with different letters in the same row. 
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Acetate was the most abundant SCFA, followed by propionic and butyric 
acids in all substrates. Formation of acetate has been related to an 
enhancement of the ileal motility, a protection against genotoxic agents and 
pathogens and an increase of colonic blood (Hong et al. 2005). In our study, 
the only significant differences found between samples after 48 h of analysis 
were with artichoke and citrus MPs. Results demonstrated a sharp increase of 
this compound in the first 10 h of fermentation. Although it is challenging to 
attribute a particular fermentation end-product to a specific bacterial group in 
a mixed culture system, overall the increase in acetate is in agreement with 
the dynamics of the microbial populations, since all samples promoted the 
growth of Bifidobacterium and Lactobacillus (Table 3), which are acetate 
producers. Additionally, these end-products may serve as substrates for other 
bacteria due to metabolic cross-feeding (Belenguer et al. 2006). Acetate is 
generated by many bacterial groups that inhabit the colon, with 
approximately one-third of the product coming from reductive acetogenesis 
(Miller & Wolin, 1996). In contrast, bacterial groups that form propionate 
and butyrate are specialised and are of particular interest in terms of their 
beneficial effects. The main propionate-producing bacteria in the human 
colon are Bacteroides and Clostridium whereas butyrate production is related 
to bacterial groups such as Clostridium histolyticum (clusters I, II, IV, XIVa, 
XV and XVI) and Eubacterium rectale.  
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An increase in propionate concentration was seen in all samples after 48 h of 
fermentation, whereas fermentation of inulin and FOS resulted in the highest 
increase among all samples. Similarly to acetate, the high variability found 
among the five donors meant that propionate differences between all samples 
were not considered statistically significant (p > 0.05) during the first 24 h of 
fermentation. However, the increase in this end-product is in good agreement 
with the increase in Bacteroides population displayed in Table 3. Propionate 
has also been shown to exert beneficial effects on host health, such as 
reduction of food intake and enhancement of satiety via augmentation of the 
satiety hormone leptin (Zeng 2014), and a protective role against 
carcinogenesis through the decrease in human colon cancer cell growth via 
hyperacetylation of histone proteins and stimulation of apoptosis 
(Hinnebusch et al. 2002; Jan et al. 2002).  
Butyrate production resulted in a significant increase in all samples after 24 h 
of fermentation. FOS and inulin showed the highest increase after 48 h of 
fermentation, although non-significant differences were observed among all 
substrates due to the high inter-individual variability (Table 4). The low but 
significant increase in butyrate levels are in accordance with the increase of 
Erec482 and Chis150 numbers which also include some of the major 
butyrate-produces (Eubacterium rectale and Clostridium histolyticum). 
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Although acetate, propionate and butyrate are all metabolised to some extent 
by the epithelium to provide energy, butyrate plays a critical role in 
maintaining colonic health and moderating cell growth (Zeng 2014). 
Compared to acetate and propionate, butyrate exhibits strong anti-
inflammatory properties, likely mediated by inhibition of TNF-α production, 
NF-κB activation, and IL-8, -10, -12 expression in immune and colonic 
epithelial cells and a protective role against colon cancer (Bailón et al. 2010; 
Zeng 2014).  
Conclusions:  
Findings in this work highlight the suitability of artichoke and sunflower by-
products as renewable sources of bioactive pectic compounds since the 
reported yields were within the range observed for other well-established 
pectin sources. To the best of our knowledge, this is the first evidence of 
prebiotic potential of pectic compounds from sunflower and artichoke and 
also supports the important role played by the arabinose-rich 
rhamnogalacturonic acids in stimulating Bifidobacteria. A positive effect of 
decreasing molecular weight on fermentation properties was found in 
artichoke and citrus sources since their respective enzymatically-modified 
pectins promoted significantly higher growth in Bifidobacterium and 
Lactobacillus than the corresponding unmodified pectin. In the case of 
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sunflower, this behaviour was only observed in Bacteroides/Prevotella, 
which also grew to significantly higher population levels on artichoke MP as 
compared to the unmodified pectin. No significant effects of the molecular 
weight of pectin samples on SCFA production were observed, although this 
could be due to the high inter-individual variability observed in acetate, 
propionate and butyrate formation. Likewise, the degree of methoxylation did 
not have any significant impact on the fermentability nor SCFA production, 
regardless the origin of the pectic compounds. 
To conclude, although further in vivo studies should be conducted, our data 
reveal that either pectin or enzymatically-modified pectin from sunflower and 
artichoke by-products might be considered as efficient prebiotic candidates 
for human consumption showing similar ability to promote the in vitro 
growth of beneficial gut bacteria as Bifidobacterium and Lactobacillus in 
comparison to well-recognized prebiotics as inulin and FOS. 
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Abstract:  
 
The behaviour of citrus pectin during digestion and its potential prebiotic properties were 
examined using a Dynamic Gastrointestinal Simulator (simgi®) model for the human gut, 
which simulates processes in the stomach, small intestine, ascending, transverse and 
descending colon. A remarkable non-digestibility of pectin in the upper gastrointestinal tract 
was observed by HPLC-ELSD analysis, where ~88% of citrus pectin remained intact during 
its transit through the stomach and small intestine. Fermentation of pectin stimulated the 
growth of beneficial bacteria such as Bifidobacterium spp, Bacteroides spp and 
Faecalobacterium prausnitzii. High increases of short-chain fatty acids (SCFA) were 
observed, especially in acetate and butyrate produced due to direct fermentation of pectin or 
by cross-feeding interaction between bacteria. This is the first study on the digestibility and 
fermentation of pectin carried out in a complex dynamic gastrointestinal simulator, being of 
special relevance the results obtained for F. prausnitzii. 
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Introduction:  
Pectins are a family of plant cell wall polysaccharides with glycan domains 
that contain galacturonic acid (GalA) units with α-1,4 linkages. It mainly 
consists of a GalA -rich backbone, known as homogalacturonan (HG ≈ 65%), 
of which a number of residues are methyl esterified at the C-6 position, 
thereby conferring a specific degree of methoxyl esterification (DM) to the 
polymer. This degree of esterification and its distribution pattern define the 
charge distribution over the polymer playing a major role in the dimerization 
of pectin chains through the formation of junction zones, either via 
cooperative Ca2+ complexation or at reduced water activity as well as pH, 
thus defining the gelation properties of pectin (Dongowski et al. 2002; Fraeye 
et al. 2010). Furthermore, rhamnose residues interrupt the HG structure to 
form rhamnogalacturonan I (RG-I ≈ 20-35%) which is based on a backbone 
consisting of a repeating disaccharide of [→2)-α-L-Rhap-(1→4)-α-D-GalAp-
(1→] residues. RG-I has a number of side chains attached to its backbone and 
the length of these chains can vary from single glycosyl to polymeric side 
chains of different types (1→5)-α-L-arabinans, (1→4)-β-D-galactans, 
arabinogalactans-I, arabinogalactans-II (Buffetto et al. 2015). RG-II 
constitutes ≈ 2-10% of pectin and is the most complex part of pectin, it has a 
HG backbone branched with rhamnose and other minor sugars such as 
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fucose, glucuronic acid, methyl-esterified glucuronic acid, apiose, 2-O-
methylxylose, and 2-O-methylfucose (Holck et al. 2014; Lara-Espinoza et al. 
2018; Noreen et al., 2017). The suitability of pectin for specific applications 
is governed by the structural features, including molecular weight (Mw), 
neutral sugar content, proportion of HG:RG-I regions or the DM (Ferreira-
Lazarte et al. 2018; Sila et al. 2009). These factors can affect its applicability 
as thickeners or as gelling and stabilizing agents (Gullón et al. 2013). 
Pectins, as other dietary fibres, are believed to be resilient to digestion 
reaching the hindgut where they are fermented by the colonic microbiota 
(Lunn & Buttriss, 2007). However, before they reach the colon, these 
heteropolysaccharides are subjected to the singular luminal environment of 
the upper digestive tract that can contribute to chemical and physicochemical 
changes affecting the rate and extent of the fermentation in the colon 
(Hoebler et al. 1998). The intestinal degradation of pectin has been studied 
with substantially dissimilar results. In studies involving human subjects, 
Chinda et al. (2003) and Saito et al. (2005) as well as  Holloway (1983) 
observed that around 90%  and  60-85% of apple and citrus pectin, 
respectively, reached the terminal ileum but the procedures to evaluate total 
pectin were not robust enough to identify the possible structural and physical 
changes that take place. 
However, the capability of pectins to be fermented by the intestinal 
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microbiota it is well known, being the arabino- and galacto-oligosaccharides 
content one of the most important factors, even more relevant than Mw (Di et 
al. 2017; Onumpai et al. 2011). In this sense, there are some investigations 
that report a better bifidogenic effect, which means a growth of 
Bifidobacteria population, of pectins and pectic-polysaccharides with higher 
arabino- and galacto-oligosaccharides content, over modified pectin and 
pectic-oligosaccharides (POS) with lower Mw (Di et al. 2017; Ferreira-
Lazarte et al. 2018).  
Most of these studies are in vitro and often restricted to faecal samples, since 
in vivo investigations with animals and human trials have various drawbacks, 
such as high costs, ethical constraints, inter-individual variations and 
limitations in sampling from the small and large bowel (Venema & Van Den 
Abbeele, 2013; Verhoeckx et al. 2015). Nonetheless, even if they have 
limitations based on the absence of a physiological host environment, in vitro 
models are reproducible, since they allow better control of the experimental 
variables than animal or human studies. In general, they are rapid and simple 
methods and, therefore, relatively inexpensive and cost-effective. 
Furthermore, they allow a reduction of the samples size when this is a 
limiting factor (Verhoeckx et al. 2015). 
Therefore, several in vitro models have been developed to simulate the 
multistage processes of human gastrointestinal digestion (Alminger et al. 
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2014; Cascone et al. 2016; Hur et al. 2011; Marzorati et al. 2011; Verhoeckx 
et al. 2015). Among all these models, complex multi-compartmental 
continuous systems overcome the limitations present on static models, which 
do not reproduce the dynamic environment of the GIT (e.g. pH changes, 
peristaltic movements, gastric emptying, continuous changes, and secretion 
flow rates) (Ouwehand & Vaughan 2006). Nowadays, dynamic 
gastrointestinal digestion simulators are still limited. The SIMulator Gastro-
Intestinal (simgi®, Madrid, Spain) (Barroso et al. 2015) comprise five 
different compartments system, which simulates the different regions of the 
GIT such as, stomach (ST), small intestine (SI) and three compartments 
simulating the ascending (AC), transverse (TC) and descending (DC) regions 
of the human colon. The simgi® represents a fully computer controlled 
multi-compartmental system, which allows joint or separated simulation of 
the gastric and colonic fermentative processes. Thus, this is a flexible 
modulating system that combines a gastric compartment that simulates 
peristaltic mixing movements, a reactor that simulates the small intestine and 
three-stage continuous reactors for reproducing the colon region-specific 
microbiota and its metabolism (Barroso et al. 2015).  
Therefore, the aim of the present study was to examine the in vitro 
gastrointestinal digestion of a commercial citrus pectin using the Dynamic 
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Gastrointestinal Simulator (simgi®), and its impact on the subsequent 
fermentation by the colonic microbiota. 
 
Materials and methods:  
 
Samples of pectin. Commercial citrus pectin (trade name Ceampectin®, 
ESS-4400) was kindly provided by CEAMSA (Porriño, Pontevedra, Spain). 
Galacturonic acid (GalA) content, degree of methoxylation (DM), molecular 
weight (Mw) and neutral sugar content of the tested pectin were described in 
a previous study in our laboratory (Muñoz-Labrador et al. 2018) (Table S1, 
Annex C). 
Simgi® model assays digestion. The dynamic gastrointestinal simulator 
simgi® was used in the operating mode to work with the five units simulating 
the stomach (ST), small intestine (SI) and the ascending (AC), transverse 
(TC) and descending colon (DC) regions (Barroso et al. 2015). Figure 1 
shows the experimental protocol of the simgi® trial. The operation of the 
dynamic model was validated and optimized in previous studies (Barroso et 
al. 2016, Barroso et al. 2015; Cueva et al. 2015). Faecal slurry was obtained 
from a healthy volunteer who had no received any antibiotic treatment in the 
previous 3 months of the experiment. Then, faecal samples were diluted 
(20% w/w) in sterilised phosphate-buffered saline (PBS; 0.1 mol/L, pH 7.0, 
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Oxoid, Basingstoke, UK) containing 1 g/L sodium thioglycolate as reduced 
agent. The nutritive medium was adapted from the studies mentioned before 
and it was constituted by potato starch (Difco™, BD) (7 g/L), glucose 
(Difco™, BD) (0.4 g/L), yeast extract (Oxoid, ThermoFisher Scientific) (3 
g/L), special peptone (Oxoid, ThermoFisher Scientific) (1 g/L), mucin from 
porcine stomach (Sigma-Aldrich, Merk) (4 g/L) and L-cysteine (Panreac 
AppliChem) (0.5 g/L). All compounds were dissolved in 1 L of distilled 
water and sterilized at 121 ºC for 21 min with a final pH of 6.0. 
 
 
Figure 1. Schematic representation of the experimental protocol of the simgi® trial 
developed to assess the gastrointestinal digestion and fermentation properties of citrus pectin 
(30 g/L in nutritive medium) 
 
 
The ascending, transverse and descending colon compartments were filled 
and pre-conditioned with the nutritive medium that feed the system during 
the stabilization period; 250 mL (AC), 400 mL (TC) and 300 mL (DC) of 
nutritive medium were added and later inoculated with 20 mL of fresh faecal 
slurry (20% w/v).  
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A stabilisation period of 12 days was applied to allow the intestinal 
microbiota to adapt to environmental conditions present in the colon 
compartments and to form a stable microbial community (Barroso et al. 
2015). This stabilisation was approached by feeding the small intestine with 
nutritive medium (75 mL, pH 2) mixed with pancreatic juice (40 mL of a 
solution of 12 g/L NaHCO3 (VWR Chemicals), 6 g/L oxgall dehydrated 
fresh bile (DifcoTM, BD) and 0.9 g/L porcine pancreatin (Sigma-aldrich) 
three times a day during 12 days (Van Den Abbele et al. 2010). After 
stabilisation period of the colonic microbiota, the simgi® was subjected to a 
2-week experiment, which consisted of adding 240 mL of the commercial 
citrus pectin per day (3 doses of 80 mL) dissolved in the feeding nutritive 
medium (30 g/L, pH 3.1). This sample was added directly to the stomach 
during 14 days, where it was mixed with gastric electrolytes and pepsin by 
the simulated peristaltic moves, controlling the decrease of pH by adding 0.5 
M HCl. After stomach digestion, stomach content was automatically 
transferred to the small intestine vessel where digestion was performed 
during 2 h at 37 °C (pH = 7.0). Then, this content was transferred to the 
following compartment (AC) at a flow rate of 5 mL/min, which 
simultaneously activated the transit of colonic content between the AC, TC 
and DC compartments at the same flow rate. The temperature (37 °C), 
continuous flushing of nitrogen and pH were continuously controlled by the 
 202 
system. pH in the colonic units was controlled by addition of 0.5 M NaOH 
and 0.5 M HCl to keep values of 5.6 ± 0.2 in the AC, 6.3 ± 0.2 in the TC and 
6.8 ± 0.2 in the DC. Finally, a 1-week washout period was included at the end 
of the experiment by feeding the simgi® daily with nutritive medium. During 
the whole study, samples were collected every day at regular time points 
from the three colon vessels: During stabilisation period (< Day 13, and 
immediately prior to pectin feeding (Day 13*), during pectin feeding period, 
samples were also taken in stomach and small intestine compartments (Day 
13-27) and after the beginning of washout period (Day 27- 34). Finally, all 
collected samples were immediately centrifuged at 10,000 rpm for 10 min at 
4 °C. Supernatants were aliquoted and stored at – 20 °C until being analysed 
for short-chain fatty acids (SCFA), ammonium and molecular weight 
estimation of the tested pectin. Microbial plate count analyses were 
performed at the time of the sample collection. Pellets were stored at – 80 °C 
until further analysis of total bacteria and main bacterial groups by qPCR. 
Estimation of the molecular weight (Mw) of pectin. The estimation and 
monitoring of Mw of pectin samples during the gastrointestinal digestion 
with the simgi® was carried out by Size Exclusion Chromatography (SEC), 
according to the method described by Muñoz-Almagro et al. (2018b). 
Analysis was carried out on a LC Agilent Technologies 1220 Infinity LC 
System 1260 (Agilent Technologies, Boeblingen, Germain), equipped with 
 203 
two consecutive TSK-GEL columns (G5000 PWXL. 7.8 x 300 mm, particle 
size 10 µm, G2500 PWXL, 7.8 x 300 mm, particle size 6 µm; Tosoh 
Bioscience, Stuttgart, Germany). Centrifuged samples from the different 
compartments were first diluted before HPLC analysis: 1/10, 1/4 and 1/2 in 
HPLC water for ST, SI and AC, TC, DC compartments, respectively. Diluted 
samples were filtered and eluted (20 µL) with 0.1 M NH₄CH₃CO₂ at a flow 
rate of 0.5 mL/min for 80 min at 30 °C. The eluent was monitored with an 
Evaporative Light Scattering Detector (ELSD) (Boeblingen, Germain) at 30 
°C. Pullulans of Mw 805, 200, 10, 3 and 0.3 kDa were used as standards to 
calibration. All Mw values specified were weight-average. 
Short-chain fatty acids (SCFA) analysis. SCFA analysis was performed by 
liquid chromatography using a UV-975 detector following the method 
described by Sanz et al. (2005). Briefly, samples from the different colon 
compartments (AC, TC and DC) were filtered and injected on a HPLC 
system (Agilent Technologies, Germany) equipped with a UV-975 detector 
and automatic injector. SCFA were separated using a Rezex ROA Organic 
Acids column (300 x 7.8 mm) (Phenomenex, Macclesfield, UK) thermostated 
at 50 °C. Mobile phase was sulphuric acid 0.005 mM in HPLC grade water at 
a flow rate of 0.5 mL/min under isocratic elution. The elution profile was 
monitored at 210 nm and peaks were compared to standards to be identified. 
Data acquisition and integration were done using Agilent ChemStation 
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software (Wilmington, DE, USA). Calibration curves of all SCFA were 
obtained from the analysis of standard solutions of lactic, formic, acetic, 
propionic, butyric, valeric and isovaleric acid, ranging the concentrations of 
1-100 mM. 
Ammonium determination. Ammonium levels were determined using the 
Ammonium test (Spectroquant Ammonium Test, Merck), following the 
manufacturer’s instructions. Briefly, serial dilutions of an ammonium 
standard solution (10 g/L) were used to prepare calibration curves. Simgi® 
samples were diluted with deionized water (1:10). Just prior to performing 
the measurement at 25 ºC, 5 mL of reactive NH4-1 and reactive NH4-2 were 
added to the diluted standards or samples. The mixture was shaken between 
each reagent addition. Then, the absorbance was quantified at 690 nm. 
Analyses were performed in duplicate. The results were expressed as mg of 
NH4
+ contained in each colon compartment. 
Microbial analyses: 
Plate counts. Collected samples from the different colon compartments were 
diluted (1/10) in a physiological solution (0.9 %) and were plated on eight 
types of genera and selective media as follows: Tryptic Soy Agar (TSA) 
(Becton and Dickson & Company, BD) for total aerobes; Wilkins-Chalgren 
agar (BD) for total anaerobes; MacConkey agar (BD) for 
Enterobacteriaceae; Enterococcus agar (BD) for Enterococcus spp.; MRS 
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agar (Pronadisa) for lactic acid bacteria and Tryptose Sulfite Cycloserine agar 
(TSC) (Pronadisa) for Clostridium spp. Plates were incubated at 37 °C for 
24-48 h in an anaerobic chamber (BACTRON Anaerobic/Environmental 
Chamber, SHELLAB, USA), except for TSA which was incubated in aerobic 
conditions (Nüve Incubator EN 120, NÜVE, Turkey). 
Bacterial DNA extraction and quantitative polymerase chain reaction 
(qPCR). Bacterial DNA extraction of pellets from AC, TC and DC 
compartments was performed using a QIAamp DNA Stool Mini Kit (Qiagen, 
Hilden, Germany), following the manufacturer’s recommended protocol. 
Extracted DNA of all samples was stored at -80 °C until analysis. 
The amplification and detection of bacterial DNA was carried out on a ViiA7 
Real-Time PCR System (Applied Biosystems). Specific 16s rRNA-targeting 
primers were used in this study to determine total bacteria, Bacteroides spp, 
Bifidobacterium spp, Enterobacteriaceae, Enterococcaceae, Lactobacillus 
spp, Faecalibacterium prausnitzii and the Clostridium cluster XIVa. 
Reactions were done in triplicate in 384-well plates using SYBR® Green 
PCR Master Mix (Applied Biosystems). Final volume of each amplification 
reaction was 10 µL: 5 µL of SYBR® Green, 0.3 µL of each primer (10 µM), 
3.4 µL of nuclease-free water purified for PCR (Sigma-Aldrich) and 1 µL of 
DNA template. Thermal cycling consisted of an initial cycle of 95 °C, 3 min, 
followed by 40 cycles of 95 °C, 15 s and 1 min at the appropriate primer-pair 
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temperature (Gil-Sánchez et al. 2017). In order to quantify bacterial groups, 
DNA isolated from selected bacterial strains was used, Bacteroides fragilis 
for Bacteroides, Bifidobacterium longum for Bifidobacterium, Blautia 
coccoides for Clostridia XIVa, F. prausnitzi for Faecalobacterium prausnitzi, 
Escherichia coli for Enterobacteriaceae, Enterococcus falcium for 
Enterococcaceae, Lactobacillus plantarum for Lactobacillus and B. fragilis 
for total bacteria. Standard curves were generated by plotting threshold 
cycles (CT) vs. bacterial quantity expressed as colony-forming units 
(CFU)/mL. 
Statistical analysis. Statistical analysis was performed using SPSS for 
Windows, version 23.0. One-way analysis of variance (ANOVA) and 
Tukey’s post hoc test was used to determine significant differences among 
the bacterial group populations obtained after the qPCR analysis and organic 
acid concentrations to test the main effects of factors studied (time, pectin 
feeding, compartment). Differences were considered significant at p < 0.05 (n 
= 3). 
 
Results:  
 
Characterisation results showed GalA as the main component with 66.5 ± 0.2 
% of the total carbohydrates; galactose was the second main component with 
20.2 ± 0.1 % and rhamnose and arabinose were present with 5.8 and 3.5 %, 
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respectively. Glucose, mannose and xylose were also determined in minor 
values, 1.8, 1.4 and 0.9 %, respectively. Interval of Mw and methoxylation 
degree of pectin were determined as 100-800 kDa (average 350 ± 30 kDa) 
and 70.7 %, respectively (Ferreira-Lazarte et al. 2018).   
Effect of digestion and fermentation on pectin molecular weight. The 
behaviour of pectin during the chronic feeding period (Figure 1) was 
evaluated by monitoring the Mw during its passage through the different 
compartments (ST, SI, AC, TC and DC). Table 1 shows the quantitative 
results obtained by SEC-ELSD determination. Analyses were carried out just 
before starting the feeding period at day 13 (representing the nutritive 
medium), and three random days during the chronic feeding (Day 15, 24 and 
27) as well as the last day of the washout period (Day 34). Results showed a 
high average Mw for citrus pectin (350 ± 30 kDa) which represented almost 
54 % of total content when mixed with nutritive medium, whereas the latter 
was mainly constituted of low Mw carbohydrates (<18 kDa). Values at Day 
13* (before feeding with citrus pectin) showed almost no changes between all 
compartments. During the chronic feeding, pectin showed no changes in the 
stomach compartment when compared to the intact pectin (before feeding the 
system), whereas a slight decrease can be observed after the small intestine 
passage, showing a high resistance of citrus pectin to the upper 
gastrointestinal digestion.  
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However, fermentation in the three different sections of colon gave rise to a 
remarkable effect on pectin Mw. At this stage, it can be seen the presence of 
 
Table 1. Effect of the gastrointestinal digestion (simgi®) on the estimation 
and distribution of Mw (Average Mw) of the studied pectin (3%, w/v). 
    
Concentration of carbohydrate fraction 
(%) 
Sample/Day Compartment 350 ± 30 kDa 40 ± 5 kDa < 18 kDa 
Medium - - 6.0 ± 1.5 94.0 ± 0.0 
Medium+Pectin - 53.6 ± 1.2 - 46.4 ± 0.0 
Day 13* ST - 5.7 ± 0.5 94.2 ± 0.1 
 SI - 6.9 ± 0.1 93.0 ± 0.3 
 AC - 5.0 ± 0.2 94.9 ± 0.2 
 TC - 4.2 ± 0.1 95.8 ± 0.1 
 DC - 4.3 ± 0.0 95.5 ± 0.0 
Day 15 ST 56.6 ± 0.6 - 42.8 ± 0.9 
 
SI 52.9 ± 0.4 - 46.7 ± 0.5 
 
AC 8.5 ± 0.6 15.1 ± 0.8 75.8 ± 0.6 
 
TC 9.5 ± 0.2 4.8 ± 0.1 85.2 ± 0.3 
 
DC 9.8 ± 0.1 4.6 ± 0.1 85.1 ± 0.1 
Day 24 ST 56.5 ± 1.5 - 42.0 ± 0.3 
 
SI 47.6 ± 0.3 - 55.9 ± 0.7 
 
AC 5.4 ± 0.1 17.2 ± 0.9 76.9 ± 0.1 
 
TC 4.8 ± 0.4 3.5 ± 0.0 91.4 ± 0.5 
 
DC 4.7 ± 0.2 2.2 ± 0.0 92.8 ± 0.3 
Day 27 ST 55.8 ± 0.9 - 43.5 ± 0.2 
 
SI 47.7 ± 0.8 - 55.7 ± 0.6 
 
AC 1.9 ± 0.0 17.7 ± 0.6 79.7 ± 0.1 
 
TC 0.6 ± 0.0 3.7 ± 0.1 95.5 ± 0.1 
 
DC 0.5 ± 0.0 2.5 ± 0.0 96.8 ± 0.0 
Day 34 ST 9.8 ± 0.0 - 89.7 ± 0.4 
 
SI 7.0 ± 0.1 - 92.8 ± 0.7 
 
AC 4.0 ± 0.0 - 95.8 ± 0.6 
 
TC 3.9 ± 0.0 - 96.0 ± 0.2 
 
DC 2.0 ± 0.0 - 98.0 ± 0.0 
Data are expressed as the mean ± SD (n=2). 
*Sample taken before feeding with citrus pectin. 
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a new chromatographic peak of lower Mw (40 ± 5 kDa) than the peak 
corresponding to the intact pectin (350 ± 30 kDa), as well as an increase in 
the abundance of the peak including low Mw carbohydrates (<18 kDa), 
probably due to the fermentation of pectin (Figure 2). Lastly, washout period 
showed almost no presence of any carbohydrates since feeding with nutritive 
medium/pectin was substituted with only nutritive medium (Table 1). 
Evolution of the microbial community. The computer-controlled 
multicompartmental dynamic gastrointestinal model used in this study, 
allowed us to monitoring the gastrointestinal digestion and fermentation in 
the different compartments/sections due to its capability to simulate in vitro 
the microbial conditions that characterize the different regions of the gut.  
qPCR analysis. Given that important modifications in the HPLC profiles of 
pectin were found together with slight trends observed by the plate counts 
(Table 2S, Annex C), a qPCR analysis was done at the last day of each period 
in the AC, TC and DC compartments in order to better assess changes in the 
microbial population during the in vitro fermentation of citrus pectin (Table 
2). In general, higher amounts of bacteria were obtained with qPCR as 
compared with plate counts, which is in consonance with the fact that only a 
small fraction of the range of gut bacterial groups found had been, up to now, 
cultured (Zoetendal et al. 2006). 
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Figure 2. Qualitative evolution of citrus pectin (Mw distribution) in the five compartments (Stomach (dilution 1/10), Small Intestine (1/4), 
Ascending Colon (1/2), Transverse Colon (1/2) and Descending Colon (1/2)) during feeding of the dynamic simulator of the gastrointestinal 
tract (simgi®). 
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The rest of bacteria were often labelled as “unculturable” due to the generally 
fastidious anaerobic growth requirements (Allen-Vercoe 2013). Counts of 
total bacteria group were about 9.5 log copy number/mL at the end of 
stabilisation period and increased significantly (p < 0.05) after citrus pectin 
feeding in AC and TC whereas in DC a lower and non-significant increase (p 
> 0.05) was determined. In addition, a decrease was observed in all 
compartments after washout period. 
Among all bacterial groups that were studied, a huge and significant increase 
in counts of Bifidobacterium spp, Bacteroides spp, F. prausnitzii and 
Enterobacteriaceae was observed after the feeding with the citrus pectin in 
all colon sections with the exception of Enterobacteriaceae in TC. 
Furthermore, an overall and statistically significant decrease was found after 
the washout period, with some exceptions (i.e., Bacteroides spp in AC, or 
Enterobacteriaceae in all colon sections). In contrast, a decrease in 
Lactobacillus spp (in all colon sections) and Enterococaceae (in TC) was 
also observed after the feeding period with pectin. These values increased 
during the washout period for Enterococaceae whereas did not present any 
changes in Lactobacillus spp. 
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Table 2. Mean values (n = 3) of the qPCR data as copy number/mL for the microbial groups analysed in 
the ascending (AC), transverse (TC) and descending colon (DC) of the dynamic gastrointestinal model 
(simgi®) at the end of stabilization period (day 13), chronic intake (day 27) and washout period (day 34) 
with citrus pectin. Values in brackets represents the data as the log10 of copy number/mL 
 
Bacteria group 
  
Compartment Stabilisation period Chronic intake period Washout period 
  
Day 13* 
 
Day 27 
 
Day 34 
 
Total bacteria AC 3.1x109 (9.49 ± 0.05)a 6.6x109 (9.82 ± 0.02)c 4.8x109 (9.68 ± 0.04)b 
  TC 3.4x109 (9.50 ± 0.23)a 1.5x1010 (10.16 ± 0.01)b 3.0x109 (9.48 ± 0.06)a 
  DC 2.7x109 (9.43 ± 0.01)a 3.9x109 (9.59 ± 0.02)a 1.6x109 (9.14 ± 0.33)a 
  
 
      
Lactobacillus AC 1.8x105 (5.24 ± 0.13)b ≤104 (≤ 4)a ≤104 (≤ 4)a 
  TC 6.7x105 (5.79 ± 0.24)b ≤104 (≤ 4)a ≤104 (≤ 4)a 
  DC 3.6x105 (5.53 ± 0.18)b 2.8x104 (4.39 ± 0.28)a 1.5x104 (4.03 ± 0.48)a 
  
 
      
Bifidobacterium AC 2.8x105 (5.44 ± 0.04)a 3.7x108 (8.56 ± 0.06)c 2.8x106 (6.43 ± 0.13)b 
  TC 7.6x105 (5.87 ± 0.14)a 1.1x108 (8.02 ± 0.09)c 6.0x106 (6.77 ± 0.05)b 
  DC 3.2x105 (5.50 ± 0.07)a 3.4x108 (8.54 ± 0.02)c 9.6x106 (6.98 ± 0.02)b 
  
 
      
Bacteroides AC 2.8x108 (8.45 ± 0.08)a 1.7x109 (9.24 ± 0.01)b 1.5x109 (9.18 ± 0.02)b 
  TC 7.0x108 (8.85 ± 0.01)a 4.4x109 (9.64 ± 0.03)b 6.2x108 (8.79 ± 0.07)a 
  DC 3.4x108 (8.53 ± 0.05)a 8.5x109 (8.93 ± 0.02)c 5.0x108 (8.70 ± 0.02)b 
  
 
      
Faecalobacterium  AC ≤105 (≤ 5)a 2.8x107 (7.43 ± 0.14)b ≤105 (≤ 5)a 
prausnitzii TC ≤105 (≤ 5)a 1.3x108 (8.08 ± 0.18)b ≤105 (≤ 5)a 
  DC ≤105 (≤ 5)a 1.6x107 (7.17 ± 0.21)b 1.1x105 (5.05 ± 0.10)a 
  
 
    
Enterococaceae AC ≤104 (≤ 4)a 4.9x105 (5.68 0.06)b ≤104 (≤ 4)a 
  TC 6.8x106 (6.83 ± 0.05)b 1.8x104 (4.19 0.28)a 2.5x106 (6.40 0.02)b 
  DC 1.1x106 (6.05 ± 0.04)a 3.2x105 (5.50 0.03)a 6.4x105 (5.69 0.45)a 
  
  
  
Enterobacteriaceae AC 9.5x106 (6.98 ± 0.02)a 4.6x108 (8.66 ± 0.03)b 3.6x108 (8.55 ± 0.07)b 
  TC 2.1x108 (8.32 ± 0.08)ab 1.7x108 (8.21 ± 0.19)a 4.1x108 (8.60 ± 0.07)b 
  DC 5.6x107 (7.70 ± 0.24)a 1.9x108 (8.23 ± 0.25)b 2.3x108 (8.37 ± 0.02)b 
  
  
  
a,b,c Significant differences (p < 0.05, ANOVA) were determined for log10 values (in brackets) for the same bacterial 
group. Letters represent significant differences between days for the same compartment in each bacterial group.  
*Sample taken before feeding with citrus pectin. 
Standard deviation values are in brackets. 
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Metabolic activity. The metabolic activity of the microbiota before, during 
and after feeding with pectin in the different colonic reactors of the simgi® 
was evaluated by monitoring the content of SCFA (fermentative metabolism) 
and of ammonium (proteolytic metabolism).  
Ammonium determination. Evolution of ammonia during the simulation of 
the gastrointestinal digestion in the three colon compartments is shown in 
Figure 3.  
 
 
 
 
Figure 3. Ammonium Evolution (mM) during gastrointestinal digestion of citrus pectin in 
the simgi® 
 
A slight but significant decrease (p < 0.05) in ammonium concentration is 
observed during the feeding with the citrus pectin, as compared with 
stabilisation and washout periods. Also, as it has been observed in previous 
studies with the same system (simgi®) (Barroso et al. 2016, Barroso et al. 
2015; Gil-Sánchez et al. 2017), ammonium concentration gradually increased 
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from AC to the DC compartment because of the accumulation of products in 
the system, which lacks of any absorption steps between the different 
compartments. These values showed that proteolytic metabolism occurred 
through the entire colon compartments during the whole experiment, but it 
was substantially diminished during the chronic feeding period with citrus 
pectin. 
Short-chain fatty acid (SCFA) analysis. The major end-products of 
indigestible carbohydrates metabolism by the colonic microbiota are SCFA. 
SCFA evolution (mM) during the stabilisation period, chronic feeding of 
citrus pectin and washout period is shown in Figure 4. SCFA concentrations 
presented no changes during the stabilisation period in all three 
compartments. During the chronic feeding with pectin these levels showed a 
significant increase in all major SCFA (acetate, propionate and butyrate) 
which decreased after elimination of nutritive medium/pectin administration. 
As expected, SCFA production consisted mainly of acetate, butyrate and 
propionate with small amounts of lactate and valerate in all compartments. 
Acetate was the most abundant SCFA, followed by butyric and propionic 
acid, showing increases up to 297, 92 and 60 %, respectively, after chronic 
feeding, as compared to the initial levels (Day 13). Afterwards, they showed 
a considerable decrease during washout period started.  
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Figure 4. Evolution in concentration of SCFA in the ascending (AC), transverse (TC) and 
descending colon (DC) of the simgi® during the stabilisation (D1-D13), feeding (D13-D27) 
and washout period (D27-34) with citrus pectin solution (3 g/L). 1,2,3 Numbers represent 
differences (p < 0.05) between the data at the end of each period. 
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Overall, the total SCFA average molar production was compartment-
dependent, being higher in the transverse and descending colon. Regarding 
minor SCFA, results also showed significant values of valerate in all three 
compartments (Khodaei et al. 2016). Formic acid was detected in the AC 
compartment reaching values of 2.7-8.0 mM whereas TC and DC presented 
concentrations below 1.1 mM. Lactic acid production was only detected at 
fermentation days with the citrus pectin (1.3, 8.7 and 4.0 mM in ascending, 
transverse and descending colon, respectively). Although lactate is not a 
SCFA, it is usually considered in the metabolism of bacteria as a product of 
saccharolytic fermentation. Furthermore, valerate has been described as a 
primary end product of lactate fermentation (Almeida et al. 2017; Unger et al. 
2016; Yoshikawa et al 2018). 
 
Discussion:  
 
Several studies have shown that oligosaccharides deriving from pectins exert 
bifidogenic activities. Furthermore, there are also studies that have 
demonstrated a significant growth of bacteria in intact pectins suggesting a 
potential role of this polysaccharide as a prebiotic (Ferreira-Lazarte et al. 
2018; Gómez et al. 2016; Yang et al. 2013). In fact, in a static in vitro study, 
we have recently shown that either pectin or enzymatically-modified pectin 
from different by-products stimulates beneficial bacteria of colonic 
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microbiota (Ferreira-Lazarte et al. 2018). However, no investigation has been 
carried out on the properties of pectin as a substrate for fermentation 
including a previous passage through the upper gastrointestinal tract. This 
study remarks, for the first time, the use of the simgi® to evaluate the effect 
of the upper gastrointestinal digestion on a commercial citrus pectin and its 
effect on colonic microbiota metabolism. 
Pectin taken from the stomach compartment showed almost no changes when 
compared to the initial status, whereas samples taken from the small intestine 
revealed some loss of pectin, 6.5, 15.7 and 14.7 % for Day 15, Day 24 and 
Day 27, respectively. Holloway et al. (1983) observed a loss of pectin of 15-
40 % in an in vivo study with ileostomy samples. In the same way, Saito et al. 
(2005) found that approximately 90 % of ingested pectin was recovered in 
the terminal ileum in an in vivo study collecting endoscopy retrograde 
samples. These studies attributed the loss of pectin to the possible 
degradation by bacteria within the digestive tract, especially the terminal 
ileum. However, given that in our prototype of digestion the presence of 
bacteria is confined to the colon compartments, changes observed in the Mw 
of pectin after its passage through the SI could be related to other chemical 
effects due to the interaction with pancreatic fluids and bile salts (Miller et al. 
1995).  
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Regarding the effect of digested pectin on microbiota, results obtained 
showed that citrus pectin favourably impacts on microbiota composition and 
functionality in the three compartments (AC, TC and DC) of the simgi® 
model. 
Pectin fermentation produced an increase in the counts of total bacteria, 
compared to the initial state, with significant increases in the proximal 
regions (ascending and transverse colon) probably due to the content of 
polysaccharide coming from the small intestine. Furthermore, high methoxyl 
pectins, as it is the case of citrus pectin here assayed, have showed a slower 
fermentation in the large intestine of rats, which allows the fermentation to 
take part in all three compartments (Dongowski et al. 2002). 
According to some authors, increments up to 0.5 - 1.0 log10 in 
Bifidobacterium populations could be considered as a major shift in the gut 
microbiota towards a potentially healthier composition of intestinal 
microbiota (Kolida & Gibson 2007). Bifidobacterium and lactobacilli have 
been traditionally considered as the major microbial targets for prebiotic 
action, due to their beneficial effects (Roberfroid et al. 2010). Similar values 
of Lactobacillus spp and Bifidobacterium spp populations at the end of 
stabilisation period were observed (Table 2). Increases up to 2.15 - 3.12 log10 
in Bifidobacterium group was determined in all compartments, being the 
highest increase of all bacteria determined. This could be attributed to the 
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high galactose/arabinose content of the studied pectin (23.8 %) (Di et al 
2017; Onumpai et al. 2011). However, unlike Bifidobacterium, Lactobacillus 
group showed a significant decrease after feeding with citrus pectin. In 
related studies, Olano-Martin et al. (2002) reported that both POS and citrus 
pectin significantly increased the number of Bifidobacteria, whereas 
lactobacilli numbers only increased with POS although this increase was not 
statistically significant. Furthermore, Chen et al. (2013), showed an increase 
of Bifidobacteria during the in vitro fermentation of apple pectin (DM 70%) 
and POS, whereas Lactobacillus population presented no changes or even 
similar values for pectin compared to the negative control after 24 h of 
fermentation. Li et al. (2018) also showed a decrease of Lactobacillus when 
feeding rats with pectin extracted from citrus peels in an in vivo study.  
Faecalobacterium prausnitzii values reported to be the second highest 
increase during the fermentation of pectin in the simulator (2.17 – 3.03 log10). 
F. prausnitzii is one of the most abundant commensal bacteria in the healthy 
large intestine and is one of the main producers of butyrate in the human 
colon (Louis et al. 2007; Louis et al. 2014). Furthermore, low F. prausnitzii 
levels were correlated with the recurrence of inflammatory bowel disease and 
it has confirmed to have anti-inflammatory effects (Onumpai et al. 2011; 
Sokol et al. 2008). Likewise, it has been suggested that this bacterium could 
be a good probiotic candidate to counterbalance dysbiosis in Crohn’s disease 
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patients (Scott et al. 2014; Sokol et al. 2009). Moreover, previous studies 
have shown that this bacterium could have a major role in pectin utilization in 
comparison with other two abundant pectin-utilizing species, Bacteroides 
thetaiotaomicron and Eubacterium eligens (Lopez-Siles et al. 2012). 
Bacteroides population showed also a high increase being the third highest 
increase of all bacteria determined with values of 0.4 – 0.8 log10. Bacteroides 
are one of the enterotypes of the human microbiota, which are responsible for 
the major part of polysaccharide digestion occurring in the human large 
intestine (Flint et al. 2012; Salazar et al. 2009). In fact, many strains from 
human faeces can produce various pectinolytic enzymes, including 
polygalacturonase, pectin methylesterase, extracellular and cell-associated 
pectate lyase (Dekker & Palmer, 1981; Jensen & Canale-Parola 1986). 
Hence, Bacteroides could be involved in cross-feeding with Bifidobacteria 
by releasing breakdown products of pectin which might be utilized by the 
latter.  
Enterococaceae and Enterobacteriaceae groups presented different 
behaviour compared to the bacteria mentioned before. Significant increase 
were found in the AC for both bacteria during the feeding period with citrus 
pectin, whilst TC showed a decrease of Enterococaceae and no significant 
change for Enterobacteriaceae. Nevertheless, a significant increase in 
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Enterobacteriaceae population was found in DC whereas stable levels were 
observed for Enterococaceae after feeding with citrus pectin.  
Concerning the proteolytic and saccharolytic activity of microorganisms, 
SCFA concentrations increased during the chronic feeding with pectin. Lactic 
and formic acid were observed in low concentrations since produced lactic 
acid is considered to be an intermediate metabolite and can be further 
metabolized within the colon and turned into butyric and propionic acids 
through cross-feeding by gut bacteria (Duncan et al. 2004; Reichardt et al. 
2014). Similarly, formic acid is used by microorganisms, which have a 
particularly important role in anaerobic metabolism, via interspecies cross-
feeding interactions (Louis et al. 2014). Results obtained showed an increase 
for valerate during the pectin fermentation. Khodaei et al. (2016) also 
reported a small amount of valerate when testing a galactose/rhamnose rich 
polysaccharide with similar values compared with recognised prebiotic, such 
as FOS. 
The major end-products of saccharolytic fermentation are acetate, propionate 
and butyrate, which have a combined concentration of 50-150 mM in the 
colon (Louis et al. 2014). High levels of SCFA are desirable since, among 
other benefits, the corresponding decrease in the pH values can suppress the 
growing of pathogenic bacteria. Figure 4 shows a significant high increase of 
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these compounds, being acetate the major SCFA produced followed by 
butyric and propionic, respectively.  
Given the complexity of the human microbiota, it is challenging to attribute a 
particular fermentation end-product to a specific bacterial group, however, 
acetate is typically generated via bifidus pathway, and more specifically it is a 
major end-product of Bifidobacterium fermentation (Sanz et al. 2005). Thus, 
the high production of acetate observed in our study can be ascribed to the 
growth of Bifidobacterium population in presence of pectin. The high 
increase of propionate concentrations after feeding the system with pectin is 
in good agreement with the increase in Bacteroides population, one of the 
main propionate-producing bacteria in the human colon. Propionate has also 
been shown to exert beneficial effects such as protective role against 
carcinogenesis through the decrease in human colon cancer cell growth 
(Hinnebusch et al. 2002; Jan et al. 2002). In addition, propionate and formate 
were reported to reduce the activity of E. coli and Salmonella at pH 5 (Gullón 
et al. 2011; Topping & Clifton 2001). Significant increases in butyrate 
concentrations were also observed in all three compartments, with the second 
highest levels after acetate. F. prausnitzii might utilise apple, citrus and sugar 
beet pectin as a source of growth and butyrate formation as shown by using 
pure cultures and in vitro models (Lopez-Siles et al. 2012; Chung et al. 2017; 
Onumpai et al 2011; Gómez et al. 2016). Thus, butyrate levels concur with 
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the high increase of F. prausnitzii population observed. Furthermore, higher 
levels of butyrate can also be explained due to cross-feeding between 
Bifidobacteria and F. prausnitzii since the latter is able to use the acetate 
produced by B. adolescentis thereby boosting butyrate formation (Rios-
Covian et al. 2015). Apart from these effects, butyrate is known to affect 
several components of the colonic defence barrier, resulting in enhanced 
protection against luminal antigens (Hamer et al. 2008; Havenaar 2011). 
Regarding ammonia concentration, Figure 3 showed a slight but significant 
decrease in ammonium concentration during the feeding with citrus pectin. It 
is noteworthy that lower proteolytic activities are usually associated with 
health-promoting effects (Ichikawa & Sakata 1998), since it can be a 
potential carcinogenic agent at relatively low concentrations, as has been 
shown by the increase in mucosal damage and colonic adenocarcinoma in a 
rat model (Louis et al. 2014; Windey et al. 2012). A significant positive 
correlation was observed between SCFA levels and ammonia excretion 
where more acidic conditions favour the excretion of ammonia due to the 
protonation and formation of poorly absorbed ammonium ion (Louis et al. 
2014).  
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Conclusions:  
 
The in vitro study of citrus pectin using the dynamic gastrointestinal 
simulator simgi® pointed out its high indigestibility, since a reduced 
hydrolysis of pectin (~12%) was detected in the upper gastrointestinal tract 
(ST and SI), mainly due to chemical interactions with pancreatic fluids and 
bile salts. Findings also highlight the important role played by pectin in 
stimulating beneficial bacteria such as Bifidobacteria, F. prausnitzii and 
Bacteroides (especially in the first two bacterial groups). A high increase in 
acetate, propionate and butyrate concentration was observed due to 
fermentation of pectin by the microbiota but also to cross-feeding interactions 
between different bacteria. Increase in SCFA also produced a decrease in 
ammonia concentration, which is associated with health-promoting effects. 
This is the first study of gastrointestinal digestion and fermentation of pectin 
in a dynamic gastrointestinal simulator and, although further in vivo studies 
should be conducted, the data obtained confirmed the potential of pectin to be 
considered shortly as emergent prebiotics with a possible use for human 
consumption. 
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5. General Discussion 
As was already underlined in the previous sections, the scientific 
interest towards the regulation of the gut microbiota has considerably grown 
due to its relationship with health and several important diseases. In this 
regard, the ability of prebiotic ingredients to modulate the composition and/or 
activity of the gut microbiota has received the greatest attention. However, 
given that prebiotic properties such as their resistance to digestion or the 
ability to be fermented by specific bacteria, will depend on their structure 
(degree of polymerization, linkage types, monosaccharide composition, etc.), 
it is important to have solid knowledge about/on possible changes that these 
compounds can suffer before reaching the colon. Moreover, establishing the 
specific structure characteristics of oligosaccharides that have a direct impact 
on their resistance to digestion, could allow us to extend the knowledge for 
the sake of a future potential development of new tailored prebiotics. On the 
other hand, the interest towards amplifying the number of prebiotic 
compounds had led to the search of new and/or improved methods and 
sources of obtainment. In this sense, agro-food waste by-products could 
represent a more sustainable and promising source for prebiotics obtainment. 
In this sense, given the limitations of the current standardised 
digestion protocols for carbohydrates digestion, the first approach of this 
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Thesis was the search and the set up of a specific, easy and reproducible 
method for carbohydrate digestion using extracts derived from mammals 
such as that of small intestine of rats (RSIE) (Chapter 1). Simmilarity 
between intestinal rat disaccharidases activity (maltase, sucrase, palatinase. 
trehalase and lactase) and degradation of dietary digestible carbohydrates 
after intestinal digestion in rats and humans endorse the suitability of these 
mammalian extracts (Oku et al. 2011). Therefore, the digestion rate of 
recognised and potential prebiotics was assessed with the proposed method. 
As expected, all prebiotic and potential prebiotic compounds (GOS, FOS, 
lactulose, OsLu and lactosucrose) were highly resistant to small intestine 
enzymes, however, structural differences exhibited an important effect on 
their susceptibility to degradation. Remarkably, different predominant 
linkages in GOS demonstrated a key role on resistance to degradation. 
β(1→6) linkages in carbohydrate mixtures showed a significantly higher 
resistance when compared to β(1→4) linkages, which were the most 
susceptible to degradation in all samples of prebiotics tested. Monomeric 
composition was also a critical factor for digestibility, thus, oligosaccharides 
with a terminal fructose (those derived from lactulose) were less prone to 
hydrolysis than those with glucose (GOS). Lactulose (β-Gal-(1→4)-Fru) and 
FOS (β-Fru-(2→1)-Frun-Glu) exhibited the highest resistance compared to 
total oligosaccharides (the sum of di-, tri-, and tetrasaccharides) from GOS 
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and OsLu, due to their monomer composition and high resistant linkages. 
However, molecular weight in OsLu, which has been related with a slower 
fermentation by the colonic microbiota than lactulose being able to reach the 
distal colon without great alterations (Cardelle-Cobas et al. 2011; Cardelle-
Cobas et al. 2012), seems to also provide a higher resistance to intestinal 
enzymes. In this sense, trisaccharide fraction (mainly β-Gal-(1→6)-β-Gal-
(1→4)-Fru) present in OsLu was almost no degraded (1.4 %) compared with 
disaccharides present in the mixture (32 %) and lactulose (~11.5 %) after in 
vitro digestion. In contrast, trisaccharide fraction in GOS mainly β-Gal-
(1→4)-β-Gal-(1→4)-Glu and β-Gal-(1→6)-β-Gal-(1→4)-Glu did not showed 
this behaviour due to different monomeric composition in the structure, 32.7 
and 11.9 % degradation, respectively. 
 Thus, although relationship between structure of GOS and resistance 
to mammalian intestinal enzymes and their bioactive effect was pointed out 
in previous reports (Hernández-Hernandez et al. (2012); Rastall et al. (2005)), 
no comparison of the digestibility of different types of GOS from lactose and 
lactulose using an intestinal extract from rats was carried out before.    
Moreover, given that the mixtures of prebiotics are usually included 
in different foodstuffs, mainly milk and dairy products, the need to study the 
effect of the food matrix on prebiotics (lactulose, GOS and OsLu) 
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digestibility was considered. Therefore, the in vitro method indicated above 
was used after a previous gastrointestinal digestion following a standardised 
semidynamic method under simulated physiological conditions (Minekus et 
al. 2014) (Chapter 2). Firstly, electrophoretic analysis demonstrated that the 
presence of the studied prebiotics (at required prebiotic doses) does not affect 
the digestion of proteins. Moreover, the use of pancreatic fluids and bile salts 
(Infogest protocol) to simulate intestinal digestion evidenced the limitation of 
these models for carbohydrate digestion due that limited modifications were 
observed in the carbohydrates fraction of the samples. However, the in vitro 
proposed method using the RSIE to digest samples after their gastric stage 
demonstrated its suitability to hydrolyse carbohydrates showing considerable 
decreases in this fraction. Firstly, higher amounts of lactose did not seem to 
affect the prebiotics degradation after 2 hours of digestion with the RSIE. 
Degradation found in the oligosaccharides fraction of GOS (35 %) and OsLu 
(15 %) within the milk was similar to the obtained in Chapter 1, 34 and 18 
%, respectively. In contrast, higher degradations of lactose were found due to 
the highest initial content in milk samples. Moreover, addition of prebiotic to 
milk showed to increase the degradation of free lactose in these samples with 
75-83 % lactose degradation compared to milk samples without prebiotics 
added (61 % lactose degradation) which could contribute to a better 
degradation of lactose in this products when limited lactase activity is present 
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(Corgneau et al. 2017). Nevertheless, high decreases of lactose content were 
observed whereas lactulose remained as the less prone to degradation 
disaccharide. In line with the results of Chapter 1, oligosaccharides from 
predominant β(1→4) GOS mixture exhibited the highest degradation after 
intestinal digestion, whereas oligosaccharides from β(1→6) OsLu stood as 
the most resistant structure with 85 % of composition intact after 2 hours 
digestion highlighting the suitability of the inclusion of these substrates 
within a real food context. Therefore, in a robust digestion method for 
carbohydrates the inclusion of a step using mammalian small intestine extract 
is needed to cover all the potential structures of carbohydrates that can reach 
the gastrointestinal system. Rat intestinal enzymes provided a useful and 
reliable tool to determine digestibility of dietary carbohydrates. However, 
despite the positive results obtained, small size of these animals creates a 
challenge for their use as human disease models due to the very different 
anatomy and physiology compare to humans. Thus, pigs have emerged as an 
important model due to their anatomical, physiological similarity to human 
and human genome (98 %) (Humphray et al. 2007), as well as their broad 
availability, short generation interval, larger litter size, and the fact that they 
are a food source that avoids ethical concerns (Kuzmuk & Schook 2011). The 
use of pigs has proved to be a robust model for several studies such as the 
tissue engineering, imaging, surgery, chemotherapy, radiation studies, cancer, 
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atherosclerosis, myocardial infarction, and general cardiovascular models, 
which cannot be carried out accurately or have failed in small animals 
(Kuzmuk & Schook, 2009; Jensen et al. 2010; Schook et al. 2015). 
Moreover, physiological similarity between humans and pigs in terms of 
digestive processes places the pig as a robust model for human digestive and 
colonic studies (Heinritz et al. 2013). Therefore, the use of small intestine 
extracts from pigs could represent a more reliable method as well as a step 
forward towards the development of a robust and comparable to human 
method to gathering information about dietary carbohydrate digestion.  
Intestinal disaccharidases are identified as glycoproteins that maintain 
a structural linkage with elements of the apical membrane and are actively 
budded off as brush border membrane vesicles (BBMV) into the adjacent 
periapical space, consequently, brush border enzymes may transit to all parts 
of the lumen in this form of vesicles (McConnell et al. 2009). However, 
although proportions of BBMV that remain in the periapical space and 
diffuse into the lumen is not currently known, it is likely that the mucus layer 
overlying the ephitelia retards the egress of BBMV from the periapical space 
into the lumen so that a significant amount of BBMV would remain in close 
proximity to the intestinal mucosa (Hooton et al 2015). Therefore, BBMV 
obtained and purified from pig were used for the determination of the 
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intestinal digestibility of structurally different prebiotic oligosaccharides 
(GOS and OsLu) (Chapter 3). BBMV showed a higher enzymatic activity 
when compared to the commercial intestinal extract from rat mainly due to 
the exhaustive fractionation and purification carried out in the obtainment of 
the membrane vesicles. Digestibility assays reaffirmed the data obtained in 
previous chapters with a high resistance of β(1→6) compared to β(1→4) 
linkages. Moreover, predominantly β(1→3) linkages GOS that were also 
analysed, revealed the high susceptibility of these structures to intestinal 
disaccharidases with a 44 % degradation whereas β(1→4) and β(1→6) 
showed a 23 and 12 % hydrolysis, respectively,  after 2 hours of digestion. A 
very recent study in the obtainment of GOS using BBMV have revealed the 
high preferably synthesis of GOS linked by β(1→3) compared to those linked 
by β(1→4) or β(1→6) (Julio-González et al. 2019). Therefore, considering 
that enzymes can catalyse reversible reactions in either direction (Abdul-
Manas et al. 2018), data obtained at this stage support the hyphothesis that 
most glycosidic linkages formed when intestinal β-galactosidase act as 
transgalactosidase, are preferentially broken under hydrolytic conditions. In 
addition, specific monosaccharides composition provided a better resistance 
on several components of the samples such as galactosyl-galactoses, 
galactosyl-fructoses and specially on the trisaccharide fraction of OsLu 
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samples (β(1→6), 9.8 % hydrolysis after 2 hours),  establishing the key role 
of these monomers. 
All these findings reveal important structure-function relationships 
highlighting the strong resistance of β(1→6) oligosaccharides, especially of 
those derived from lactulose which have shown to be the most resistant to 
mammalian intestinal enzymes compared to different commercial GOS 
mixtures. Thus, when aiming for a potential development of new customized 
and new generation prebiotics, oligosaccharides derived from lactulose would 
represent an ideal candidate that have to be taken into account. In this sense, 
several evidences have also reported the technological and biological 
properties of these substrates (Villamiel et al. 2014; López-Sanz et al. 2015; 
Barroso et al. 2016; López-Sanz et al. 2018; Fernández et al. 2018) 
supporting their suitability to be considered as a good prebiotic candidate. 
Lastly, prebiotics definition maintains that these substrates should be “non-
digested” by intestinal enzymes reaching the colon at least almost intact, 
however, findings obtained in this Thesis have revealed a considerable high 
degradation of some of these substrates.  
Regarding the second part of this Thesis, the obtainment of new 
prebiotics from agro-food by-products was presented as an interest and 
renewable alternative to convetional sources (Chapter 4). After successful 
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extraction, obtained artichoke, sunflower and citrus pectin subjected to 
enzymatic treatment with a cellulase from Aspergillus niger produced 
modified pectins with different structural features (lower Mw, lower 
methoxylation degree, and changes in monomer composition). In vitro batch 
fermentations with human volunteers, which intends to simulate the complex 
diversity in the colon, ratified the potential prebiotic properties of these 
substrates, which were related to their structural features. The six pectic 
samples exerted a prebiotic effect when compared with recognised prebiotics 
such as FOS and lactulose. As products of metabolism, high increases of 
acetate followed by propionate and butyrate were observed in all samples 
after pectin fermentation by microorganisms. As indicated in previous 
sections, high levels of SCFA are desirable due to the several benefits that 
have been related with their presence such as, obesity regulation, suppression 
of colonic inflammation and carcinogenesis, glucose homeostasis, 
enhancement of the ileal motility, as well as a suppression of the growth of 
pathogenic bacteria due to the decrease of pH (Hong et al. 2005; Murugesan 
et al. 2018; Li et al 2017; Sivaprakasam et al 2016; Louis et al. 2014). Lower 
Mw seemed to provide a significant higher growth of Bifidobacteria and 
Lactobacillus in citrus and artichoke modified pectin compared to their 
corresponding intact pectin, whereas higher amounts of potential galactans 
chains branched to RG-I (Gal:Rha) provided a better growth of Bacteroides 
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in modified pectins from sunflower and artichoke compared to their 
unmodified pectins. Remarkably, a higher content of arabinose and galactose 
in the structure was related to a better growth in bifidobacteria in previous 
reports (Di et al. 2017; Onumpai et al. 2011). Therefore in line with those 
reports, artichoke pectin, which had the higher content of these two 
monosaccharides combined, was the substrate that promoted the significantly 
highest growth in Bifidobacteria, Lactobacillus and Bacteroides, similar to 
the obtained after FOS and inulin fermentation. In general, all studied 
substrates evidenced a good capability to promote growth of beneficial 
bacteria and to produce SCFA highlighting the suitability of agro-food by-
products as a renewable source of bioactive pectin.  
In this regard, pectins are generally accepted to be scarcely 
hydrolyzed by the gastrointestinal enzymes, however, it has been 
demonstrated that pancreatic enzymes as well as acidic gastric conditions 
might exert some hydrolysis towards methyl esters and O-acetyl esters 
groups in pectins (Miller et. al. 1995). Degradation of the Mw of pectin and 
cleavage of mono- and oligosaccharide has been also observed after 
successive acid and enzymatic in vitro hydrolysis of different pectin 
substrates (Mikhaleva et al. 2011). Moreover, similar to the results obtained 
in previous chapters concerning the important relationship between chemical 
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structure and function, few studies have evidenced an influence of certain 
structural characteristics such as methylation degree or the arabinoxylan 
structure on pectin fermentability (Dongowski et al. 2002; Rumpagaporn et 
al. 2015). Thus, given that the possible chemical and physicochemical 
structural changes could affect the fermentation properties of pectins, a 
continuous gastrointestinal digestion and fermentation of citrus pectin was 
carried out to evaluate pectin fermentation after its potential degradation 
during the upper gastrointestinal digestion (Chapter 5). Therefore, a dynamic 
gastrointestinal model (SIMGI®), which provides a better mimic of the 
physical processing and physiological events occurring during the digestion, 
was used to evaluate pectin gastric and small intestinal digestion and colonic 
fermentation. In vitro digestion of citrus pectin results emphasized the 
suitability of this substrate as a potential prebiotic candidate. Unmodified 
commercial pectin subjected to a continuous simulated gastric and small 
intestinal digestion, showed a slight decrease (~12%) on initial concentration 
before reaching colonic vessels, probably due to chemical effects produced 
by pancreatic fluids and bile salts (Miller et al. 1995). Moreover, some 
authors have reported degradation of these substrates after intestinal digestion 
in human subjects (Chinda et al. 2003; Saito et al. 2005) attributing 
degradation to the scarce microflora present in the small intestine, specially 
in the terminal ileum where bacterial densities can reach similar levels to 
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those found in the large intestine (Donaldson et al. 2016). However, SIMGI® 
in vitro model used lacks of microflora present at the small intestine, thus, 
changes observed can be attributed specifically to pancreatic fluids and bile 
salts. Fermentative and proteolytic metabolism reflected also the potential 
benefits of citrus pectin given the high values found of SCFA (acetate, 
propionate and butyrate) and diminution of ammonia levels during the 
feeding with citrus pectin. Furthermore, qPCR analysis during pectin 
fermentation pointed out huge and significant increases on the populations of 
beneficial bacteria such as Bifidobacteria, Bacteroides and the emerging 
probiotic candidate, Faecalibacterium prausnitzii which has been related 
with several health benefits (Martín et al 2017; Miquel et al. 2013), whereas a 
decrease was observed before and after citrus pectin inclusion on the system. 
Therefore, changes observed after small intestine digestion did not seem to 
affect the fermentability of the studied citrus pectin. Similar behaviour was 
observed during fermentation with) and without previous digestion passage, 
Chapter 5 and Chapter 4, respectively where a high increase of 
Bifidobacteria and Bacteroides was observed. Findings obtained here 
upholds the potential of pectin to be considered as an emergent prebiotic as 
well as the suitability of agricultural byproducts to obtain functional 
ingredientes. Moreover, as well as GOS and OsLu, structural features play an 
important role on their prebiotic potential, therefore, structural diversity (Mw, 
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degree of methoxyl esterification) in pectin prebiotics could be possible 
whether arabino- and galactooligosaccharides are present in the structure. 
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6. General Conclusions 
 
Results obtained in the present PhD Thesis concerning the in vitro 
digestibility and fermentability of selected prebiotics and functional 
carbohydrates with prebiotic potential have led to the following conclusions:  
 The in vitro digestion model established on the utilization of rat small 
intestinal extract has proved to be a useful, reliable and an efficient 
approach to evaluate the digestibility of dietary carbohydrates 
(digestible and non-digestible), overcoming the limitations of the 
current standardised methods for in vitro gastrointestinal digestion. 
 The combination of Infogest protocol with rat small intestinal extract 
was useful to assess the digestibility of galactooligosaccharides, 
lactulose and oligosaccharides derived from lactulose added to milk, 
as well as to demonstrate their resistance to gastric and pancreatic 
fluids and bile salts. 
 Using a digestion model based on small intestinal brush border 
membrane vesicles (BBMV) from pig pointed out the influence of 
glycosidic linkages, degree of polymerization and monomer 
composition on the resistance to intestinal digestion of selected 
prebiotics. 
 246 
 Galactooligosaccharides containing β(1→3) and β(1→4) linkages 
were more prone to degradation after intestinal digestion than β(1→6) 
using pig BBMV. 
 Oligosaccharides derived from lactulose (OsLu) having β(1→6) as 
the predominant glycosidic linkage were more resistant to intestinal 
digestion than any type of galactooligosaccharides and lactulose, due 
to the combined effect of monosaccharide composition and linkage 
type. 
  Pectin and modified pectins obtained from agricultural by-products 
of artichoke and sunflower presented a similar prebiotic potential as 
compared to recognized prebiotic such as inulin and FOS, 
highlighting the suitability of these substrates as renewable sources of 
bioactive compounds. 
 Considering the structural characteristics of pectin (molecular weight, 
degree of methoxyl esterification, and monomeric composition) the 
most influencing factor on the bifidogenic properties was the presence 
of arabinose, being artichoke pectin the one that had the highest 
proportion of this monosaccharide. 
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 Citrus pectin was highly resistant to gastrointestinal digestion in a 
dynamic gastrointestinal simulator, and presented a high 
fermentability by colon microbiota producing great increases in the 
population of Bifidobacteria, Bacteroides and Faecalibacterium 
prausnitzii, and SCFA levels. 
 
Therefore, based on all these conclusions, this PhD Thesis contributes to gain 
deeper knowledge on the digestibility of prebiotics. Moreover, high 
degradation of some subtrates studied in this Thesis challenge the belief that 
they reach the colon fully intact, and, although more studies are required, 
could suggest a possible revision of the current prebiotic concept. 
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6. Conclusiones Generales 
Los resultados obtenidos en esta tesis doctoral enfocada hacia la 
evaluación de la digestibilidad y fermentabilidad de compuestos prebióticos y 
carbohidratos con potencial prebiótico, ha permitido alcanzar las siguientes 
conclusiones:  
 El modelo de digestión in vitro basado en la utilización de un extracto 
de intestino delgado de rata ha demostrado ser una alternativa útil, 
fiable y eficiente para la evaluación de la digestibilidad de 
carbohidratos dietéticos (digeribles y no digeribles), subsanando las 
limitaciones de los métodos estandarizados actuales para la digestión 
gastrointestinal in vitro. 
 La combinación del modelo de digestión Infogest con el extracto de 
intestino delgado de rata fue de gran utilidad para la determinación de 
la digestibilidad de galactooligosacáridos derivados de lactosa y 
lactulosa incluidos en leche, además de demostrar la resistencia de 
estos compuestos a los fluidos gástricos, pancreáticos y las sales 
biliares. 
 El uso de vesículas procedentes del borde en cepillo del intestino 
delgado (BBMV) de cerdos demostró la influencia del tipo de enlace 
glucosídico, grado de polimerización y la composición monomérica 
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de distintos prebióticos sobre la resistencia de los mismos a la 
digestión intestinal.   
 Los galactooligosacáridos con enlace predominante β(1→3) y 
β(1→4) fueron más susceptibles a la degradación intestinal, 
comparados con los enlaces β(1→6), utilizando las vesículas del 
intestino delgado de cerdo.  
 Los oligosacáridos derivados de lactulosa (OsLu, β(1→6)) fueron más 
resistentes a la degradación intestinal comparados con la lactulosa y 
otros galactooligosacáridos estudiados, debido a un efecto combinado 
de la composición monomérica y tipo de enlace. 
 Las pectinas y pectinas modificadas obtenidas a partir de 
subproductos de alcachofa y girasol mostraron un potencial prebiótico 
similar a prebióticos reconocidos como los FOS e inulina, reforzando 
la idoneidad de estos sustratos como fuente alternativa de compuestos 
bioactivos. 
 De acuerdo con las características estructurales de la pectina (tamaño 
molecular, grado de metoxil esterificación y composición 
monomérica), el contenido en arabinosa demostró ser el más 
influyente sobre las propiedades bifidogénicas, siendo predominante 
en la pectina procedente de alcachofa. 
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 La pectina de cítricos presentó una elevada resistencia a la digestión 
gastrointestinal llevada a cabo en un simulador dinámico y continuo, 
y presentó una elevada fermentabilidad en las fases colónicas 
produciendo grandes incrementos en las poblaciones de 
Bifidobacteria, Bacteroides y Faecalibacterium prausnitzii y en los 
niveles de SCFA. 
 
Teniendo en cuenta todas estas conclusiones, el trabajo desarrollado en esta 
tesis contribuye a ampliar el conocimiento con respecto a la digestibilidad de 
los prebióticos. Además, la degradación de sustratos prebióticos observada 
tras su digestión intestinal, lleva a cuestionar la creencia general de que estos 
compuestos son capaces de llegar intactos al colon, sugiriendo, por lo tanto, 
una posible revisión de la definición de prebióticos.   
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Table 1S. Composition of simulated salivary fluid 
(SSF) 
 
 
Constituent 
 
SSF (pH 7) /mmol/L) 
 
K+ 18.8 
Na+ 13.6 
Cl- 19.5 
H2PO4- 3.7 
HCO3-, CO32- 13.7 
Mg2+ 0.15 
NH4+ 0.12 
Ca2+ 1.2 
α-amilase at 150 units per mL of SSF (Verhoeckx et al., 
2015) 
 
 
 
 
 
Figure 1S. pH profile of milk samples with the prebiotic ingredients during gastric digestion. 
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Table 2S. Carbohydrate composition (% of total carbohydrates) of OsLu, Vivinal®GOS and Duphalac®. 
Samples Glucose Fructose Galactose Other 
Disaccharides 
Lactose Lactulose Trisaccharides Tetrasaccharides Pentasaccharides Hexasaccharides 
OsLu - - 14.1 
(1.0) 
21.1 
(1.1) 
N.D. 26.1 
(1.2) 
25.6 
(0.7) 
9.7 
(0.7) 
2.6 
(0.6) 
0.2 
(0.1) 
Vivinal®G
OS 
20.7 
(2.1) 
- 1.4 
(0.1) 
20.5 
(0.6) 
18.0 
(0.2) 
- 21.0 
(0.7) 
13.1 
(0.8) 
4.8 
(0.6) 
0.7 
(0.4) 
Duphalac
® 
0.3 
(0.0) 
- 7.9 
(0.7) 
- 3.2 
(0.2) 
88.7 
(0.6) 
 
- - - - 
 
Data are expressed as the mean (SD) (p>0.05).  
N.D. No detected. 
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Figure 2S. GC-FID profile of TMSO derivatives of carbohydrates present in milk samples with OsLu after 1 h of gastric digestion. Peak 1 
Galactose; 2 Glucose; 3 Galactose + Glucose; I.S. Internal Standard; 4 Lactose; 5 Other disaccharides. * Matrix effect, DP: Degree of 
Polymerisation. 
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Table 1S. Hydrolysis degree (%) of di-, tri, oligosaccharides and lactose, lactulose in all samples 
during digestion with BBMV. 
 
Σ Disaccharides    
   Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu 
  0 0 0 0 0 
  1 13.8 0.0 13.3 2.4 
  2 18.3 0.0 15.9 10.1 
  3 22.8 0.0 19.7 13.2 
  4 33.0 0.0 25.0 19.1 
  5 43.7 0.0 32.6 21.5 
  Σ Trisaccharides 
      Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu 
  0 0 0 0 0 
  1 17.4 24.7 3.0 6.4 
  2 29.2 29.8 8.5 11.3 
  3 44.0 37.1 9.2 12.8 
  4 46.5 45.3 22.0 19.1 
  5 54.6 50.2 24.1 25.5 
  Σ Oligosaccharides 
      Digestion time (min) GOS-1 GOS-2* GOS-3 OsLu 
  0 0 0 0 0 
  1 15.7 15.1 6.6 3.9 
  2 24.7 19.5 10.9 10.5 
  
3 34.9 26.4 12.9 13.2 
  4 41.0 31.2 23.0 19.0 
  5 50.1 34.9 27.1 22.8 
  
      Lactose/Lactulose Lactose Lactose Lactose Lactulose 
  Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu Lactose Lactulose 
0 0 0 0 0 0 0 
1 27.2 5.6 19.9 10.8 42.9 6.3 
2 30.1 11.1 35.9 18.1 65.4 12.4 
3 39.2 27.8 53.8 23.9 69.5 17.3 
4 49.7 33.3 61.0 27.6 81.4 23.9 
5 68.7 50.0 68.5 32.9 97.1 29.6 
 
*Represents the sum of di-, tri and tetrasaccharide (GOS-2) 
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Table S1. 
 
Physico-chemical overall characterization of 
citrus pectin. (Adapted from Muñoz-Almagro et 
al (2018) and Ferreira-Lazarte et al. (2018) 
Humidity (%) 9.8 ± 0.6 
aw 0.22 
pH 3.04 ± 0.01 
Proteins (%) 0.67 ± 0.03 
Minerals (mg g-1)  
     Sodium 2.36 
     Magnesium 0.32 
     Potassium 0.60 
     Calcium 4.15 
Furosine (mg 100 g-1 protein) 782.1 ± 5.2 
Average Mw (kDa) 350 
DM (%) 70.7 
GalA content (%) 66.5 % 
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Table S2 
Average plate count measurements (n=3) expressed in log CFU/mL, analysed in the 
ascending (AC), transverse (TC) and descending colon (DC) of the dynamic 
gastrointestinal model (simgi®) at the end of stabilization period (day 13), chronic intake 
(day 27) and washout period (day 34) with citrus pectin. 
  
Sampling Day 
Bacterial group  Day 13 Day 27 Day 34 
  
Stabilisation period Feeding period Washout period 
Total aerobes  AC 7.56 (0.01)b,1 8.04 (0.12)c,2 7.26 (0.13)a 
 
TC 7.57 (0.11)c,1 7.52 (0.08)b,1 7.24 (0.12)a 
 
DC 7.37 (0.01)b 6.86 (0.03)a 6.93 (0.22)a 
Total anaerobes  AC 8.26 (0.07)a 8.50 (0.02)ab,2 8.59 (0.08)b,1 
 
TC 8.38 (0.04)b 7.96 (0.07)a,1 8.10 (0.14)ab 
 
DC 8.30 (0.11)c 7.35 (0.02)a 7.95 (0.10)b 
Lactic bacteria AC 5.76 (0.10)b 6.42 (0.14)c,1 4.59 (0.02)a 
 
TC 6.30 (0.06)b,3 6.63 (0.12)b,2 4.57 (0.15)a 
 
DC 5.98 (0.23)c,2 5.81 (0.04)b 5.08 (0.05)a,1 
Enterobacteria AC 7.79 (0.05)b,1 7.90 (0.03)b,2 7.26 (0.23)a,1 
 
TC 7.67 (0.13)b,1 7.48 (0.12)b,1 7.22 (0.02)a,1 
 
DC 7.37 (0.28)b 6.88 (0.03)a 6.69 (0.02)a 
Enterococcos AC 5.90 (0.05)a 7.77 (0.07)c,2 6.91 (0.24)b,1 
 
TC 6.42 (0.12)c,1 6.29 (0.09)bc 5.37 (0.23)a 
 
DC 6.03 (0.03)a 7.50 (0.04)c,1 6.58 (0.04)b,1 
C. perfringens AC 7.55 (0.09)a,1 7.51 (0.01)a,1 7.45 (0.03)a,2 
 
TC 7.63 (0.07)b,1 7.75 (0.05)b,2 6.19 (0.06)a 
 
DC 7.22 (0.02)b 7.22 (0.09)b 6.52 (0.06)a,1 
Lactobacillus AC 6.14 (0.11)c,1 3.78 (0.07)b 2.97 (0.14)a 
 
TC 6.15 (0.07)b,1 4.67 (0.09)b,1 3.56 (0.08)a,1 
 
DC 5.59 (0.03)c 5.14 (0.05)b,2 3.95 (0.10)a,2 
a,b,c Different letters mean significant differences (p < 0.05) between the end of stabilisation (Day 13), feeding 
(Day 24-27) and washout period (Day 34) on the same compartment. 
1,2,3 Different numbers mean significant differences (p < 0.05) between compartments on the same day of analysis. 
Standard deviation values are in brackets. 
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Abstract: 
 
Strategies to avoid lactose malabsorption, which affects 70% of the world's population, are 
focused on the restriction of milk and dairy products or the use of non-human β-
galactosidases or probiotics endowed with β-galactosidase activity added at mealtime. The 
evaluation of a commercial blend of probiotics and enzymes (protease, lactase, lipase and 
amylase) and its potential application in lactase non-persistence management are described in 
this work. Recommended amounts (460-1000 mg) of commercial probiotics/enzymes blend 
showed to be adequate for in vitro lactose hydrolysis in standard solutions (0.25-5 %) and 
commercial dairy products, milk (5% lactose) and yogurts (3% lactose) reaching hydrolysis 
values between 44-96%. According to these percentages, the use of the enzymatic 
preparation would guarantee the intake of less than 12 g, recommendations of the EFSA for 
lactose intolerant. Furthermore, formation of prebiotic galactooligosaccharides was also 
detected increasing the potential benefits of the enzymatic preparation in the gastrointestinal 
system.
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1. Introduction 
Over the past years, the interest toward human well-being and disease 
prevention has increased the consumption of healthy diets and a prudent 
addition of dietetic supplements,1 being the gastrointestinal function one of 
the main targets. Particularly, the digestion and absorption of carbohydrates 
has been one of the main topics widely studied during the last years. 
Digestible di-, oligo - and polysaccharides are hydrolysed to their 
corresponding monomers before being absorbed in the small intestine; 
however, in some specific physiological or pathological situations, as in the 
case of lactose intolerance, these carbohydrates are hardly hydrolysed and 
absorbed, reaching the gut lumen where they are fermented by the intestinal 
microbiota.2 
Lactose intolerance is a common problem resulting from -galactosidase 
(i.e., lactase) deficiency at the level of the small intestine. With the rare 
exception of congenital hypolactasia, this enzyme is always present in the 
new-born, but its activity naturally diminishes after weaning. In Caucasians, a 
specific mutation favoured by the high intake of milk, permits the presence of 
lactase also in adults. However, in other geographical area these changes are 
not common and, approximately, a 70% of the world's population have non-
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persistence of lactase. Particularly, in some Asian countries this rate increases 
up to 100%.2,3 
Although lactose intolerance is not considered as a true ailment, its symptoms 
(abdominal spasms, swelling, flatulence and diarrhoea, with a considerable 
intraindividual and interindividual variability in the severity) may disturb the 
quality of life. The strategies to avoid this problem are mainly focused on the 
restriction of milk and dairy products and the intake of lactose-depleted and 
lactose-free products, non-exempt of nutritional and/or technical problems.4 
In this sense, some published studies have shown that thermal processing 
could involve a strong advance of the Maillard reaction (MR), with loss of 
available lysine and modifications in the sensorial properties when lactase is 
added before the heat treatment. As after hydrolysis the increase in galactose 
and glucose can greatly favour the evolution of this reaction, the addition of 
the enzyme after thermal processing is recommended; however, this involves 
the use of aseptic conditions with the consequent increase in the price of the 
products.5,6 Moreover, in pack addition of lactase after milk sterilisation can 
have adverse organoleptic and nutritional concerns related to the enzyme side 
proteolytic activity especially for extended storage time.7  
The intake of commercially lactase enzyme preparations in solid from fungal 
or yeast origin before lactose consumption has been also suggested as a 
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possibility for people with these problems. Although there are interesting 
studies that underline their potential applications, its usefulness is not fully 
established due to technical and dose discordances. In spite of this, the EFSA 
Panel on Dietetic Products, Nutrition and Allergies concluded that there is a 
cause-effect relationship between their consumption and breaking down 
lactose in individuals with symptomatic lactose malabsorption.8 The 
administration of probiotics endowed with a lactase activity has been also 
showed to be very useful to treat patients with this problem.3  
Recently, a new commercial product formulated with enzymes (protease, 
lactase, lipase and amylase) and non-dairy, heat-stable and stomach acid 
resistant probiotics (Lactobacillus gasseri, Bifidobacterium bifidum and 
Bifidobacterium longum) is offered as a supplement to support healthy 
digestive function and help alleviate occasional gas and bloating. The same 
supplement without enzymes has been proved to have anti-inflamatory effect 
due to the changes in the gut microbiota communities. An intervention study 
reported a higher percentage of participants who had an increase in 
bifidobacteria and lactobacillus in their faecal samples during the probiotic 
intervention versus the placebo.9 However, to the best of our knowledge, no 
studies on the potential application of this preparation on malabsorption of 
carbohydrates have been carried out. Thus, the objectives of this work have 
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been: i) to characterise the carbohydrase activity of the commercial 
preparation of probiotics with enzymes and ii) to evaluate its in vitro 
effectiveness during the hydrolysis of lactose in lactose solutions and 
commercial dairy products such as whole milk, skimmed milk and two 
different yogurts.  
2. Materials and methods 
2.1.Chemicals and reagents 
Fructose (Fru) standard was purchased from Fluka analyticalTM. D-galactose 
(Gal), D-glucose (Glc), lactose, sucrose, phenyl-β-glucoside, o-nitrophenyl 
(o-NP), p-nitrophenyl (p-NP), o-nitrophenyl-β-D-glucopyranoside (o-NPG) 
and p-nitrophenyl-α-glucopyranoside (p-NPG) standards were obtained from 
Sigma-Aldrich (St Louis, MO). Commercial whole and skimmed milk and 
yogurt samples were purchased from local markets in Madrid, Spain. 
Commercial enzymatic preparation (Kyo-Dophilus® plus enzymes) (human 
strains of Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1 and 
Bifidobacterium longum MM2 together with protease (Aspergillus melleus), 
lactase (A. oryzae), lipase (A. niger) and amylase (A. oryzae)) was kindly 
supplied by Vitae® Natural Nutrition S. L. (Barcelona, Spain). 
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2.2.Characterisation of commercial preparation 
Commercial enzymatic preparation was used to prepare an enzymatic 
solution according to the method of Olaokun, et al,10 with minor 
modifications. Probiotics plus enzymes (10 mg/mL) was homogenized in ice-
cold 0.05 M sodium phosphate buffer solution (pH 7.0, 6.5 and 6.5). Then, 
the clear solution was used for determining protein content, enzymatic 
activity and subsequent analysis by HPLC-ELSD and GC-FID. Furthermore, 
pH, water activity and dry matter analysis were carried out directly on the 
enzymatic preparation. 
2.2.1. Physico-chemical characterisation  
The dry matter content was gravimetrically determined in an oven at 110 °C 
during 48 hours until constant weight according to the Association of Official 
Analytical Chemists (AOAC).11 Water activity (aw) measurement was carried 
out in an AW Sprint TH-500 instrument (Novasina, Lachen, Switzerland). 
The pH of enzymatic preparation (1%, w/v) was obtained using a pHmeter 
(Mettler Toledo GmBH, Schwerzenbach, Switzerland). Protein content in 
enzymatic solution was determined by the Kjeldahl method as described by 
AOAC.12 
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2.2.2. Carbohydrase characterisation 
The determination of β-galactosidase or lactase activity was adapted from 
Warmerdam et al.13 A solution of o-NPG (o-nitrophenyl-β-D-
glucopyranoside) in phosphate buffer 0.05 M, (pH 7.0, 6.5 and 6.0) with a 
concentration of 0.5 mg/mL (0.05% w/v) was prepared. Enzymatic activity 
was determined by incubating 1,900 µL of the o-NPG solution and 100 µL of 
enzyme solution from this commercial product (10 mg/mL in phosphate 
buffer 0.05 M, pH 7.0, 6.5 and 6.0) for 2 h at 37 ºC. The method is based on 
the measuring of the continuous release of o-NP from o-NPG. Absorbance of 
released o-NP was measured at 420 nm every 20 s using a spectrophotometer 
(Specord® Plus, Analytik Jena) together with a temperature controller (Jumo 
dTRON 308, Jumo Instrument Co.). Considering the lactase content on the 
enzymatic preparation, specific enzymatic activity (U) was expressed in µmol 
min-1 g-1, where one unit was defined as the amount of enzyme that produced 
1 µmol of o-NP in one min of reaction (n = 6).  
Similar procedure was used to determine the maltase activity but using a 
solution of p-NPG (p-nitrophenyl-α-glucopyranoside) in phosphate buffer 
0.05 M, pH 7.0, 6.5 and 6.0 with (0.05% w/w) and monitoring the release of 
p-NP at 410 nm every 20 s (n = 4). 
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Invertase activity was determined following the method described by Ghazi 
et al,14 with slight modifications. An individual solution of sucrose (1 
mg/mL) in sodium phosphate buffer 0.05 M, pH 7.0 was used. 50 mL of this 
solution were incubated together with 50 mg of enzymatic preparation with 
enzymes at 37 ºC during 2 h. Aliquots were taken at different times (15, 30, 
60, 90 and 120 min) and reaction was stopped on boiling water during 5 min. 
Sucrase activity was determine by monitoring sucrose hydrolysis and 
increase of fructose by GC-FID. The specific enzymatic activity (U) was 
expressed in µmol min-1 g-1, where one unit was defined as the amount of 
enzyme that produced 1 µmol of reducing sugars in one min of reaction (n = 
4). 
2.3.In vitro digestion of buffered standard solutions of lactose 
To determine the effectiveness of the commercial preparation in the 
hydrolysis of lactose, an in vitro digestion study was carried out under 
simulated physiological conditions. This is a first common approach to 
understand the digestion of functional ingredients.15  
First of all, to evaluate the resistance of lactose to the enzymatic preparation, 
several assays of lactose digestion were carried out using different 
carbohydrate-enzymatic preparation ratios (Table 1). Lactose concentrations 
were chosen to cover most of the commercial lactose-content products, such 
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as milk, yogurt, cheese, and free-lactose products.16,17 In regard of the 
enzymatic preparation, doses were chosen taking into account recommended 
prescription (2 capsules/920 mg per day). Thus, 460 mg (1 capsule), 1000 mg 
and 155 mg of preparation were tested with each lactose concentration. 
Reactions that presented similarity on the ratio preparation/lactose with other 
reaction were discarded. 
 
 
 
 
 
 
 
Hence, assays aimed to determine the capability of enzymatic preparation to 
hydrolyse lactose at different concentrations. Thus, different solutions of 
lactose (5.0, 1.0 and 0.25 %, w/v) in phosphate buffer 0.05 M pH 7.0 and 6.5 
were tested with the following doses of enzymatic preparation: 155, 460 and 
1000 mg. Finally, 250 mL of solution of lactose (5.0, 1.0 and 0.25 %, w/v) 
were mixed with each dose of enzymatic preparation (155, 460 and 1000 
Table 1. Ratios of lactose to the probiotic preparation with enzymes during 
digestion at pH 7.0 or 6.5 at 37 ºC for 2h. 
 
Lactose 
(g) 
Commercial 
preparation 
(mg) 
Final 
volume 
(mL) 
Commercial 
preparation/lactose 
ratio (E:S) 
Lactose 5 %  12.5 155 250 0.01 
Reactions 12.5 460 250 0.04 
 
12.5 1000 250 0.08 
 
    Lactose 1.0 %  2.5 460 250 0.18 
Reactions 2.5 1000 250 0.40 
     
Lactose 0.25 %  0.63 460 250 0.74 
Reactions 0.63 1000 250 1.60 
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mg). The mixture was incubated at 37 ºC (pH 7.0 and 6.5) under continuous 
agitation (400 rpm) for 2 h. Aliquots were taken at 15, 30, 60, 90 and 120 
min of digestion and heated in boiling water for 5 min to stop the reaction. 
The digestion of lactose was monitored by analysis of the trimethyl silylated 
oximes (TMSO) of carbohydrates by GC-FID as described below. 
In addition, a series of control samples, based on the incubation of enzymatic 
preparation without lactose during the same reaction times, were also 
analysed. Results showed a minor increase of monosaccharides, galactose 
and glucose as the digestion proceeded. These values were conveniently 
subtracted in order to avoid any overestimation of the monosaccharide 
fraction. 
2.4.In vitro digestion of lactose commercial products 
Since buffered standard solutions of lactose would be more prone to changes 
as they are not protected in a food medium, the effectiveness of enzymatic 
preparation on lactose commercial products (two commercial milk and two 
yogurts) was tested. First, commercial products were characterised (Table 2) 
by measuring its pH, protein content, total carbohydrates and lactose content 
by GC-FID. Later, 250 mL of commercial milk and yogurt were mixed with 
1000 mg of the commercial preparation of probiotics with enzymes and the 
mixture was incubated at 37 ºC (pH of milk and yogurt), 400 rpm for 2 h. 
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Aliquots were taken at 15, 30, 60, 90 and 120 min of digestion and the 
reaction was stopped by heating samples in boiling water for 5 min.  
Before chromatographic analysis, samples were subjected to a clarification 
procedure using Carrez reagents in order to remove interfering compounds 6. 
Carbohydrates analysis was performed by GC-FID as described below. 
2.5.Carbohydrate analysis by GC-FID 
Trimethyl silylated oximes (TMSO) of carbohydrates (mono-, di- and 
trisaccharides) present in samples were determined following the method of 
Cardelle-Cobas.18 Chromatographic analysis was carried out on an Agilent 
Technologies gas chromatograph (Mod7890A) equipped with a flame 
ionization detector (FID). The TMSO were separated using a 15 m x 0.32 
mm x 0.10 µm film, fused silica capillary column (DB-5HT, J&W Scientific, 
Folson, California, USA). Nitrogen was used as carrier gas at a flow rate of 1 
mL/min. Injector and detector temperatures were 280 and 385 ˚C, 
respectively. The oven temperature was programmed from 150 to 380 ˚C at a 
heating ratio of 3 ˚C/min. Injections were made in the split mode (1:20 or 
1:5) depending on lactose content of the solution.  
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The TMSO derivatives were formed following the method of Ruiz-Matute et 
al.6 First, a volume of 100 or 200 µL of the digested sample was added to 400 
µL of internal standard solution, containing 0.5 mg/mL of phenyl-β-
glucoside. Afterwards, the mixture was dried at 40 ˚C in a rotary evaporator 
(Büchi Labortechnik AG, Flawil, Switzerland). Sugar oximes were formed 
by adding 250 µL hydroxylamine chloride (2.5%) in pyridine and heating the 
mixture at 70 ˚C for 30 min. Subsequently, the oximes obtained in this step 
were silylated with hexamethyldisylazane (250 µL) and trifluoroacetic acid 
(25 µL) at 50 ˚C for 30 min.19 Derivatization mixtures were centrifuged at 
6,700 x g for 2 min and supernatants were injected in the GC.  
Data acquisition and integration were done using Agilent ChemStations 
software (Wilmington, DE, USA). Response factors were calculated after the 
duplicate analysis of standard solutions (fructose, galactose, glucose, lactose, 
sucrose, raffinose and stachyose), at different concentrations ranging from 
0.005 to 4 mg/mL. 
 
Table 2.      Physico-chemical characteristics of lactose commercial products. 
 
Product 
Carbohydrate 
content (%) 
Lactose 
content (%) pH 
Protein 
content (%) 
Theoretical Fat 
content (%) 
 
Whole milk 4.9 ± 0.1 4.9 ± 0.1 6.9 3.0 3.6 
Skimmed milk 5.1 ± 0.2 5.1 ± 0.2 6.9 3.1 0.3 
Natural Yogurt 4.4 ± 0.2 3.6 ± 0.2 4.5 3.9 0.1 
Liquid Yogurt 
 
4.0 ± 0.2 
 
3.2 ± 0.2 
 
4.5 
 
3.1 
 
0.5 
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2.6. Statistics 
All digestions were carried out in duplicate and two GC-FID analysis were 
carried out for each digestion treatment (n = 4). The comparisons of means 
using analysis of variance (ANOVA) were made using the statistical package 
(SPSS Inc., Chicago, Il). The differences were considered significant when P 
< 0.05. 
3. Results and discussion 
3.1. Characterisation of the commercial preparation of probiotics with 
enzymes 
The overall characterisation of the enzymatic preparation showed that the pH 
was 6.46, similar to that of small intestine in adults and children, where the 
hydrolysis of carbohydrates takes places.15,20 The aw (0.186) and dry matter 
(94.6%) values guarantee its microbiological stability. Regarding protein, 
data obtained by the Kjeldhal method were slightly higher (17.4%) than the 
sum of the amounts of all enzymes reported in the product (for 1 capsule of 
460 mg: 35 mg protease, 17.5 mg lactase, 12.5 mg lipase y 12.5 mg amylase; 
total 77.5 mg, 16.8%). This small difference could be due to the different 
methods used and the presence of proteins coming from the probiotic 
bacteria.  
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The next step was the evaluation of the main carbohydrase activities in the 
enzymatic preparation, being lactase, maltase and invertase the tested 
activities as indicated in Material and Methods. Although, according to the 
data sheet, the commercial preparation presented other enzymatic activities 
different from those related to carbohydrates, they were not evaluated. This 
was out from the aim of the work and, as indicated earlier, nowadays a lot of 
attention is paid to the carbohydrate malabsorption. Figure 1 shows the 
evolution of the corresponding activities carried out at pH 6, 6.5 and 7. 
Maltase (B) and invertase (C) followed a similar behaviour with a constant 
increase through the time; however, lactase (A) had a different pattern with a 
first lineal phase to reach a plateau after 10 min at pH 7 and 5 min at pH 6.5 
and 6. In lactase and maltase the highest activity was detected at pH 7. 
Taking into account the data of Figure 1, the specific enzymatic activities 
were calculated (Table 3), the highest activity being lactase, followed by 
maltase and invertase. Cardelle-Cobas, (2009)18 tested an enzymatic 
preparation from the same source (Aspergillus oryzae) and found a β-
galactosidase activity of 7000 U/g. Taking into account these results, the 
main objective of this work was focused on the usefulness of the commercial 
enzymatic preparation on lactose hydrolysis, in order to broaden its 
applicability.
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Figure 1.   Release rate of compounds during enzymatic activity measurement of the commercial preparation (CP) (µmol). A) 
o-NP release, β-galactosidase activity. B) p-NP release, maltase activity. C) Glucose and Fructose release, Invertase activity. 
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Table 3      Enzymatic activities of the commercial preparation measured at the 
studied conditions. 
 
Activity Substrate U (µmol/min*g) 
  
pH = 7.0 pH = 6.5 pH = 6.0 
 
β-Galactosidase o-NPG 6815.9 ± 119.5 5006.3 ± 29.0 3342.4 ± 39.5 
Maltase p-NPG 487.3 ± 14.4 290.7 ± 23.4 132.8 ± 12.7 
Invertase 
 
Sucrose 
 
39.2 ± 3.6 
 
- 
 
- 
 
 
 
3.2. Hydrolysis of lactose in buffered standard solutions 
Figure 2 depicts the chromatograms obtained by GC-FID of the hydrolysis 
of lactose (A, 5%; B, 1%; C, 0.25%) after 2 h of digestion with 1000 mg of 
commercial preparation. Galactose and glucose were formed together with 
different di- and trisaccharides derived from the transgalactosylation of 
lactose. It has been previously described that β-galactosidase can hydrolyse 
or transgalactosylate lactose forming molecules of higher molecular mass 
depending on the reaction conditions.21,22 As lactases from A. oryzae 
synthesise galactooligosaccharides (GOS) prebiotic with β(1-6) linkages it is 
plausible that the structures formed during the in vitro digestion of lactose 
with the enzymatic preparation are prebiotics. In addition to the action of 
lactase derived from A. oryzae, it is also presumable that the probiotic 
bacteria (bifidobacteria and lactobacilli) also present in the supplement 
contribute to these reactions. 
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Figure 2.  Chromatographic profiles obtained by GC-FID corresponding to the hydrolysis of 
lactose (A, 5%; B, 1%; C, 0.25%) with the commercial preparation (1000 mg) at 37 ˚C, pH 
7.0, at 0 h of reaction (blank, red) and 2 h of reaction (blue). 
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In this sense, β-galactosidases derived from lactic acid bacteria and 
bifidobacteria are also of valuable interest for production of GOS with better 
selectivity for the growth and metabolic activity of these two bacteria genera 
in the gut, which may lead to an improved prebiotic effect.23  
Tables 4 and 5 show the results obtained after all the reactions carried out 
with lactose solutions at pH 7 and 6.5, taking into account the ratios 
commercial preparation/lactose (w/w) indicated in Materials and Methods 
(Table 1). As expected, lactose hydrolysis increased with the increase of 
preparation and with the decrease of lactose concentration. In general, the 
highest hydrolysis was found in the reactions performed at the lowest pH. At 
pH 6.5, three reactions led to percentage values of hydrolysis higher than 
90%, and in one of them was almost 99%, whereas at pH 7 only in one 
reaction the hydrolysis value exceeded 90% (maximum amount of enzyme, 
1000 mg, and minimum of lactose, 0.25%). However, the β-galactosidase 
activity carried out with o-NPG above mentioned, was higher at pH 7 than at 
pH 6.5. These dissimilarities could be ascribed to different selectivity of 
enzymes (from A. oryzae and probiotics bacteria) toward substrates, o-NPG 
and lactose. 
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Table 4      Lactose hydrolysis (%) during the treatment of different solutions of lactose with enzymatic preparation at 
pH 7.0. 
Time 
(min) 
CP 155* - 
La5%  
CP 460 - 
La5%  
CP 1000 - 
La5%  
CP 460 - 
La1%  
CP 1000 - 
La1%  
CP 460 - 
La0.25%  
CP 1000 - 
La0.25%  
0 - - - - - - - 
15 8.0 ± 0.9a 21.5 ± 1.2b 22.0 ± 0.8b 24.6 ± 0.1b 25.9 ± 0.9b 32.9 ± 0.9c 44.4 ± 0.8d 
30 14.1 ± 1.1a 25.8 ± 0.9b 29.2 ± 1.1b 33.0 ± 0.5b 37.3 ± 1.1b.c 45.2 ± 0.7c 57.7 ± 0.6d 
60 19.8 ± 0.6a 35.0 ± 1.1b 40.4 ± 0.4c 43.8 ± 0.3d 52.6 ± 1.6e 64.2 ± 0.5f 80.6 ± 1.5g 
90 22.8 ± 0.7a 39.2 ± 1.2b 45.4 ± 0.3c 50.7 ± 0.4d 61.7 ± 0.3e 77.2 ± 0.7f 89.4 ± 1.1g 
120 26.8 ± 1.2a 44.0 ± 0.8b 50.9 ± 0.5c 57.6 ± 0.7d 68.8 ± 1.0e 80.6 ± 0.8f 93.1 ± 1.2g 
Data are presented as mean ± SD (n = 4). 
*Represents the amount of commercial preparation used (mg). 
a, b, c Different letters indicate statistical differences in lactose hydrolysis (%) between all tested samples at the same reaction time using a one-way 
analysis of variance (ANOVA) (p < 0.05) (n=4). 
Table 5      Lactose hydrolysis (%) during the treatment of different solutions of lactose with enzymatic preparation 
at pH 6.5. 
Time 
(min) 
CP 155* - 
La5% 
CP 460 - 
La5% 
CP 1000 - 
La5% 
CP 460 - 
La1% 
CP 1000 - 
La1% 
CP 460 - 
La0.25% 
CP 1000 - 
La0.25% 
0 - - - - - - - 
15 15.5 ± 1.6a 28.1 ± 1.1b 34.2 ± 0.8b 34.9 ± 0.2b 49.1 ± 0.1c 47.6 ± 1.9c 68.7 ± 0.9d 
30 21.7 ± 0.9a 32.0 ± 0.8b 45.8 ± 1.1c 48.9 ± 0.9c 67.5 ± 0.9d 70.7 ± 1.0d 85.7 ± 1.2e 
60 31.3 ± 0.6a 42.0 ± 0.6b 56.5 ± 1.2c 66.4 ± 1.0d 81.9 ± 1.2e 86.5 ± 0.5f 95.3 ± 1.4g 
90 37.0 ± 0.4a 49.2 ± 1.0b 62.3 ± 0.9c 73.1 ± 0.9d 90.2 ± 1.6e 93.7 ± 1.8e 98.5 ± 1.6f 
120 41.0 ± 0.9a 54.0 ± 0.8b 68.3 ± 0.7c 78.3 ± 1.8d 91.6 ± 1.8e 96.6 ± 1.6f 99.3 ± 1.2f 
Data are presented as mean ± SD (n = 4). 
* Represents the amount of commercial preparation used (mg). 
a, b, c Different letters indicate statistical differences in lactose hydrolysis (%) between all tested samples at the same reaction time using a one-way 
analysis of variance (ANOVA) (p < 0.05) (n=4). 
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Figure 3 shows the evolution at pH 7 (A) and 6.5 (B) of GOS (di- and 
trisaccharides) formed during the corresponding reactions of lactose 
hydrolysis. At both pH values, the highest GOS content was detected at the 
maximum lactose concentration (5%) since at lower concentration of 
substrate the transgalactosylation is not favoured and the GOS formed are 
hydrolysed rapidly by the enzymes.22 Values of GOS concentrations in the 
range 30-120 mg/g lactose were found.  
 
Figure 3. Evolution of the Galactooligosaccharides (GOS) content during the treatment with 
the commercial preparation (CP) of probiotics and enzymes at 37 ˚C, for 2 h and pH 7.0 (A) 
and 6.5 (B). 
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The evolution of the hydrolysis of lactose in these products is revealed in 
Figure 4. It is clear that both types of products had a different behaviour 
against the enzymatic preparation with a higher hydrolysis in yogurts (>91%) 
than in milk (>55%), probably due to the lower amount of initial lactose in 
yogurts and/or the lower pH, since the maximum activity of lactase from A. 
oryzae takes places at pH values of 2.5-5.5. In addition, the presence of 
lactase coming from the live starter cultures could also contribute to the 
lactose hydrolysis.24 
 
 
 
Figure 4.  Hydrolysis of lactose (%) in commercial products (milk and yogurt) during the 
treatment with commercial preparation (1000 mg) at 37 ˚C for 2 h. 
 
When whole and skimmed milks were compared, the hydrolysis occurred in 
significant less extent in the former (54.8%) than in the latter (60.4%). These 
values are slightly lower than those obtained during the hydrolysis of lactose 
 339 
in buffered standard solutions under the same conditions which gave rise to a 
value of 69.3%. Therefore, a protection effect of milk composition against 
the hydrolysis of lactose with lactase from A. oryzae was observed. The 
upper thickness and, therefore, reduced distribution rates of both the enzyme 
and the substrate, in addition to possible hydrophobic binding by fat globules 
in whole milk, are likely reasons of these data.25 
Similarly to the results with lactose solutions, there was higher formation of 
GOS (Table 6) in the commercial products with lower hydrolysis (milks, 
around 5,500 mg/L) and this amount was almost kept as a plateau during all 
the digestion process and were much higher than the values of GOS found by 
Ruiz-Matute et al.6  in commercial UHT milks (average, 2,134 mg/L). Later, 
Larsen et al (2015)26 reported a patented method for preparing lactose-
depleted and rich GOS products having a stable content of GOS using lactase 
from B. bifidum. 
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3. Conclusions 
The data found in this research allow us to conclude that the studied 
commercial supplement of enzymes and probiotics, in the quantities (≤1000 
mg, two capsules) and conditions here assayed, is adequate for the hydrolysis 
of lactose in buffered solutions (0.25 - 5%) and in commercial dairy products, 
milk (5% lactose) and yogurts (3% lactose). Hydrolysis of lactose values 
ranged from 27 to 99%, depending on the relationship of enzyme preparation 
/ lactose and the type of the product. The highest hydrolysis was found in 
lactose solutions followed by yogurts, and especially a protective effect of the 
matrix was also observed in whole milk. In this commercial product, 
considering the intake of 1000 mg, a hydrolysis higher than 55% was 
observed, which would guarantee the intake of less than 12 g, 
recommendations of the EFSA Panel on Dietetic Products, Nutrition and 
 
Table 6      GOS content evolution (mg/L) during the treatment of commercial dairy 
products with the enzymatic preparation Kyo-Dophilus® (1000 mg) with enzymes. 
 
Time (min) 
Kyo 1000 – WM 
(5%)  
Kyo 1000 – SM 
(5%) 
Kyo 1000 – NY 
(3.6%) 
Kyo 1000 – LY 
(3.2%) 
0 - 
 
- 
 
- 
 
- 
 15 5162.8 (11.9 %) 5626.8 (12.7 %) 5385.6 (10.1 %) 2637.3 (6.4 %) 
30 4603.6 (11.8 %) 5705.3 (13.2 %) 4496.0 (8.5 %) 2506.6 (5.8 %) 
60 5099.5 (11.9 %) 4784.7 (12.3 %) 3450.5 (6.4 %) 1912.0 (4.1 %) 
90 5216.2 (11.1 %) 5361.3 (11.5 %) 2634.8 (4.7 %) 1323.5 (2.9 %) 
120 5069.3 (10.8 %) 5321.4 (11.1 %) 2196.0 (3.7 %) 1099.3 (2.3 %) 
 
*() Represents the percentage of GOS in every sample. 
WM, Whole Milk; SM, Skimmed Milk; NY; NY, Natural Yogurt; LY, Liquid Yogurt 
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Allergies for lactose intolerant 8. In addition, due to the transgalactosylation 
potential of lactases present in this commercial preparation under the 
conditions tested, prebiotic GOS are also formed, expanding the applications 
of probiotics plus enzymes. Although more research is needed, this 
preparation could be taken with meals to assist in the digestion of lactose or 
be also used to easily prepare lactose-depleted and enriched in GOS products 
before consumption.  
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Assessment of in Vitro Digestibility of Dietary Carbohydrates Using
Rat Small Intestinal Extract
Alvaro Ferreira-Lazarte, Agustín Olano, Mar Villamiel, and F. Javier Moreno*
Instituto de Investigacioń en Ciencias de la Alimentacioń, CIAL (CSIC-UAM). C/Nicolaś Cabrera, 9, Campus de la Universidad
Autońoma de Madrid, 28049 Madrid, Spain
ABSTRACT: There are few studies on the assessment of digestibility of nondigestible carbohydrates, despite their increasingly
important role in human health. In vitro digestibility of a range of dietary carbohydrates classiﬁed as digestible (maltose, sucrose,
and lactose), well-recognized (lactulose, fructooligosaccharides (FOS), and two types of galactooligosaccharides (GOS) diﬀering
in the predominant glycosidic linkage), and potential (lactosucrose and GOS from lactulose, OsLu) prebiotics using a rat small
intestinal extract (RSIE) under physiological conditions of temperature and pH is described. Recognized and potential prebiotics
were highly resistant to RSIE digestion although partial hydrolysis at diﬀerent extents was observed. FOS and lactulose were the
most resistant to digestion, followed closely by OsLu and more distantly by both types of GOS and lactosucrose. In GOS, β(1→
6) linkages were more resistant to digestion than β(1 → 4) bonds. The reported in vitro digestion model is a useful, simple, and
cost-eﬀective tool to evaluate the digestibility of dietary oligosaccharides.
KEYWORDS: nondigestible oligosaccharides, prebiotics, in vitro digestion model, intestinal digestibility, mammalian digestive enzymes,
carbohydrases
■ INTRODUCTION
There is growing evidence indicating that dietary nondigestible
oligosaccharides (NDO) play an increasingly important role in
health. Low glycemic index foods, characterized by slowly
absorbed carbohydrates, are linked with reduced risk of
common chronic Western diseases associated with central
obesity and insulin resistance.1,2 These pieces of evidence have
boosted the interest in the use of nondigestible (or with slow
digestion rate) carbohydrates as food ingredients due to their
ability to reduce postprandial glycemic response.3 The attention
to NDO is also reinforced by the fact that regulatory agencies
such as the EFSA have acknowledged that the consumption of
foods/drinks, in which NDO replace simple sugars, reduces
postprandial glycaemic and insulinaemic responses. This
behavior is attributed to the resistance of NDO to hydrolysis
and absorption in the small intestine.4−7
A speciﬁc subset of nondigestible carbohydrates, so-called
prebiotics, have attracted especial interest due to their capability
to reach the colon and be selectively fermented by the intestinal
microbiota that results in speciﬁc changes in its composition
and/or activity, thus contributing to human health promo-
tion.8,9 Intestinal microbiota plays an important role in a great
variety of physiological process, such as the development of the
host immune system, anti-inﬂammatory activity, uptake of
energy from the host diet, production of short-chain fatty acids
by fermentation, alteration of human glucose and fatty acid
metabolism, regulation of intestinal permeability, or stimulation
of mineral absorption by the large intestine.10−13
However, despite the generally accepted concept that NDO
pass through the upper gastrointestinal tract without substantial
modiﬁcations,9 few eﬀorts have been made toward the study of
the resistance of this type of oligosaccharides to the digestion in
the small intestine, and only scarce and fragmented information
on their pass throughout the small intestine is available. In this
context, the limitations of AOAC method 2009.0114 for the
measurement of NDO have already been highlighted, such as
the use of a very limited number of enzymes (i.e., α-amylase
and amyloglucosidase) which fail to hydrolyze digestible
saccharides (including sucrose or starch-decomposed prod-
ucts), as well as the use of enzymes from fungal origin despite it
being well-known that the hydrolyzing activity of enzymes from
fungal or microbial sources does not reﬂect the carbohydrase
activities of enzymes of the human gastrointestinal tract.15
Consequently, alternative methods which are based on the use
of mammalian intestinal enzymes, such as those derived from
pigs16 and weaning piglets,17 have recently been proposed.
However, up to date, the regular supply of porcine small
intestinal enzymes is not commercially available, which may
hinder an easy and broad implementation of these useful
methods to evaluate the in vitro intestinal digestion of
oligosaccharides. In this sense, the use of rat small intestinal
extract (RSIE) can be advantageous because of its commercial
availability, as well as the reported similarity of hydrolyzing
activities between human and rat small intestinal disacchar-
idases.18 In fact, the use of RSIE has been successfully applied
for the assessment of digestibility of prebiotics, such as
fructooligosaccharides (FOS)19 and galactooligosaccharides
(GOS),20,21 as well as to a range of maltose and sucrose
isomers3 and isomaltooligosaccharides.22 However, to the best
of our knowledge, a comparative study of well-recognized
prebiotics, that is FOS, GOS, and lactulose, and potential and
novel candidates, such as lactosucrose and GOS derived from
lactulose (OsLu), has not been carried out. Particularly, GOS
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comprise a complex mixture of, mainly, disaccharides and
trisaccharides having a variety of glycosidic linkages with β-
anomeric conﬁguration. While β(1 → 4) and β(1 → 6) are the
most common glycosidic linkages found in GOS structures, β(1
→ 2) and β(1 → 3) are quite rarely.23,24 Bearing in mind that
there is evidence in the literature indicating that the linkage
type could be a factor more important than monomer
composition in determining the susceptibility of carbohydrates
to digestive glycosidases,3 the enzymatic susceptibility of GOS
could be largely aﬀected by diﬀerences in the predominant
glycosidic linkage.
Therefore, the aim of the present study was to evaluate the
small intestinal digestibility of well-recognized prebiotics, that is
lactulose, FOS (kestose and nystose), and two types of
conventional GOS with predominant β(1 → 4) or β(1 → 6)
linkages, respectively, as well as emerging prebiotic candidates
such as lactosucrose and OsLu, and their comparison with
digestible disaccharides (lactose, sucrose, and maltose) used as
appropriate controls in an in vitro digestion model using RSIE.
■ MATERIALS AND METHODS
Chemicals and reagents. Fructose (Fru) standard was purchased
from Fluka analytical. D-Galactose (Gal), D-glucose (Glc), lactose (β-D-
Gal(1 → 4)-D-Glc), sucrose (β-D-Fru(2 → 1)-α-D-Glc), maltose (α-D-
Glc(1 → 4)-D-Glc), trehalose (α-D-Glc(1 → 1)-α-D-Glc), palatinose
(also termed isomaltulose) (α-D-Glc(1 → 6)-D-Fru), lactulose (β-D-
Gal(1 → 4)-D-Fru), kestose (β-D-Fru(2 → 1)-β-D-Fru(2 → 1)-α-D-
Glc), nystose (β-D-Fru(2 → 1)-β-D-Fru(2 → 1)-β-D-Fru(2 → 1)-α-D-
Glc), phenyl-β-glucoside, o-nitrophenyl (o-NP), p-nitrophenyl (p-NP),
o-nitrophenyl-β-D-glucopyranoside (o-NPG) and p-nitrophenyl-α-
glucopyranoside (p-NPG) standards, and intestinal acetone powders
from rat (Rat Small Intestinal Extract, RSIE) were obtained from
Sigma-Aldrich (St Louis, MO). Lactosucrose (β-D-Gal(1 → 4)-α-D-
Glc(1 → 2)-β-D-Fru) standard was obtained from Wako Chemical
Industries (Neuss, Germany). All standard carbohydrates were of
analytical grade (purity ≥95%).
Obtainment of prebiotic ingredients. OsLu were obtained at
pilot scale by the company Innaves S.A. (Vigo, Spain) following the
method described by Loṕez-Sanz et al.25 In brief, OsLu were
synthesized using a commercial lactulose preparation (670 g/L;
Duphalac, Abbott Biologicals B.V., Olst, The Netherlands), diluted
with water at 350 g/L and pH adjusted to 6.7 with KOH, and a β-
galactosidase from Aspergillus oryzae (16 U/mL; Sigma). The mixture
of oligosaccharides (20% [w/v]) was treated with fresh Saccharomyces
cerevisiae (1.5% [w/v]; Levital, Paniberica de Levadura S.A., Valladolid,
Spain) at 30 °C and aeration at 20 L/min to remove monosaccharides.
Finally, the samples were vacuum concentrated at 40 °C in a rotary
evaporator (Büchi Labortechnik AG, Flawil, Switzerland). The two
commercial GOS syrups with predominant β(1→ 4) (named GOS-1)
and β(1 → 6) (named GOS-2) linkages were kindly provided by the
corresponding manufacturers whereas a mixture of FOS consisting of
kestose and nystose was obtained from Wako Chemical Industries
(Neuss, Germany).
The composition of OsLu syrup, whose main involved glycosidic
linkage was β(1 → 6), expressed in g per 100 g of ingredient was as
follows: 0.5% fructose, 12.5% galactose, 26% lactulose, 19.6% OsLu
disaccharides, 16.0% OsLu trisaccharides (making 61.6% of potential
NDO) and 25.7% moisture. GOS-1 syrup had 21% moisture and the
composition of carbohydrates was 1% galactose, 21.4% glucose, 13%
lactose, 19.2% GOS-disaccharides, 20.8% GOS-trisaccharides and 3.6%
GOS-tetrasaccharides (equivalent to 43.6% of potential NDO). GOS-2
syrup composition was: 6.7% galactose, 22.6% glucose, 19.0% lactose,
9.9% GOS-disaccharides, 14.2% GOS-trisaccharides, 0.7% GOS-
tetrasaccharides (equivalent to 24.8% of potential NDO) and 27%
moisture.
Determination of protein content and main enzyme
activities of the Rat Small Intestinal Extract (RSIE). RSIE was
used to prepare an enzyme/enzymatic solution according to the
method of Olaokun et al.,26 with minor modiﬁcations. RSIE (10 mg/
mL) was homogenized in ice-cold 0.05 M sodium phosphate buﬀer
solution. Then, the solution was centrifuged at 2,415 x g for 15 min
and the supernatant obtained was used as the enzyme solution for
determining protein content and enzymatic activity.
Protein content. The total protein content of the enzymatic
solution was quantiﬁed according to the Bradford method27 using the
Bio-Rad Protein Assay kit and bovine serum albumin as a standard.
The absorbance was monitored at 595 nm.
Hydrolytic activities. β-galactosidase and maltase activities.
The determination of the rat intestinal β-galactosidase activity was
adapted from Warmerdam et al.28 A solution of o-NPG in phosphate
buﬀer 0.05 M, pH 7.0 with a concentration of 0.5 mg/mL (0.05% w/
w) was prepared. The enzymatic activity was determined by incubating
1,900 μL of the o-NPG solution and 100 μL of enzyme solution from
RSIE for 2 h at 37 °C. The method is based on the measuring of the
continuous release of o-NP from o-NPG. Absorbance of released o-NP
was measured at 420 nm every 20 s using a spectrophotometer
(Specord Plus, Analytik Jena) together with a temperature controller
(Jumo dTRON 308, Jumo Instrument Co.). The speciﬁc enzymatic
activity (U) was expressed in μmol min−1 g−1, where one unit was
deﬁned as the amount of enzyme that produced 1 μmol of o-NP in one
min of reaction (n = 6).
Similar procedure was used to determine the maltase activity but
using a solution of p-NPG in phosphate buﬀer 0.05M, pH 6.8 with
(0.05% w/w) and monitoring the release of p-NP at 420 nm every 20 s
(n = 3).
Sucrase, trehalase and palatinase activities. Sucrase, trehalase
and palatinase activities were determined following the method
described by Ghazi et al.,29 with slight modiﬁcations. An individual
solution of sucrose, trehalose or palatinose (0.5% w/w) in sodium
phosphate buﬀer 0.05 M, pH 6.5 was used. An eppendorf tube with
250 μL of sucrose, trehalose or palatinose solution was preheated at
the reaction temperature, 37 °C. Subsequently, 100 μL of enzyme
solution was added and the mixture was incubated for 2 h and diﬀerent
aliquots were taken at diﬀerent times (5, 10, 15, 30, 60, 90, and 120
min). Hydrolysis was stopped by adding 350 μL of a 3,5-
dinitrosalicylic acid (DNS) solution prepared according to Asare-
Brown & Bullock.30 Sucrase, trehalase and palatinase activities were
determined measuring the reducing sugars released from the
corresponding disaccharide hydrolysis, at 540 nm, according to the
DNS method.31 The speciﬁc enzymatic activity (U) was expressed in
μmol min−1 g−1, where one unit was deﬁned as the amount of enzyme
that produced 1 μmol of reducing sugars in one min of reaction (n =
3).
In vitro small intestinal digestion using RSIE. The digestibility
of two types of conventional GOS, (GOS-1 and GOS-2), OsLu, a
mixture of FOS (comprised of kestose and nystose), lactosucrose,
lactulose and digestible oligosaccharides such as lactose, sucrose and
maltose were evaluated using RSIE. In a ﬁrst step, preliminary assays
aimed to determine an optimal RSIE-carbohydrate weight ratio within
2 h of reaction were carried out using lactulose and lactose as
appropriate controls. Finally, a solution of 20 mg of RSIE and 1 mL
distilled water was prepared as a digestive enzyme solution, resulting in
a pH value of 6.8. Subsequently, 0.5 mg of carbohydrate was added
and the mixture was incubated at 37 °C under continuous agitation
(450 rpm) for 2 h. Aliquots were taken at 15, 30, 60, 90, and 120 min
of digestion and heated in boiling water for 5 min to stop the reaction.
The digestion was monitored by GC-FID as described below.
In addition, a series of control samples, based on the incubation of
RSIE without carbohydrates during the same reaction times, were
analyzed. Results showed a slight increase of galactose and a notable
release of glucose as the digestion proceeded. These values were
conveniently subtracted in order to avoid any overestimation of the
monosaccharide fraction.
Carbohydrate analysis by GC-FID. Trimethylsilylated oximes
(TMSO) of carbohydrates (mono-, di- and trisaccharides) present in
samples were determined following the method of Cardelle-Cobas et
al.32 Chromatographic analysis was carried out on an Agilent
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Technologies gas chromatograph (Mod7890A) equipped with a ﬂame
ionization detector (FID). The TMSO were separated using a 15 m x
0.32 mm × 0.10 μm ﬁlm, fused silica capillary column (DB-5HT, J&W
Scientiﬁc, Folson, California, USA). Nitrogen was used as carrier gas at
a ﬂow rate of 1 mL/min. Injector and detector temperatures were 280
and 385 °C, respectively. The oven temperature was programmed
from 150 to 380 °C at a heating ratio of 3 °C/min. Injections were
made in the split mode (1:5).
The TMSO derivatives were formed following the method of Ruiz-
Matute et al.33 First, a volume of 450 μL of the resulting intestinal
digesta, corresponding to 225.0 μg of saccharides was added to 200 μL
of internal standard solution, containing 0.5 mg/mL of phenyl-β-
glucoside. Afterward, the mixture was dried at 40 °C in a rotary
evaporator (Büchi Labortechnik AG, Flawil, Switzerland). Sugar
oximes were formed by adding 250 μL hydroxylamine chloride
(2.5%) in pyridine and heating the mixture at 70 °C for 30 min.
Subsequently, the oximes obtained in this step were silylated with
hexamethyldisylazane (250 μL) and triﬂuoroacetic acid (25 μL) at 50
°C for 30 min.34 Derivatization mixtures were centrifuged at 6,700 x g
for 2 min and supernatants were injected in the GC.
Data acquisition and integration were done using Agilent
ChemStations software (Wilmington, DE, USA). Response factors
were calculated after the duplicate analysis of standard solutions
(fructose, galactose, glucose, lactose, lactulose, sucrose, raﬃnose and
stachyose), at diﬀerent concentrations ranging from 0.005 to 4 mg/
mL.
Statistics. All digestions were carried out in duplicate and two GC-
FID analysis were performed for each digestion treatment (n = 4). The
comparisons of means using analysis of variance (ANOVA) were made
using the statistical package (SPSS Inc., Chicago, Il). The diﬀerences
were considered signiﬁcant when P < 0.05.
■ RESULTS AND DISCUSSION
Determination of the main enzymatic activities of the
RSIE. Table 1 shows the protein content and β-galactosidase,
maltase, sucrase, trehalase, and palatinase activities of RSIE
measured under the assayed digestion conditions. Maltase
activity was the highest with 17-, 19-, 65-, and 134-fold
increases as compared to β-galactosidase, sucrose, trehalase, and
palatinase activities, respectively. These data are in agreement
with the huge diﬀerence previously reported between the
activities of maltase and the rest of the disaccharidases of the
whole region of the small intestine of rats.18 As a consequence,
RSIE exhibited much more moderate β-galactosidase and
sucrase activities with similar values of 26.7 U and 23.5 U,
respectively. In contrast to these values, Oku et al.18 observed a
4-fold increase of sucrase activity as compared to β-
galactosidase activity in the small intestine. This dissimilarity
could be attributed to several methodological factors, such as
diﬀerent assay and detection methods, and/or diﬀerent
substrates (lactose vs o-NPG) used in both studies. In addition,
β-galactosidase activity gradually decreases during aging of the
rat,35 which could impair the comparison between diﬀerent
studies. Finally, RSIE showed low trehalase and palatinose
activities whose speciﬁc values were in agreement with previous
work.18
Small intestinal digestion of digestible carbohy-
drates. Figure 1 shows the evolution of maltose, sucrose,
and lactose throughout the intestinal digestion process with the
extract. Although substantial hydrolysis rates were observed in
all cases, dissimilar trends were observed for each carbohydrate.
Thus, maltose was rapidly and fully digested, as it disappeared
after 15 min of digestion, which was the ﬁrst sampling time
(Figure 1A). Sucrose showed a slower but also high digestion
rate, achieving a relative hydrolysis rate of 88.1% at the end of
the digestion (Figure 1B), whereas lactose was the less
hydrolyzed substrate with a maximum degradation of 55.8%
(Figure 1C). Among the main human and rat dissacharidases,
β-galactosidase has been reported to have the lowest activity,
which could explain the lower hydrolysis rate of lactose as
compared to maltose and sucrose.18
Small intestinal digestion of prebiotic carbohydrates.
The digestibility of a total of six carbohydrates classiﬁed as well-
known (lactulose, GOS-1, GOS-2, and FOS) or potential
prebiotics (lactosucrose and OsLu) was assessed using RSIE
and, conveniently, monitored and quantiﬁed by GC-FID in
order to draw insights from the partial breakdown, if any, of the
tested prebiotics.
Single carbohydrates, such as lactosucrose and, specially,
lactulose, showed a high resistance to the intestinal digestion,
resulting in low hydrolysis degrees of 26.0% and 11.1% (Table
2), respectively, after 2 h of digestion.
Table 1. Protein Content and Enzymatic Activities of Rat
Small Intestine Extract (RSIE) Measured at the Studied
Conditionsa
Activity Substrate Conditions (pH; T) U (μmol/min g)
β-galactosidase o-NPGb 7.0; 37 °C 26.7 ± 2.0c
Maltase p-NPGb 6.8; 37 °C 443.2 ± 2.0d
Sucrase Sucrosee 6.8; 37 °C 23.5 ± 0.7d
Palatinase Palatinosee 6.8; 37 °C 3.3 ± 0.4d
Trehalase Trehalosee 6.8; 37 °C 6.8 ± 1.0d
aProtein content of RSIE: 8.9 ± 0.4% (w/w). bEnzyme activity
determined by measuring the absorbance of released NP at 420 nm.
cValues are expressed as means ± SD (n = 6). dValues are expressed as
means ± SD (n = 3). eEnzyme activity determined by measuring the
absorbance of released reducing sugars at 540 nm.
Figure 1. Hydrolysis rates of maltose (A), sucrose (B), and lactose (C) and their released monosaccharides upon small intestinal digestion at 37 °C,
pH 6.8 for 2 h using RSIE.
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Remarkably, GOS-2, with β(1 → 6) the predominant
linkage, showed a signiﬁcantly higher overall resistance to
intestinal digestion (23.3% of hydrolysis degree at the end of
digestion) than GOS-1 (34.2% of hydrolysis degree), whose
main linkage is β(1 → 4), highlighting the key role played by
the glycosidic linkage involved in the oligosaccharide chain.
Novel galacto-oligosaccharides derived from lactulose
(OsLu) presented an overall hydrolysis degree (i.e., 18%)
which was signiﬁcantly higher than that of lactulose only at
longer digestion times (90 and 120 min), whereas no signiﬁcant
diﬀerences between both carbohydrates were observed during
the ﬁrst hour of digestion. Nevertheless, OsLu had a hydrolysis
degree signiﬁcantly lower than those of GOS-2 and, specially,
GOS-1 throughout the digestion process (Table 2). OsLu and
GOS-2 are mainly comprised of oligosaccharides containing
β(1 → 6) as the main glycosidic linkage, but they diﬀer in the
presence of fructose at the reducing end of OsLu instead of
glucose. Therefore, this result reveals that the monomer
composition is also a critical factor for carbohydrate
digestibility. These data are in good agreement with previous
ﬁndings described by Hernańdez-Hernańdez et al.,36 who
reported a lower ileal digestibility of OsLu as compared to GOS
following an in vivo approach using rats. In addition, also in line
with our ﬁndings, these authors observed that β(1 → 6) and
β(1 → 2) linkages between galactose and glucose monomers
were signiﬁcantly more resistant to in vivo gastrointestinal
digestion than the β(1 → 4) linkage between galactose units
within the GOS mixture. According to these comparative
ﬁndings, it could be inferred that the in vitro digestion model
developed in the present work is suitable for replacing in vivo
rat models, stressing the usefulness of the RSIE as a reliable,
simple, and cost-eﬀective tool to assess carbohydrate
digestibility. Recently, OsLu have also been shown to be
more resistant to in vitro digestion than conventional GOS
following their inclusion in milk.21
Finally, FOS, a mixture comprised of kestose and nystose,
were also less prone to intestinal degradation than GOS-1 and
GOS-2, showing a low hydrolysis degree of 12.0% after 2 h of
digestion (Table 2). These data conﬁrm the high resistance to
mammalian digestive enzymes of β(2 → 1) linkages previously
observed in FOS.9,19 In addition, the overall hydrolysis degree
obtained with the current in vitro digestion model is fairly
similar to a previous in vivo study carried out with healthy
humans and based on aspiration of the gut content at the
terminal ileum.37 Concretely, up to 89% of ingested FOS in a
single meal was recovered in intact form. Consequently, these
authors indicated that around 11% of FOS was hydrolyzed by
either acidic conditions or digestive enzymes in the small
intestine.
Table 3 shows the individual content in the monosaccharide
fraction of all prebiotic oligosaccharides assayed, as well as the
joint content of di-, tri-, and tetrasaccharide fractions in GOS
and OsLu mixtures. In agreement with the overall hydrolysis
degree displayed in Table 2, in GOS-1 the minor tetrasacharide
fraction was substantially reduced and also, although at a lesser
extent, the tri- and disaccharide fractions, whereas GOS-2 and
OsLu presented substantial hydrolysis only in the disaccharide
fraction (Table 3). Furthermore, Figures 2 and 3 illustrate the
diﬀerent resistance of the individual carbohydrates of GOS-1
and OsLu, respectively, to intestinal digestion based on their
corresponding GC-FID proﬁles. Peaks 5 and 7, identiﬁed as 4′-
galactosyl-lactose (β-D-Gal(1 → 4)-β-D-Gal-(1 → 4)-D-Glc)
and 4′-digalactosyl-lactose (β-D-Gal(1→ 4)-β-D-Gal(1→ 4)-β-
D-Gal-(1 → 4)-D-Glc), respectively,32 were the main tri- and
tetrasaccharide present in GOS-1 and clearly diminished after 2
h of RSIE digestion (Figure 2). However, peak 4, identiﬁed as
allolactose (β-D-Gal-(1 → 6)-D-Glc), an isomer of lactose
having a β(1 → 6) linkage, and the minor peak 8, identiﬁed as
6′-digalactosyl-lactose (β-D-Gal(1 → 6)-β-D-Gal(1 → 6)-β-D-
Gal-(1 → 4)-D-Glc), appeared to be fully resistant to RSIE
digestion. In contrast, no measurable diﬀerences were observed
in any of the individual chromatographic peaks corresponding
to the trisaccharide fractions of OsLu, and only very small
decreases could be detected in the disaccharide fraction (Figure
3). Therefore, the contribution to the overall hydrolysis degree
of OsLu displayed in Table 2 seems to be due basically to the
disaccharide fraction (Table 3).
Regarding FOS, nystose was partially hydrolyzed and,
probably, converted to kestose, as indicated by the slight
increase found in fructose content and the nondetection of
released glucose and/or the trisaccharide inulotriose (β-D-
Fru(2→1)-β-D-Fru(2→1)-β-D-Fru) (Table 3). This could be
indicative of a higher lability of the linkage β(2→1) when it is
bonding fructose monomers instead of fructose and glucose in
inulin-type FOS. Finally, the partial hydrolysis of lactosucrose
gave rise to the release of similar levels of sucrose and lactose,
indicating, thus, no particular preference of the digestive
enzymes between the β(1→4) linkage of the lactose moiety and
the β(2→1) linkage of the sucrose moiety.
To sum up, nine dietary carbohydrates, three digestible and
six considered as nondigestible, were subjected to digestion
using RSIE combined with physiological conditions (i.e.,
temperature and pH), and their hydrolysis products were
comprehensively analyzed and quantiﬁed by GC-FID. The
results conﬁrmed the high and ready digestibility of maltose
and sucrose, followed distantly by lactose. In any case, either
the well-known or the potential prebiotics showed a higher
resistance to RSIE digestion although partial hydrolysis at
Table 2. Hydrolysis Degreeb (%) of Nondigestible Carbohydrates during the Small Intestinal Digestion Treatment using RSIE
at 37 °C, pH 6.8a
Digestion time (min) Lactulose GOS-1c GOS-2c OsLud FOSe Lactosucrose
15 3.2 ± 0.5 a 13.2 ± 1.7 c 9.7 ± 1.5 b 2.5 ± 1.3 a 2.9 ± 0.1 a 7.4 ± 0.8 b
30 4.5 ± 0.3 a 21.1 ± 1.2 d 15.7 ± 1.5 c 6.2 ± 1.0 a 4.3 ± 0.2 a 10.4 ± 0.4 b
60 7.9 ± 0.1 a 30.1 ± 1.0 c 18.0 ± 1.1 b 8.1 ± 0.8 a 7.2 ± 0.3 a 18.0 ± 1.4 b
90 8.9 ± 0.2 a 34.2 ± 1.3 d 22.4 ± 1.7 c 16.0 ± 1.1 b 10.3 ± 0.4 a 21.4 ± 2.3 c
120 11.1 ± 0.1 a 34.2 ± 0.5 d 23.3 ± 0.7 c 18.0 ± 3.2 b 12.0 ± 0.6 a 26.0 ± 1.7 c
aDiﬀerent letters indicate statistical diﬀerences between all tested carbohydrate samples at the same reaction time using a one-way analysis of
variance (ANOVA) (p < 0.05) (n = 4). bData are expressed as the mean ± SD (n = 4). cHydrolysis degree (%) based on the joint digestibility of di-,
tri-, and tetrasaccharide fractions. dHydrolysis degree (%) based on the joint digestibility of di- and trisaccharide fractions. eHydrolysis degree (%)
based on the joint digestibility of kestose and nystose.
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diﬀerent extents was observed in all tested carbohydrates. Thus,
FOS (a mixture of kestose and nystose) and lactulose were the
most resistant carbohydrates to intestinal digestion, followed
closely by OsLu and, then, by GOS-2, lactosucrose, and, ﬁnally,
GOS-1 (Tables 2 and 3). To the best of our knowledge, the
present data are the ﬁrst comparing the digestibility rates of two
types of GOS diﬀering in the predominant glycosidic linkage,
revealing the higher resistance of β(1→6) compared to β(1→
4) linkages to rat digestive enzymes. Moreover, the observed
diﬀerences between OsLu and GOS-2 also pointed out the role
of the monomer composition and, more concretely, the higher
resistance of galactosyl-fructoses compared to galactosyl-
glucoses.
There are currently very few studies and reliable data on the
digestibility of potentially nondigestible carbohydrates, despite
their increasingly important role in human health. The in vitro
digestion model, based on the use of RSIE under physiological
conditions of temperature and pH, described in this work has
been shown to be a useful, simple, and cost-eﬀective tool to
evaluate the digestibility of dietary oligosaccharides. In general
terms, the described method allows the distinction between
digestible and nondigestible carbohydrates of degree of
polymerization up to four, as the tested digestible carbohy-
drates were readily hydrolyzed whereas the oligosaccharides
classiﬁed as nondigestible were barely or signiﬁcantly less
hydrolyzed than the digestible carbohydrates. The combination
Figure 2. GC-FID proﬁles of TMSO derivatives of carbohydrates present in GOS-1 undigested (red) and after 2 h of small intestinal digestion with
RSIE (blue). Peaks: 1: Galactose, 2: Glucose, I.S.: Internal standard (phenyl-β-D-glucoside), 3: Lactose, 4: Allolactose, 5: 4′-galactosyl-lactose, 6: 6′-
galactosyl-lactose + unknown peak, 7: 4′-digalactosyl-lactose, 8: 6′-digalactosyl-lactose. +: other disaccharides, ++: other trisaccharides, +++: other
tetrasaccharides. *: Disaccharides were considered the sum of peaks 4 and other disaccharides labelled as +. **: Trisaccharides were the sum of peaks
5, 6, and other trisaccharides. ***: Tetrasaccharides were quantiﬁed as the sum of peaks 7, 8, and other tetrasaccharides.
Figure 3. GC-FID proﬁles of TMSO derivatives of carbohydrates present in OsLu undigested (red) and after 2 h of small intestinal digestion with
RSIE (blue). Peaks: 1: Fructose, 2: Galactose, 3: Glucose, I.S.: Internal standard (phenyl-β-D-glucoside), 4: Lactulose, 5: 1,1-galactobiose, 6: 1,3-
galactobiose, 7: 1,1-galactosyl-fructose, 8: 1,6-galactobiose E, 9: 1,6-galactobiose Z, 10: 6′-galactosyl-lactulose. +: Other disaccharides, ++: Other
trisaccharides. *Disaccharides were considered the sum of peaks 5 to 9. **Trisaccharides were the sum of peaks 10 and other trisaccharides.
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of RSIE digestion with sensitive and powerful separation
methods, such as GC-FID, instead of colorimetric methods as
has been traditionally performed, allows much more
informative read-outs of the digestion process (e.g., lability of
diﬀerent glycosidic linkages, determination of the released
carbohydrates resisting digestion). In addition, the developed in
vitro digestion model has the advantage of requiring a minimum
quantity of carbohydrates (0.5 mg), which is typically a limiting
factor when the digestibility of novel carbohydrates produced at
laboratory scale is assessed.
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The behaviour of oligosaccharides from lactulose (OsLu) included with milk was examined during in vitro
gastrointestinal digestion using the Infogest protocol as well as some small intestine rat extract. The
digestion was compared with commercial prebiotics GOS and Duphalac. Electrophoretic analysis
demonstrated that the prebiotic carbohydrates did not modify the gastric digestion of dairy proteins.
Similarly, no significant effect of gastrointestinal digestion was shown on the prebiotic studied. In con-
trast, under the intestinal conditions using a rat extract, the oligosaccharides present in OsLu samples
were less digested (<15%) than in GOS (35%). Moreover, lactulose was more prone to digestion than their
corresponding trisaccharides. These results demonstrate the limited digestion of OsLu and their availabil-
ity to reach the large intestine as prebiotic.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Prebiotics can reach the distal portions of the colon to selec-
tively stimulate the growth of bifidobacteria and lactobacilli, pro-
viding important benefits to health (Gibson, Probert, Loo, Rastall,
& Roberfroid, 2004). The most relevant compounds are oligosac-
charides. These prebiotics may exert other bioactive properties
such as improving mineral absorption and metabolic disorders
and slow gastric emptying, among other effects (Moreno,
Montilla, Villamiel, Corzo, & Olano, 2014).
Several commercial preparations of galactooligosaccharides
(GOS) and fructooligosaccharides (FOS) are used as prebiotic ingre-
dients in some foods such as infant formula and dairy products
(Sabater, Prodanov, Olano, Corzo, & Montilla, 2016). Lactulose
(i.e. lactose isomer) is also a recognized prebiotic for the treatment
of constipation and systemic portal encephalopathy (Corzo-
Martínez et al., 2013). Given the huge interest in recent years
towards the gastrointestinal function and new structures with
improved properties, new routes to obtain a second-generation
of prebiotic oligosaccharides are being explored (Moreno, Corzo,Montilla, Villamiel, & Olano, 2017). This is the case of the oligosac-
charides derived from lactulose (OsLu). These prebiotic mixtures,
obtained by enzymatic synthesis using b-galactosidases from
microbial origin, might impart better prebiotic properties than
commercial GOS (Moreno et al., 2014).
One of the requirements for oligosaccharides to be considered
as prebiotics is their resistance to digestion in the upper gastroin-
testinal tract. The susceptibility of prebiotic oligosaccharides to
hydrolysis during their passage through the gastrointestinal tract
is largely affected by the chemical structure and can impact their
final state when they reach the colon to be fermented by the
microbiota. Ohtsuka et al. (1990) found that the trisaccharide 40-
galactosyl-lactose was hardly digested in vitro with a homogenate
of intestinal mucosa of rats. According to Torres, Gonçalves,
Teixeira, and Rodrigues (2010), more than 90% of GOS are stable
to digestive enzymes and can reach the colon to exert their positive
effect. Carbohydrate analysis before and after exposure to
certain protocols of in vitro digestion have shown that xylo-
oligosaccharides, palatinose condensates, commercial GOS and lac-
tulose were very resistant to hydrolysis, In contrast, lactosucrose,
gentio-oligosaccharides, soybean oligosaccharides, fructo-
oligosaccharide and inulin were slightly hydrolysed under such
conditions (Playne & Crittenden, 2009).
To our knowledge, limited studies have been carried out on the
digestibility of OsLu. Hernandez-Hernandez et al. (2012) pointed
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during gastrointestinal digestion. This was ascribed to the presence
of fructose in b(1? 4) linkage with galactose at the reducing end
of the OsLu molecules. However, there is a lack of studies on the
susceptibility of OsLu to the gastrointestinal digestion when they
are added in a food matrix and the impact of these compounds
on the digestion of other food components. These considerations
are important since standards would be more prone to changes
as they are not protected in a food medium. Establishing the
digestibility of prebiotic carbohydrates is of great practical applica-
tion, since this influence the final dose of substrate that reaches the
distal portions of gut to exert its prebiotic effect. Thus, the aim of
this work has been to study the effect of the OsLu inclusion in milk
on the digestion of proteins and the changes in the carbohydrate
fraction using standardised in vitro digestive conditions with a
more physiological relevant gastric digestion approach. A subse-
quent treatment with a rat small intestine extract has been
included to study the effect of intestinal enzymes from mammals.
The commercial prebiotics GOS and Duphalac were also
employed for comparison purposes.2. Materials and methods
2.1. Chemicals and reagents
Galactose, glucose, fructose, lactose, lactulose, raffinose, sta-
chyose, phenyl-b-glucoside and intestinal acetone powders from
rat (rat intestine extract) from Sigma-Aldrich chemical Company
(St Louis, MO).
2.2. Obtainment of prebiotic ingredients
OsLu were obtained at pilot scale by Innaves S.A. (Vigo, Spain)
following the method described by Anadón et al. (2013). In brief,Fig. 1. Scheme of the expOsLu were synthesised using a commercial lactulose preparation
(670 g/L; Duphalac, Abbott Biologicals B.V., Olst, The Nether-
lands), diluted with water to 350 g/L and pH adjusted to 6.7 with
KOH, and b-galactosidase from Aspergillus oryzae (16 U/mL; Sigma),
selected by its high yield for synthesis of OsLu (Cardelle-Cobas
et al., 2016). Enzymatic reactions were carried out at 50 C in an
orbital shaker at 300 rpm for 24 h. Afterwards, samples were
immediately immersed in boiling water for 10 min to inactivate
the enzyme. The mixture of oligosaccharides (20% [w/v]) was trea-
ted with fresh Saccharomyces cerevisiae (1.5% [w/v]; Levital,
Paniberica de Levadura S.A., Valladolid, Spain) at 30 C and aeration
at 20 L/min, to decrease the monosaccharides content (Sanz et al.,
2005). Finally, the samples were vacuum concentrated at 40 C in a
rotary evaporator (Büchi Labortechnik AG, Flawil, Switzerland).
GOS syrup was kindly provided by Friesland Campina Domo (Han-
zeplein, The Netherlands).
2.3. Milk samples
Skim Milk Powder (low-heat organic, protein 42.34%, fat 0.89%,
lactose 49.8% (w/w) (SMP) was kindly provided by Fonterra NZ.
The SMP was reconstituted at 10% with distilled water and,
subsequently, lactulose (Duphalac), GOS or OsLu were added at
5% (w/w), taking into account previous recommendations for pre-
biotic doses (3.3 g of prebiotic carbohydrates/100 mL) (Lopez-Sanz,
Montilla, Moreno, & Villamiel, 2015; Walton et al., 2012; Whisner
et al., 2013). The samples were labelled as SMP + Duphalac, SMP +
GOS and SMP + OsLu and were kept refrigerated until subsequent
assays.
2.4. In vitro gastrointestinal digestion
The solutions (see Fig. 1) used for the simulation of the oral and
gastric phases were based on the standardised static digestionerimental procedure.
Fig. 2. Electrophoretic profiles of milk protein fractions (caseins, b-Lg, a-La, BSA)
before and after 2 h of digestion (Bis-Tris-Gel, Novex, NuPage). M: Marker, 1: SMP
0 h, 2: SMP 2 h, 3: SMP + OsLu 0 h, 4: SMP + OsLu 2 h, 5: SMP + Duphalac 0 h, 6:
SMP + Duphalac 2 h, 7: SMP + GOS 0 h, 8: SMP + GOS 2 h, 9: blank
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into a 70 mL glass v-form vessel thermostated at 37 C. To simulate
the oral phase, 4 mL of Simulated Salivary Fluid (SSF, Table 1S,
Verhoeckx et al., 2015), 25 mL 0.3 M CaCl2(H2O)2 and 0.975 mL
Milli-Q water were added and mixed for approximately 2 min
using a 3D action shaker (Mini-gyro rocker-SSM3-Stuart, Bar-
loworld Scientific limited, UK) at 35 rpm. The simulation of the
gastric phase was conducted using a semi-dynamic model
described by Mulet-Cabero, Rigby, Brodkorb, and Mackie (2017).
The gastric fluids and enzyme solution were added gradually.
Two solutions were added at a constant rate for 2 h: (1) 9 mL of
a mixture consisted of 88.9% Simulated Gastric Fluid (SGF), 0.06%
0.3 M CaCl2(H2O)2, 4.4% Milli-Q water and 6.7% 2 M HCl was added
using the dosing device of an autotitrator (836 Titrando-Metrohm,
Switzerland); and (2) 1 mL of pepsin (3214 U/mg solid, using hae-
moglobin as substrate) solution (in water) was added to reach the
protease activity of 2000 U/mL in the final digestion mixture. This
enzyme solution was added using a syringe pump (Harvard appa-
ratus, PHD ultra, USA). The systemwas agitated using the 3D action
shaker at 35 rpm during the digestion time.
The pH was recorded throughout the procedure. Samples
(0.5 mL) were taken after 0, 1 and 2 h of digestion and the pepsin
activity was stopped with 100 lL of 1 M NaHCO3 for a subsequent
analysis of the protein fraction and the rest of the sample with
150 lL of 5 M NaOH for the following intestinal digestion. This last
sample was labelled as GPhase sample. After gastric digestion two
different procedures for small intestinal digestion were carried
out:
(i) 2 mL of GPhase was freeze-dried and kept at 20 C until
used for intestinal digestion assays with a crude enzyme of
rat small intestine extract (RSIE). 5 mg of GPhase was mixed
with 100 mg of RSIE and 1 mL distilled water. The mixture
was incubated at 37 for 2 h, taking samples after 0, 0.5, 1
and 2 h. These samples were centrifuged at 10,000 rpm for
2 min and 100 mL of the supernatant was taken for carbohy-
drate analysis.
(ii) The rest of the liquid GPhase (16.5 mL) was subjected to
the small intestine conditions following the Infogest proto-
col (Minekus et al., 2014). The digestion was carried out at
37 C for 2 h. Samples (5 mL) were taken at 0, 1 and 2 h of
small intestinal digestion, which were respectively labelled
as 0-IPhase, 1-IPhase and 2-IPhase. They were freeze-dried
until further analysis.
2.5. Protein determination
The changes in the protein fraction during gastric digestion of
milk containing prebiotic ingredients (GPhase 0, 1 and 2 h) were
followed by SDS-PAGE. 65 mL of sample was mixed with 25 lL of
4X NuPAGE LSD sample buffer (Invitrogen, Carlsbad, California,
USA) and 10 lL of 8% dithiothreitol. The mixture was heated at
70 C for 10 min. 20 lL of mixture was loaded on a 12% polyacry-
lamide NuPAGE Novex Bis-Tris precast gel (Invitrogen, Carlsbad,
California, USA) and RunBlue Precast SDS-PAGE gel cassette (Expe-
deon Ltd., Cambridgeshire, United Kingdom). SDS-PAGE was per-
formed according to the manufacture’s instructions. Mark 12
Unstained Standard (Invitrogen) was used as a molecular weight
marker (ranging from 2.5 to 200 kDa).
2.6. Carbohydrate analysis by GC-FID
Trimethyl silylated oximes (TMSO) of carbohydrates (mono-, di-
and oligosaccharides) present in samples were determined by Gas
Chromatography following the method described by Montilla,
Corzo, Olano, and Jimeno (2009). Samples corresponding to0.5 mg of saccharides were added to 0.2 mL of Internal Standard
(I.S.) solution which contained 0.5 mg/mL of phenyl-b-glucoside.
Response factors respect to I.S. were calculated after the duplicate
analysis of standard solutions (fructose, galactose, glucose, lactose,
lactulose, sucrose, raffinose and stachyose), at different concentra-
tions ranging from 0.005 to 4 mg/mL.
2.7. Statistical analysis
All digestions were carried out in duplicate and analyses were
also performed in duplicate (n = 4). The comparison of means
was carried out using one-way analysis of variance (Tukey HSD
Multiple Range Test). Statistical analyses were performed using
the SPSS statistical package (Inc., Chicago, Il). The differences were
considered significant when P < 0.05.
3. Results and discussion
3.1. Effect on protein digestion
Fig. 1S (complementary material) shows the pH profile of the
different samples of SMP with the addition of prebiotic ingredients
(Table 2S, carbohydrate composition analysed by GC-FID) during
their digestion in the semi-dynamic gastric model. The initial pH
values were close to 7 in all cases and gradually decreased to 1.8
at the end of the gastric digestion. In general, the profiles of the
milk samples with prebiotic ingredients were similar to that of
the SMP (no prebiotic ingredient added). The gradual lowering of
pH enables the restructuring of the proteins due to acid induced
coagulation to be simulated and is based on typical pH profiles
measured in vivo (Malagelada, Go, & Summerskill, 1979).
The electrophoretic profile of proteins corresponding to sam-
ples 0, 1 and 2 h of gastric digestion are illustrated in Figs. 2 and
3. These figures show bands of pepsin, caseins, BSA, b-
lactoglobulin (b-Lg) and a-lactalbumin (a-La). In the case of mix-
tures with OsLu and GOS at 0 h (Fig. 2) more intense bands
appeared in the area corresponding to a-La, probably due to the
formation of complexes between the protein and carbohydrates,
which disappeared during the digestion. In general, after 2 h of
Fig. 3. Electrophoretic profiles of milk protein fractions (caseins, b-Lg, a-La, BSA)
during 0, 1 and 2 h of digestion (RunBlue Precast gels). M: Marker; 1, 5 and 9 SMP;
2, 6 and 10 SMP + OsLu; 3, 7 and 11 SMP + GOS; 4, 8 and 12 SMP + Duphalac.
*Optical density was measured in the maximum of the peak with the Software
Quantity One.
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from both SMP and SMP with added prebiotics were not detected
with the exception of b-Lg which has been shown to be more resis-
tant to pepsin hydrolysis (Mandalari et al., 2009). Fig. 3 shows
some diffuse, low molecular weight bands in samples correspond-
ing to 1 and 2 h of digestion which could be related to small
molecular weight peptides formed after milk protein digestion
(lanes 5–12). The intensity of these bands was estimated by the
Quantity One software. This showed an increase of intensity with
digestion time obtaining values of 0.54 at 0.62 after 1 h and 0.64
at 0.75 after 2 h, with the lowest values corresponding to skimmilk
control.
These results show that the SDS-PAGE profile of milk with pre-
biotic carbohydrates was similar to that of milk without addition of
these ingredients, indicating that the presence of these prebiotics
in milk at the concentration required to achieve a prebiotic effect,
did not modify the gastric digestion of dairy proteins.Table 1
Carbohydrate evolution of milk samples during Intestinal digestion (G + I Phase), accordin
Carbohydrate content (%)
Galactose Glucose Lactulose Lactose O
SMP 0 h 0.3 ± 0.1 0.4 ± 0.2 N.D. 99.4 ± 0.2 N
1 h 0.3 ± 0.1 0.5 ± 0.1 N.D. 99.2 ± 0.1 N
2 h 0.3 ± 0.0 0.4 ± 0.2 N.D. 99.4 ± 0.2 N
SMP + GOS 0 h 0.5 ± 0.1 7.6 ± 1.0 N.D. 65.6 ± 3.7 1
1 h 0.5 ± 0.0 7.7 ± 1.5 N.D. 66.3 ± 3.3 1
2 h 0.5 ± 0.0 6.9 ± 0.2 N.D. 68.4 ± 1.4 1
SMP + Duphalac 0 h 3.6 ± 0.4 0.4 ± 0.4 22.0 ± 5,1 73.6 ± 4.9 N
1 h 3.4 ± 0.8 0.2 ± 0.2 20.6 ± 1,1 76.5 ± 1.1 N
2 h 3.1 ± 0.2 0.4 ± 0.2 21.6 ± 1,9 75.6 ± 1.7 N
SMP + OsLu 0 h 5.0 ± 0.3 0.3 ± 0.1 6.3 ± 2.1 68.4 ± 1.7 9
1 h 5.0 ± 0.1 0.4 ± 0.2 7.1 ± 1.4 67.4 ± 1.3 9
2 h 5.3 ± 0.3 0.3 ± 0.0 6.0 ± 0.4 69.0 ± 1.1 1
The data are expressed as the mean ± SD (p > 0.05). No statistical difference was determ
variance (ANOVA) (n = 4). N.D. No detected.
a Oligosaccharides: Values represent the sum of di-, tri- and tetrasaccharides.3.2. Effect on carbohydrate fraction
The effect of gastrointestinal digestion on the three different
prebiotics, Duphalac, GOS and OsLu included in milk was investi-
gated. For this purpose, the samples from the semi-dynamic gastric
model were subjected to two different intestinal digestion proto-
cols, as indicated above (Infogest protocol or RSIE). In the case of
the Infogest method, Fig. 2S (complementary material) illustrates,
as an example, the chromatogram obtained by GC-FID of TMSO
derivatives of carbohydrates present in the milk samples with OsLu
after gastric digestion and the beginning of the intestinal phase (G
+ I 0 h). The peaks corresponding to carbohydrates with degree of
polymerisation (DP) from 1 to 4 were found; among them galac-
tose, lactulose and di-, tri- and tetrasaccharides derived from OsLu
ingredient, and galactose, glucose and lactose from milk. Galactose
was present in SMP with OsLu in higher proportion than in SMP
with GOS (Table 1) in which the most abundant monosaccharide
was glucose, due to their presence in the original prebiotic mix-
tures. In this respect, the addition of OsLu to milk or other products
could be more interesting since OsLu presents lower proportion of
caloric carbohydrates with lower glycaemic index than GOS
(Lopez-Sanz et al., 2015). As observed in Table 1, SMP + Duphalac
had higher concentration of lactulose than SMP + OsLu because
lactulose is used as substrate during its enzymatic hydrolysis and
transgalactosylation.
Limited modifications were observed in the carbohydrate frac-
tion following digestion using the Infogest protocol. In spite of
the fact that there was a slight decrease of OS and trisaccharides
in SMP + GOS after 2 h of digestion, these differences were not sta-
tistically significant. None of the carbohydrates derived from the
prebiotic ingredients provided any significant change, indicating
their stability during this enzymatic digestion by pancreatic fluids
and bile salts. Moreover, it seems to be clear that the presence of
other milk components did not impact the passage of GOS, Dupha-
lac and OsLu throughout the gastrointestinal digestion evaluated
by the Infogest protocol.
In order to gain more insight in this subject and given that the
Infogest protocol is mainly focus on the digestion of proteins, this
study was completed with the evaluation of carbohydrate fraction
of SMP with the three prebiotic ingredients after a subsequent
digestion by means of an intestinal extract from rats, labelled as
RSIE, as indicated in Materials and Methods section. Fig. 4A–D
illustrates the evolution of each carbohydrate fraction in the SMP
added with Duphalac, GOS and OsLu after their gastric and
intestinal (Infogest) and with RSIE (0.5, 1 and 2 h) of digestion.
Data are expressed as % of hydrolysis, for lactose, lactulose andg to Infogest protocol.
ther Disaccharides Trisaccharides Tetrasaccharides Oligosaccharidesa
.D. N.D. N.D. N.D.
.D. N.D. N.D. N.D.
.D. N.D. N.D. N.D.
1.0 ± 0.8 12.9 ± 1.8 2.4 ± 0.6 26.4 ± 3.1
2.0 ± 2.2 12.3 ± 1.4 3.3 ± 0.7 27.6 ± 4.2
0.8 ± 1.3 10.9 ± 0.7 2.4 ± 1.7 24.1 ± 1.5
.D. N.D. N.D. N.D.
.D. N.D. N.D. N.D.
.D. N.D. N.D. N.D.
.8 ± 0.3 9.3 ± 0.2 0.9 ± 0.2 20.1 ± 0.6
.8 ± 0.4 9.5 ± 0.4 0.8 ± 0.3 20.1 ± 0.3
0.2 ± 0.5 8.6 ± 1.0 0.8 ± 0.6 19.6 ± 1.6
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Fig. 4. Evolution of carbohydrates over time during the gastric and intestinal
digestion with RSIE. Figure shows the results for each fraction analysed (A)
Monosaccharides, (B) Lactose, (C) Lactulose and (D) Oligosaccharides after 0.5, 1.0
and 2.0 h of digestion. Grey bar represents SMP samples; Striped bar, SMP
+ Duphalac; Black bar, SMP + GOS and White bar, SMP + OsLu. The results are
shown as percentage of increase (A) or hydrolysis (B, C, D) relatively to their
respective controls. Results are presented as mean ± SD (n = 4). Bar with different
lower-case letters (a–d) represent statistical significant differences between each
carbohydrate fraction at the same digestion time for their mean values at the 95.0%
confidence.
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account the control samples immediately taken after the addition
of RSIE. The hydrolysis of compounds with DP  2 and mainly lac-
tose increased with time of reaction, probably due to the presence
of lactase (b-galactosidase) in the RSIE, in good agreement with the
increase of the monosaccharide proportion.
In general, lactose was more hydrolysed than lactulose due to
the presence of fructose instead of glucose in the b linkage of the
latter (Olano & Corzo, 2009), being SMP + Duphalac the sample
with the highest degree of hydrolysis of lactose. In general, no sig-
nificant differences (p > 0.05) were found for SMP samples with
OsLu and GOS. Lactulose was significantly less susceptible to
hydrolysis in SMP + Duphalac than in SMP + OsLu. Furthermore,
lactulose present in OsLu and Duphalacwas more prone to degra-
dation than OS, probably ascribed to its lower Mw, although the
difference was only significant after 1 h of digestion. Finally, OS
were significantly more hydrolysed in SMP + GOS than in SMP
+ OsLu reaching values of 35% and 15%, respectively after 2 h; this
was probably due to the more stable b(1–6) linkages in the OsLu
mixture as compared to b(1–4) in GOS and the presence of fructose
at the terminal end of molecule (Hernandez-Hernandez et al.,
2012). These results indicate that OS (DP  3) present in OsLu were
scarcely affected by the gastrointestinal digestion under the condi-
tions used in the present work, being digested in a very low pro-
portion in the small intestine which would favour the presence
of a OS in the distal portions of colon to be fermented by beneficial
bacteria.
To the best of our knowledge this is the first in vitro study on the
digestion of prebiotics derived from lactose and lactulose as ingre-
dients in a real food. The results obtained underline those of
Hernandez-Hernandez et al. (2012) who pointed out, in in vivo
assays with rats, that mixtures of OsLu were less digested than
GOS. Particularly, the trisaccharide fraction of the former was
13% digested in the ileum, whereas in the latter case digestion
was close to 53%. In both cases, the studied samples were the cor-
responding enzymatic mixtures obtained by transglycosylation
and the presence of other food components was not considered.
The small differences found in the total hydrolysis values with
respect of our results could be ascribed to the differences in the
experimental conditions.
4. Conclusions
According to the results obtained is possible to conclude that
the presence of prebiotic carbohydrates in milk, at prebiotic doses,
did not affect the gastric digestion of milk proteins, following the
Infogest protocol. Similarly, under the same gastrointestinal diges-
tion method, hardly any change was detected in the carbohydrate
fraction of milk with GOS, Duphalac and OsLu after 2 h of diges-
tion. This might indicate the resistance of the three prebiotic mix-
tures, including OsLu, to gastric and pancreatic fluids and bile salts.
However, when the digested samples of milk with prebiotics were
subjected to intestinal digestion by a small gut intestinal extract of
rat a dissimilar behaviour in the three cases was observed, OsLu
samples being the most resistant to the action of enzymes present
in the rat intestine extract, mainly in the case of OS fraction. These
results highlight the possibility of OsLu to reach the large intestine,
target organ, to exert their potential prebiotic effects.
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Abstract  18 
Small intestinal brush border membrane vesicles (BBMV) from pig were used to 19 
digest galactooligosaccharides from lactose (GOS) and from lactulose (OsLu). 20 
Dissimilar hydrolysis rates were detected after digestion. Predominant glycosidic 21 
linkages and monomeric composition affected the resistance to intestinal digestive 22 
enzymes. β(1→3) GOS mixture was the most susceptible to hydrolysis (50.2%), 23 
followed by β(1→4) (34.9%), whereas β(1→6) linkages were highly resistant to 24 
digestion (27.1%). Monomeric composition provided a better resistance in β(1→6) 25 
OsLu (22.8%) as compared to β(1→6)-GOS (27.1%). This was also observed for β-26 
galactosyl-fructoses and β-galactosyl-glucoses where the presence of fructose provided 27 
higher resistance to digestion. Thus, the resistance to small intestinal digestive enzymes 28 
highly depends on structure and composition of prebiotics. Increasing knowledge on 29 
this regard could contribute to the future synthesis of new mixtures of carbohydrates, 30 
highly resistant to digestion and with potential to be tailored prebiotic with specific 31 
properties, targeting, for instance, specific probiotic species. 32 
 33 
 34 
 35 
Keywords: prebiotics, galactooligosaccharides, glycosidic linkages, in vitro digestion 36 
model, small intestine. 37 
38 
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1. Introduction 39 
Knowledge about the diversity of human microbiota and its relation to health has 40 
been largely gathered during last years. Moreover, there is a clear evidence suggesting 41 
that our microbiota is deeply implicated in a wide range of metabolic functions 42 
extending beyond the gut1, such as, the regulation of the central nervous system 43 
homeostasis through immune, vagal and metabolic pathways 2,3,4 or the prevention of 44 
bone and respiratory diseases.5,6 One of the most used strategies to modulate the 45 
composition and metabolic activity of microbiota is the use of prebiotics.7   46 
Prebiotics definition refers to a “substrate that is selectively utilized by host 47 
microorganisms conferring a health benefit”.8 These compounds are characterized by 48 
the resistance to the digestion and acid conditions in the upper gastrointestinal tract and 49 
the ability to reach the colon without alteration in their structure.9 To date, although a 50 
considerable number of compounds have been proposed as potential prebiotics, all well-51 
recognized prebiotics are carbohydrates, mainly inulin, fructooligosaccharides (FOS), 52 
galactooligosaccharides (GOS) and lactulose. Among these, GOS have attracted 53 
growing interest due to the presence of galactose-based oligosaccharides, similar to 54 
those in human milk oligosaccharides (HMOs).10  55 
GOS are commonly obtained by enzymatic synthesis from lactose by β-56 
galactosidases and they are constituted by a complex mixture of galactoses linked by 57 
different linkages β(1→1), β(1→2), β(1→3), β(1→4) and β(1→6)  and can vary from 1 58 
to 8 units and a terminal glucose.11 Composition of the obtained GOS mixture is deeply 59 
affected by several factors such as, the enzyme source, lactose concentration, substrate 60 
composition and reaction conditions (temperature, time and pH).12,11,13 61 
Galactooligosaccharides derived from lactulose (OsLu) have been also proposed as 62 
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emerging prebiotic compounds since they might provide enhanced prebiotic properties 63 
compared to conventional GOS by increasing short-chain fatty acids content and the 64 
population of Bifidobacterium and Lactobacillus species.14,11 OsLu are obtained 65 
similarly to GOS using lactulose as substrate and they are constituted by galactose units, 66 
linked by a variety of glycosidic linkages (β(1→6), β(1→1) and/or β(1→4)) determined 67 
by the enzyme source, and a terminal fructose.15   68 
The susceptibility of oligosaccharides to small intestinal digestion highly depends 69 
on their structure, compromising their digestion fate and absorption.16 However, ever 70 
since prebiotics were first defined, most of the investigations have been carried out 71 
focusing on their effect on the gut microbiota composition and/or activity, and few 72 
efforts have been made towards the study of the resistance of these compounds to 73 
digestion in the small intestine.17-22 Moreover, the standardized official methods to 74 
determine the digestibility of carbohydrates present several limitations, such as those 75 
related to the matrix composition of the sample should be limited in complexity, the 76 
lack of simulation of realistic enzyme substrate ratios and removal of digested products; 77 
but most importantly, they do not take into consideration the disaccharidases that are 78 
present in the small intestinal brush border membrane vesicles in mammals.23-25 79 
Recently, the use of mammalian intestinal enzymes has been reported as an excellent 80 
alternative method to determine carbohydrate digestion.18,22,26  81 
 In vivo and in vitro studies have described considerable digestion rates in the small 82 
intestine of different types of GOS in rats (15-53% hydrolysis degree after 2 h of 83 
digestion),21,22,14,27,28 questioning the general acceptance that these compounds reach 84 
intact the colon. These authors also have reported a different resistance to the upper 85 
gastrointestinal tract conditions as well as a different effect on microbiota depending on 86 
the main β-linkage in the mixture. Thus, β(1→6) linkages have been reported to be less 87 
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prone to degradation by intestinal enzymes and to exert better prebiotic effect as 88 
compared to other β-linkages. 89 
Bearing that in mind, the aim of the present study was to evaluate the digestibility of 90 
recognized prebiotics such as GOS, with predominant β(1→3), β(1→4) or β(1→6) 91 
linkages, as well as emerging prebiotic candidates derived from lactulose (OsLu, 92 
β(1→6)) using small intestinal brush border membrane vesicles from pig.  93 
 94 
2. Materials and methods 95 
2.1 Chemical and reagents 96 
D-Galactose (Gal), D-glucose (Glc), sucrose (β-D-Fru(2→1)-α-D-Glc), trehalose (α-97 
D-Glc(1→1)-α-D-Glc), lactulose (β-D-Gal(1→4)-D-Fru), phenyl-β-glucoside, o-98 
nitrophenyl (o-NP), p-nitrophenyl (p-NP), o-nitrophenyl-β-D-galactopyranoside (o-99 
NPG) and p-nitrophenyl-α-glucopyranoside (p-NPG) standards were obtained from 100 
Sigma-Aldrich (St Louis, MO). Lactose (β-D-Gal(1→4)-D-Glc) was obtained from 101 
ACROS organics (Geel, Belgium) and fructose was obtained from Fluka analytical (St. 102 
Gallen, Switzerland). All standard carbohydrates were of analytical grade (purity ≥ 103 
95%). 104 
Kluyveromyces marxianus cells were kindly provided by Professor Robert Rastall from 105 
The University of Reading (United Kingdom). Nutritive medium (peptone, lactose and 106 
yeast extract) were supplied by Sigma-Aldrich. 107 
2.2 Small intestinal brush border membrane vesicles (BBMV) preparation 108 
Small intestinal brush border vesicles from six post-weaned pigs (7-10 months old) 109 
were obtained following methodology previously reported.18,29 Briefly, three pig small 110 
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intestines, from the duodenum to the ileum, were obtained from a local slaughterhouse 111 
(Coca, Segovia, Spain). Immediately after sacrifice, the samples were kept at 4 ºC and 112 
transferred to the laboratory in less than 2 h. The small intestines were rinsed with cold 113 
phosphate buffered saline solution (PBS) (pH 7.3 – Oxoid; Basingstoke, UK), then slit 114 
open and scrapped with a glass slide. The mucose scrapped was suspended (1:1, w/v) in 115 
50 mM mannitol dissolved in PBS at 4 ºC, homogenized during 10 min using a Ultra-116 
Turrax® (IKA T18 Basic), adjusted with CaCl2 to a final concentration of 10 mM and 117 
centrifuged at 3,000 g during 30 min. The supernatant was centrifuged at 27,000 g 118 
during 40 min and the resulting pellet, containing the BBMV, was re-suspended in 119 
buffer maleate (50 mM) pH 6.0 containing CaCl2 (2 mM) and sodium azide (0.02%). 120 
Samples were lyophilized and kept at -80ºC. 121 
2.3 Prebiotic oligosaccharides 122 
OsLu were obtained at pilot plant scale by Innaves S.A. (Vigo, Spain) following the 123 
method described by López-Sanz et al. (2015).30 Briefly, OsLu were synthesized using a 124 
commercial lactulose preparation (670 g/L; Duphalac, Abbott Biologicals B.V., Olst, 125 
The Netherlands), and a commercial preparation including β-galactosidase from 126 
Aspergillus oryzae (16 U/mL; Sigma) at pH 6.5, 50 ºC and 350 rpm during 24 h. In 127 
addition, three different commercially available GOS mixtures with predominant 128 
β(1→3) linkages GOS (named GOS-1), predominant β(1→4) linkages GOS (named 129 
GOS-2) and predominant β(1→6) GOS (named GOS-3), were tested. 130 
2.3.1 Prebiotic oligosaccharides purification 131 
Purification of prebiotic compounds was carried out by yeast treatment with K. 132 
marxianus.  133 
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K. marxianus cells were grown in YPD (1 % (w/v) yeast extract, 2 % peptone and 2 134 
% lactose) (500 mL) at 37 ºC during 48 h. Samples were then centrifuged at 4,000 g for 135 
10 min and washed three times on PBS (500 mL), supernatant was discarded, and 136 
washed samples were taken to incubation. Twenty-five mL of prebiotic ingredients 137 
(10% in PBS) and K. marxianus yeast (equivalent to 25 mL YPD) were incubated at 37 138 
ºC for 48 h. Samples were then centrifuged at 4,000 xg for 20 min, filtered by 0.2 µm 139 
and then lyophilized and kept at -20ºC until analysis. Purification process was carried 140 
out three times for each sample (n=3) and monitored by GC-FID as explained below. 141 
GOS-1 mixture which was previously constituted by 30% monosaccharides, 22% 142 
lactose, 25% disaccharides and 23% trisaccharides (w:w) showed a loss of 67 % 143 
monosaccharides after K. marxianus treatment. GOS-2 was composed by 22% 144 
monosaccharides, 19% lactose, 8% disaccharides, 44% trisaccharides and 7% 145 
tetrasaccharides (w:w) showing a 97.4 % decrease in monosaccharides composition. 146 
GOS-3 composition which was 38% monosaccharides, 14% lactose and 52% 147 
oligosaccharides (w:w) showed a decrease of 95 % of monosaccharides. OsLu was 148 
constituted by 7.8% monosaccharides, 49.3% lactulose 28.8% disaccharides and 14.1% 149 
trisaccharides (w:w). 150 
2.4 Small Intestinal BBMV characterization 151 
Pig small intestinal BBMV (10 mg/mL) was homogenized in ice-cold 0.05 M 152 
sodium phosphate buffer solution and then centrifuged at 6,000 xg for 15 min. 153 
Supernatant was used as enzyme solution for determining protein content and enzymatic 154 
activity.  155 
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2.4.1 Protein content determination 156 
Total protein content of the pig small intestinal BBMV was quantified according 157 
to the Bradford method31, using the Bio-Rad Protein Assay kit and bovine serum 158 
albumin as a standard. The absorbance was monitored at 595 nm.  159 
2.4.2 Hydrolytic activities 160 
2.4.2.1     β-galactosidase and maltase activities 161 
The determination of the pig intestinal β-galactosidase activity was adapted from 162 
Warmerdam et al. (2014).32 Briefly, a solution of o-NPG (0.5 mg/mL) in phosphate 163 
buffer 0.05 M, pH 7.0 was prepared. The enzymatic activity was determined by 164 
incubating 1,900 μL of the o-NPG solution and 100 μL of enzyme solution from BBMV 165 
for 2 h at 37 °C. The method is based on the measurement of the continuous release of 166 
o-NP from o-NPG. The absorbance of released o-NP was measured at 420 nm every 30 167 
s using a spectrophotometer (Specord Plus, Analytik Jena) together with a temperature 168 
controller (Jumo dTRON 308, Jumo Instrument Co.). The specific enzymatic activity 169 
(U) was expressed in μmol min−1 g−1, where one unit was defined as the amount of 170 
enzyme that produced 1 μmol of o-NP in one min of reaction (biological replicates - n = 171 
3). Similar procedure was used to determine the maltase activity by using a solution of 172 
p-NPG in phosphate buffer 0.05 M, pH 6.8 (0.05% w/w) and monitoring the release of 173 
p-NP at 420 nm every 20 s (n = 3). 174 
2.4.2.2     Sucrase and trehalase activities 175 
Sucrase and trehalase activities were determined following a method described 176 
in a previous work.21 A solution of sucrose or trehalose (0.5% w/v) in sodium phosphate 177 
buffer 0.05 M, pH 6.5 was used. An eppendorf tube with 500 μL of sucrose or trehalose 178 
solution was preheated at the reaction temperature, 37 °C. Subsequently, 200 μL of 179 
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enzyme solution was added and the mixture was incubated for 2 h and different aliquots 180 
were taken at different times (5, 10, 15, 30, 60, 90 and 120 min). Hydrolysis was 181 
stopped by adding 700 μL of a 3,5-dinitrosalicylic acid (DNS) solution. Sucrase and 182 
trehalase activity were determined measuring the reducing sugars released from the 183 
corresponding disaccharide hydrolysis at 540 nm, according to the DNS method.33 The 184 
specific enzymatic activity (U) was expressed in μmol min−1 g−1, where one unit was 185 
defined as the amount of enzyme that produced 1 μmol of reducing sugars in one min of 186 
reaction (n = 3). 187 
2.5 In vitro digestion of prebiotic compounds with BBMV 188 
The digestibility of three different types of GOS, OsLu and lactose and lactulose 189 
was evaluated using BBMV.  190 
First, a solution of BBMV (10 mg/mL) in PBS solution, 6.8 pH, was prepared. Fifteen 191 
milliliters of this solution containing BBMVs (10 mg/mL) were placed in centrifuge 192 
tubes (two per sample) and prebiotic or disaccharides samples were added at a 193 
concentration of 0.2 mg/mL. Digestions were then initiated at 37 ºC during 5 h using 194 
750 rpm in an orbital Thermomixer comfort (Eppendorf®). Aliquots of 1 mL (x2) were 195 
taken at 0, 1, 2, 3, 4 and 5 h of digestion and immediately heated in boiling water for 5 196 
min to stop the reaction.  197 
Furthermore, incubation of BBMV without any carbohydrate source was also analyzed. 198 
Results showed quantifiable amounts of glucose as the digestion proceeded. These 199 
values were conveniently substracted to avoid any overestimation of the 200 
monosaccharide fraction. 201 
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2.6 Carbohydrates quantification by GC-FID 202 
Carbohydrates present in the samples and digested mixtures were analysed as 203 
trimethylsilylated oximes (TMSO) by gas chromatography coupled to ionization flame 204 
detector (GC-FID) following the method of Brobst & Lott Jr, (1966).34 First, 500 µL of 205 
samples (0.1 mg carbohydrates) was added to 500 µL of phenyl-β-glucoside (Internal 206 
Standard, IS) and the mixture was dried in a rotary evaporator (Büchi Labortechnik AG, 207 
Flawil, Switzerland). TMSO derivatives were formed by adding 250 µL of 208 
hydroxylamine chloride in pyridine (2.5% w/v) and heating the mixture at 70 ºC for 30 209 
min, followed by the addition of hexamethyldisilazane (250 µL) and trifluoroacetic acid 210 
(25 µL) and incubated at 50 ºC for 30 min. Mixtures were centrifuged at 6,700 g for 2 211 
min and supernatants were injected in the GC-FID. 212 
TMSO derivatives were separated using a fused silica capillary column DB-5HT 213 
(5%-phenyl-methylpolysiloxane; 30m x 0.25mm x 0.10µm, Agilent). Nitrogen at 1 214 
mL/min was used as carrier gas. Injector and detector temperatures were set at 280 and 215 
385 ºC, respectively. The oven temperature was set from 150 ºC to 380 ºC at a ratio of 3 216 
ºC/min. Data acquisition and integration were done using Agilent ChemStation software 217 
(Wilmington, DE, USA). Response factors were calculated after duplicate analysis of 218 
standard solutions (fructose, glucose, galactose, lactose, lactulose and raffinose) over 219 
the expected concentration range in samples, (0.005–1 mg) and IS (0.25 mg). 220 
2.7 Statistical Analysis 221 
Statistical analysis was carried out using SPSS for Windows, version 23.0. One-way 222 
analysis of variance (ANOVA) and Tukey’s post hoc test was used to determine 223 
significant differences (p < 0.05) between concentrations of carbohydrates in each 224 
prebiotic sample (n=3). 225 
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3. Results and Discussion 226 
High decreases in monosaccharide composition was observed after K. Marxianus 227 
(Material and methods section 2.3.1). In this sense, monosaccharides are the major 228 
impurities in GOS obtainment, therefore, removal of these compounds is recommended 229 
mainly due to their undesirable caloric value and glycaemic index.16 Furthermore, 230 
inhibition of β-galactosidase by glucose and galactose in transgalactosylation and 231 
hydrolysis reaction of carbohydrates was reported.35  232 
3.1 BBMV enzymatic characterization 233 
The brush border of the mammalian intestinal mucosa contains several key enzymes 234 
present as multienzyme complexes, i.e. sucrase-isomaltase, lactase-phlorizin hydrolase, 235 
maltase-glucoamylase and trehalase.36 Accordingly, it is well reported the presence of 236 
those carbohydrases in the brush border of the intestinal mucosa of pig.37,18,38 Table 1 237 
shows the protein content and main enzymatic activities (β-galactosidase, maltase, 238 
sucrase and trehalase) of BBMV measured under the assayed digestion conditions. 239 
Maltase activity (753.1 U/g) was the highest with ten-fold higher values than the other 240 
measured activities. This higher value can be ascribed to the multiple maltase activities 241 
carried out by different enzymatic complexes such as maltase-glucoamylase which has 242 
two catalytic sites able to hydrolyse maltose. This maltase activity is also present in 243 
both catalytic sites found in the complex sucrase-isomaltase. Both enzymatic complexes 244 
are the most abundant glycosidases in the small intestine. 39 245 
To date, some studies have characterized the carbohydrase activities of small 246 
intestinal enzymes in pigs40,38,41,18, showing a clear predominance of maltase activity as 247 
compared to other activities, which agrees with the data obtained in this work. 248 
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3.2 Digestion of prebiotic carbohydrates by BBMV  249 
Figure 1 shows GC-FID profiles of oligosaccharides before and after 5 h of 250 
digestion with BBMV. Differences were observed between the profiles of the three 251 
GOS mixtures, 1,4-galactobiose (β-Gal-(1→4)-Gal) and 1,6-galactobiose (β-Gal-252 
(1→6)-Gal) were identified as peaks 2 and 5, respectively in all samples. β-Gal-(1→3)-253 
Glc and allolactose (β-Gal-(1→6)-Glc), both isomers of lactose were also detected in all 254 
samples as peaks 3 and 4, respectively. Further structural differences were found in the 255 
trisaccharides fraction. β-1,4-Galactosyl-lactose (β-Gal-(1→4)-β-Gal-(1→4)-Glc, peak 256 
6)  was detected in all samples, β-1,6-galactosyl-lactose (β-Gal-(1→6)-β-Gal-(1→4)-257 
Glc, peak 8) was found in GOS-2 and GOS-3 samples and β-1,3-galactosyl-lactose (β-258 
Gal-(1→3)-β-Gal-(1→4)-Glc, peak 7) was only detected in GOS-1 mixture. 259 
Tetrasaccharides were also noticed in GOS-2 mixture (Table 2) and this fraction was 260 
mainly constituted by β-Gal-(1→4)-β-Gal-(1→4)-β-Gal-(1→4)-Glc and other 261 
tetrasaccharides not identified in this work.42,11,43 262 
OsLu mixture was constituted by β(1→6) as the main glycosidic linkage and mostly 263 
by galactosyl galactoses (Gal-Gal) and galactosyl fructoses (Gal-Fru). β-(1→6)-264 
galactosyl-lactulose (β-Gal-(1→6)-β-Gal-(1→4)-Fru) was identified as the main 265 
trisaccharide in the sample. In general, all assessed GOS and OsLu showed a diminution 266 
after BBMV digestion, although considerable differences among all studied samples 267 
were observed. 268 
Tables 2 and 3 show the quantitative determination of individual carbohydrates in 269 
GOS and OsLu during digestion, respectively. A progressive increase in the level of 270 
monosaccharides was found in all samples as digestion proceeded, which was 271 
concomitant with the decrease in di- and trisaccharide fractions. Digestion of standard 272 
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solutions of lactose or lactulose with BBMV is also shown for comparative purposes. 273 
As expected, lactose was much more prone to degradation than lactulose due to the 274 
presence of fructose instead of glucose in the β-linkage of the latter.44 Lactose 275 
degradation in GOS samples was remarkably lower (50-68 %) when compared to the 276 
standard solution (97 %) (Table 1S, Supplementary Information), probably due to the 277 
fact that the degradation of particular GOS trisaccharides or tetrasaccharides could 278 
revert released lactose, as well as to the presence of other carbohydrates in the GOS 279 
mixtures which might mitigate the straightforward digestion of lactose when is present 280 
alone. Regarding lactulose digestion, the standard solution showed a slight lower 281 
hydrolysis than that observed for lactulose present in OsLu (29.5 and 32.8 %, 282 
respectively, after 5 h of digestion). Similar behaviour was obtained in a previous work 283 
comparing the digestibility of prebiotics added to milk in an in vitro study with a small 284 
intestine rat extract.22   285 
Concerning disaccharides degradation, β-Gal-(1→3)-Glc and β-Gal-(1→6)-Glc 286 
(allolactose) exhibited a slight decrease in their content after the BBMV digestion. 287 
Allolactose (β(1→6)) was the most resistant to hydrolysis when compared to lactose 288 
(β(1→4)) and β(1→3) structures. In this regard, it has been previously reported the high 289 
resistance of allolactose to intestinal mucosa with less than 5% of hydrolysis compared 290 
with lactose in an in vitro human assay45 and in an in vivo study with rats.14 Concerning 291 
galactosyl galactoses, none of these carbohydrates provided any noticeable change, 292 
indicating their stability during the digestion with BBMV. Indeed, an increase of these 293 
compounds was found in some samples. Specifically, GOS-2 mixture showed an 294 
increase of 4’ and 6’-galactosyl galactose, respectively, suggesting the possible 295 
breakdown of the β(1→4) linkage of the terminal glucose in their trisaccharide fraction. 296 
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Regarding OsLu disaccharides, high resistance of galactosyl galactoses was also 297 
observed. Limited hydrolysis of galactosyl-fructoses was found, with β(1→6)-298 
galactosyl-fructose linkages as the lowest decrease among all determined disaccharides 299 
(Table 3). According to Hernandez-Hernandez et al.14 it is plausible that, in a similar 300 
way to lactulose, the other galactosyl-fructoses can be highly resistant to digestion 301 
within the mammalian small intestinal system. In line with our results, Julio-Gonzalez 302 
et al. (2019)46 have recently reported the potential higher resistance to mammalian 303 
digestion of galactosyl-galactoses than galactosyl-glucoses. 304 
Regarding trisaccharides fraction, data in Table 2 shows that β(1→3)-galactosyl-305 
lactose in GOS-1 exhibited a higher hydrolysis than β(1→4)-galactosyl-lactose in GOS-306 
2 and β(1→6)-galactosyl-lactose in GOS-3. However, to provide more insight into the 307 
effect on linkage on trisaccharides fraction, Table 4 shows the hydrolysis degree of 308 
each different linkage trisaccharide present in all samples. In addition, the slope of the 309 
representation of hydrolysis degree (%) vs time (h), which could be considered as the 310 
hydrolysis rate, is also shown. Taking into account a standard intestinal digestion time 311 
of 2 h, the hydrolysis degree of trisaccharides showed β(1→3)-galactosyl-lactose 312 
(hydrolysis rate of 21.9% as determined in GOS-1) to be more prone to degradation by 313 
intestinal enzymes followed by β(1→4)-galactosyl-lactose (7.8-17.4%), whereas 314 
β(1→6)-galactosyl-lactose (5.0-7.1%) and β(1→6)-galactosyl-lactulose (4.9%) 315 
exhibited the highest resistance to hydrolysis.  316 
Concerning oligosaccharides as a whole (that is, the sum of di, tri and 317 
tetrasaccharides), the linkages β(1→6), abundant in GOS-3 and OsLu, demonstrated to 318 
be the most resistant to intestinal degradation (Figure 2, Table 1S, Supplementary 319 
Information), where the presence of fructose at the reducing end of molecules provided 320 
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OsLu a slight better resistance to digestion with 22.8 % against 27.1 % of hydrolysis for 321 
GOS-3 after 5 h (Figure 2C). Furthermore, hydrolysis rate for GOS-3 and OsLu (Table 322 
5) showed a lower degradation for OsLu as compared to GOS-3 after 2 and 5 h of 323 
digestion. GOS-2 oligosaccharides mixture was slightly more prone to degradation 324 
(34.9 %) with a higher hydrolysis rate after the BBMV digestion whereas GOS-1 325 
oligosaccharides mixture exhibited the highest degree of hydrolysis with 50.1 % (Table 326 
1S) degradation and the highest hydrolysis rate after 2 h (12.3) and 5 h (9.6) of 327 
treatment with BBMV from pig small intestine as compared to the other samples (Table 328 
5). 329 
In this sense, a recent work highlighted the utility of a similar BBMV from pig 330 
small intestine to produce prebiotic GOS, and revealed that BBMV preferably 331 
synthesizes GOS linked by β(1→3) bonds, finding β-Gal-(1→3)-β-Gal-(1→4)-Glc as 332 
the main trisaccharide after comprehensive NMR analysis.46 This study also pointed out 333 
no presence of β-Gal-(1→6)-β-Gal-(1→4)-Glc, whereas the β-Gal-(1→4)-β-Gal-334 
(1→4)-Glc trisaccharide was present but only at trace amounts. These findings support 335 
the data obtained in the current work since the most abundant glycosidic linkages, 336 
formed when mammalian intestinal -galactosidase act as transgalactosidase, are 337 
expected to be preferentially broken under hydrolytic conditions. 338 
In the other hand, regarding monosaccharides release, galactose amounts were 339 
slightly higher compared to glucose release, probably due to the composition of the 340 
main oligosaccharides in the samples. Table 2 showed that the highest hydrolysis of 341 
GOS-1 oligosaccharides produced a higher release of total monosaccharides (62 mg/100 342 
mg of total carbohydrates) after 5 h of digestion as compared to GOS-2, GOS-3 and 343 
OsLu (34.6, 38.9 and 33.8 mg/100 mg total carbohydrates, respectively). In this sense, 344 
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the highest resistance of galactobioses and galactosyl-fructoses could affect positively to 345 
regulate the caloric intake and diminish the possible absorption of free monosaccharides 346 
in the small intestine, highlighting the key role of the monomer composition and type of 347 
glycosidic linkage in prebiotic oligosaccharide samples. 348 
Results obtained in this work have demonstrated that the use of small intestinal 349 
BBMV from pig is a reliable and useful strategy to evaluate prebiotic carbohydrate 350 
digestibility. Intestinal in vitro digestion with BBMV revealed the partial degradation of 351 
recognized prebiotics such as lactulose, different mixtures of GOS and an emerging 352 
prebiotic OsLu at considerably dissimilar levels. Our findings have revealed a stronger 353 
resistance of β(1→6) linkages oligosaccharides to in vitro digestion when compared to 354 
β(1→4) and β(1→3) linkages GOS. In general, β(1→3) followed by β(1→4) linkages 355 
were more prone to small intestinal degradation using BBMV. This less resistance to 356 
intestinal digestion was also found for galactosyl-glucose disaccharides as compared to 357 
galactosyl-galactoses (galactobioses). The key role of monomer composition was also 358 
underlined by the presence of fructose in OsLu mixture, providing, thus, a higher 359 
resistance to digestion of galactosyl-fructoses. Findings described in this work could be 360 
extrapolated to humans providing evidence on the structure-function relationship, as 361 
well as an increase on the knowledge of the different resistance of β-linkages for the 362 
sake of a future potential development of new tailored prebiotics. Moreover, the 363 
observed hydrolysis with mammalian small intestinal enzymes of recognized prebiotics 364 
could challenge the general belief that these compounds reach the colon without any 365 
alterations in their structure. More investigation should be done in order to gain more 366 
insight in the concept of prebiotics’ digestibility. 367 
 368 
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Table 1. Specific enzymatic activities and protein content of pig 
small intestinal BBMV.  
Activity Substrate Conditions U (µmol/min g) 
β-galactosidase o-NPG 7.0; 37 °C 70.1 ± 1.4 
Maltase p-NPG 6.8; 37 °C 753.1 ± 16.5 
Sucrase Sucrose 6.8; 37 °C 19.9 ± 2.2 
Trehalase Trahalose 6.8; 37 °C 21.4 ± 7.6 
Protein content of BBMV was 7.3 ± 0.5 % 
Data are expressed as means ± SD (n = 3) 
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Table 2. Carbohydrate content (mg/100 mg of total carbohydrates) determined by GC-FID analysis in  GOS samples during the digestion with pig small intestinal brush 
border membrane vesicles at 37 °C, pH 6.8 
Digestion 
time (h) Galactose Glucose Lactose 
β(1→4)  
Gb 
β(1→3) 
Gal-Glc 
β(1→6) 
Gb  Allolactose 
Other 
Disaccharides 
β(1→4) 
Gal-la 
β(1→3) 
Gal-la 
β(1→6) 
Gal-la 
Other 
Trisaccharides Σ DI  Σ TRI 
 
Σ TETRA OSa 
Lactose     
 
         
 
 
0 0.7 ± 0.0 1.1 ± 0.0 98.2 ± 0.0 - - - - - - - - - - - - - 
1 26.7 ± 4.5 17.3 ±  7.0 56.1 ± 7.2 - - - - - - - - - - - - - 
2 37.1 ± 6.3 28.9 ± 0.7 34.0 ± 2.7 - - - - - - - - - - - - - 
3 31.5 ± 7.8 38.4 ± 11.5 30.0 ± 11.0 - - - - - - - - - - - - - 
4 39.8 ± 7.7 41.9 ± 2.4 18.3 ± 6.6 - - - - - - - - - - - - - 
5 47.4 ± 4.5 49.8 ± 5.1 2.8 ± 0.4 - - - - - - - - - - - - - 
 
    
 
    
   
  
 
 
GOS-1                 
0 5.5 ± 0.0 5.5 ± 0.0 34.2 ± 0.0 1.3 ± 0.0 5.4 ± 0.0 2.5 ± 0.0 4.8 ± 0.0 8.3 ± 0.0 9.6 ± 0.0 15.5 ± 0.0* - 7.4 ± 0.0 22.4 ± 0.0 32.4 ± 0.0 - 54.8 ± 0.0 
1 13.1 ± 3.5 15.7 ± 3.7 24.9 ± 2.4 1.3 ± 0.5 4.5 ± 1.1 2.7 ± 0.8 4.8 ± 0.7 6.0 ± 3.1 7.8 ± 1.1 12.0 ± 3.1* - 7.1 ± 0.6 19.3 ± 4.1 26.9 ± 2.0 - 46.2 ± 6.1 
2 18.2 ± 3.0 16.6 ± 3.0 23.9 ± 1.9 1.3 ± 0.3 4.2 ± 0.3 2.1 ± 0.6 4.7 ± 0.6 6.1 ± 0.7 8.1 ± 3.0 8.7 ± 1.1* - 6.2 ± 0.7 18.3 ± 0.8 23.0 ± 2.6 - 41.3 ± 1.8 
3 23.6 ± 3.2 29.9 ± 7.1 20.8 ± 2.2 1.1 ± 0.4 3.5 ± 0.3 2.3 ± 0.5 4.1 ± 2.3 6.1 ± 2.4 4.4 ± 1.0 9.1 ± 4.6* - 4.9 ± 1.6 17.3 ± 4.5 18.4 ± 7.2 - 35.7 ± 11.5 
4 29.0 ± 1.2 21.5 ± 2.2 17.2 ± 1.2 1.2 ± 0.1 3.2 ± 0.3 2.1 ±  0.6 3.6 ± 0.6 4.9 ± 0.1 3.3 ± 0.1 8.2 ± 0.3* - 5.9 ± 0.7 15.0 ± 0.6 17.4 ± 1.0 - 32.3 ± 1.2 
5 33.1 ± 4.0 28.9 ± 0.6 10.7 ± 2.1 1.2 ± 0.2 2.8 ± 0.3 2.1 ± 0.3 3.3 ± 0.2 3.2 ± 0.5 3.1 ± 0.1 6.0 ± 0.5* - 4.7 ± 0.1 12.6 ± 0.2 14.7 ± 0.4 - 27.3 ± 0.7 
 
    
 
    
   
  
 
 
GOS-2                 
0 0.6 ± 0.0 0.0 ± 0.0 1.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.9 ± 0.0 20.4 ± 0.0 - 18.2 ± 0.0 38.5 ± 0.0 4.1 ± 0.0 77.1 ± 0.0 16.4 ± 0.0 97.6 ± 0.0 
1 8.6 ± 1.2 6.9 ± 0.2 1.7 ± 0.1 2.4 ± 0.6 0.9 ± 0.5 0.4 ± 0.1 3.2 ± 0.5 2.9 ± 0.6 15.0 ± 0.9 - 16.2 ± 1.0 26.9 ± 1.1 9.9 ± 0.7 58.1 ± 3.2 14.9 ± 0.5 82.9 ± 1.2 
2 13.5 ± 1.0 9.5 ± 1.1 1.6 ± 0.5 2.2 ± 0.2 1.1 ± 0.1 0.4 ± 0.2 5.0 ± 0.9 3.1 ± 1.1 13.3 ± 1.3 - 15.6 ± 0.9 25.3 ± 0.9 11.7 ± 1.1 54.1 ± 2.0 12.8 ± 1.1 78.6 ± 0.9 
3 16.0 ± 0.7 10.9 ± 0.2 1.3 ± 0.4 2.1 ± 0.5 1.2 ± 0.2 0.3 ± 0.3 5.8 ± 1.0 3.0 ± 0.5 10.5 ± 0.7 - 14.3 ± 0.7 23.7 ± 1.3 12.5 ± 0.4 48.5 ± 1.5 10.8 ± 1.3 71.8 ± 1.3 
4 18.3 ± 0.3 12.3 ± 0.5 1.2 ± 0.3 2.4 ± 1.1 1.2 ± 0.3 0.3 ± 0.1 6.8 ± 0.7 3.9 ± 0.4 9.7 ± 0.4 - 14.1 ± 0.5 18.4 ± 0.8 14.5 ± 1.2 42.1 ± 0.9 10.5 ± 0.9 67.2 ± 0.7 
5 21.2 ± 1.5 13.4 ± 1.0 0.9 ± 0.1 2.5 ± 0.8 1.0 ± 0.4 0.4 ± 0.2 8.0 ± 0.8 3.3 ± 0.2 8.8 ± 1.1 - 13.5 ± 0.3 16.1 ± 0.7 15.1 ± 0.9 38.4 ± 1.4 10.1 ± 1.1 63.5 ± 1.6 
 
    
 
    
   
  
 
 
GOS-3                 
0 0.7 ± 0.0 1.1 ± 0.0 25.1 ± 0.0 1.6 ± 0.0 4.1 ± 0.0 2.6 ± 0.0 9.0 ± 0.0 9.0 ± 0.0 9.4 ± 0.0 - 32.1 ± 0.0 5.3 ± 0.0 26.4 ± 0.0 46.8 ± 0.0 - 73.1 ± 0.0 
1 5.9 ± 1.6 4.5 ± 1.0 20.1 ± 1.5 1.1 ± 0.1 3.1 ± 0.1 2.9 ± 0.2 9.2 ± 1.0 6.6 ± 0.2 8.2 ± 1.3 - 31.0 ± 2.2 6.2 ± 1.0 22.9 ± 1.4 45.4 ± 2.6 - 68.3 ± 1.2 
2 10.3 ± 0.9 8.5 ± 1.7 16.1 ± 1.5 1.0 ± 0.0 2.5 ± 0.1 3.1 ± 0.3 9.2 ± 0.3 6.4 ± 0.2 7.7 ± 1.5 - 28.9 ± 1.7 6.2 ± 0.7 22.2 ± 0.2 42.8 ± 2.3 - 65.1 ± 2.2 
3 13.7 ± 0.4 11.0 ± 0.1 11.6 ± 0.6 0.9 ± 0.1 2.4 ± 0.4 3.0 ± 0.2 8.7 ± 1.1 6.2 ± 0.6 7.1 ± 1.5 - 29.2 ± 1.1 6.2 ± 0.7 21.2 ± 0.8 42.5 ± 0.6 - 63.7 ± 0.4 
4 18.3 ± 1.2 15.6 ± 0.5 9.8 ± 0.4 0.9 ± 0.2 2.2 ± 0.3 2.9 ± 0.1 8.3 ± 2.0 5.5 ± 0.2 6.7 ± 0.2 - 25.1 ± 1.0 4.7 ± 0.6 19.8 ± 1.7 36.5 ± 1.3 - 56.3 ± 0.9 
5 21.9 ± 0.3 17.0 ± 1.2 7.9 ± 0.1 0.9 ± 0.1 2.0 ± 0.5 3.4 ± 0.0 6.8 ± 0.2 4.6 ± 0.7 5.1 ± 0.5 - 26.7 ± 1.1 3.7 ± 0.0 17.8 ± 0.4 35.5 ± 1.2 - 53.3 ± 1.6 
Data are expressed as the mean ± SD (n = 4). 
Gb = galactobiose (β-Gal-(1→4/6)-Gal) 
Gal-la = galactosyl-lactose (β-Gal-(1→4/6)-β-Gal-(1→4)-Glc) 
a Oligosaccharides content based on the sum of di-, tri- and tetrasaccharides. 
*Represents the peak constituted mainly by β-1,3 galactosyl-lactose and traces of β-1,6 galactosyl-lactose 
 
27 
 
 
 
 
 
 
 
 
Table 3. Carbohydrate content (mg/100 mg of total carbohydrates) determined by GC-FID analysis in OsLu samples during the digestion with pig small 
intestinal brush border membrane vesicles at 37 °C, pH 6.8  
Digestion time 
(h) Fructose Galactose Lactulose 
β(1→4) 
Gb 
β(1→3)  
β(1→2) Gb 
β(1→6) 
Glc-Fru 
β(1→1) 
Gal-Fru 
β(1→6) 
Gb 
Other 
Disaccharides 
β(1→6) 
Gal-lu 
Other 
Trisaccharides Σ DI  Σ TRI OSa 
Lactulose             
  
0 5.1 ± 0.0 5.5 ± 0.0 89.5 ± 0.0 - - - - - - - - - - - 
1 8.1 ± 3.2 8.0 ± 2.5 83.9 ± 4.2 - - - - - - - - - - - 
2 10.4 ± 2.7 11.2 ± 2.2 78.4 ± 4.1 - - - - - - - - - - - 
3 11.9 ± 1.0 14.2 ± 1.0 74.0 ± 2.4 - - - - - - - - - - - 
4 15.2 ± 2.0 16.7 ± 1.3 68.1 ± 3.1 - - - - - - - - - - - 
5 18.1 ± 0.4 18.9 ± 0.3 63.0 ± 0.5 - - - - - - - - - - - 
      
      
 
  
OsLu         
0 1.2 ± 0.0 6.6 ± 0.0 49.3 ± 0.0 6.9 ± 0.0 5.7 ± 0.0 2.9 ± 0.0 5.5 ± 0.0 5.3 ± 0.0 2.5 ± 0.0 8.2 ± 0.0 5.9 ± 0.0 28.8 ± 0.0 14.1 ± 0.0 42.9 ± 0.0 
1 2.3 ± 0.2 12.5 ± 2.1 44.0 ± 0.6 6.4 ± 0.3 5.4 ± 0.9 3.1 ± 0.0 5.6 ± 0.2 5.4 ± 0.2 2.2 ± 0.3 7.9 ± 0.8 5.4 ± 0.1 28.1 ± 1.1 13.2 ± 0.5 41.2 ± 1.5 
2 3.4 ± 0.2 17.5 ± 0.3 40.4 ± 1.5 5.9 ± 0.3 5.1 ± 1.0 2.9 ± 0.8 5.2 ± 0.2 4.9 ± 0.1 2.0 ± 0.7 7.4 ± 1.1 5.1 ± 0.3 25.9 ± 1.0 12.5 ± 0.1 38.4 ± 1.0 
3 4.7 ± 0.4 20.5 ± 1.1 37.5 ± 1.0 5.6 ± 0.6 4.6 ± 0.3 2.8 ± 0.1 5.1 ± 0.1 4.9 ± 0.1 2.0 ± 0.1 7.3 ± 0.2 5.0 ± 0.1 25.0 ± 0.6 12.3 ± 0.3 37.3 ± 0.8 
4 5.0 ± 0.5 24.5 ± 0.5 35.7 ± 0.5 5.4 ± 0.2 4.5 ± 0.7 2.5 ± 0.5 4.7 ± 0.1 4.5 ± 0.2 1.7 ± 0.5 7.1 ± 0.5 4.4 ± 0.6 23.3 ± 0.5 11.4 ± 0.9 34.7 ± 0.9 
5 7.1 ± 0.2 26.7 ± 2.4 33.1 ± 1.5 5.6 ± 0.6 4.3 ± 0.3 2.6 ± 0.1 4.6 ± 0.1 4.5 ± 0.1 1.1 ± 0.0 6.6 ± 0.8 4.0 ± 0.9 22.6 ± 0.5 10.5 ± 1.3 33.1 ± 1.4 
Data are expressed as the mean ± SD (n = 4). 
Gb = galactobiose (β-Gal-(1→1/2/3/4/6)-Gal) 
Gal-lu = galactosyl-lactulose (β-Gal-(1→6)-β-Gal-(1→4)-Fru) 
a Oligosaccharides content based on the sum of di- and trisaccharides. 
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Table 4. Hydrolysis degree (%) evolution of different linkage trisaccharides (Tri) in each sample during the 
in vitro digestion with pig small intestinal BBMV. 
 
GOS-1  GOS-2  GOS-3  OsLu 
Digestion time 
(min) 
β(1→3) 
Gal-la 
β(1→4) 
Gal-la 
 β(1→4) 
Gal-la 
β(1→6) 
Gal-la 
 β(1→4) 
Gal-la 
β(1→6) 
Gal-la 
 β(1→6) 
Gal-lu 
 
0 0.0 0.0 
 
0.0 0.0 
 
0.0 0.0 
 
0.0 
1 22.6 18.8  26.5 11.0  12.8 3.4  3.7 
2 43.9 15.6  34.8 14.3  18.1 10.0  9.8 
3 41.3 54.2  48.5 21.4  24.5 9.0  11.0 
4 47.1 65.6  52.5 22.5  28.7 21.8  13.4 
5 61.3 67.7  56.9 25.8  45.7 16.8  19.5 
           
Hydrolysis rate 
(after 2 h) 
21.9 7.8  17.4 7.1  9.0 5.0  4.9 
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Table 5. Hydrolysis rate of oligosaccharides (sum of di- and 
trisaccharides)* in samples during the in vitro digestion with pig 
small intestinal BBMV. 
 
 GOS-1 GOS-2 GOS-3 OsLu 
 OS OS* OS OS 
 
Hydrolysis rate 
(after 2 h) 
 
12.3 9.7 5.5 5.2 
Hydrolysis rate 
(after 5 h) 
 
9.6 6.6 5.3 4.6 
* In the case of GOS-2, tetrasaccharides were also considered. 
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Figure 1. Chromatographic profiles of TMSO derivatives of prebiotics oligosaccharides before (continuous line) and 
after 5 h of digestion with pig small intestinal BBMV (striped line). GOS disaccharides: 1, lactose; 2, 1,4-
galactobiose; 3, β-Gal-(1→3)-Glc; 4, allolactose; 5, 1,6-galactobiose and * other disaccharides. GOS trisaccharides: 
6, β-Gal-(1→4)-β-Gal-(1→4)-Glc; 7, β-Gal-(1→3)-β-Gal-(1→4)-Glc; 8, β-Gal-(1→6)-β-Gal-(1→4)-Glc and ** other 
trisaccharides. OsLu disaccharides: a, lactulose; b, 1,4-galactobiose; c, 1,2-galactobiose+1,3-galactobiose; d, β-Glc-
(1→6)-Fru; e, β-Glc-(1→1)-Fru; f, 1,6-galactobiose and * other disaccharides. OsLu trisaccharides: g, β-Gal-(1→6)-
β-Gal-(1→4)-Fru and ** other trisaccharides. 
31 
 
 
 
 
Figure 2. Evolution of hydrolysis (%) of carbohydrates during digestions with pig small intestinal BBMV from pig at 
37 ºC, pH 6.8. Disaccharides (A), trisaccharides (B) and oligosaccharides (C). The later were expressed as the sum of 
di- and trisaccharides in GOS-1 and GOS-3; tetrasaccharides were also included in GOS-2.  
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Table 1S. Hydrolysis degree (%) of di-, tri, oligosaccharides and lactose, lactulose in all samples during 
digestion with pig small intestinal BBMV. 
  
Σ Disaccharides    
   Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu 
  0 0 0 0 0 
  1 13.8 0.0 13.3 2.4 
  2 18.3 0.0 15.9 10.1 
  3 22.8 0.0 19.7 13.2 
  4 33.0 0.0 25.0 19.1 
  5 43.7 0.0 32.6 21.5 
  Σ Trisaccharides 
      Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu 
  0 0 0 0 0 
  1 17.4 24.7 3.0 6.4 
  2 29.2 29.8 8.5 11.3 
  3 44.0 37.1 9.2 12.8 
  4 46.5 45.3 22.0 19.1 
  5 54.6 50.2 24.1 25.5 
  Σ Oligosaccharides 
      Digestion time (min) GOS-1 GOS-2* GOS-3 OsLu 
  0 0 0 0 0 
  1 15.7 15.1 6.6 3.9 
  2 24.7 19.5 10.9 10.5 
  
3 34.9 26.4 12.9 13.2 
  4 41.0 31.2 23.0 19.0 
  5 50.1 34.9 27.1 22.8 
  
      Lactose/Lactulose Lactose Lactose Lactose Lactulose 
  Digestion time (min) GOS-1 GOS-2 GOS-3 OsLu Lactose Lactulose 
0 0 0 0 0 0 0 
1 27.2 5.6 19.9 10.8 42.9 6.3 
2 30.1 11.1 35.9 18.1 65.4 12.4 
3 39.2 27.8 53.8 23.9 69.5 17.3 
4 49.7 33.3 61.0 27.6 81.4 23.9 
5 68.7 50.0 68.5 32.9 97.1 29.6 
*Represents the sum of di-, tri and tetrasaccharide (GOS-2) 
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In vitro digestibility of galactooligosaccharides: Effect of the structural features on their 
intestinal degradation 
 
Highlights (Ferreira-Lazarte et al.) 
 
1.- Pig small intestinal brush border membrane vesicles were used for prebiotic digestion 
2.- Chemical structure and monomer composition altered resistance to intestinal digestion 
3.- β-1,6 linkages showed higher resistance to degradation than β-1,4 and β-1,3 linkages 
4.- Oligosaccharides derived from lactulose were less hydrolysed than β-1,6-GOS 
5.- Fructose presence in the molecular structure provided higher resistance to digestion 
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A B S T R A C T
The suitability of artichoke and sunﬂower by-products as renewable sources of pectic compounds with prebiotic
potential was evaluated by studying their ability to modulate the human faecal microbiota in vitro. Bacterial
populations and short-chain fatty acid (SCFA) production were measured. Reduction of the molecular weight of
artichoke pectin resulted in greater stimulation of the growth of Biﬁdobacterium, Lactobacillus and Bacteroides/
Prevotella, whilst this eﬀect was observed only in Bacteroides/Prevotella for sunﬂower samples. In contrast, the
degree of methoxylation did not have any impact on fermentability properties or SCFA production, regardless of
the origin of pectic compounds. Although further in vivo studies should be conducted, either pectin or en-
zymatically-modiﬁed pectin from sunﬂower and artichoke by-products might be considered as prebiotic can-
didates for human consumption showing similar ability to promote the in vitro growth of beneﬁcial gut bacteria
as compared to well-recognized prebiotics such as inulin or fructo-oligosaccharides.
1. Introduction
One of the most complex polysaccharides that exist in the cell wall
of all higher plants is pectin (Kacŭráková, Capek, Sasinková, Wellner, &
Ebringerová, 2000). Pectin is not a single structure and comprises of a
family of plant cell wall polysaccharides that contain galacturonic acid
(GalA) linked at α-1,4 positions. It mainly consists of a GalA-rich
backbone, known as homogalacturonan (HG≈ 65%) which is partially
methyl-esteriﬁed in C-6 and O-acethyl-esteriﬁed in positions 2 and 3
(Mohnen, 2008). Rhamnose residues interrupt the HG structure to form
rhamnogalacturonan I (RG-I≈ 20–35%) which is based on a backbone
consisting of a repeating disaccharide of GalA and rhamnose residues.
In addition, some rhamnose residues may contain sidechains consisting
of α-L-arabinose and/or β-D-galactose (arabinans, galactans and ara-
binogalactans). RG-II constitutes ≈ 2–10% of pectin and is the most
complex, but is also believed to be the most conserved part of pectin
molecules. RG-II has a HG backbone and is branched with rhamnose
and other minor sugars such as fucose, glucuronic acid and methyl-
esteriﬁed glucuronic acid among other rare carbohydrates such as
apiose, 2-O-methylxylose, and 2-O-methylfucose (Holck, Hotchkiss,
Meyer, Mikkelsen, & Rastall, 2014; Noreen et al., 2017).
The biological eﬀects of pectins have been mainly studied on in vitro
assays and they are highly fermentable dietary ﬁbres. Furthermore,
pectic-oligosaccharides (POS) have been proposed as a new class of
prebiotics capable of exerting a number of health-promoting eﬀects
(Olano-Martin, Gibson, & Rastall, 2002). These beneﬁts include a de-
sirable fermentation proﬁle in the gut (Gómez, Gullón, Yáñez, Schols, &
Alonso, 2016), potential in vitro anti-cancer properties (Maxwell et al.,
2015), potential for cardiovascular protection (Samuelsson et al.,
2016), as well as antibacterial, anti-inﬂammatory and antioxidant
properties, among others (Míguez, Gómez, Gullón, Gullón, & Alonso,
2016). Nevertheless, the details of the underlying mechanisms are still
largely unknown and additional studies are needed on the structure-
function interrelationship, as well as on the claimed eﬀects caused by
POS in humans (Gullón et al., 2013).
Apart from POS, whose degree of polymerization range from 3 to
10, during the past few years there has been a ﬂourishing interest to-
wards pectin derivatives, especially the so-called “modiﬁed pectins”
(MP), a term standing for pectin-derived, water-soluble polysaccharide
of lower molecular weight (Mw) than the original pectin and, normally,
produced from citrus peel and pulp (Holck et al., 2014). These com-
pounds can be obtained from pectins in their native form using che-
mical and enzymatic treatments, which produce lower Mw HG and
fragments enriched in RG (Morris, Belshaw, Waldron, & Maxwell,
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2013). The break-down of pectins not only leads to modiﬁcation of
their physico-chemical and gelling properties (Ngouémazong,
Christiaens, Shpigelman, Van Loey, & Hendrickx, 2015), but also
modulation of their bioactivity (Morris et al., 2013).
There are several in vitro and in vivo studies on the ability of MP to
inhibit tumour growth and metastasis (Morris et al., 2013; Nangia-
Makker et al., 2002; Park et al., 2017). Citrus MP inhibits in vitro and in
vivo angiogenesis in diﬀerent types of cancer by blocking the associa-
tion of galectin-3 to its receptors (Zhang, Xu, & Zhang, 2015). Other
beneﬁcial health properties might include the reduction of athero-
sclerotic lesions (Lu et al., 2017), anti-inﬂammatory and antioxidant
properties (Popov & Ovodov, 2013; Ramachandran, Wilk, Melnick, &
Eliaz, 2017) or immunostimulatory properties (Vogt et al., 2016).
However, most of these studies were performed using cell cultures or in
mice and extrapolation of the results to human or clinical investigations
should be considered with caution.
Nonetheless, only a few recent studies have addressed the prebiotic
potential of MP in terms of the fermentation properties. A slight or no
increase was observed in the faecal lactobacilli count during an in vivo
study with rats fed with citrus MP (Odun-Ayo, Mellem, & Reddy, 2017).
Di et al. (2017) compared ﬁve structurally diﬀerent citrus pectic sam-
ples (3 of them were POS and 2 were MP) and found that two POS and
one MP exhibited biﬁdogenic eﬀects with similar fermentabilities in
human faecal cultures. These authors concluded that Mw and degree of
methoxylation did not aﬀect their biﬁdogenic properties; however,
structural diversity in pectic compounds is possible as long as sig-
niﬁcant arabino- and galacto-oligosaccharide content is present. Fanaro
et al. (2005) investigated the eﬀect of acidic oligosaccharides from
pectin on intestinal ﬂora and stool characteristics in infants, showing
that they were well tolerated as ingredient in infant formulae but did
not aﬀect intestinal microecology.
To the best of our knowledge, the fermentation and prebiotic
properties of pectin derived from artichoke (Sabater, Corzo, Olano, &
Montilla, 2018) and sunﬂower (Muñoz-Almagro, Rico-Rodriguez,
Wilde, Montilla, & Villamiel, 2018) by-products have not been ex-
plored. In the case of artichoke, only one previous study showed a se-
lective growth of two speciﬁc strains, i.e. Lactobacillus plantarum 8114
and Biﬁdobacterium biﬁdum ATCC 11,863 which was ascribed to the
combination of its high inulin and low methoxylated pectin contents
(Fissore, Santo Domingo, Gerschenson, & Giannuzzi, 2015). Also,
Costabile et al. (2010) reported, in a double-blind, cross-over study
carried out in healthy adults, a pronounced prebiotic eﬀect (i.e., in-
creasing of bidifobacteria and lactobacilli) of a very-long-chain inulin
derived from artichoke on the human faecal microbiota composition.
The lack of knowledge of potential alternative sources of active pectic
compounds for human consumption is surprising as previous studies
reported that structure and composition can make a signiﬁcant diﬀer-
ence to the fermentation properties (Onumpai, Kolida, Bonnin, &
Rastall, 2011). Thus, biﬁdogenic properties seem to highly depend on
the composition and structure of pectins, with neutral sugar content
and GalA:Rha ratio being critical factors (Di et al., 2017).
In this context, considering the structural diversity of pectins de-
pendent on their origin, the aim of this study was to evaluate the eﬀect
of a variety of pectins and enzymatic-modiﬁed pectins from diﬀerent
sources (in particular, citrus, sunﬂower and artichoke) on the proﬁle
changes in human faecal microbiota population and fermentation me-
tabolites, i.e. short-chain fatty acids.
2. Materials and methods
2.1. Raw material
Sunﬂower by-products based on heads and leftover stalks and arti-
choke by-products derived from external bracts, leaves and stems, were
supplied by Syngenta AG and Riberebro S.L. (Spain), respectively. Prior
to experiments, raw material was ground with a knife mill to particle
size< 500 μm. Commercial citrus pectin (trade name Ceampectin®,
ESS-4400) was kindly provided by CEAMSA (Porriño, Pontevedra,
Spain).
2.2. Pectin extraction and modiﬁcation
Sunﬂower pectin was extracted from 1 kg of dried substrate by
suspending in 20 L of sodium citrate (0.7%) at 52 °C, pH 3.2 for 184min
under agitation and the residue was precipitated with ethanol and then
freeze-dried (Muñoz-Almagro, Rico-Rodriguez, Wilde et al., 2018).
Artichoke pectin was extracted using a cellulase from Trichoderma reesei
(Celluclast® 1.5 L, Novozymes, Bagsvaerd, Denmark) in an orbital
shaker at 50 °C, pH 5 with constant shaking (200 rpm) following the
method described by Sabater et al. (2018). After hydrolysis, samples
were centrifuged (1300 x g for 10min at 4 °C) and supernatants were
ﬁltered through cellulose paper. Residues were washed and pre-
cipitated in 70% ethanol, centrifuged (1200 x g, 20min) and then
freeze-dried. Extraction yield of pectin (expressed as percentage) re-
presents the amount of pectin extracted from 100 g of initial dried raw
material, being 10.0% and 22.1% the obtained values for sunﬂower and
artichoke pectin, respectively.
The extracted sunﬂower and artichoke pectins, as well as the com-
mercial citrus pectin were then subjected to an enzymatic treatment
using a commercial cellulase from Aspergillus niger (Sigma Aldrich,
Steinheim, Germany) with pectinolytic activity to reduce their Mw.
Then, the resulting material was transferred to a continuous membrane
reactor to separate the modiﬁed pectin from oligosaccharides and free
sugars formed (Olano-Martin, Mountzouris, Girbson, & Rastall, 2001).
The reactor consisted of an ultraﬁltration dead-end stirred cell (model
8000, Amicon, Watford, U.K.) where the substrate was added and then
pushed from a pressurized feed tank ﬁlled with water at a rate matching
the permeate ﬂow rate. All ﬁltrations were carried out with an Ultracel®
ultraﬁltration disk membrane, with a Mw cut-oﬀ (MWCO) of 3 kDa and
a diameter of 76mm as determined by the manufacturers. Checking of
absence of low Mw carbohydrates in the ultraﬁltered samples was ac-
complished by the analysis of the resulting retentates and permeates by
SEC-ELSD following the method described in Section 2.3.2. All pectin
and MP samples were free from monosaccharides, as well as oligo-
saccharides below 10 kDa (Fig. 1).
2.3. Characterisation of pectin and enzymatic-modiﬁed pectin samples
2.3.1. Monosaccharide analysis
Monosaccharide analysis was performed after the acid hydrolysis of
samples with 2M triﬂuoroacetic acid (TFA) at 110 °C for 4 h. After that,
released monosaccharides were analysed by gas chromatography (GC)
in an Agilent Technologies gas chromatograph (7890 A) equipped with
a ﬂame ionisation detector (FID). Prior to GC analysis, trimethylsilyl
oximes (TMSO) of monosaccharides were formed (Cardelle-Cobas,
Martínez-Villaluenga, Sanz, & Montilla, 2009). 500 μL of hydrolysed
samples were evaporated to remove the acid and then 400 μL of phenyl-
β-glucoside (0.5 mg/mL) used as internal standard (IS) were added.
Afterward, the mixture was dried at 40 °C in a rotary evaporator (Büchi
Labortechnik AG, Flawil, Switzerland). Sugar oximes were formed by
adding 250 μL hydroxylamine chloride (2.5%) in pyridine and heating
the mixture at 70 °C for 30min. Subsequently, the oximes obtained in
this step were silylated with hexamethyldisylazane (250 μL) and TFA
(25 μL) at 50 °C for 30min. Derivatisation mixtures were centrifuged at
6700 x g for 2min and supernatants were injected in the GC-FID.
Analyses were carried out using a DB-5HT capillary column (15m x
0.32mm x 0.10 μm, J&W Scientiﬁc, Folson, California, USA). Nitrogen
was used as carrier gas at a ﬂow rate of 1mL/min. Injector and detector
temperatures were 280 and 385 °C, respectively. The oven temperature
was programmed from 150 to 380 °C at a heating rate of 1 °C/min until
165 °C and then up to 300 °C at a heating rate of 10 °C/min. Injections
were made in the split mode (1:5).
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Fig. 1. SEC-ELSD proﬁles of pectins (blue), enzymatic-modiﬁed pectins (MP) (green), and corresponding ultraﬁltrated permeates (black) derived from A) citrus, B)
sunﬂower, and C) artichoke sources. Elution positions of standard polysaccharide polymers (pullulans) are indicated by arrows (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article).
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Data acquisition and integration were done using Agilent
ChemStations software (Wilmington, DE, USA). Response factors were
calculated after duplicate analysis of standard solutions (glucose,
mannose, rhamnose, arabinose, galactose, GalA and xylose) over the
expected concentration range in samples, (0.01–2mg) and IS (0.2 mg).
2.3.2. Estimation of the molecular weight (Mw)
Estimation of Mw was carried out by Size Exclusion
Chromatography (SEC) according to the method described by (Muñoz-
Almagro, Rico-Rodriguez, Villamiel, & Montilla, 2018). The analysis
was performed on a LC Agilent Technologies 1220 Inﬁnity LC System
1260 (Agilent Technologies, Germain), equipped with two consecutive
TSK-GEL columns (G5000 PWXL, 7.8× 300mm, particle size 10 μm,
G2500 PWXL, 7.8× 300mm, particle size 6 μm) connected in series
with a TSK-Gel guard column (6.0mm×400mm) (Tosoh Bioscience,
Stuttgart, Germany). Samples (20 μL) were eluted with 0.1 M NaCl at a
ﬂow rate of 0.5mL/min for 50min at 30 °C. The eluent was monitored
with an Evaporative Light Scattering Detector (ELSD) (Boeblingen,
Germain) at 30 °C. Pullulans of Mw 805, 200, 10, 3 and 0.3 kDa were
used as standards to calibration. All the Mw values speciﬁed were
weight-average.
2.3.3. Estimation of the degree of methoxylation
Degree of methoxylation of samples was determined by Fourier
transform infrared spectroscopy (FTIR). KBr discs were prepared mixing
the pectin and enzymatic-modiﬁed pectin samples with KBr (1:100) and
pressing. FTIR spectra Bruker IFS66v (Bruker, US) were collected in
absorbance mode in the frequency range of 400-4000 cm−1, at a re-
solution of 4 cm−1 (mid infrared region) with 250 co-added scans. The
degree of methoxylation was determined as the average of the ratio of
the peak area at 1747 cm−1 (COO-R) and 1632 cm−1 (COO-) as pre-
viously described (Singthong, Cui, Ningsanond, & Douglas Goﬀ, 2004).
2.4. Determination of in vitro fermentation properties and prebiotic activity
2.4.1. Faecal inocula
Faecal samples from ﬁve healthy adults (2 males, 3 females, mean
age of 30.6 ± 4.2 years old) who had not consumed prebiotic or pro-
biotic products, nor had received antibiotic treatment within 3 months
before study were obtained in situ. Samples were kept in an anaerobic
cabinet and used within a maximum of 15min after collection.
Faecal samples were diluted (10% w/w) in anaerobic phosphate-
buﬀered saline (PBS; 0.1 mol/L, pH 7.4, Oxoid, Basingstoke, UK) and
homogenised in a stomacher (Stomacher 400, Seward, UK) at normal
speed for 2min.
2.4.2. In vitro batch fermentations
Sterile stirred batch culture fermentation systems were set up and
aseptically ﬁlled with a volume of sterile, basal medium: (per litre) 2 g
peptone water, 2 g yeast extract, 0.1 g NaCl, 0.04 g K2HPO4, 0.04 g
KH2PO4, 0.01 g MgSO4·7H2O, 0.01 g CaCl2·6H2O, 2 g NaHCO3, 2mL
Tween 80, 0.05 g haemin, 10 μL vitamin K1, 0.5 g L-cysteine HCl, 0.5 g
bile salts and 4mL resazurin (0.25 g/L). Medium was sterilised at
120 °C for 30min before aseptically dispensing into the sterile fer-
menters. Sterile stirred fermenters were ﬁlled with 9mL of autoclaved
basal medium and were gassed overnight by constant sparging oxygen-
free nitrogen to maintain anaerobic conditions. 100mg of substrates
were added (ﬁnal concentration of 1% (w/v)) to the respective fer-
mentation just prior to the addition of the faecal inoculum (1mL). The
temperature was maintained at 37 °C using a water jacket and the pH
was maintained between 6.7 and 6.9 using an automated pH controller
(Fermac 260; Electrolab, Tewkesbury, UK). The batch cultures were run
for a period of 48 h and samples were taken from each vessel at 0 and
24 h for bacterial enumeration by ﬂuorescent in situ hybridisation
(FISH) and at 0, 10, 24, 36 and 48 h for SCFA by GC-FID. 3 extra vessels
with inulin, fructooligosaccharides (FOS) and no added carbohydrate
source were also included as positive and negative control, respectively.
2.4.3. Short-chain fatty acid (SCFA) analysis
Before chemical analysis, samples from each fermentation time
were centrifuged at 13,000 x g for 10min to obtain the supernatant. The
clear solutions were kept at −20 °C until analysis. SCFA analysis was
carried out using GC-FID based on the method described by
(Richardson, Calder, Stewart, & Smith, 1989). Before analysis, samples
were thawed on ice and then vortexed. After that, 400 μL of each
sample were taken into a glass tube and 25 μL of 2-ethylbutyric acid
(0.1M) (IS) was added. Following that, 250 μL of concentrated HCl and
1.5 mL of diethyl ether were added and the solution was mixed 1min
and centrifuged 10min at 2000 x g. 400 μL of the upper layer (ether
layer) was transferred to a GC screw-cap vial and 50 μL of N-(tert-bu-
tyldimethylsilyl)-N-methyltriﬂuoroacetamide (MTBSTFA) was added
and leave 72 h to produce fully derivatisation.
A 5890 Series II Gas Chromatograph (Hewlett Packard) ﬁtted with a
Rtx-1 10m x 0.18mm column with a 0.20 μm coating (Crossbond 100%
dimethyl polysiloxane; Restek) was used for analysis. Helium was used
as carrier gas at a ﬂow rate of 0.7 mL/min. Injector and detector tem-
peratures were 275 °C. Oven temperature was programmed from 63 °C
for 3min and then heated to 190 °C at a heating rate of 3 °C/min and
held at 190 °C for 3min. Injections were made in the split mode (100:1).
SCFA standards analysis was also carried out to quantify concentrations
of all compounds.
2.4.4. Enumeration of bacterial populations
Enumeration of the target faecal bacteria groups was achieved by
FISH with ﬂuorescently labelled 16S rRNA probes according to the
method described by (Wagner, Hornt, & Daims, 2003). Brieﬂy, 375 μL
aliquots were obtained from each fermenter and were mixed with
1.125mL 4% (w/v), ice-cold paraformaldehyde and ﬁxed for 4–10 h at
4 °C. Fixed cells were then centrifuged at 13,000 x g for 5min and
washed twice on 1mL cold ﬁlter-sterilised PBS (0.1 M). The washed
cells were then resuspended in 150 μL PBS and 150 μL of absolute
ethanol (99%) and stored at −20 °C until analysis.
To obtain an appropriate number of ﬂuorescent cells in each ﬁeld of
view of the microscope, samples to hybridise were then diluted in a
suitable volume of PBS with 1% (v/v) of sodium dodecyl sulphate, and
20 μL of the dilution was added to each well of a six-well polytetra-
ﬂuoroethylene/poly-L-lysine-coated slide (Tekdon Inc., Myakka City,
USA). Samples were dried at 48–50 °C for 15min in a desktop plate
incubator and dehydrated in an alcohol series (50, 80 and 96% (v/v)
ethanol, 2 min each) and placed again at 48–50 °C to evaporate the
excess of ethanol before adding the hybridisation solution. 50 μL of
hybridisation solution (per 1mL; 5M NaCl 180 μL, 1M Tris/HCl 20 μL,
ddH2O 799 μL, 1 μL SDS 10% (w/v) and 100 μL of probe) was added to
each well and left to hybridise for 4 h in a microarray hybridisation
incubator (Grant-Boekel, UK) at 46–50 °C depending on the probe. After
hybridisation, slides were washed in 50mL washing buﬀer (5M NaCl
9mL, ddH2O 40mL and 1M Tris/HCl 1mL) for 15min and dipped in
cold distilled water for 2–3 seconds. Slides were then dried with com-
pressed N2 and a drop of PVA-DABCO antifade (polyvinyl alcohol
mounting medium with 1,4-diazabicyclo (2.2.2) octane) was added
onto each well. A coverslip (20mm, thickness no. 1; VWR) was placed
on each slide and cell numbers of microorganisms were determined by
direct counting under an epiﬂuorescence microscope (Eclipse 400;
Nikon, Surrey, UK) with Fluor 100 lens. A total of 15 random ﬁelds of
view were counted for each well.
The oligonucleotide probes used and conditions for each one are
detailed in Table 1. These probes were selected to account for major
bacterial groups in the Actinobacteria (Bif164), Bacteroidetes (Bac303),
and Firmicutes (Lab158, Erec482, Chis150) phyla.
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2.5. Statistical analysis
Statistical analysis was performed using SPSS for Windows, version
23.0. One-way analysis of variance (ANOVA) and Tukey’s post hoc test
was used to determine signiﬁcant diﬀerences among the bacterial group
populations and organic acid concentrations among the diﬀerent sub-
strates. Diﬀerences were considered signiﬁcant at p < 0.05 (n=5).
3. Results and discussion
The yields of extraction of pectin from artichoke (22.1%) and sun-
ﬂower by-products (10.0%) were in line with those obtained for other
well-established sources of pectin, such as citrus peel (Kurita, Fujiwara,
& Yamazaki, 2008), lime peel (Dominiak et al., 2014), apple pomace
(Wikiera, Mika, Starzyńska-Janiszewska, & Stodolak, 2015) or passion
fruit peels (Liew, Chin, Yusof, & Sowndhararajan, 2016), suggesting
their potential use as renewable pectin sources.
3.1. Characterisation of pectin and enzymatic-modiﬁed pectin samples
Pectins from diﬀerent sources (that is, citrus, artichoke and sun-
ﬂower) and their enzymatic modiﬁed polysaccharides (modiﬁed pectin
(MP)) were evaluated in this study. Neutral sugars and GalA content,
average degree of methoxylation and average estimated Mw are in-
cluded in Table 2. The GalA:Rha ratio displayed in the table shows the
number of GalA residues per Rha residue, giving an indication of the
RG-I backbone respect to HG content. Thus, a lower value shows a
compound richer in RG-I chains. Ara:Rha and Gal:Rha ratios indicate
the number of neutral sugar residues attached to the RG-I backbone.
As expected, GalA was the major monosaccharide residue in all
pectic samples, ranging from 46.5% (w/w) to 88.1% (w/w). The lowest
values of GalA content were observed in those samples which had the
highest values of rhamnose content. In consequence, the GalA:Rha ratio
indicated that citrus MP, artichoke pectin, artichoke MP and citrus
pectin were the most enriched samples in RG-I as compared to sun-
ﬂower samples, which were the most enriched in HG structure ac-
cording to the monomeric composition (27.4 and 24.1 for GalA:Rha
ratio for sunﬂower pectin and sunﬂower MP, respectively). Instead,
artichoke pectin and MP presented high amounts of arabinose, sur-
passing rhamnose content, which could be indicative of a highly en-
riched structure in arabinan and arabinogalactan branches to the RG-I
chains. The amount of rhamnose and arabinose with respect to GalA
may also indicate the substitution of the rhamnogalacturonan
branching along the HG with arabinan and arabinogalactan structures
(Manderson et al., 2005; Yuliarti, Goh, Matia-Merino, Mawson, &
Brennan, 2015). The high content of arabinose and GalA determined in
artichoke samples support the data obtained in previous studies
(Femenia, Robertson, Waldron, & Selvendran, 1998; Sabater et al.,
2018). Galactose content in all samples was higher than other neutral
sugars, with the exception of arabinose in artichoke pectin, which may
also indicate the presence of galactose-based oligosaccharides branched
to the HG backbone. Xylose that can be present in more complex
structural features of pectin, such as RG-II regions or arabinoxylans and
xylogalacturonan (Maxwell, Belshaw, Waldron, & Morris, 2012),
ranged from 0.9% to 2.3%. Lastly, glucose (from 0.9% to 16.7%) and
mannose (from 0.1% to 2.4%) were found in all samples and they could
likely derive from non-pectic polysaccharides extracted in minor
amounts together the target pectins, such as xyloglucan, hemicellulose,
and/or cellulose (Sabater et al., 2018; Wang et al., 2016; Yapo, 2009).
In both artichoke samples the degree of methoxylation was the
Table 1
Oligonucleotide probes used in this study for FISH enumeration of bacteria.
Probe Speciﬁcity DNA Sequence (5’ to 3’) Temperature (°C) Reference
HB* WB*
Bac303 Most Bacteroidaceae and Prevotellaceae. some Porphyromonadaceae CCA ATG TGG GGG ACC TT 46 48 Manz, Amann, Ludwig, Vancanneyt, and
Schleifer, (1996)
Bif164 Biﬁdobacterium spp. CAT CCG GCATTA CCA CCC 50 50 Langendijk et al. (1995)
Chis150 Most of the Clostridium histolyticum group (Clostridium cluster I and
II)
TTA TGC GGT ATT AAT
CT(C/T) CCT TT
50 50 Franks et al. (1998)
Erec482 Most of the Clostridium coccoides-Eubacterium rectale group
(Clostridium cluster XIVa and XIVb)
GCTTCT TAGTCA (A/G)GT
ACC G
50 50 Franks et al. (1998)
Lab158 Lactobacillus; Enterococcus GGT ATT AGC A(C/T)C TGT
TTC CA
50 50 Harmsen, Elﬀerich, Schut, and Welling,
(1999)
*HB: hybridisation buﬀer; WB: washing buﬀer.
Table 2
Chemical characterisation of pectins and enzymatic-modiﬁed pectins from diﬀerent renewable bioresources.
Monosaccharide (%*)
Sample Xylose Arabinose Rhamnose Galactose Mannose Glucose Galacturonic acid Average
Mw (kDa)
GalA:Rha Ara:Rha Gal:Rha Average degree of
methoxylation
(%)
Citrus
Pectin
0.9 ± 0.0 3.5 ± 0.0 5.8 ± 0.0 20.2 ± 0.1 1.4 ± 0.0 1.8 ± 0.0 66.5 ± 0.2 800-100 11.52 0.61 3.50 70.7
Citrus MP 1.3 ± 0.2 3.7 ± 0.2 9.8 ± 0.1 14.0 ± 0.3 2.4 ± 0.3 13.3 ± 0.3 55.6 ± 0.6 12.0-10.0 5.70 0.38 1.44 14.2
Sunﬂower
Pectin
2.2 ± 0.1 1.1 ± 0.0 3.2 ± 0.4 4.3 ± 0.0 0.1 ± 0.0 0.9 ± 0.0 88.1 ± 0.9 800-100 27.39 0.35 1.35 45.7
Sunﬂower
MP
0.9 ± 0.0 2.3 ± 0.0 3.2 ± 0.1 12.2 ± 0.0 1.3 ± 0.0 1.8 ± 0.0 78.2 ± 0.5 12.5 24.13 0.71 3.77 17.0
Artichoke
Pectin
1.1 ± 0.1 18.9 ± 0.6 7.6 ± 0.1 8.2 ± 0.3 1.0 ± 0.3 16.7 ± 0.7 46.5 ± 0.6 > 500 6.13 2.50 1.09 8.9
Artichoke
MP
2.3 ± 0.2 10.7 ± 0.1 5.4 ± 0.0 21.1 ± 0.0 1.2 ± 0.0 3.9 ± 0.0 55.5 ± 0.8 300-80 10.34 1.99 3.94 8.5
Analysis were carried out at least in duplicate (n=2).
*Monosaccharide content (%) is referred regarding the total carbohydrate measured on each sample.
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lowest (8.9 and 8.5% for pectin and MP, respectively), whereas MP
samples from citrus and sunﬂower had moderately higher values (14.2
and 17.0%, respectively) and citrus and sunﬂower pectin had the
highest data of all samples with 70.7% and 45.7% of degree of meth-
oxylation, respectively. This behaviour could be ascribed to the pectin
methyl esterase activity of the enzyme employed to produce the cor-
responding MP.
On the other hand, all resulting MP showed a reduction of the Mw
as compared to their respective pectin due to the polygalacturonase
enzyme activity, which was concomitant with a decrease in GalA and
an increase in RG-I to HG. However, modiﬁed artichoke pectin showed
a decrease in arabinose which led to a higher relative content of GalA
compared to its parent pectin. The initial high content of arabinose
observed in artichoke pectin could be related to the resulting high Mw
of artichoke MP following enzymatic treatment. It is well known that
arabinose is present in pectin as arabinan side chains and, conse-
quently, a high degree of branching may create steric hindrance im-
pairing the eﬃcient cutting of the main chain composed by GalA. The
decrease in Mw was correlated to the diminution of degree of meth-
oxylation observed in citrus and sunﬂower samples. It is interesting to
note that citrus and sunﬂower MP exhibited a Mw of 10–12.5 kDa
which is in line with other modiﬁed pectins obtained from citrus
(1̴0 kDa) that have shown to be eﬀective supplements in the treatment
of cancer and other diseases (Morris et al., 2013). Artichoke MP showed
a small decrease in this parameter which is in accordance with its high
Mw, as shown in Fig. 1.
3.2. In vitro fermentation
3.2.1. Bacterial population changes during in vitro fermentation
Changes in the human faecal bacterial populations during the in
vitro fermentation with the diﬀerent pectins and enzymatic-modiﬁed
pectins after 24 h are shown in Table 3. A signiﬁcant increase
(p<0.05) of Biﬁdobacterium (Bif164) population for all carbohydrate
samples was observed after 24 h of fermentation. It is well known that
oligosaccharides deriving from pectins have biﬁdogenic activities,
however there are also studies that have demonstrated a biﬁdogenic
eﬀect in intact pectins suggesting a potential role of this polysaccharide
as a prebiotic (Gómez et al., 2016; Yang, Martínez, Walter,
Keshavarzian, & Rose, 2013). In our study, numerical increases up to
0.79–1.19 log10 in population were determined. Some authors indicated
that increments of 0.5–1.0 log10 in biﬁdobacteria could be considered
as a major shift in the gut microbiota towards a potentially healthier
composition of intestinal microbiota (Kolida & Gibson, 2007). Thus, all
pectic samples could be considered biﬁdogenic under the studied con-
ditions. Remarkably, artichoke MP was the substrate, which promoted
the signiﬁcantly highest growth in biﬁdobacteria among all assayed
samples, including positive controls as inulin and FOS which in turn
showed a similar biﬁdobacterial growth as compared to sunﬂower and
citrus samples. This fact could be attributed to the high combined
content of arabinose and galactose found in artichoke MP (Table 2)
according to previous studies reporting a correlation between arabinose
and galactose content with biﬁdogenic properties (Di et al., 2017;
Manderson et al., 2005; Onumpai et al., 2011). Moreover, a positive
eﬀect of the decrease of Mw in pectin on its ability to promote biﬁdo-
bacteria growth was observed for citrus and artichoke sources since
their MP derivatives exhibited a signiﬁcant (p < 0.05) increase as
compared to unmodiﬁed pectin (9.63 vs 9.42 log10 for citrus and 9.82
vs. 9.50 for artichoke), whereas sunﬂower pectin and MP presented a
statistically identical biﬁdogenic activity. Evidently, there was not any
signiﬁcant increase during fermentation of negative controls, con-
ﬁrming the suitability of these substrates as a carbon source for the
metabolism of biﬁdobacteria. The degree of methoxylation did not have
impact on the biﬁdogenic properties. More speciﬁcally, sunﬂower
samples had diﬀerent value of this parameter with the same biﬁdogenic
activity and artichoke samples had almost the same one with diﬀerent
biﬁdogenic activity.
The second highest increase (up to 0.56–0.93 log10) was observed in
Bacteroides/Prevotella (Bac303) population. This general increase is
explained by the fact that Bacteroides species are major carbohydrate-
degrading organisms in the gut and have the capacity to degrade di-
verse plant polysaccharides, including pectins (Dongowski, Lorenz, &
Anger, 2000; Flint, Scott, Duncan, Louis, & Forano, 2012; Onumpai
et al., 2011). Indeed, many Bacteroides strains from human faeces can
produce pectinolytic enzymes, including polygalacturonase and pectin
methylesterase (Dekker & Palmer, 1981; Jensen & Canale-Parola,
1986). Therefore, Bacteroides can be involved in cross-feeding with
Biﬁdobacteria by releasing breakdown products of pectin or MP which
might be utilised by the latter, thus, promoting their growth. Inulin,
FOS and artichoke MP samples exhibited the highest increase in
Table 3
Bacterial populations (log10 cells per ml) enumerated by FISH at 0 and 24 h of in vitro fermentation with Inulin, FOS, citrus pectin, citrus modiﬁed pectin (MP),
sunﬂower pectin, sunﬂower MP, artichoke pectin and artichoke MP.
Probe/Strain Time
point (h)
Bacterial concentration (log10 cells/mL)
Control Inulin FOS Citrus Pectin
800-100 kDa
Citrus MP 10.0
– 12.0 kDa
Sunﬂower Pectin
800-100 kDa
Sunﬂower MP
12.50 kDa
Artichoke Pectin
> 500 kDa
Artichoke MP
300-80 kDa
Bif164 0 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08) 8.63 (0.08)
24 8.75 (0.03)a 9.52
(0.15)bc,1
9.48
(0.05)bc,1
9.42 (0.06)b,1 9.63 (0.04)cd,1 9.72 (0.12)cd,1 9.74 (0.06)cd,1 9.50 (0.14)bc,1 9.82 (0.13)d,1
Bac303 0 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08) 8.46 (0.08)
24 8.59 (0.08)a 9.36
(0.05)ef,1
9.39
(0.04)f,1
9.05 (0.08)bc,1 9.06 (0.03)bc,1 9.02 (0.09)b,1 9.19 (0.07)cd,1 9.23 (0.11)de,1 9.45 (0.04)f,1
Lab158 0 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12) 8.35 (0.12)
24 8.38 (0.07)a 9.05
(0.04)de,1
8.98
(0.03)cd,1
8.65 (0.06)b,1 9.04 (0.03)d,1 9.05 (0.02)d,1 8.98 (0.09)cd,1 8.92 (0.05)c,1 9.17 (0.05)e,1
Erec482 0 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07) 8.50 (0.07)
24 8.51 (0.04)a 8.97
(0.11)bc,1
9.08
(0.11)c,1
9.02 (0.05)bc,1 9.06 (0.06)c,1 8.83 (0.11)b,1 8.97 (0.07)bc,1 8.95 (0.06)bc,1 9.01 (0.11)bc,1
Chis150 0 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05) 8.29 (0.05)
24 8.35 (0.04)a 8.77
(0.06)b,1
8.72
(0.03)b,1
8.70 (0.09)b,1 8.73 (0.03)b,1 8.77 (0.01)b,1 8.70 (0.02)b,1 8.72 (0.04)b,1 8.70 (0.06)b,1
A control sample without carbohydrate source is also included. Experiments were carried out in batch cultures systems inoculated with faecal inocula from ﬁve
healthy human donors. Results shown as mean (n=5) with the corresponding standard deviation in parentheses.
a.b.c Signiﬁcant diﬀerences (p < 0.05) between substrates are indicated with diﬀerent letters in the same row.
1 Signiﬁcant diﬀerence (p < 0.05) from the 0 h value for each bacterial group and for the same substrate.
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Bacteroides. With respect to the eﬀect of Mw on Bacteroides/Prevotella
growth, sunﬂower and artichoke MP demonstrated a signiﬁcantly
higher increase than their respective pectins. This diﬀerence could be
attributed to the galactan chains branched to the RG-I since Gal:Rha
ratio increased in both sunﬂower and artichoke MP after the enzymatic
hydrolysis.
A signiﬁcant increase in Lactobacillus/Enterococcus (Lab158) was
also observed for all tested carbohydrate samples, with the most sig-
niﬁcant increases found in inulin and artichoke MP. Similar to
Biﬁdobacterium, Lactobacillus is considered one of the major microbial
targets for prebiotic action due to their health eﬀects. The high incre-
ment in Lactobacillus/Enterococcus population following artichoke MP
fermentation further established the correlation of arabinose and ga-
lactose content with the prebiotic properties. Mw did not aﬀect sun-
ﬂower samples but it seemed to have an impact on citrus and artichoke
sources, in a similar manner to the behaviour observed for
Biﬁdobacterium selectivity.
Clostridium coccoides/Eubacterium rectale (Erec482) showed a sig-
niﬁcant increase in all tested samples but no signiﬁcant diﬀerences
were found among any of the carbohydrate substrates including inulin
and FOS. Increase in Eubacterium rectale is of particular interest due to
its ability to produce butyrate (Manderson et al., 2005). Di et al. (2017)
reported an increase of Erec482 numbers when testing a citrus MP of
similar Mw (9.2 kDa), although they did not ﬁnd a positive correlation
with the determined butyrate concentrations. In the same way, Chen
et al. (2013) reported enhanced Eubacteria growth on apple pectin
compared to the respective POS, suggesting that the Mw was not a
relevant factor. In our work, similar behaviour was observed since all
pectic samples resulted in a signiﬁcant stimulation of the butyrate
producing bacteria groups (Erec482) and no diﬀerences were found
between samples with diﬀerent Mw or origin.
Clostridium histolyticum (Chis150) population displayed the lowest
changes in all cases, leading to a rather moderate increase (lower than
0.5 log10) after 24 h of fermentation. No signiﬁcant diﬀerences among
any substrates were observed after fermentation. In general, Clostridium
species are considered as potentially harmful bacteria, so in this way,
all pectic samples induced a favourable behaviour.
3.2.2. Short-chain fatty acids (SCFA) production
Acetate, propionate, butyrate and total SCFA formation was ana-
lysed throughout the fermentation in batch cultures (Table 4). Total
SCFA concentration increased strongly during the ﬁrst 10 or 24 h of
fermentation in all tested substrates. In general terms, neither the de-
gree of methoxylation nor Mw of pectin samples had an inﬂuence on
the SCFA production, as reﬂected by the values contained in Table 4.
Acetate was the most abundant SCFA, followed by propionic and
butyric acids in all substrates. Formation of acetate has been related to
an enhancement of the ileal motility, a protection against genotoxic
agents and pathogens and an increase of colonic blood (Hong et al.,
2005). In our study, the only signiﬁcant diﬀerences found between
samples after 48 h of analysis were with artichoke and citrus MPs.
Results demonstrated a sharp increase of this compound in the ﬁrst 10 h
of fermentation. Although it is challenging to attribute a particular
fermentation end-product to a speciﬁc bacterial group in a mixed cul-
ture system, overall the increase in acetate is in agreement with the
dynamics of the microbial populations, since all samples promoted the
growth of Biﬁdobacterium and Lactobacillus (Table 3), which are acetate
producers. Additionally, these end-products may serve as substrates for
other bacteria due to metabolic cross-feeding (Belenguer et al., 2006).
Acetate is generated by many bacterial groups that inhabit the colon,
with approximately one-third of the product coming from reductive
acetogenesis (Miller & Wolin, 1996). In contrast, bacterial groups that
form propionate and butyrate are specialised and are of particular in-
terest in terms of their beneﬁcial eﬀects. The main propionate-produ-
cing bacteria in the human colon are Bacteroides and Clostridium
whereas butyrate production is related to bacterial groups such as
Clostridium histolyticum (clusters I, II, IV, XIVa, XV and XVI) and Eu-
bacterium rectale.
An increase in propionate concentration was seen in all samples
after 48 h of fermentation, whereas fermentation of inulin and FOS
resulted in the highest increase among all samples. Similarly to acetate,
the high variability found among the ﬁve donors meant that propionate
diﬀerences between all samples were not considered statistically sig-
niﬁcant (p>0.05) during the ﬁrst 24 h of fermentation. However, the
increase in this end-product is in good agreement with the increase in
Bacteroides population displayed in Table 3. Propionate has also been
shown to exert beneﬁcial eﬀects on host health, such as reduction of
food intake and enhancement of satiety via augmentation of the satiety
hormone leptin (Zeng, 2014), and a protective role against carcino-
genesis through the decrease in human colon cancer cell growth via
hyperacetylation of histone proteins and stimulation of apoptosis
(Hinnebusch, Meng, Wu, Archer, & Hodin, 2002; Jan et al., 2002).
Butyrate production resulted in a signiﬁcant increase in all samples
after 24 h of fermentation. FOS and inulin showed the highest increase
after 48 h of fermentation, although non-signiﬁcant diﬀerences were
observed among all substrates due to the high inter-individual varia-
bility (Table 4). The low but signiﬁcant increase in butyrate levels are
in accordance with the increase of Erec482 and Chis150 numbers which
also include some of the major butyrate-produces (Eubacterium rectale
and Clostridium histolyticum). Although acetate, propionate and butyrate
are all metabolised to some extent by the epithelium to provide energy,
butyrate plays a critical role in maintaining colonic health and mod-
erating cell growth (Zeng, 2014). Compared to acetate and propionate,
butyrate exhibits strong anti-inﬂammatory properties, likely mediated
by inhibition of TNF-α production, NF-κB activation, and IL-8, -10, -12
expression in immune and colonic epithelial cells and a protective role
against colon cancer (Bailón et al., 2010; Zeng, 2014).
4. Conclusions
Findings in this work highlight the suitability of artichoke and
sunﬂower by-products as renewable sources of bioactive pectic com-
pounds since the reported yields were within the range observed for
other well-established pectin sources. To the best of our knowledge, this
is the ﬁrst evidence of prebiotic potential of pectic compounds from
sunﬂower and artichoke and also supports the important role played by
the arabinose-rich rhamnogalacturonic acids in stimulating
Biﬁdobacteria. A positive eﬀect of decreasing molecular weight on fer-
mentation properties was found in artichoke and citrus sources since
their respective enzymatically-modiﬁed pectins promoted signiﬁcantly
higher growth in Biﬁdobacterium and Lactobacillus than the corre-
sponding unmodiﬁed pectin. In the case of sunﬂower, this behaviour
was only observed in Bacteroides/Prevotella, which also grew to sig-
niﬁcantly higher population levels on artichoke MP as compared to the
unmodiﬁed pectin. No signiﬁcant eﬀects of the Mw of pectin samples on
SCFA production were observed, although this could be due to the high
inter-individual variability observed in acetate, propionate and buty-
rate formation. Likewise, the degree of methoxylation did not have any
signiﬁcant impact on the fermentability nor SCFA production, regard-
less the origin of the pectic compounds.
To conclude, although further in vivo studies should be conducted,
our data reveal that either pectin or enzymatically-modiﬁed pectin from
sunﬂower and artichoke by-products might be considered as eﬃcient
prebiotic candidates for human consumption showing similar ability to
promote the in vitro growth of beneﬁcial gut bacteria as Biﬁdobacterium
and Lactobacillus in comparison to well-recognized prebiotics as inulin
and FOS.
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A B S T R A C T
The behaviour of citrus pectin during digestion and its potential prebiotic properties were examined using a
Dynamic Gastrointestinal Simulator (simgi®) model for the human gut, which simulates processes in the sto-
mach, small intestine, ascending, transverse and descending colon. A remarkable non-digestibility of pectin in
the upper gastrointestinal tract was observed by HPLC-ELSD analysis, where ∼88% of citrus pectin remained
intact during its transit through the stomach and small intestine. Fermentation of pectin stimulated the growth of
beneﬁcial bacteria such as Biﬁdobacterium spp, Bacteroides spp and Faecalobacterium prausnitzii. High increases of
short-chain fatty acids (SCFA) were observed, especially in acetate and butyrate concentration due to direct
fermentation of pectin or by cross-feeding interaction between bacteria. This is the ﬁrst study on the digestibility
and fermentation of pectin carried out in a complex dynamic gastrointestinal simulator, being of special re-
levance the results obtained for F. prausnitzii.
1. Introduction
Pectins are a family of plant cell wall polysaccharides with glycan
domains that contain galacturonic acid (GalA) units with α-1,4 lin-
kages. It mainly consists of a GalA-rich backbone, known as homo-
galacturonan (HG ≈ 65%), of which a number of residues are methyl
esteriﬁed at the C-6 position, thereby conferring a speciﬁc degree of
methoxylation (DM) to the polymer. This parameter and its distribution
pattern deﬁne the charge distribution over the polymer playing a major
role in the dimerization of pectin chains through the formation of
junction zones, either via cooperative Ca2+ complexation or at reduced
water activity as well as pH, thus deﬁning the gelation properties of
pectin (Dongowski, Lorenz, & Proll, 2002; Fraeye, Duvetter, Doungla,
Van Loey, & Hendrickx, 2010). Furthermore, rhamnose residues inter-
rupt the HG structure to form rhamnogalacturonan I (RG-I≈ 20–35%)
which is based on a backbone consisting of a repeating disaccharide of
[→2)-α-L-Rhap-(1→4)-α-D-GalAp-(1→] residues. RG-I has a number of
side chains attached to its backbone and the length of these chains can
vary from single glycosyl to polymeric side chains of diﬀerent types
(1→5)-α-L-arabinans, (1→4)-β-D-galactans, arabinogalactans-I, arabi-
nogalactans-II (Buﬀetto et al., 2015). RG-II constitutes ≈ 2–10% of
pectin and is the most complex part of pectin, it has a HG backbone
branched with rhamnose and other minor sugars such as fucose, glu-
curonic acid, methyl-esteriﬁed glucuronic acid, apiose, 2-O-methylxy-
lose, and 2-O-methylfucose (Holck, Hotchkiss, Meyer, Mikkelsen, &
Rastall, 2014; Lara-Espinoza, Carvajal-Millán, Balandrán-Quintana,
López-Franco, & Rascón-Chu, 2018; Noreen et al., 2017). The suitability
of pectins for speciﬁc applications is governed by the structural fea-
tures, including molecular weight (Mw), neutral sugar content, pro-
portion of HG:RG-I regions or the DM(Ferreira-Lazarte, Kachrimanidou,
Villamiel, Rastall, & Moreno, 2018; Sila, Van Buggenhout, Duvetter,
Van Loey, & Hendrickx, 2009). These factors can aﬀect their applic-
ability as thickeners or as gelling and stabilizing agents (Gullón et al.,
2013).
Pectins, as other dietary ﬁbers, are believed to be resilient to di-
gestion reaching the hindgut where they are fermented by the colonic
microbiota (Lunn & Buttriss, 2007). However, before they reach the
colon, these heteropolysaccharides are subjected to the singular luminal
environment of the upper digestive tract that can contribute to che-
mical and physicochemical changes aﬀecting the rate and extent of the
fermentation in the colon (Hoebler, Guillon, Fardet, Cherbut, & Barry,
1998). The intestinal degradation of pectin has been studied with
substantially dissimilar results. In studies involving human subjects,
Chinda et al. (2003) and Saito et al. (2005) as well as Holloway,
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Tasman-Jones, and Maher, (1983) observed that around 90% and
60–85% of apple and citrus pectin, respectively, reached the terminal
ileum but the procedures to evaluate total pectin were not robust en-
ough to identify the possible structural and physical changes that take
place.
However, the capability of pectins to be fermented by the intestinal
microbiota it is well known, being the arabino- and galacto-oligo-
saccharides content one of the most important factors, even more re-
levant than Mw (Di et al., 2017; Onumpai, Kolida, Bonnin, & Rastall,
2011). In this sense, there are some investigations that report a better
biﬁdogenic eﬀect, which means a growth of Biﬁdobacteria population,
of pectins and pectic-polysaccharides with higher arabino- and galacto-
oligosaccharides content, over modiﬁed pectin and pectic-oligo-
saccharides (POS) with lower Mw (Di et al., 2017; Ferreira-Lazarte
et al., 2018).
Most of these studies are in vitro and often restricted to faecal
samples, since in vivo investigations with animals and human trials have
various drawbacks, such as high costs, ethical constraints, inter-in-
dividual variations and limitations in sampling from the small and large
bowel (Venema & Van Den Abbeele, 2013; Verhoeckx et al., 2015).
Nonetheless, even if they have limitations based on the absence of a
physiological host environment, in vitro models are reproducible, since
they allow better control of the experimental variables than animal or
human studies. In general, they are rapid and simple methods and,
therefore, relatively inexpensive and cost-eﬀective. Furthermore, they
allow a reduction of the samples size when this is a limiting factor
(Verhoeckx et al., 2015).
Therefore, several in vitro models have been developed to simulate
the multistage processes of human gastrointestinal digestion (Alminger
et al., 2014; Cascone et al., 2016; Hur, Lim, Decker, & McClements,
2011; Marzorati et al., 2011; Verhoeckx et al., 2015). Among all these
models, complex multi-compartmental continuous systems overcome
the limitations present on static models, which do not reproduce the
dynamic environment of the GIT (e.g. pH changes, peristaltic move-
ments, gastric emptying, continuous changes, and secretion ﬂow rates)
(Ouwehand & Vaughan, 2006). Nowadays, dynamic gastrointestinal
digestion simulators are still limited. The SIMulator Gastro-Intestinal
(simgi®, Madrid, Spain) (Barroso, Cueva, Peláez, Martínez-Cuesta, &
Requena, 2015) comprises ﬁve diﬀerent compartments system, which
simulates the diﬀerent regions of the GIT such as, stomach (ST), small
intestine (SI) and three compartments simulating the ascending (AC),
transverse (TC) and descending (DC) regions of the human colon. The
simgi® represents a fully computer controlled multi-compartmental
system, which allows joint or separated simulation of the gastric and
colonic fermentative processes. Thus, this is a ﬂexible modulating
system that combines a gastric compartment that simulates peristaltic
mixing movements, a reactor simulating the small intestine and three-
stage continuous reactors for reproducing the colon region-speciﬁc
microbiota and its metabolism (Barroso et al., 2015).
Therefore, the aim of the present study was to examine the in vitro
gastrointestinal digestion of a commercial citrus pectin using the
Dynamic Gastrointestinal Simulator (simgi®), and its impact on the
subsequent fermentation by the colonic microbiota.
2. Materials and methods
2.1. Samples of pectin
Commercial citrus pectin (trade name Ceampectin®, ESS-4400) was
kindly provided by CEAMSA (Porriño, Pontevedra, Spain). Galacturonic
acid (GalA) content, degree of methoxylation (DM), molecular weight
(Mw) and neutral sugar content of the tested pectin were described in a
previous study in our laboratory (Muñoz-Labrador, Moreno, Villamiel,
& Montilla, 2018) (Table S1, Supplementary material).
2.2. simgi® model assays digestion
The dynamic gastrointestinal simulator simgi® was used in the op-
erating mode to work with the ﬁve units simulating the stomach (ST),
small intestine (SI) and the ascending (AC), transverse (TC) and des-
cending colon (DC) regions (Barroso et al., 2015). Fig. 1 shows the
experimental protocol of the simgi® trial. The operation of the dynamic
model was validated and optimized in previous studies (Barroso et al.,
2015; Barroso et al., 2016; Cueva et al., 2015). Faecal slurry was ob-
tained from a healthy volunteer who had no received any antibiotic
treatment in the previous 3 months of the experiment. Then, faecal
samples were diluted (20% w/w) in sterilised phosphate-buﬀered saline
(PBS; 0.1 mol/L, pH 7.0, Oxoid, Basingstoke, UK) containing 1 g/L so-
dium thioglycolate as reduced agent. The nutritive medium was
adapted from the studies mentioned before and it was constituted by
potato starch (Difco™, BD) (7 g/L), glucose (Difco™, BD) (0.4 g/L), yeast
extract (Oxoid, ThermoFisher Scientiﬁc) (3 g/L), special peptone
(Oxoid, ThermoFisher Scientiﬁc) (1 g/L), mucin from porcine stomach
(Sigma-Aldrich, Merk) (4 g/L) and L-cysteine (Panreac AppliChem)
(0.5 g/L). All compounds were dissolved in 1 L of distilled water and
sterilized at 121 °C for 21min with a ﬁnal pH of 6.0.
The ascending, transverse and descending colon compartments were
ﬁlled and pre-conditioned with the nutritive medium that feed the
system during the stabilization period; 250mL (AC), 400mL (TC) and
300mL (DC) of nutritive medium were added and later inoculated with
20mL of fresh faecal slurry (20% w/v).
A stabilisation period of 12 days was applied to allow the intestinal
microbiota to adapt to environmental conditions present in the colon
compartments and to form a stable microbial community (Barroso
et al., 2015). This stabilisation was approached by feeding the small
intestine with nutritive medium (75mL, pH 2) mixed with pancreatic
juice (40mL of a solution of 12 g/L NaHCO3 (VWR Chemicals), 6 g/L
oxgall dehydrated fresh bile (Difco™, BD) and 0.9 g/L porcine pan-
creatin (Sigma-aldrich) three times a day during 12 days (Van Den
Abbeele et al., 2010). After stabilisation period of the colonic micro-
biota, the simgi® was subjected to a 2-week experiment, which con-
sisted of adding 240mL of the commercial citrus pectin per day (3 doses
of 80mL) dissolved in the feeding nutritive medium (30 g/L, pH 3.1).
This sample was added directly to the stomach during 14 days, where it
was mixed with gastric electrolytes and pepsin by the simulated peri-
staltic moves, controlling the decrease of pH by adding 0.5M HCl. After
stomach digestion, stomach content was automatically transferred to
the small intestine vessel where digestion was performed during 2 h at
37 °C (pH=7.0). Then, this content was transferred to the following
compartment (AC) at a ﬂow rate of 5mL/min, which simultaneously
Fig. 1. Schematic representation of the experimental protocol of
the simgi® trial developed to assess the gastrointestinal digestion
and fermentation properties of citrus pectin (30 g/L in nutritive
medium).
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activated the transit of colonic content between the AC, TC and DC
compartments at the same ﬂow rate. The temperature (37 °C), con-
tinuous ﬂushing of nitrogen and pH were continuously controlled by
the system. pH in the colonic units was controlled by addition of 0.5 M
NaOH and 0.5M HCl to keep values of 5.6 ± 0.2 in the AC, 6.3 ± 0.2
in the TC and 6.8 ± 0.2 in the DC. Finally, a 1-week washout period
was included at the end of the experiment by feeding the simgi® daily
with nutritive medium. During the whole study, samples were collected
every day at regular time points from the three colon vessels: During
stabilisation period (<Day 13, and immediately prior to pectin feeding
(Day 13*), during pectin feeding period, samples were also taken in
stomach and small intestine compartments (Day 13–27) and after the
beginning of washout period (Day 27–34). Finally, all collected samples
were immediately centrifuged at 10,000 rpm for 10min at 4 °C. Su-
pernatants were aliquoted and stored at – 20 °C until being analysed for
short-chain fatty acids (SCFA), ammonium and Mw estimation of the
tested pectin. Microbial plate count analyses were performed at the
time of the sample collection. Pellets were stored at – 80 °C until further
analysis of total bacteria and main bacterial groups by qPCR.
2.3. Estimation of the molecular weight (Mw) of pectin
The estimation and monitoring of Mw of pectin samples during the
gastrointestinal digestion with the simgi® was carried out by Size
Exclusion Chromatography (SEC), according to the method described
by Muñoz-Almagro, Rico-Rodriguez, Villamiel, and Montilla, (2018).
Analysis was carried out on a LC Agilent Technologies 1220 Inﬁnity LC
System 1260 (Agilent Technologies, Boeblingen, Germain), equipped
with two consecutive TSK-GEL columns (G5000 PWXL. 7.8 x 300mm,
particle size 10 μm, G2500 PWXL, 7.8 x 300mm, particle size 6 μm;
Tosoh Bioscience, Stuttgart, Germany). Centrifuged samples from the
diﬀerent compartments were ﬁrst diluted before HPLC analysis: 1/10,
1/4 and 1/2 in HPLC water for ST, SI and AC, TC, DC compartments,
respectively. Diluted samples were ﬁltered and eluted (20 μL) with
0.1 M NH₄CH₃CO₂ at a ﬂow rate of 0.5mL/min for 80min at 30 °C. The
eluent was monitored with an Evaporative Light Scattering Detector
(ELSD) (Boeblingen, Germain) at 30 °C. Pullulans of Mw 805, 200, 10, 3
and 0.3 kDa were used as standards to calibration. All Mw values spe-
ciﬁed were weight-average.
2.4. Short-chain fatty acids (SCFA) analysis
SCFA analysis was performed by liquid chromatography using a UV-
975 detector following the method described by Sanz et al. (2005).
Brieﬂy, samples from the diﬀerent colon compartments (AC, TC and
DC) were ﬁltered and injected on a HPLC system (Agilent Technologies,
Germany) equipped with a UV-975 detector and automatic injector.
SCFA were separated using a Rezex ROA Organic Acids column
(300 x 7.8mm) (Phenomenex, Macclesﬁeld, UK) thermostated at 50 °C.
Mobile phase was sulphuric acid 0.005mM in HPLC grade water at a
ﬂow rate of 0.5mL/min under isocratic elution. The elution proﬁle was
monitored at 210 nm and peaks were compared to standards to be
identiﬁed. Data acquisition and integration were done using Agilent
ChemStation software (Wilmington, DE, USA). Calibration curves of all
SCFA were obtained from the analysis of standard solutions of lactic,
formic, acetic, propionic, butyric, valeric and isovaleric acid, ranging
the concentrations of 1–100mM.
2.5. Ammonium determination
Ammonium levels were determined using the Ammonium test
(Spectroquant Ammonium Test, Merck), following the manufacturer’s
instructions. Brieﬂy, serial dilutions of an ammonium standard solution
(10 g/L) were used to prepare calibration curves. simgi® samples were
diluted with deionized water (1:10). Just prior to performing the
measurement at 25 °C, 5mL of reactive NH4-1 and reactive NH4-2 were
added to the diluted standards or samples. The mixture was shaken
between each reagent addition. Then, the absorbance was quantiﬁed at
690 nm. Analyses were performed in duplicate. The results were ex-
pressed as mg of NH4+ contained in each colon compartment.
2.6. Microbial analyses
2.6.1. Plate counts
Collected samples from the diﬀerent colon compartments were di-
luted (1/10) in a physiological solution (0.9%) and were plated on eight
types of genera and selective media as follows: Tryptic Soy Agar (TSA)
(Becton and Dickson & Company, BD) for total aerobes; Wilkins-
Chalgren agar (BD) for total anaerobes; MacConkey agar (BD) for
Enterobacteriaceae; Enterococcus agar (BD) for Enterococcus spp.; MRS
agar (Pronadisa) for lactic acid bacteria and Tryptose Sulﬁte
Cycloserine agar (TSC) (Pronadisa) for Clostridium spp. Plates were in-
cubated at 37 °C for 24–48 h in an anaerobic chamber (BACTRON
Anaerobic/Environmental Chamber, SHELLAB, USA), except for TSA
which was incubated in aerobic conditions (Nüve Incubator EN 120,
NÜVE, Turkey).
2.6.2. Bacterial DNA extraction and quantitative polymerase chain reaction
(qPCR)
Bacterial DNA extraction of pellets from AC, TC and DC compart-
ments was performed using a QIAamp DNA Stool Mini Kit (Qiagen,
Hilden, Germany), following the manufacturer’s recommended pro-
tocol. Extracted DNA of all samples was stored at -80 °C until analysis.
The ampliﬁcation and detection of bacterial DNA was carried out on
a ViiA7 Real-Time PCR System (Applied Biosystems). Speciﬁc 16 s
rRNA-targeting primers were used in this study to determine total
bacteria, Bacteroides spp, Biﬁdobacterium spp, Enterobacteriaceae,
Enterococcaceae, Lactobacillus spp, Faecalibacterium prausnitzii and the
Clostridium cluster XIVa. Reactions were done in triplicate in 384-well
plates using SYBR® Green PCR Master Mix (Applied Biosystems). Final
volume of each ampliﬁcation reaction was 10 μL: 5 μL of SYBR® Green,
0.3 μL of each primer (10 μM), 3.4 μL of nuclease-free water puriﬁed for
PCR (Sigma-Aldrich) and 1 μL of DNA template. Thermal cycling con-
sisted of an initial cycle of 95 °C, 3min, followed by 40 cycles of 95 °C,
15 s and 1min at the appropriate primer-pair temperature (Gil-Sánchez
et al., 2017). In order to quantify bacterial groups, DNA isolated from
selected bacterial strains was used, Bacteroides fragilis for Bacteroides,
Biﬁdobacterium longum for Biﬁdobacterium, Blautia coccoides for Clos-
tridia XIVa, F. prausnitzi for Faecalobacterium prausnitzi, Escherichia coli
for Enterobacteriaceae, Enterococcus falcium for Enterococcaceae, Lacto-
bacillus plantarum for Lactobacillus and B. fragilis for total bacteria.
Standard curves were generated by plotting threshold cycles (CT) vs.
bacterial quantity expressed as colony-forming units (CFU)/mL.
2.7. Statistical analysis
Statistical analysis was performed using SPSS for Windows, version
23.0. One-way analysis of variance (ANOVA) and Tukey’s post hoc test
was used to determine signiﬁcant diﬀerences among the bacterial group
populations obtained after the qPCR analysis and organic acid con-
centrations to test the main eﬀects of factors studied (time, pectin
feeding, compartment). Diﬀerences were considered signiﬁcant at
p < 0.05 (n = 3).
3. Results
Characterisation results showed GalA as the main component with
66.5 ± 0.2% of the total carbohydrates; galactose was the second main
component with 20.2 ± 0.1% and rhamnose and arabinose were pre-
sent with 5.8 and 3.5%, respectively. Glucose, mannose and xylose
were also determined in minor values, 1.8, 1.4 and 0.9%, respectively.
Interval of Mw and DM of pectin were determined as 100–800 kDa
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(average 350 ± 30 kDa) and 70.7%, respectively (Ferreira-Lazarte
et al., 2018).
3.1. Eﬀect of digestion and fermentation on pectin molecular weight
The behaviour of pectin during the chronic feeding period (Fig. 1)
was evaluated by monitoring the Mw during its passage through the
diﬀerent compartments (ST, SI, AC, TC and DC). Table 1 shows the
quantitative results obtained by SEC-ELSD determination. Analyses
were carried out just before starting the feeding period at day 13 (re-
presenting the nutritive medium), and three days during the chronic
feeding (Day 15, 24 and 27) as well as the last day of the washout
period (Day 34). Results showed a high average Mw for citrus pectin
(350 ± 30 kDa) which represented almost 54% of total content when
mixed with nutritive medium, whereas the latter was mainly con-
stituted of low Mw carbohydrates (< 18 kDa). Values at Day 13* (be-
fore feeding with citrus pectin) showed almost no changes between all
compartments. During the chronic feeding, pectin showed no changes
in the stomach compartment when compared to the intact pectin (be-
fore feeding the system), whereas a slight decrease can be observed
after the small intestine passage, showing a high resistance of citrus
pectin to the upper gastrointestinal digestion. However, fermentation in
the three
diﬀerent sections of colon gave rise to a remarkable eﬀect on pectin
Mw. At this stage, it can be seen the presence of a new chromatographic
peak of lower Mw (40 ± 5 kDa) than the peak corresponding to the
intact pectin (350 ± 30 kDa), as well as an increase in the abundance
of the peak including low Mw carbohydrates (< 18 kDa), probably due
to the fermentation of pectin (Fig. 2). Lastly, washout period showed
almost no presence of any carbohydrates since feeding with nutritive
medium/pectin was substituted with only nutritive medium (Table 1).
3.2. Evolution of the microbial community
The computer-controlled multicompartmental dynamic gastro-
intestinal model used in this study, allowed us to monitoring the gas-
trointestinal digestion and fermentation in the diﬀerent compartments/
sections due to its capability to simulate in vitro the microbial condi-
tions that characterize the diﬀerent regions of the gut.
3.2.1. qPCR analysis
Given that important modiﬁcations in the HPLC proﬁles of pectin
were found together with slight trends observed by the plate counts
(Table 2S, Supplementary material), a qPCR analysis was done at the
last day of each period in the AC, TC and DC compartments in order to
better assess changes in the microbial population during the in vitro
fermentation of citrus pectin (Table 2). In general, higher amounts of
bacteria were obtained with qPCR as compared with plate counts,
which is in consonance with the fact that only a small fraction of the
range of gut bacterial groups found had been, up to now, cultured
(Zoetendal, Vaughan, & De Vos, 2006). The rest of bacteria were often
labelled as “unculturable” due to the generally fastidious anaerobic
growth requirements (Allen-Vercoe, 2013). Counts oftotal bacteria
group were about 9.5 log copy number/mL at the end of stabilisation
period and increased signiﬁcantly (p<0.05) after citrus pectin feeding
in AC and TC whereas in DC a lower and non-signiﬁcant increase (p>
0.05) was determined. In addition, a decrease was observed in all
compartments after washout period.
Among all bacterial groups that were studied, a huge and signiﬁcant
increase in counts of Biﬁdobacterium spp, Bacteroides spp, F. prausnitzii
and Enterobacteriaceae was observed after the feeding with the citrus
pectin in all colon sections with the exception of Enterobacteriaceae in
TC. Furthermore, an overall and statistically signiﬁcant decrease was
found after the washout period, with some exceptions (i.e., Bacteroides
spp in AC, or Enterobacteriaceae in all colon sections). In contrast, a
decrease in Lactobacillus spp (in all colon sections) and Enterococaceae
Table 1
Eﬀect of the gastrointestinal digestion (simgi®) on the estimation and distribution of Mw (Average Mw) of the studied pectin (3%, w/v).
Concentration of carbohydrate fraction (%)
Sample/Day Compartment 350 ± 30 kDa 40 ± 5 kDa < 18 kDa
Medium – – 6.0 ± 1.5 94.0 ± 0.0
Medium+Pectin – 53.6 ± 1.2 – 46.4 ± 0.0
Day 13* ST – 5.7 ± 0.5 94.2 ± 0.1
SI – 6.9 ± 0.1 93.0 ± 0.3
AC – 5.0 ± 0.2 94.9 ± 0.2
TC – 4.2 ± 0.1 95.8 ± 0.1
DC – 4.3 ± 0.0 95.5 ± 0.0
Day 15 ST 56.6 ± 0.6 – 42.8 ± 0.9
SI 52.9 ± 0.4 – 46.7 ± 0.5
AC 8.5 ± 0.6 15.1 ± 0.8 75.8 ± 0.6
TC 9.5 ± 0.2 4.8 ± 0.1 85.2 ± 0.3
DC 9.8 ± 0.1 4.6 ± 0.1 85.1 ± 0.1
Day 24 ST 56.5 ± 1.5 – 42.0 ± 0.3
SI 47.6 ± 0.3 – 55.9 ± 0.7
AC 5.4 ± 0.1 17.2 ± 0.9 76.9 ± 0.1
TC 4.8 ± 0.4 3.5 ± 0.0 91.4 ± 0.5
DC 4.7 ± 0.2 2.2 ± 0.0 92.8 ± 0.3
Day 27 ST 55.8 ± 0.9 – 43.5 ± 0.2
SI 47.7 ± 0.8 – 55.7 ± 0.6
AC 1.9 ± 0.0 17.7 ± 0.6 79.7 ± 0.1
TC 0.6 ± 0.0 3.7 ± 0.1 95.5 ± 0.1
DC 0.5 ± 0.0 2.5 ± 0.0 96.8 ± 0.0
Day 34 ST 9.8 ± 0.0 – 89.7 ± 0.4
SI 7.0 ± 0.1 – 92.8 ± 0.7
AC 4.0 ± 0.0 – 95.8 ± 0.6
TC 3.9 ± 0.0 – 96.0 ± 0.2
DC 2.0 ± 0.0 – 98.0 ± 0.0
Data are expressed as the mean ± SD (n= 2).
*Sample taken before feeding with citrus pectin.
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(in TC) was also observed after the feeding period with pectin. These
values increased during the washout period for Enterococaceae whereas
did not present any changes in Lactobacillus spp.
Finally, it should be pointed out that Clostridia XIVa group was also
determined showing no changes in all compartments between stabili-
sation, chronic and washout period (data not shown).
3.3. Metabolic activity
The metabolic activity of the microbiota before, during and after
feeding with pectin in the diﬀerent colonic reactors of the simgi® was
evaluated by monitoring the content of SCFA (fermentative metabo-
lism) and of ammonium (proteolytic metabolism).
Fig. 2. Qualitative evolution of citrus pectin (Mw distribution) in the ﬁve compartments (Stomach (dilution 1/10), Small Intestine (1/4), Ascending Colon (1/2),
Transverse Colon (1/2) and Descending Colon (1/2)) during feeding of the dynamic simulator of the gastrointestinal tract (simgi®).
Table 2
Mean values (n=3) of the qPCR data as copy number/mL for the microbial groups analysed in the ascending (AC), transverse (TC) and descending colon (DC) of the
dynamic gastrointestinal model (simgi®) at the end of stabilization period (day 13), chronic intake (day 27) and washout period (day 34) with citrus pectin. Values in
brackets represents the data as the log10 of copy number/mL.
Bacteria group Compartment Stabilisation period Chronic intake period Washout period
Day 13* Day 27 Day 34
Total bacteria AC 3.1× 109 (9.49 ± 0.05)a 6.6× 109 (9.82 ± 0.02)c 4.8× 109 (9.68 ± 0.04)b
TC 3.4× 109 (9.50 ± 0.23)a 1.5× 1010 (10.16 ± 0.01)b 3.0× 109 (9.48 ± 0.06)a
DC 2.7× 109 (9.43 ± 0.01)a 3.9× 109 (9.59 ± 0.02)a 1.6× 109 (9.14 ± 0.33)a
Lactobacillus AC 1.8× 105 (5.24 ± 0.13)b ≤104 (≤ 4)a ≤104 (≤ 4)a
TC 6.7× 105 (5.79 ± 0.24)b ≤104 (≤ 4)a ≤104 (≤ 4)a
DC 3.6× 105 (5.53 ± 0.18)b 2.8× 104 (4.39 ± 0.28)a 1.5× 104 (4.03 ± 0.48)a
Biﬁdobacterium AC 2.8× 105 (5.44 ± 0.04)a 3.7× 108 (8.56 ± 0.06)c 2.8× 106 (6.43 ± 0.13)b
TC 7.6× 105 (5.87 ± 0.14)a 1.1× 108 (8.02 ± 0.09)c 6.0× 106 (6.77 ± 0.05)b
DC 3.2× 105 (5.50 ± 0.07)a 3.4× 108 (8.54 ± 0.02)c 9.6× 106 (6.98 ± 0.02)b
Bacteroides AC 2.8× 108 (8.45 ± 0.08)a 1.7× 109 (9.24 ± 0.01)b 1.5× 109 (9.18 ± 0.02)b
TC 7.0× 108 (8.85 ± 0.01)a 4.4× 109 (9.64 ± 0.03)b 6.2× 108 (8.79 ± 0.07)a
DC 3.4× 108 (8.53 ± 0.05)a 8.5× 109 (8.93 ± 0.02)c 5.0× 108 (8.70 ± 0.02)b
Faecalobacterium AC ≤105 (≤ 5)a 2.8× 107 (7.43 ± 0.14)b ≤105 (≤ 5)a
prausnitzii TC ≤105 (≤ 5)a 1.3× 108 (8.08 ± 0.18)b ≤105 (≤ 5)a
DC ≤105 (≤ 5)a 1.6× 107 (7.17 ± 0.21)b 1.1× 105 (5.05 ± 0.10)a
Enterococaceae AC ≤104 (≤ 4)a 4.9× 105 (5.68 0.06)b ≤104 (≤ 4)a
TC 6.8× 106 (6.83 ± 0.05)b 1.8× 104 (4.19 0.28)a 2.5× 106 (6.40 0.02)b
DC 1.1× 106 (6.05 ± 0.04)a 3.2× 105 (5.50 0.03)a 6.4× 105 (5.69 0.45)a
Enterobacteriaceae AC 9.5× 106 (6.98 ± 0.02)a 4.6× 108 (8.66 ± 0.03)b 3.6× 108 (8.55 ± 0.07)b
TC 2.1× 108 (8.32 ± 0.08)ab 1.7× 108 (8.21 ± 0.19)a 4.1× 108 (8.60 ± 0.07)b
DC 5.6× 107 (7.70 ± 0.24)a 1.9× 108 (8.23 ± 0.25)b 2.3× 108 (8.37 ± 0.02)b
a,b,c Signiﬁcant diﬀerences (p < 0.05, ANOVA) were determined for log10 values (in brackets) for the same bacterial group. Letters represent signiﬁcant diﬀerences
between days for the same compartment in each bacterial group.
*Sample taken before feeding with citrus pectin.
Standard deviation values are in brackets.
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3.3.1. Ammonium determination
Evolution of ammonia during the simulation of the gastrointestinal
digestion in the three colon compartments is shown in Fig. 3. A slight
but signiﬁcant decrease (p< 0.05) in ammonium concentration is
observed during the feeding with the citrus pectin, as compared with
stabilisation and washout periods. Also, as it has been observed in
previous studies with the same system (simgi®) (Barroso et al., 2015;
Barroso et al., 2016; Gil-Sánchez et al., 2017), ammonium concentra-
tion gradually increased from AC to the DC compartment because of the
accumulation of products in the system, which lacks of any absorption
steps between the diﬀerent compartments. These values showed that
proteolytic metabolism occurred through the entire colon compart-
ments during the whole experiment, but it was substantially diminished
during the chronic feeding period with citrus pectin.
3.3.2. Short-chain fatty acid (SCFA) analysis
The major end-products of indigestible carbohydrates metabolism
by the colonic microbiota are SCFA. SCFA evolution (mM) during the
stabilisation period, chronic feeding of citrus pectin and washout period
is shown in Fig. 4. SCFA concentrations presented no changes during
the stabilisation period in all three compartments. During the chronic
feeding with pectin these levels showed a signiﬁcant increase in all
major SCFA (acetate, propionate and butyrate) which decreased after
elimination of nutritive medium/pectin administration. As expected,
SCFA production consisted mainly of acetate, butyrate and propionate
with small amounts of lactate and valerate in all compartments. Acetate
was the most abundant SCFA, followed by butyric and propionic acid,
showing increases up to 297, 92 and 60%, respectively, after chronic
feeding, as compared to the initial levels (Day 13). Afterwards, they
showed a
considerable decrease during washout period started. Overall, the
total SCFA average molar production was compartment-dependent,
being higher in the transverse and descending colon. Regarding minor
SCFA, results also showed signiﬁcant values of valerate in all three
compartments (Khodaei, Fernandez, Fliss, & Karboune, 2016). Formic
acid was detected in the AC compartment reaching values of
2.7–8.0 mM whereas TC and DC presented concentrations below
1.1 mM. Lactic acid production was only detected at fermentation days
with the citrus pectin (1.3, 8.7 and 4.0 mM in ascending, transverse and
descending colon, respectively). Although lactate is not a SCFA, it is
usually considered in the metabolism of bacteria as a product of sac-
charolytic fermentation. Furthermore, valerate has been described as a
primary end product of lactate fermentation (Almeida et al., 2017;
Unger et al., 2016; Yoshikawa et al., 2018).
4. Discussion
Several studies have shown that oligosaccharides deriving from
pectins exert biﬁdogenic activities. Furthermore, there are also studies
that have demonstrated a signiﬁcant growth of bacteria in intact pectins
suggesting a potential role of this polysaccharide as a prebiotic
(Ferreira-Lazarte et al., 2018; Gómez, Gullón, Yáñez, Schols, & Alonso,
2016; Yang, Martínez, Walter, Keshavarzian, & Rose, 2013). In fact, in a
static in vitro study, we have recently shown that either pectin or en-
zymatically-modiﬁed pectin from diﬀerent by-products stimulates
beneﬁcial bacteria of colonic microbiota (Ferreira-Lazarte et al., 2018).
However, no investigation has been carried out on the properties of
pectin as a substrate for fermentation including a previous passage
through the upper gastrointestinal tract. This study remarks, for the
ﬁrst time, the use of the simgi® to evaluate the eﬀect of the upper
gastrointestinal digestion on a commercial citrus pectin and its eﬀect on
colonic microbiota metabolism.
Pectin taken from the stomach compartment showed almost no
changes when compared to the initial status, whereas samples taken
from the small intestine revealed some loss of pectin, 6.5, 15.7 and
14.7% for Day 15, Day 24 and Day 27, respectively. Holloway et al.
(1983) observed a loss of pectin of 15–40 % in an in vivo study with
ileostomy samples. In the same way, Saito et al. (2005) found that
approximately 90% of ingested pectin was recovered in the terminal
ileum in an in vivo study collecting endoscopy retrograde samples.
These studies attributed the loss of pectin to the possible degradation by
bacteria within the digestive tract, especially the terminal ileum.
However, given that in our prototype of digestion the presence of
bacteria is conﬁned to the colon compartments, changes observed in the
Mw of pectin after its passage through the SI could be related to other
chemical eﬀects due to the interaction with pancreatic ﬂuids and bile
salts (Miller, Buchanan, Eastwood, & Fry, 1995).
Regarding the eﬀect of digested pectin on microbiota, results ob-
tained showed that citrus pectin favourably impacts on microbiota
composition and functionality in the three compartments (AC, TC and
Fig. 3. Ammonium evolution (mM) during gastrointestinal digestion of citrus pectin in the simgi®.
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DC) of the simgi® model.
Pectin fermentation produced an increase in the counts of total
bacteria, compared to the initial state, with signiﬁcant increases in the
proximal regions (ascending and transverse colon) probably due to the
content of polysaccharide coming from the small intestine.
Furthermore, high methoxyl pectins, as it is the case of citrus pectin
here assayed, have showed a slower fermentation in the large intestine
of rats, which allows the fermentation to take part in all three
compartments (Dongowski et al., 2002).
According to some authors, increments up to 0.5–1.0 log10 in
Biﬁdobacterium populations could be considered as a major shift in the
gut microbiota towards a potentially healthier composition of intestinal
microbiota (Kolida & Gibson, 2007). Biﬁdobacterium and lactobacilli
have been traditionally considered as the major microbial targets for
prebiotic action, due to their beneﬁcial eﬀects (Roberfroid et al., 2010).
Similar values of Lactobacillus spp and Biﬁdobacterium spp populations
at the end of stabilisation period were observed (Table 2). Increases up
to 2.15–3.12 log10 in Biﬁdobacterium group was determined in all
compartments, being the highest increase of all bacteria determined.
This could be attributed to the high galactose/arabinose content of the
studied pectin (23.8%) (Di et al., 2017; Onumpai et al., 2011). How-
ever, unlike Biﬁdobacterium, Lactobacillus group showed a signiﬁcant
decrease after feeding with citrus pectin. In related studies,
Olano‐Martin, Gibson, & Rastall, (2002) reported that both POS and
citrus pectin signiﬁcantly increased the number of Biﬁdobacteria,
whereas lactobacilli numbers only increased with POS although this
increase was not statistically signiﬁcant. Furthermore, Chen et al.
(2013), showed an increase of Biﬁdobacteria during the in vitro fer-
mentation of apple pectin (DM 70%) and POS, whereas Lactobacillus
population presented no changes or even similar values for pectin
compared to the negative control after 24 h of fermentation. Li, Zhang,
and Yang, (2018) also showed a decrease of Lactobacillus when feeding
rats with pectin extracted from citrus peels in an in vivo study.
Faecalobacterium prausnitzii values reported to be the second highest
increase during the fermentation of pectin in the simulator (2.17–3.03
log10). F. prausnitzii is one of the most abundant commensal bacteria in
the healthy large intestine and is one of the main producers of butyrate
in the human colon (Louis, Scott, Duncan, & Flint, 2007; Louis, Hold, &
Flint, 2014). Furthermore, low F. prausnitzii levels were correlated with
the recurrence of inﬂammatory bowel disease and it has conﬁrmed to
have anti-inﬂammatory eﬀects (Onumpai et al., 2011; Sokol et al.,
2008). Likewise, it has been suggested that this bacterium could be a
good probiotic candidate to counterbalance dysbiosis in Crohn’s disease
patients (Scott, Martin, Duncan, & Flint, 2014; Sokol et al., 2009).
Moreover, previous studies have shown that this bacterium could have
a major role in pectin utilization in comparison with other two abun-
dant pectin-utilizing species, Bacteroides thetaiotaomicron and Eu-
bacterium eligens (Lopez-Siles et al., 2012).
Bacteroides population showed also a high increase being the third
highest increase of all bacteria determined with values of 0.4 – 0.8
log10. Bacteroides are one of the enterotypes of the human microbiota,
which are responsible for the major part of polysaccharide digestion
occurring in the human large intestine (Flint, Scott, Duncan, Louis, &
Forano, 2012; Salazar et al., 2009). In fact, many strains from human
faeces can produce various pectinolytic enzymes, including poly-
galacturonase, pectin methylesterase, extracellular and cell-associated
pectate lyase (Dekker & Palmer, 1981; Jensen & Canale-parola, 1986).
Hence, Bacteroides could be involved in cross-feeding with Biﬁdobacteria
by releasing breakdown products of pectin which might be utilized by
the latter.
Enterococaceae and Enterobacteriaceae groups presented diﬀerent
behaviour compared to the bacteria mentioned before. Signiﬁcant in-
crease were found in the AC for both bacteria during the feeding period
with citrus pectin, whilst TC showed a decrease of Enterococaceae and
no signiﬁcant change for Enterobacteriaceae. Nevertheless, a signiﬁcant
increase in Enterobacteriaceae population was found in DC whereas
stable levels were observed for Enterococaceae after feeding with citrus
pectin.
Concerning the proteolytic and saccharolytic activity of micro-
organisms, SCFA concentrations increased during the chronic feeding
with pectin. Lactic and formic acid were observed in low concentrations
since produced lactic acid is considered to be an intermediate meta-
bolite and can be further metabolized within the colon and turned into
butyric and propionic acids through cross-feeding by gut bacteria
Fig. 4. Evolution in concentration of SCFA in the ascending (AC), transverse
(TC) and descending colon (DC) of the simgi® during the stabilisation (D1-D13),
feeding (D13-D27) and washout period (D27-34) with citrus pectin solution
(3 g/L). 1,2,3 Numbers represent diﬀerences (p<0.05) between the data at the
end of each period.
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(Duncan, Louis, & Flint, 2004; Reichardt et al., 2014). Similarly, formic
acid is used by microorganisms that have a particularly important role
in anaerobic metabolism, via interspecies cross-feeding interactions
(Louis et al., 2014). Results obtained showed an increase for valerate
during the pectin fermentation. Khodaei et al. (2016) also reported a
small amount of valerate when testing a galactose/rhamnose rich
polysaccharide with similar values compared with recognised prebiotic,
such as FOS.
The major end-products of saccharolytic fermentation are acetate,
propionate and butyrate, which have a combined concentration of
50–150mM in the colon (Louis et al., 2014). High levels of SCFA are
desirable since, among other beneﬁts, the corresponding decrease in the
pH values can suppress the growing of pathogenic bacteria. Fig. 4
shows a signiﬁcant high increase of these compounds, being acetate the
major SCFA produced followed by butyric and propionic, respectively.
Given the complexity of the human microbiota, it is challenging to
attribute a particular fermentation end-product to a speciﬁc bacterial
group, however, acetate is typically generated via biﬁdus pathway, and
more speciﬁcally it is a major end-product of Biﬁdobacterium fermen-
tation (Sanz et al., 2005). Thus, the high production of acetate observed
in our study can be ascribed to the growth of Biﬁdobacterium population
in presence of pectin. The high increase of propionate concentrations
after feeding the system with pectin is in good agreement with the in-
crease in Bacteroides population, one of the main propionate-producing
bacteria in the human colon. Propionate has also been shown to exert
beneﬁcial eﬀects such as protective role against carcinogenesis through
the decrease in human colon cancer cell growth (Jan et al., 2002;
Hinnebusch, Meng, Wu, Archer, & Hodin, 2002). In addition, propio-
nate and formate were reported to reduce the activity of E. coli and
Salmonella at pH 5 (Gullón, Gullón, Sanz, Alonso, & Parajó, 2011;
Topping & Clifton, 2001). Signiﬁcant increases in butyrate concentra-
tions were also observed in all three compartments, with the second
highest levels after acetate. F. prausnitzii might utilise apple, citrus and
sugar beet pectin as a source of growth and butyrate formation as
shown by using pure cultures and in vitro models (Chung et al., 2017;
Gómez et al., 2016; Lopez-Siles et al., 2012; Onumpai et al., 2011).
Thus, butyrate levels concur with the high increase of F. prausnitzii
population observed. Furthermore, higher levels of butyrate can also be
explained due to cross-feeding between Biﬁdobacteria and F. prausnitzii
since the latter is able to use the acetate produced by B. adolescentis
thereby boosting butyrate formation (Rios-Covian, Gueimonde,
Duncan, Flint, & De Los Reyes-Gavilan, 2015). Apart from these eﬀects,
butyrate is known to aﬀect several components of the colonic defence
barrier, resulting in enhanced protection against luminal antigens
(Hamer et al., 2008; Havenaar, 2011).
Regarding ammonia concentration, Fig. 3 showed a slight but sig-
niﬁcant decrease in ammonium concentration during the feeding with
citrus pectin. It is noteworthy that lower proteolytic activities are
usually associated with health-promoting eﬀects (Ichikawa & Sakata,
1998), since it can be a potential carcinogenic agent at relatively low
concentrations, as has been shown by the increase in mucosal damage
and colonic adenocarcinoma in a rat model (Louis et al., 2014; Windey,
de Preter, & Verbeke, 2012). A signiﬁcant positive correlation was
observed between SCFA levels and ammonia production where more
acidic conditions favour the excretion of ammonia due to the proto-
nation and formation of poorly absorbed ammonium ion (Louis et al.,
2014).
5. Conclusions
The in vitro study using the dynamic gastrointestinal simulator
simgi® pointed out the high indigestibility of citrus pectin, since a re-
duced hydrolysis (∼12%) was detected in the upper gastrointestinal
tract (ST and SI), being mainly due to chemical interactions with pan-
creatic ﬂuids and bile salts. Findings also highlight the important role
played by pectin in stimulating beneﬁcial bacteria such as
Biﬁdobacteria, F. prausnitzii and Bacteroides (especially in the ﬁrst two
bacterial groups). A high increase in acetate, propionate and butyrate
concentration was observed due to fermentation of pectin by the mi-
crobiota but also to cross-feeding interactions between diﬀerent bac-
teria. Increase in SCFA also produced a decrease in ammonia con-
centration, which is associated with health-promoting eﬀects. This is
the ﬁrst study of gastrointestinal digestion and fermentation of pectin in
a dynamic gastrointestinal simulator and, although further in vivo stu-
dies should be conducted, the data obtained conﬁrmed the potential of
pectin to be considered shortly as emergent prebiotics with a possible
use for human consumption.
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